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Wednesday 7:30 pm 1  Stem Cells and Early Developmental 
Decisions 
   
Thursday 9:00 am 2  Regulation of Immune Cell Development 
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Saturday 9:00 am 8  Regulation of Immune Cell Function I 
   
Saturday 2:00 pm 9  Regulation of Immune Cell Function II 
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Sunday 9:00 am 10  Innate Immunity 
 
Poster sessions are located in Bush Lecture Hall 
* Airslie Lawn, weather permitting 
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PROGRAM 
 
 
WEDNESDAY, April 21—7:30 PM 
 
 
SESSION 1 STEM CELLS AND EARLY DEVELOPMENTAL 
DECISIONS 
 
Chairperson: S. Smale, UCLA School of Medicine, Los Angeles,  
  California 
 
 
Regulation of hematopoietic stem cell differentiation and 
transformation by the ubiquitin system 
Linsey Reavie, Jie Gao, Shannon Buckley, Kelly Crusio, Iannis Aifantis. 
Presenter affiliation: Howard Hughes Medical Institute and NYU School 
of Medicine, New York, New York.  
 
 
 
 
1 
  
p53-mediated hematopoietic stem cell competition 
Ruslan Medzhitov.  
Presenter affiliation: HHMI, Yale University Medical School, New 
Haven, Connecticut.  
 
 
 
2 
  
NKAP is required for adult HSC maintenance and survival 
Anthony Pajerowski, Michael Shapiro, Kim Gwin, Rhianna Sundsbak, 
Molly Nelson-Holte, Kay Medina, Virginia Shapiro.  
Presenter affiliation: University of Pennsylvania, Philadelphia, 
Pennsylvania.  
 
 
 
 
3 
  
Reprogramming of T cells to natural killer-like cells upon Bcl11b 
deletion 
Peng Li, Shannon A. Burke, Juexuan Wang, Xiongfeng Chen, Dong 
Lu, Gordon Dougan, Brian Huntly, Bertie Gottgens, Nancy A. Jenkins, 
Neal G. Copeland, Francesco Colucci, Pentao Liu.  
Presenter affiliation: Wellcome Trust Sanger Institute, Cambridge, 
United Kingdom.  
 
 
 
 
 
 
4 
  
Selective functions of the modulatory DNA-binding zinc fingers of 
Ikaros 
Hilde Schjerven, Sarah Wadsworth, Steven Bensinger, Stephen T. 
Smale.  
Presenter affiliation: UCLA, Los Angeles, California.  
 
 
 
 
5 
  
 vi 
Genetic relationship between the classical and plasmacytoid 
dendritic cell lineages 
Boris Reizis, Hiyaa S. Ghosh, Anna Bunin, Kanako L. Lewis, Babacar 
Cisse.  
Presenter affiliation: Columbia University, New York, New York.  
 
 
 
 
6 
  
Identification of Hoxa9 target genes in lympho-hematopoietic 
progenitors 
Kay L. Medina, Kimberly Gwin.  
Presenter affiliation: Mayo Clinic, Rochester, Minnesota.  
 
 
 
7 
  
PU. 1 controls dendritic cell and plasma cell development through 
distinct mechanisms 
Sebastian Carotta, Jhagvaral Hasbold, Aleksander Dakic, Angela 
D’Amico, Phil Hodgkin, Lynn Corcoran, Li Wu, Stephen Nutt.  
Presenter affiliation: The Walter and Eliza Hall Institute, Parkville, 
Australia.  
 
 
 
 
 
8 
 
 
THURSDAY, April 22—9:00 AM 
 
 
SESSION 2 REGULATION OF IMMUNE CELL DEVELOPMENT 
 
Chairperson: M. Schlissel, University of California, Berkeley 
 
  
The molecular mechanism of Aire 
Jakub Abramson, Matthieu Giraud, Christophe Benoist, Diane Mathis.  
Presenter affiliation: Harvard Medical School, Boston, Massachusetts.  
 
 
9 
  
Promiscuous expression of tissue-restricted antigens in thymic 
medullary epithelial cells: selection and regulation 
Bruno Kyewski, Benedikt Brors, Sheena Pinto.  
Presenter affiliation: German Cancer Research Center, Heidelberg, 
Germany.  
 
 
 
 
10 
  
Cis- and trans-acting factors involved in initiating ThPOK 
expression 
Sawako Muroi, Hirokazu Tanaka, Chizuko Miyamoto, Ichiro Taniuchi.  
Presenter affiliation: RIKEN, RCAI, Yokohama, Japan.  
 
 
 
11 
  
 vii 
BATF family AP-1 transcription factors regulate immune lineage 
decisions 
Kenneth M. Murphy, Kai Hildner, Barbara Schraml, Brian Edelson, 
Wataru Ise, Masako Kohyama-Ise, Jorn Albring, Wumesh KC, Ansu 
Satpathy, Wan-Lin Lee, Mona Mashayehki, Michelle Sandau, Theresa 
Murphy.  
Presenter affiliation: Washington University School of Medicine, St. 
Louis, Missouri.  
 
 
 
 
 
 
 
12 
  
Gfi-1b negatively regulates RAG expression in v-Abl transformed 
pro-B cells 
Mark S. Schlissel, Danae Schulz, Lothar Vassen, Ehssan Sharif-
Askari, Tarik Moroy.  
Presenter affiliation: University of California-Berkeley, Berkeley, 
California.  
 
 
 
 
 
13 
  
Regulation of B lymphopoiesis by transcription factor EBF 
Ildiko Györy, Thomas Treiber, Elizabeth Mandel, Robert Nechanitzky, 
Rudolf Grosschedl.  
Presenter affiliation: Max Planck Institute of Immunobiology, Freiburg, 
Germany.  
 
 
 
 
14 
  
The BTB/POZ domain protein Miz-1 (Zbtb17) controls IL-7 
receptor signaling at commitment stages of B cell differentiation 
by regulating expression of Bcl-2 and the Jak inhibitor SOCS1 
Christian Kosan, Ingrid Saba, Tarik Moroy.  
Presenter affiliation: Institut de Recherches Cliniques de Montreal 
IRCM, Montreal, Canada; Université de Montreal, Montreal, Canada.  
 
 
 
 
 
15 
  
Control of B cell development and IgH recombination by Pax5 
Anja Ebert, Shane McManus, Hiromi Tagoh, Jasna Medvedovic, 
Markus Jaritz, Meinrad Busslinger.  
Presenter affiliation: Research Institute of Molecular Pathology, 
Vienna, Austria.  
 
 
 
 
16 
  
Genetic and epigenetic repression of the Igκ intronic enhancer by 
STAT 5 
Malay Mandal, Sarah Powers, Barbara Kee, Marcus R. Clark.  
Presenter affiliation: University of Chicago, Chicago, Illinois.  
 
 
 
17 
 
 
 viii 
THURSDAY, April 22—2:00 PM 
 
 
SESSION 3 POSTER SESSION I 
 
  
E2A and CBP/p300 act in synergy to promote chromatin 
accessibility of the immunoglobulin κ locus in nonlymphoid cells 
Yasutoshi Agata.  
Presenter affiliation: Kyoto University, Kyoto, Japan.  
 
 
 
18 
  
Modulation of FasL and activation-induced cell death (AICD) of T 
cells by imiquimod 
Maíra M. Sant'Anna Pernavia, Ricardo Weinlich, Júlia C. Campopiano, 
Welbert O. Pereira, Gustavo P. Amarante-Mendes.  
Presenter affiliation: Universidade de Sao Paulo, Sao Paulo, Brazil.  
 
 
 
 
19 
  
Dual function of the Polycomb group proteins in differentiated T 
helper cells 
Eyal Jacob, Reut Hod-Dvorai, Or Lea Ben-Mordechai, Yulia Boyko, 
Orly Avni.  
Presenter affiliation: Technion/Medical School, Haifa, Israel.  
 
 
 
 
20 
  
Dual role of BCL11B in iNKT development in controlling 
glycolipid presentation by DP thymocytes and early iNKT 
progenitors 
Diana I. Albu, Jeff VanValkenburgh, Nicole Morin, Nancy A. Jenkins, 
Neal G. Copeland, Pentao Liu, Dorina Avram.  
Presenter affiliation: Albany Medical College, Albany, New York.  
 
 
 
 
 
21 
  
Mycobacterium bovis BCG induced expression of 
cyclooxygenase-2 involves nitric oxide dependent and 
independent signaling pathways 
Kushagra Bansal, Yeddula Narayana, Nisha Kapoor, Shripad A. Patil, 
Germain Puzo, Martine Gilleron, Kithiganahalli N. Balaji.  
Presenter affiliation: Indian Institute of Science, Bangalore, India.  
 
 
 
 
 
22 
  
Class switch recombination requires histone chaperone FACT 
assisted chromatin assembly of IgH locus 
Andre Stanlie, Nasim A. Begum, Tasuku Honjo.  
Presenter affiliation: Kyoto University, Kyoto, Japan.  
 
 
 
23 
  
 ix 
Redundant and specific roles of NFAT transcription factors in 
generation and function of dendritic cells 
Martin Vaeth, Stefan Klein-Hessling, Andris Avots, Manfred Lutz, 
Edgar Serfling, Friederike Berberich-Siebelt.  
Presenter affiliation: University of Wuerzburg, Wuerzburg, Germany.  
 
 
 
 
24 
  
A role for E-box binding transcriptional repressor Zeb2 in the 
CD8+ T-cell response to infection 
John A. Best, Eve Seuntjens, Danny Heulebroeck, Ananda W. 
Goldrath.  
Presenter affiliation: University of California, San Diego, La Jolla, 
California.  
 
 
 
 
 
25 
  
High affinity carbohydrate and non-carbohydrate ligands for 
lectin-type activation receptors of natural killer cells regulate 
effector function through PI3K pathway, and generate permanent 
immune protection against melanomas 
Veronika Benson, Valeria Grobárová, Katarína Hulíková, Jan Svoboda, 
Daniel Rozbeský, Daniel Kavan, Alan Kádek, David Adámek, Karel 
Krenek, Anna Fišerová, Vladimir Kren, Karel Bezouška.  
Presenter affiliation: Institute of Microbiology and Charles University, 
Prague, Czech Republic.  
 
 
 
 
 
 
 
 
26 
  
The PPE protein Rv1168c of Mycobacterium tuberculosis 
activates transcription of HIV-1 LTR promoter via binding to Toll 
Like Receptor 2 
Khalid H. Bhat, Akhilesh D. Pandey, Nooruddin Khan, Sangita 
Mukhopadhyay.  
Presenter affiliation: Centre for DNA Fingerprinting and Diagnostics, 
Hyderabad, India.  
 
 
 
 
 
 
27 
  
IRF-5 regulates plasmacytoid dendritic cell colonization of 
peripheral tissues 
Deepta Bhattacharya, Whitney E. Purtha, Michael S. Diamond.  
Presenter affiliation: Washington University School of Medicine, Saint 
Louis, Missouri.  
 
 
 
 
28 
  
Alternative end-joining catalyzes class switch Recombination, 
intra-switch deletions and chromosomal translocations in the 
absence of both Ku70 and DNA ligase 4 
Cristian Boboila, Catherine T. Yan, Duane R. Wesemann, Mila 
Jankovic, Jing H. Wang, Tingting Zhang, Alex Fazeli, Lauren Feldman, 
John Manis, Andre Nussenzweig, Michel Nussenzweig, Frederick W. 
Alt.  
Presenter affiliation: Howard Hughes Medical Institute, Children's 
Hospital and Harvard Medical School, Boston, Massachusetts.  
 
 
 
 
 
 
 
 
29 
 x 
Flt3L mediated dendritic cell homeostasis during steady state and 
in immunological stress conditions 
Sekhar Boddupalli, Dior Kingston, Christian Mayer, Tim Sparwasser, 
Markus G. Manz.  
Presenter affiliation: University Hospital, Zurich, Switzerland.  
 
 
 
 
30 
  
Histone demethylase KDM5A is an integral part of the core Notch-
RBP-J repressor complex 
Tilman Borggrefe, Franz Oswald, Dolores Ferres-Marco, Cristobal 
Alvarado, Gerhard Mittler, Patrick Rodriguez, Maria Dominguez, 
Robert Liefke.  
Presenter affiliation: Max-Planck-Institute, Freiburg, Germany.  
 
 
 
 
 
31 
  
Cell intrinsic E47 is required for stem cell self-renewal and 
differentiation but is dispensable for short-term myeloid 
development 
Qi Yang, Brandt Esplin, Lisa Borghesi.  
Presenter affiliation: University of Pittsburgh, Pittsburgh, Pennsylvania.  
 
 
 
 
32 
  
Vitamin D receptor gene 3’ methylation is influenced by ethnicity 
and TaqI genotype—Possible impact on tuberculosis 
susceptibility 
Charlene Andraos, Gerrit Koorsen, Liza Bornman.  
Presenter affiliation: University of Johannesburg, Johannesburg, South 
Africa.  
 
 
 
 
 
33 
  
CTCF and cohesin organize the MHC-II locus and regulate the 
expression of human MHC-II genes 
Jeremy M. Boss, Parimal Majumder.  
Presenter affiliation: Emory University, Atlanta, Georgia.  
 
 
 
34 
  
Contributions of the transcription factors Gata3 and Thpok to the 
establishment and maintenance of CD4-lineage differentiation.  
Lie Wang, Yumei Xiong, Kathryn Wildt, Ehydel Castro, Rémy Bosselut.  
Presenter affiliation: Center for Cancer Research, NCI, NIH, Bethesda, 
Maryland.  
 
 
 
 
35 
  
Investigating Dicer functions in VDJ recombination and repair 
Brenna L. Brady, Craig H. Bassing.  
Presenter affiliation: University of Pennsylvania and Children's Hospital 
of Philadelphia, Philadelphia, Pennsylvania.  
 
 
 
36 
  
 xi 
Cyclin D2 incompletely overlaps with cyclin D3 in the antibody 
response and is essential for synergistic cell cycle control by 
BAFF and IL-4 
Jamieson C. Bretz, Catherine Sawai, Xiangao Huang, Iannis Aifantis, 
Selina Chen-Kiang.  
Presenter affiliation: Weill Medical College of Cornell University, New 
York, New York.  
 
 
 
 
 
 
37 
  
A novel role for the TRAFs as co-activators and co-repressors of 
transcriptional activity 
George C. Brittain, IV, John R. Bethea.  
Presenter affiliation: University of Miami Miller School of Medicine, 
Miami, Florida; MD Anderson Cancer Center, Houston, Texas.  
 
 
 
 
38 
  
Regulation of basal and inducible expression of the 
transcriptional co-activator BOB. 1/OBF. 1 in B versus T cells 
Kerstin Müller, Jasmin Quandt, Melanie Kilzheimer, Thomas Wirth, 
Cornelia Brunner.  
Presenter affiliation: University Ulm, Ulm, Germany.  
 
 
 
 
39 
  
TNFR:TNFR-ligand interactions drive CD8 T cell clonal 
competition 
Matthew A. Burchill, Jonathan S. Kurche, Phillip J. Sanchez, Philippa 
Marrack, Ross M. Kedl.  
Presenter affiliation: National Jewish Health, Denver, Colorado.  
 
 
 
 
40 
  
NF-κB signaling cooperates with cMyc to induce B-cell 
transformation and multiple myeloma 
Dinis P. Calado, Baochun Zhang, Yoshiteru Sasaki, Thomas 
Wunderlich, Marc Schmidt-Supprian, Klaus Rajewsky.  
Presenter affiliation: Immune Disease Institute, Harvard Medical 
School, Boston, Massachusetts.  
 
 
 
 
 
41 
  
Role of miR-142 function in the hematopoietic system 
Tirtha Chakraborty.  
Presenter affiliation: Harvard Medical School, Boston, Massachusetts.  
 
 
42 
  
De novo synthesis of truncated Notch1 receptor proteins in 
Ikaros-deficient leukemic T cells using a cryptic intragenic 
promoter 
Robin Jeannet, Jérôme Mastio, Alejandra Macias Garcia, Todd 
Ashworth, Freddy Radtke, Jon C. Aster, Philippe Kastner, Susan 
Chan.  
Presenter affiliation: Institut de Génétique et de Biologie Moléculaire et 
Cellulaire (IGBMC), Illkirch, France.  
 
 
 
 
 
 
 
43 
  
 xii 
Repression of Tcrb recombination at the nuclear lamina 
Elizabeth Chan, Michael S. Krangel.  
Presenter affiliation: Duke University Medical Center, Durham, North 
Carolina.  
 
 
 
44 
  
Interferon regulatory factor-5 activation in innate immune 
signaling 
Hui-Chen J. Chang, Sarah Van Scoy, Tsu-Fan Cheng, Nancy C. C. 
Reich.  
Presenter affiliation: Stony Brook University, Stony Brook, New York.  
 
 
 
 
45 
  
Interleukin-23 production in dendritic cells is negatively regulated 
by protein phosphatase 2A 
JiHoon Chang, Timothy J. Voorhees, Yusen Liu, Cheong-Hee Chang.  
Presenter affiliation: University of Michigan, Ann Arbor, Michigan.  
 
 
 
46 
  
Selective gene activation by the NF-κB family of transcription 
factors 
Abraham B. Chang, Kevin J. Williams, Christine A. Hong, Kaylin T. 
Nguyen, Joseph T. Rodrigues, Stephen T. Smale.  
Presenter affiliation: University of California, Los Angeles, Los 
Angeles, California.  
 
 
 
 
 
47 
  
Dynamic changes in transcription factor binding at 3' regulatory 
region (3'RR) of immunoglobulin heavy chain locus during B cell 
activation 
Sanjukta Chatterjee, Barbara K. Birshtein.  
Presenter affiliation: Albert Einstein College of Medicine, Bronx, New 
York.  
 
 
 
 
 
48 
  
Sustained expression of miR-155 in hematopoietic progenitor 
cells causes a myeloproliferative disorder in mice via repression 
of the Ship1 phosphatase 
Aadel A. Chaudhuri, Ryan M. O'Connell, Dinesh S. Rao, David 
Baltimore.  
Presenter affiliation: Caltech, Pasadena, California.  
 
 
 
 
 
49 
  
Epigenetic regulation of Tcra gene recombination in developing T 
cells 
Julie Chaumeil, Kristen Johnson, Susannah L. Hewitt, Craig H. 
Bassing, Michael Farrar, Michel C. Nusseinzweig, David G. Schatz, 
Jane A. Skok.  
Presenter affiliation: New York Unviversity School of Medicine, New 
York, New York.  
 
 
 
 
 
 
50 
  
 xiii 
Nuclear transport dynamics of STAT6 
Hui-Chen Chen, Nancy C. Reich.  
Presenter affiliation: Stony Brook University, Stony Brook, New York.  
 
 
51 
  
Akt is required for NF-κB-dependent TNF-α production 
Jing Cheng, Lawrence P. Kane.  
Presenter affiliation: University of Pittsburgh, Pittsburgh, Pennsylvania.  
 
 
52 
  
p18INK4c orchestrates homeostatic cell cycle control of plasma 
cell differentiation in rapidly cycling and apoptotic precursors 
Jamieson C. Bretz, Josefina Garcia, Lin Kang, Xiangao Huang, Kai-
Michael Toellner, Selina Chen-Kiang.  
Presenter affiliation: Weill Medical College of Cornell University, New 
York, New York.  
 
 
 
 
 
53 
  
Defining principles of chromosomal translocations in lymphoid 
cells 
Monica Gostissa, Frederick W. Alt, Darienne Myers, Susanna Lewis, 
Roberto Chiarle.  
Presenter affiliation: Immune Disease Institute, Harvard Medical 
School and Children's Hospital, Boston, Massachusetts; University of 
Torino, Torino, Italy.  
 
 
 
 
 
 
54 
  
The ADP-ribosyltransferase PARP-14 mediates IL-4-induced 
survival signaling in B cells by orchestration of a coordinate 
metabolic response 
Sung Hoon Cho, Mark Boothby.  
Presenter affiliation: Vanderbilt University, Nashville, Tennessee.  
 
 
 
 
55 
  
Berberine inhibits LPS-induced NO production possibly due to 
the activation of AKT pathway in RAW 264. 7 cells 
Hye Eun Choi, Nam-In Baek, Kyung-Tae Lee.  
Presenter affiliation: Kyung Hee University, Seoul, South Korea.  
 
 
 
56 
  
Genetic regulation of human effector vs central memory cytotoxic 
lymphocyte generation by IL-12 and IFN-α 
Fatema Z. Chowdhury, Hilario J. Ramos, Laurie Davis, J. David Farrar.  
Presenter affiliation: The University of Texas Southwestern Medical 
Center, Dallas, Texas.  
 
 
 
 
57 
  
 xiv 
The activated Ras/MEK/ERK pathway reduces the anti-viral 
Interferon- response by inhibiting gene transcription of multiple 
Interferon- responsive genes 
Sherri L. Christian, Yumiko Komatsu, Maria Licursi, Kensuke 
Hirasawa. 
Presenter affiliation: Memorial University of Newfoundland, St. John’s 
Canada. 
 
 
 
 
 
 
58 
  
Stomatin-like protein 2 recruits prohibitins to cardiolipin-enriched 
microdomains and regulates mitochondrial biogenesis during T 
cell activation 
Darah A. Christie, C. D. Lemke, I. Elias, L. A. Chau, M. G. Kirchhof, B. 
Li, E. H. Ball, S. D. Dunn, G. M. Hatch, J. Madrenas.  
Presenter affiliation: University of Western Ontario, London, Canada.  
 
 
 
 
 
59 
  
Pax5 and its downstream effector CD19 are major positive 
regulators of c-Myc protein levels.  
Elaine Y. Chung, Andrei Thomas-Tikhonenko.  
Presenter affiliation: University of Pennsylvania and Children's Hospital 
of Philadelphia, Philadelphia, Pennsylvania.  
 
 
 
 
60 
  
Transcription factor network regulating CD4+ T helper 17 lineage 
differentiation 
Maria Ciofani, Kim Newberry, Preti Jain, Jason Gertz, Francis Kirigin, 
Richard M. Myers, Dan R. Littman.  
Presenter affiliation: New York University School of Medicine, New 
York, New York.  
 
 
 
 
 
61 
  
Epigenetic regulation of the human IL-3/GM-CSF locus during T 
cell development 
Fabio Mirabella, Euan Baxter, Sarion Bowers, Marjorie Boissinot, Sally 
James, Peter Cockerill.  
Presenter affiliation: Leeds Institute of Molecular Medicine, Leeds, 
United Kingdom.  
 
 
 
 
 
62 
  
Heterogeneity of human IL-22-producing CD4+ T cells 
Maryaline Coffre, Katarzyna Placek, Sylvie Maiella, Elisabetta Bianchi, 
Lars Rogge.  
Presenter affiliation: Institut Pasteur, Paris, France.  
 
 
 
63 
  
 xv 
Modular regulation of transcriptional changes induced by alveolar 
transmigration of human neutrophils 
Christopher D. Coldren, Jerry A. Nick, Michael G. Edwards, Brian W. 
Fouty, James M. O'Brien, Martin R. Zamora, Jong Sung Park, Edward 
Abraham, Mark W. Geraci.  
Presenter affiliation: University of Colorado School of Medicine, 
Aurora, Colorado.  
 
 
 
 
 
 
64 
  
Functional analysis of PP2A inhibitor protein CIP2A in 
lymphocyte development and immune system response 
Christophe Côme, Kaisa Auvinen, Rafael Casellas, Jukka 
Westermarck.  
Presenter affiliation: Centre for Biotechnology, Turku, Finland.  
 
 
 
 
65 
  
Control of IL-6 expression in B cells by octamer binding factors 
Alexander Karnowski, Gabrielle Belz, Dianne Emslie, Kathy D'Costa, 
Lynn M. Corcoran.  
Presenter affiliation: The Walter and Eliza Hall Institute, Parkville, 
Australia.  
 
 
 
 
66 
  
The SRF network in thymocyte selection 
P. S. Costello, A. Mylona, R H. Nicolas, M J. Sargent, D. Daegalen, D. 
Tuil, A. Nordheim, B. Wasylyk, R. Treisman.  
Presenter affiliation: Cancer Research UK, London, United Kingdom.  
 
 
 
67 
  
Autoreactive T cell responses against oxidative stress-induced 
modifications of self antigens 
Fernando Cruz-Guilloty, Jose J. Echegaray, Robert G. Salomon, Victor 
L. Perez.  
Presenter affiliation: Bascom Palmer Eye Institute, Miami, Florida; 
University of Miami Miller School of Medicine, Miami, Florida.  
 
 
 
 
 
68 
  
Ontogeny and epigenetic regulation of promiscuous gene 
expression—Evidence for fluctuating gene expression 
Jens Derbinski, Anna Sinemus, Lars-Oliver Tykocinski, Bruno Kyewski.  
Presenter affiliation: German Cancer Research Center, Heidelberg, 
Germany.  
 
 
 
 
69 
  
Critical role for RAG2 in suppressing V(D)J recombination-driven 
thymic lymphoma 
Ludovic Deriano, Julie Chaumiel, Asha Multani, Sandy Chang, Jane 
Skok, David Roth.  
Presenter affiliation: New York University School of Medicine, New 
York, New York.  
 
 
 
 
 
70 
  
 xvi 
Monocyte hetergeneity and c-Maf dependent M. tuberculosis 
growth in human Mycobacterium tuberculosis-infection 
Rohan Dhiman, Peter F. Barnes, Sudipto Saha, Amy Tvinnereim, 
Anuradha Bandaru, Padmaja Paidipally, Vijayalaxmi Valluri, 
Ramakrishna Vankayalapati.  
Presenter affiliation: UTHSCT, Tyler, Texas.  
 
 
 
 
 
71 
  
The novel signaling mechanism of TCR induced T cell activation 
Marc-Werner Dobenecker, Alexander Tarakhovsky.  
Presenter affiliation: The Rockefeller University, New York, New York.  
 
 
72 
  
Altered metabolic flux and T cell survival 
Andrew L. Doedens, Randall S. Johnson, Ananda W. Goldrath.  
Presenter affiliation: University of California, San Diego, La Jolla, 
California.  
 
 
 
73 
  
Flt3 signaling regulates the differentiation and survival of 
multipotent lymphohematopoietic progenitors 
Joseph J. Dolence, Kimberly Gwin, Elena Frank, Kay L. Medina.  
Presenter affiliation: College of Medicine, Mayo Clinic, Rochester, 
Minnesota.  
 
 
 
 
74 
  
USP8 controls T-cell development and immune homeostasis 
Almut Dufner, Agnes Kisser, Sandra Niendorf, Anja Basters, Christoph 
Loddenkemper, Marco Prinz, Klaus-Peter Knobeloch.  
Presenter affiliation: University Clinic, Freiburg, Germany.  
 
 
 
75 
  
The transcription factor AP4 modulates epigenetic Cd4 silencing 
Takeshi Egawa, Dan R. Littman.  
Presenter affiliation: NYU School of Medicine, New York, New York; 
Washington University, St. Louis, Missouri.  
 
 
 
76 
  
The zinc finger protein MAZR is part of the transcription factor 
network that regulates CD4/CD8 cell fate decision of DP 
thymocytes 
Shinya Sakaguchi, Matthias Hombauer, Ivan Bilic, Yoshinori Naoe, 
Alexandra Schebesta, Ichiro Taniuchi, Wilfried Ellmeier.  
Presenter affiliation: Medical University of Vienna, Vienna, Austria.  
 
 
 
 
 
77 
  
Control of interferon expression and antiviral response by 
dynamic histone H3 methylation 
Terry C. Fang, Marie S. Chen, Ingrid Mecklenbrauker, Astrid Stienen, 
Uwe Schaefer, Alexander Tarakhovsky.  
Presenter affiliation: The Rockefeller University, New York, New York.  
 
 
 
 
78 
  
 xvii 
Role of the CTCF/cohesin complex in V(D)J rearrangement 
Stephanie C. Degner, Timothy P. Wong, Roy Riblet, Yin Lin, Cornelis 
Murre, Ann J. Feeney.  
Presenter affiliation: The Scripps Research Institute, La Jolla, 
California.  
 
 
 
 
79 
  
Co-expression of the Epstein-Barr viral proteins LMP1 and 
LMP2A, mimicking constitutively active forms of CD40 and BCR, 
does not lead to B cell transformation 
Petra Fiedler, Julia. Rastelli, Ursula Zimber-Strobl.  
Presenter affiliation: Helmholtz Center Munich, Munich, Germany.  
 
 
 
 
80 
  
Temporal differences in the dependency on phosphoinositide 
dependent kinase 1 distinguish the development of Vα14 iNKT 
cells, regulatory T cells and conventional T cells 
David K. Finlay, April P. Kelly, Rosemary Clarke, Maria Deak, Dario R. 
Alessi, Doreen A. Cantrell.  
Presenter affiliation: University of Dundee, Dundee, United Kingdom.  
 
 
 
 
 
81 
  
Mzb1 regulates innate B cell functions by modulating calcium 
homeostasis and integrin activation 
Henrik Flach, Marc Rosenbaum, Shenyuan L. Zhang, Michael D. 
Cahalan, Gerhard Mittler, Rudolf Grosschedl.  
Presenter affiliation: Max Planck Institute of Immunobiology, Freiburg, 
Germany.  
 
 
 
 
 
82 
  
Extracellular autoregulation by IL-2 in T-cell activation—A time to 
cooperate, a time to compete 
Nir Waysbort, Yonatan Savir, Yaron Antebi, Tsvi Tlusty, Nir Friedman.  
Presenter affiliation: Weizmann Institute of Science, Rehovot, Israel.  
 
 
 
 
83 
  
Targeting of AID-mediated sequence diversification to 
immunoglobulin gene loci 
Naga Rama Kothapalli, Kaitlin M. Reilly, Darrell D. Norton, Sebastian 
D. Fugmann.  
Presenter affiliation: NIA, National Institutes of Health, Baltimore, 
Maryland.  
 
 
 
 
 
84 
  
Essential roles for the RNA binding proteins Tis11B and Tis11D in 
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Grace Auditorium 
 
The Carducci String Quartet 
Michelle Fleming, violin  /  Matthew Denton, violin  /  Emma Denton, cello  
/  Eoin Schmidt-Martin, viola 
 
 
 The Carducci Quartet is recognised as one of today’s most exciting young 
string quartets. Based in the UK, the quartet holds residencies at Trinity College 
of Music in London, Cardiff University and at the Cork School of Music in Ireland. 
The 2009-2010 season will see the quartet perform over 90 concerts worldwide, 
including performances at London’s Wigmore Hall and Washington’s Library of 
Congress. European tours include multiple stops in Spain, Portugal, Denmark, 
France and throughout the UK, including their own festival in Highnam. In 2009 
the quartet will also embark on debut tours of South America and Australia as 
well as engagements in North America including New York, Philadelphia, Santa 
Rosa, Los Angeles and Eureka. 
 xlvi 
Winners of the Concert Artists Guild Competition in New York, the Kuhmo 
International Chamber Music Competition and major prizes at the Bordeaux, 
London and Osaka competitions, the Anglo-Irish Carducci quartet has 
established an enthusiastic international following. The Quartet was short-listed 
for the 2008 Royal Philharmonic Society Chamber Music Award and has recently 
collaborated with such internationally renowned musicians as Nicholas Daniel, 
Julius Drake, Graham Oppenheimer, Charles Owen, Kazuki Sawa, Julian Bliss, 
Simon Rowland-Jones, James Gilchrist and Patricia Rosario. Other highlights 
include appearances at Carnegie Hall, the Verbier, West Cork and Wratislavia 
Cantans Festivals, an Aldeburgh residency, broadcasts for BBC Radio 3, RTE 
Lyric FM and BBC television, a cycle of the complete Bartok quartets and a 
Naxos recording of the Philip Glass quartets. 
 They have received wide critical acclaim for recordings on their own record 
label 'Carducci Classics', launched with a CD of Haydn String Quartets. Two 
world premiere recordings featuring C20th works by G. Whettam ('recording of 
the month' MusicWeb International) and J. Horovitz (‘beautifully crafted 
works…excellent performances’, BBC Music Magazine) were released in 2008. 
The complete quartets by Irish composer Brian Boydell was released this year, 
presented with funding from the Music Network/ Arts Council of Ireland 
Recording Scheme. The Carduccis have also recorded (Vivaldi and Piazzolla) 
with the Katona Twins Guitar Duo for Channel Classics. 
 The quartet has gained an enviable reputation for their performances of 
contemporary works and this season, the quartet will premiere new commissions 
from David Matthews, Adrian Williams, Simon Rowland Jones and Huang Ruo 
and will perform in the ‘New Music, New Places’ series, New York.They have 
also performed to great acclaim the works of Peter Maxwell-Davies, Anthony 
Powers, Michael Zev-Gordon and Joe Duddell, amongst others. The quartet has 
embraced collaborations with other disciplines, working alongside the Henri 
Oguike and Random Dance companies and with the renowned Sarod player 
Wajahat Kahn. 
 The Carducci Quartet’s international engagements have taken them to the 
USA, Japan and throughout Europe, including Italy, where after performing 
numerous concerts at the Castagnetto-Carducci Festival in 1997 the quartet 
adopted the name “Carducci” with the blessing of the Mayor. The quartet studied 
with members of the Amadeus, Alban Berg, Chilingirian, Takacs and Vanbrugh 
quartets and, as part of the ProQuartet professional training programme in 
France, studied with Gyorgy Kurtag, Walter Levin and Paul Katz. 
 The quartet are passionate about taking classical music to the next 
generation and run chamber music courses for young musicians in the UK, 
France and Ireland. Their educational work continues with performances for 
school children supported by their own trust, The Carducci Music Trust, the 
Cavatina Chamber Music Trust and West Cork Music. They also regularly coach 
on the National Youth String Quartet Weekend, run by the London String Quartet 
Foundation at Chetham’s School of Music. The Carducci Quartet gratefully 
acknowledges the support of the Coln Trust. 
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SESSION 10 INNATE IMMUNITY 
 
Chairperson: S. Ghosh, Columbia University College of Physicians  
& Surgeons, New York, New York 
 
  
TLR signaling is required for virulence of an intracellular 
pathogen 
Gregory M. Barton, Nicholas Arpaia, Jernej Godec, Laura Lau.  
Presenter affiliation: University of California, Berkeley, Berkeley, 
California.  
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TLR4 signaling regulates macrophage bactericidal activity 
through mitochondrial reactive oxygen species production 
Phillip West, Sankar Ghosh.  
Presenter affiliation: Columbia University, New York, New York.  
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Toll-like receptor activation of XBP1 regulates innate immune 
responses in macrophages 
Fabio Martinon, Xi Chen, Ann-Hwee Lee, Laurie H. Glimcher.  
Presenter affiliation: Harvard School of Public Health, Boston, 
Massachusetts; Harvard Medical School, Boston, Massachusetts.  
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DSIF controls the duration of NF-κB signaling by coordinating 
elongation with mRNA processing of negative feedback genes 
Gil Diamant, Liat Amir, Rivka Dikstein.  
Presenter affiliation: Weizmann Institute of Science, Rehovot, Israel.  
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The role of locus positioning in the regulation of cytokine gene 
expression 
Richard Flavell.  
Presenter affiliation: Yale University School of Medicine, New Haven, 
Connecticut. 
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Characterization of a cryptic cyclophilin A-dependent innate 
signaling pathway in HIV-1 infected dendritic cells 
Nicolas Manel, Brandon Hogstad, Jaming Wang, David E. Levy, Dan 
R. Littman.  
Presenter affiliation: New York University, New York, New York.  
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 xlviii 
MSKs act as negative regulators of innate immunity 
Simon Arthur, Olga Ananieva, Joanne Darragh, Suzanne Elcombe, 
Claire Monk.  
Presenter affiliation: MRC Protein Phosphorylation Unit, Dundee, 
United Kingdom.  
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Identification of the organizational principles of enhancers 
controlling inflammatory gene expression in macrophages 
Serena Ghisletti, Iros Barozzi, Flore Mietton, Sara Polletti, Francesca 
De Santa, Elisa Venturini, Lorna Gregory, Lorne Lonie, Jiannis 
Ragoussis, Adeline Chew, Chia-Lin Wei, Gioacchino Natoli.  
Presenter affiliation: European Institute of Oncology (IEO), Milan, Italy.  
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 1 
REGULATION OF HEMATOPOIETIC STEM CELL 
DIFFERENTIATION AND TRANSFORMATION BY THE UBIQUITIN 
SYSTEM 
 
Linsey Reavie, Jie Gao, Shannon Buckley, Kelly Crusio, Iannis Aifantis  
 
Howard Hughes Medical Institute and NYU School of Medicine, 
Department of Pathology, 550, 1st Avenue, New York, NY, 10016 
 
Differentiation and self-renewal of hematopoietic stem cells (HSC) is 
controlled by an orchestrated integration of bone marrow environmental 
cues. Although much is known about the transcriptional control of this 
process, recent reports propose that post-translational regulation, including 
ubiquitination could also control stem cell differentiation. To test this 
hypothesis we visualize in vivo, using a novel reporter mouse strain, the 
ubiquitin-regulated protein stability of a single transcription factor, c-Myc. 
We demonstrate that the relative stability of c-Myc protein is instructive of 
HSC quiescence and self-renewal. These thresholds of c-Myc protein 
abundance are controlled by the E3 ubiquitin ligase Fbw7. We have 
previously shown that Fbw7 is a potent tumor suppressor acting on 
hematopoietic progenitors in acute lymphoblastic leukemia. Moreover, we 
demonstrate that the HSC “gene expression signature” is controlled by fine 
changes in relative stability of the c-Myc protein controlled by the activity 
of Fbw7. Furthermore, using whole genome genomic approaches, we 
pinpoint specific genes-regulators of HSC function that are directly 
controlled by c-Myc promoter binding. Finally, we demonstrate that 
regulation of self-renewal by c-Myc protein availability is a specific feature 
of adult HSC. Indeed, self-renewing embryonic stem cells express high 
levels of c-Myc protein that is only destabilized as cells differentiate due to 
the activity of the Fbw7 ligase. These studies offer the first example of a 
ubiquitin ligase:substrate pair able to orchestrate the molecular program of 
adult stem cell differentiation. 
 2 
P53-MEDIATED HEMATOPOIETIC STEM CELL COMPETITION 
 
Ruslan Medzhitov  
 
HHMI, Yale University Medical School, Immunobiology, 300 Cedar Street, 
New Haven, CT, 06510 
 
Cell competition was originally described in Drosophila as a process for 
selection of the fittest cells. It is likely to play an important role in tissue 
homeostasis in all metazoans, but little is known about its role and 
regulation in mammals. Using genetic mosaic mouse models and bone 
marrow chimeras, we describe here a form of cell competition in the 
hematopietic stem cell compartment. This competition is controlled by p53 
but is distinct from the classical p53-mediated DNA damage response: it 
persists for months, is specific to the hematopoietic stem and progenitor 
cells, and depends on the relative rather than absolute level of p53 in 
competing cells. The competition appears to be mediated by a non-cell 
autonomous induction of growth arrest and senescence-related gene 
expression in outcompeted cells with higher p53 activity. p53-mediated cell 
competition of this type could potentially contribute to the clonal expansion 
of incipient cancer cells 
 3 
NKAP IS REQUIRED FOR ADULT HSC MAINTENANCE AND 
SURVIVAL 
 
Anthony Pajerowski1,2, Michael Shapiro1, Kim Gwin1, Rhianna Sundsbak1, 
Molly Nelson-Holte1, Kay Medina1, Virginia Shapiro1  
 
1University of Pennsylvania, Pathology and Laboratory Medicine, 3600 
Spruce Street, Philadelphia, PA, 19104, 2Mayo Clinic, Immunology, 200 
First St SW, Rochester, MN, 55905 
 
Steady state hematopoiesis is sustained through differentiation balanced 
with proliferation and self-renewal of hematopoietic stem cells (HSCs). 
Disruption this balance can lead to the loss of HSCs and hematopoietic 
failure. NKAP is a transcriptional repressor, and conditional ablation of 
NKAP in the T cell lineage using lck-cre demonstrated that NKAP 
expression is absolutely required for early T cell development. We now 
show that NKAP is also absolutely required for the maintenance and 
survival of adult HSCs. Using vav-cre NKAP conditional knockout mice, 
which express cre in HSCs, we found that loss of NKAP leads to perinatal 
lethality and abrogation of hematopoiesis. Mx1-cre NKAP conditional 
knockout mice die 9-14 days after induction of the cre transgene with poly-
IC, at which point hematopoiesis in the bone marrow has halted and HSCs 
(defined by lin-sca+c-kit+) have disappeared. The hematopoietic failure and 
lethality is cell intrinsic, as irradiated wild-type recipients reconstituted with 
Mx1-cre NKAP conditional knockout bone marrow also succumb with a 
similar time course. Even in the context of a completely normal bone 
marrow environment, using mixed bone marrow chimeras in which 
irradiated wild-type recipients were reconstituted with a 50/50 mix of wild-
type and Mx1-cre NKAP conditional knockout bone marrow, Mx1-cre 
NKAP conditional knockout HSCs fail to sustain granulopoiesis 6 days 
after poly-IC induction. To understand the basis of the HSC defect, mixed 
chimeras were induced with a single injection of poly-IC and examined four 
days later. Mx1-cre NKAP conditional knockout HSCs exhibited defects in 
proliferation as measured by BrdU incorporation, and survival measured by 
Annexin V staining. Using Q-PCR, NKAP-deficient HSCs upregulate the 
cyclin-dependent kinase inhibitors p21 Cip1/Waf1 and p19 Ink4d, which 
may account for the decreased proliferation that was observed. Therefore, 
NKAP is one of a very small number of transcriptional regulators that is 
absolutely required for adult HSC maintenance and survival. 
 4 
REPROGRAMMING OF T CELLS TO NATURAL KILLER-LIKE 
CELLS UPON BCL11B DELETION 
 
Peng Li1, Shannon A Burke1,2, Juexuan Wang1, Xiongfeng Chen3, Dong 
Lu1, Gordon Dougan1, Brian Huntly4, Bertie Gottgens4, Nancy A Jenkins5, 
Neal G Copeland5, Francesco Colucci2, Pentao Liu1 
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Cambridge, CB10 1HH, United Kingdom, 2The Babraham Institute, 
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21701, 4 Cambridge Institute for Medical Research, Wellcome Trust/MRC 
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T cells develop in the thymus and play critical roles in immunity. Interestingly, no 
single gene has been identified as essential for the maintenance of thymocytes and 
mature T cells. In mice, the transcription factor BCL11B plays important roles in 
fetal thymocytes, double-positive thymocyte selection, and it is dramatically 
upregulated in early T cells. Using a Bcl11b reporter mouse, we show that Bcl11b is 
expressed in T cells from DN1 thymocytes to mature T cells and absent from other 
leukocytes. To examine the function of Bcl11b in maintaining T cell identity, we 
generated conditional Bcl11b KO (flox) mice which, when crossed to the Cre-ERT2 
strain, allows deletion of Bcl11b upon Tomoxifen (OHT) exposure. Strikingly, 
treatment of flox/flox mice with OHT reduced thymocyte cellularity 5-10-fold 
compared to flox/+ controls, coincident with an increase in cells expressing NK cell 
markers, including NKp46 and NK1.1, in the thymus and spleen. When Bcl11b was 
deleted in vitro from sorted DN1, DN2 or T cell-committed DN3 thymocytes and 
exposed to T cell differentiation conditions in the OP9-DL1 system, T cell 
development failed and CD3-/TCRβ- NKp46+ and NK1.1+ cells grew out. 
Interestingly, these cells were highly cytotoxic towards the underlying OP9 stroma 
and NK cell tumor target lines, suggesting a reprogramming from T cell 
developmental pathways to that of NK cells. In single-cell assays with DN3 
thymocytes, reprogramming was 100% efficient upon removal of both Bcl11b 
alleles. Microarray analysis showed these ‘Induced T-to-Natural Killer’ (ITNK) 
cells had an NK cell genetic profile and decreased T cell gene expression. They 
were not simply the outgrowth of NK cells as they exhibited TCRβ V(D)J 
recombination, confirming a thymocyte origin. Bcl11b was also required for identity 
maintenance in mature T cells, as NKp46+ ITNKs grew out from sorted DP 
thymocytes and mature CD8+ splenocytes T cells following OHT treatment. These 
populations retained TCRβ expression, suggesting ‘transdifferentiation’ to ITNKs. 
Reprogramming is cell intrinsic not only in vitro but also in vivo as ITNKs were 
present in the spleen 6 weeks after transfer of Bcl11b-deleted DP thymocytes to 
alymphoid mice. Remarkably, these ITNKs were able to prevent the outgrowth of 
B16 melanoma in vivo compared to controls. ChIP analysis using antibodies to 
CSL/RBP-Jκ confirmed that the canonical Notch signalling directly regulates 
Bcl11b transcription level. In summary, we show here that Bcl11b is essential for T 
cell development and currently the only known transcription factor for the 
maintenance of T cell identity. Moreover, ITNK may prove to be beneficial in 
therapeutic cancer treatment. 
 5 
SELECTIVE FUNCTIONS OF THE MODULATORY DNA-BINDING 
ZINC FINGERS OF IKAROS 
 
Hilde Schjerven1, Sarah Wadsworth1, Steven Bensinger2, Stephen T Smale1  
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The C2H2 zinc finger is one of the most prevalent protein motifs in the 
mammalian proteome, with many C2H2 fingers involved in sequence-
specific DNA binding. Most zinc finger proteins contain multiple tandem 
finger motifs, with each motif recognizing 2, 3, or 4 base-pairs. The 
multiple fingers within a given protein must therefore exist either for the 
purpose of highly specific recognition of long DNA sequences, or to allow 
recognition of a variety of shorter DNA sequences using distinct subsets of 
the zinc fingers. Biochemical studies of protein-DNA interactions by zinc 
finger proteins have been consistent with both possibilities. We have 
explored this issue in a biological context through targeted mutagenesis of 
the Ikzf1 gene, which encodes the Ikaros DNA-binding protein. Ikaros is a 
critical regulator of hematopoiesis and functions as a potent tumor 
suppressor in both mice and humans. Full-length Ikaros contains four zinc 
fingers near its N-terminus that are involved in sequence-specific DNA-
binding and two additional fingers at its C-terminus that support 
dimerization and multimerization. Within the DNA-binding domain, fingers 
2 and 3 are essential for all DNA-binding activity through their recognition 
of the core Ikaros consensus sequence, GGGAA. In contrast, fingers 1 and 4 
do not appear to recognize the core consensus, but instead are important for 
binding to specific subsets of DNA motifs, presumably through contacts 
with base-pairs that flank the core consensus. To examine the mechanistic 
and biological significance of these modulatory zinc fingers, we have 
created mouse strains that lack the exons encoding either finger 1 or finger 
4. Strikingly, the two mutant strains exhibit distinct subsets of the 
phenotypes observed with Ikaros null mice, suggesting that the two 
modulatory fingers support the regulation of distinct sets of target genes and 
even distinct biological functions. These findings and a detailed analysis of 
putative target genes help explain why hundreds of C2H2 zinc finger 
proteins may contain multiple tandem finger motifs. Moreover, the results 
suggest a refined strategy for uncovering the key targets of Ikaros that are 
responsible for its important biological functions. 
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GENETIC RELATIONSHIP BETWEEN THE CLASSICAL AND 
PLASMACYTOID DENDRITIC CELL LINEAGES 
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Dendritic cells (DC) are key pathogen sensors that establish the link 
between innate and adaptive immune systems. The DC are comprised of 
two major types, classical or conventional antigen-presenting DC (cDC) 
and interferon-producing plasmacytoid DC (pDC). Although both DC types 
arise from the same progenitors, PDC are very distinct from cDC and 
instead show many features of lymphocytes. Thus, the lineage identity of 
PDC and their genetic relationship to cDC remain unclear. We have shown 
that bHLH transcription factor (E protein) E2-2 is an essential and specific 
regulator of PDC development in mice and in humans. Our recent genome-
wide analysis of E2-2 targets in PDC demonstartes that it directly binds to 
many genes expressed preferentially in PDC and/or shared between PDC 
and lymphocytes. We also found that the inducible deletion of E2-2 from 
mature peripheral PDC leads to their spontaneous differentiation into cells 
with the typical cDC phenotype. The acquisition of cDC properties was 
confirmed by functional assays and genome-wide gene expression profiling. 
These data reveal a close genetic relationship between the two DC types, 
and suggest that E2-2 overrides the “default” cDC differentiation to both 
specify and actively maintain the unique PDC cell fate. 
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IDENTIFICATION OF HOXA9 TARGET GENES IN LYMPHO-
HEMATOPOIETIC PROGENITORS. 
 
Kay L Medina, Kimberly Gwin  
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The generation of B cell precursors from hematopoietic multipotential 
progenitors (MPP) is a highly regulated process dependent on the temporal 
activation and coordinate function of multiple regulatory proteins. EBF and 
Pax5 are transcription factors essential for specification and commitment to 
the B cell fate, respectively. In this study we sought to identify novel 
developmental events that accompany specification of the B cell fate 
through comparative analysis of multipotent EBF-/- and Pax5-/- cell lines. 
Flow cytometric analysis of the cell lines revealed differential expression of 
several MPP-associated antigens that tracked with Hoxa9 
transcription/function. Realtime PCR confirmed differential expression of 
Hoxa9 in the cell lines and during B cell differentiation. Hoxa9 is a key 
regulator of MPPs and Flt3 surface levels fractionate this subset. ChIP 
analysis revealed binding of Hoxa9 and co-factors Meis1 and Pbx1, to the 
Flt3 promoter in EBF-/- cells. Flow cytometric analysis of bone marrow 
hematopoietic progenitors from wildtype, Hoxa9-/-, and Hoxa7-/- mice 
revealed significant alterations in expression of three MPP-associated cell 
surface markers including Flt3, CD34, and CD27. These findings suggest a 
non-redundant, developmental stage specific requirement for Hoxa9 in the 
induction of an MPP genetic program during the pluripotent hematopoietic 
stem cell to lymphohematopoietic progenitor transition. Finally, flow 
cytometric analysis of ex vivo isolated B cell precursor subsets revealed 
downregulation of these antigens between the Pre-Pro-B and Pro-B stages 
that tracked with Hoxa9 transcription, validating the cell line data. Taken 
together, these data provide new insight into Hoxa9 regulated networks in 
primitive hematopoietic progenitors and B cell precursors. 
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PU.1 CONTROLS DENDRITIC CELL AND PLASMA CELL 
DEVELOPMENT THROUGH DISTINCT MECHANISMS 
 
Sebastian Carotta, Jhagvaral Hasbold, Aleksander Dakic, Angela D’Amico, 
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The transcription factor PU.1 plays multiple context and concentration 
dependent roles in lymphoid and myeloid cell development. Here we have 
investigated the function of PU.1 in the differentiation of dendritic cells 
(DC) and mature B cells. We found that PU.1 is essential for DC 
development in vivo and that conditional ablation of PU.1 in defined 
precursors, including the common DC progenitor, blocks Flt3 ligand-
induced DC generation in vitro. PU.1 is also required for the parallel GM-
CSF-induced DC pathway from early hematopoietic progenitors, but 
surprisingly is not required for monocyte-derived DC formation. Molecular 
studies demonstrated that PU.1 directly regulates the important cytokine 
receptor Flt3 in a concentration-dependent manner, with PU.1+/- cells 
displaying reduced expression of Flt3 and impaired DC formation. These 
studies identify PU.1 as a central-regulator of DC development and provide 
one mechanism how altered PU.1 concentration can have profound 
functional consequences for hematopoietic cell development. 
In contrast, inactivation of PU.1 specifically in committed B cells, allows 
relatively normal lymphopoiesis. However, the removal of both PU.1 and 
one of its interaction partners, IRF8, reveals a redundancy between these 
factors and results in increased immunoglobulin class switch recombination 
and a marked overproduction of plasma cells. Molecular analysis revealed 
that key target genes of the PU.1-IRF8 complex are Pax5, Bcl6 and Blimp-1 
indicating that PU.1-IRF8 functions to maintain the transcriptional program 
of activated B cells, while concurrently repressing the plasma cell program. 
We propose that PU.1 and IRF8 function together as the genetic switch that 
controls the division-linked differentiation of B cells into plasma cells. 
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THE MOLECULAR MECHANISM OF AIRE 
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Mutations in the transcriptional regulator, AIRE, cause APECED, a 
polyglandular autoimmune disease with monogenic transmission. Animal 
models of APECED have revealed that AIRE plays an important role in T 
cell tolerance induction in the thymus, mainly by promoting ectopic 
expression of a large repertoire of transcripts encoding proteins normally 
restricted to differentiated organs residing in the periphery. The absence of 
Aire results in impaired clonal deletion of self-reactive thymocytes, which 
escape into the periphery and attack a variety of organs. In addition, Aire is 
a proapoptotic factor, expressed at the final maturation stage of thymic 
medullary epithelial cells, a function that may promote cross-presentation of 
the antigens encoded by Aire-induced transcripts in these cells. 
Transcriptional regulation by Aire is unusual in being very broad, context-
dependent, probabilistic and noisy. Structure/function analyses and 
identification of its interaction partners suggest a scenario in which Aire 
impacts transcription at several levels, including promotion of chromatin 
remodeling via induction of DNA double-stranded breaks, nucleosome 
displacement during elongation, and transcript splicing or other aspects of 
maturation. A broad siRNA screen of Aire-dependent transcription in a 
simplified cell system confirmed and extended these functional impacts. 
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PROMISCUOUS EXPRESSION OF TISSUE-RESTRICTED ANTIGENS 
IN THYMIC MEDULLARY EPITHELIAL CELLS: SELECTION AND 
REGULATION  
 
Bruno Kyewski1, Benedikt Brors2, Sheena Pinto1  
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Research Center, Theoretical Bioinformatics, Im Neuenheimer Feld 280, 
Heidelberg, 69120, Germany 
 
In the thymus a specific subset of thymic stromal cells - medullary thymic 
epithelial cells (mTECs) - express a highly diverse set of tissue-restricted 
antigens (TRAs) representing essentially all tissues of the body, which is 
known as promiscuous gene expression (pGE). This allows self-antigens, 
which otherwise are expressed in a spatially or temporarily restricted 
manner to become continuously accessible to developing T cells. The scope 
of central tolerance is to a large measure dictated by the pool of 
promiscuously expressed genes. Thus, even lack of a single TRA can result 
in spontaneous organ-specific autoimmunity. Promiscuously expressed 
gene, which have no structural or functional commonality, display two 
prominent features, they are highly clustered in the genome and show a 
preference for TRAs. In order to better understand these features, we set out 
to more precisely define the genomic organization of this gene pool. In 
particular, we probed to which extent and according to which rules 
predefined genomic clusters of TRAs are transcribed in mTECs. Our 
analysis proceeded from the bio-informatic definition of TRA clusters via 
gene expression analysis in mTECs using whole genome arrays to the in 
depth analysis of selected TRA clusters by RT- PCR at the population and 
single cell level. Patterns emerging from these studies will hopefully yield 
insight into molecular and evolutionary mechanisms responsible for 
selecting this gene pool. Conceivably, positional cues in the genome and/or 
particular properties of self-antigens (e.g. immunogenicity) could have been 
driving forces during the co-evolution of pGE and adaptive immunity.  
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CIS- AND TRANS-ACTING FACTORS INVOLVED IN INITIATING 
ThPOK EXPRESSION 
 
Sawako Muroi, Hirokazu Tanaka, Chizuko Miyamoto, Ichiro Taniuchi  
 
RIKEN, RCAI, Lab. Transcriptional Regulation, 1-7-22, Suehirocho, 
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Induction of the ThPOK gene expression upon receiving TCR signals is 
crucial to activate genetic programming towards the CD4+ helper-lineage in 
CD4+CD8+ double-positive (DP) thymocytes, as otherwise they commit to 
the CD8+ cytotoxic-lineage. We have shown that de-repression of the 
ThPOK gene takes place in entire CD4+CD8+ DP thymocyte population at 
low extent upon removal of the ThPOK silencer. This observation indicates 
that both activation of enhancer(s) and reversal of the silencer activity are 
necessary for efficient induction of the ThPOK gene expression. By using 
reporter transgenic assay, we have recently mapped the enhancer activity at 
the 5’ close proximity to the ThPOK silencer. Removal of this enhancer 
from the ThPOK locus impaired ThPOK expression only at initial phase, 
resulting in a partial redirection of class II-selected thymocytes even when 
they express monogenic class II specific TCRs. Furthermore, upcoming 
ThPOK expression at the later developmental stage, presumably by 
activating the proximal enhancer, induceed trans-differentiation in some 
class II-selected thymocytes, which are once specified toward CD8-lineage 
and turn on mature CD8 enhancer, the E8I enhancer.  
On the other hand, binding of Runx complexes to the ThPOK silencer in 
ThPOK-expressing cells indicates that reversal of the silencer involves 
other mechanisms beyond Runx binding. To identify trans-acting factors 
regulating the silencer function, we are characterizing functional properties 
of several silencer-binding proteins identified by biochemical purification. 
These results will be discussed in the context of how TCR signals are 
integrated into the regulatory pathway that initiates ThPOK gene 
expression. 
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BATF FAMILY AP-1 TRANSCRIPTION FACTORS REGULATE 
IMMUNE LINEAGE DECISIONS 
 
Kenneth M Murphy, Kai Hildner, Barbara Schraml, Brian Edelson, Wataru 
Ise, Masako Kohyama-Ise, Jorn Albring, Wumesh KC, Ansu Satpathy, 
Wan-Lin Lee, Mona Mashayehki, Michelle Sandau, Theresa Murphy 
 
Washington University School of Medicine, Department of Pathology and 
Immunology, Howard Hughes Medical Institute, 660 S. Euclid, Campus 
Box 8118, St. Louis, MO, 63110 
 
We found that the AP-1 factors Batf3 and Batf were expressed in an 
unusually restricted pattern of lineages and tissues of the immune system. 
Literature had suggested these factors were inhibitors of AP-1-dependent 
transcription, competing with Fos for Jun binding and forming 
transcriptionally inactive heterodimers. To test this idea, we generated mice 
deficient for members of the BATF family.  
 
Batf-/- mice lacked development of TH17 cells, which are induced by IL-6 
and TGF-beta, produce IL-17, and coordinate acute inflammatory 
responses. While Batf is expressed in all T helper subsets, Batf-/- T cells 
show a selective block in TH17 development, have normal TH1 and TH2 
development, and are resistant to EAE, an indicator of TH17 mediated 
autoimmune disease. Moreover, Batf is required for expression of ROR?T, 
a TH17 transcription factor, and binds directly to putative regulatory 
elements in the IL-17 cytokine locus. Thus Batf appears to be necessary for 
the unfolding of the TH17 developmental program, similar to IRF4. 
Expression analysis identified a number of genes that may be direct targets 
of Batf/Jun transactivation.  
 
Batf3-/- mice selectively lacked development of the subset CD8a+ 
conventional dendritic cells, in the lymphoid tissues, and of a related 
CD103+ subset of cDC present in many peripheral tissues. These cells were 
thought to be specialized for antigen cross-presentation to CD8 T cells. 
Consistently, Batf3-/- mice are defective in cross-presentation and have 
reduced virus-specific CD8+ T cell responses to West Nile and Sendai virus 
infections. They also are unable to reject syngeneic tumors that can be 
rejected robustly by wild type mice, indicating a role for cross-presentation 
in tumor immunity. Thus, Batf3 appears to be necessary for the 
development of a specific functional subset of dendritic cells, similar to 
IRF8. It would seem that Batf and Batf3 are not simply inhibitors of AP-1, 
since each seems necessary for expression of certain tissue specific target 
genes.  
 
We are pursuing the mechanism by which these BATF factors control the 
development of these specific immune lineage programs. 
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GFI-1B NEGATIVELY REGULATES RAG EXPRESSION IN V-ABL 
TRANSFORMED PRO-B CELLS 
 
Mark S Schlissel1, Danae Schulz1, Lothar Vassen2, Ehssan Sharif-Askari2, 
Tarik Moroy2  
 
1UC-Berkeley, Molecular & Cell Biology, 439 LSA (#3200), Berkeley, CA, 
94720, 2IRCM, Microbiology & Immunology, 110 Avenue des Pins West, 
Montreal, QC, H2W 1R7, Canada 
 
Using an AMuLV transformed pro-B cell line from a RAG-GFP knock-in 
mouse, we screened a bone marrow cDNA library for genes that could 
negatively regulate RAG expression. This screen revealed the proto-
oncogene Gfi-1b. Gfi-1b is a sequence specific DNA binding protein found 
in various chromatin remodeling complexes and is associated with both 
epigenetic activation and inactivation of target gene expression. We showed 
that the inactivation of RAG expression by Gfi-1b requires DNA replication 
and that Gfi-1b functions both by binding directly to a site near the RAG 
locus enhancer and by down-regulating expression of FoxO1, a positive 
regulator of RAG expression. We generated AMuLV transformed cell lines 
from Gfi-1b and Gfi-1 (a closely related factor) mutant mouse bone 
marrow. The former, but not the latter, displayed greatly exaggerated levels 
of RAG expression as well as DNA damage as evidenced by increased 
numbers of histone phospho-H2AX foci. Gene expression microarray 
studies revealed that Gfi-1b regulates additional markers of B cell 
development including germline kappa transcripts and the transcription 
factor SpiB. Experiments currently in progress are aimed at determining the 
role of Gfi-1b during normal B cell development. 
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REGULATION OF B LYMPHOPOIESIS BY TRANSCRIPTION 
FACTOR EBF 
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EBF1, a transcription factor, expressed in lymphoid progenitors, pro-B and 
mature B lymphocytes, participates in a regulatory network that determines 
the specification of the B cell lineage and repression of alternative cell fates. 
With the aim of understanding the molecular mechanisms underlying the 
function of EBF1 in pro-B cells, we performed a genome-wide ChIP 
sequencing analysis to identify direct EBF1 target genes. Comparison of the 
ChIP data with an analysis of gene expression in loss-and gain-of-function 
experiments allowed for the identification of three classes of direct targets 
that are poised for expression, activated or repressed by EBF1. In target 
genes that are poised for expression at a later stage of differentiation, EBF1 
induces changes in chromatin structure that are distinct from changes 
detected in target genes that are transcriptionally activated by EBF1. To 
assess the role of EBF1 at the pro-B cell stage and at later stages of B cell 
differentiation, we generated and analyzed mice carrying a conditional 
allele of Ebf1. Induced loss of EBF1 resulted in multiple defects that will be 
discussed. 
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THE BTB/POZ DOMAIN PROTEIN MIZ-1 (ZBTB17) CONTROLS IL-7 
RECEPTOR SIGNALING AT COMMITMENT STAGES OF B CELL 
DIFFERENTIATION BY REGULATING EXPRESSION OF BCL-2 AND 
THE JAK INHIBITOR SOCS1  
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B cells are generated from hematopoietic stem cells (HSC) in the bone 
marrow through a number of well defined, developmental steps that include 
the up-regulation of CD19 and the rearrangement of immunoglobulin heavy 
and light chain genes. The early steps are regulated by cytokine signaling 
through Flt3 and IL-7R and the hierarchical expression of transcription 
factors, among them E2A, EBF and Pax5. Here we present evidence that the 
BTB/POZ domain transcription factor Miz-1 is an important novel regulator 
in this process with a critical role in early steps of B-cell development. Miz-
1 deficiency correlated with an almost complete block of B-cell 
development in murine bone marrow precisely at the transition of the 
CLP/pre-pro-B cell stage to the pro-B cell stage. Although CLPs were 
present in Miz-1 deficient mice, they showed decreased expression of E2A, 
EBF and Pax5 but a high level of the JAK inhibitor Socs1. Consequently, 
Miz-1 deficient progenitors fail to activate the JAK/STAT5 pathway upon 
IL-7 stimulation. Our findings suggest that in normal CLPs Miz-1 dampens 
the expression of SOCS1 through direct binding to its transcription initiator 
site and thereby allows the activation of STAT5 and the subsequent up-
regulation of EBF by IL-7 and indirectly of Pax5 and Rag1/2. In addition, 
we show that Miz-1 deficient pro-B cells and CLPs have an increased 
propensity to undergo cell death in the presence of IL-7. Surprisingly, 
ectopic expression of EBF (or Pax5) in Miz-1 deficient progenitor cells did 
not rescue this phenotype, although EBF has been shown to overcome IL-7-
deficency, but the co-expression of a Bcl-2 transgene partly restored the 
development of committed B cells in Miz-1 deficient mice. Our expression 
analysis confirmed that in the absence of Miz-1, Bcl-2 couldn’t be 
upregulated upon IL-7 stimulation in CLPs and ChIP data demonstrated a 
direct binding of Miz-1 to the Bcl-2 promoter, suggesting that Miz-1 exerts 
a second function in the survival axis of the IL-7R pathway by acting as an 
IL-7 dependent transcriptional activator of Bcl-2. The introduction of both 
EBF and Bcl-2 in Miz-1 deficient progenitors finally enabled us to fully 
reconstitute of our experimental system and to rescue B cell development in 
Miz-1 deficient precursors cultured on OP9 stroma in vitro. This experiment 
supports a model, in which Miz-1 exerts two functions in the IL-7R 
signaling pathway: one in the regulation of the IL-7/STAT5 dependent 
EBF-Pax5-Rag1/2 axis responsible for B-cell differentiation, and another 
role in IL-7 dependent up regulation of Bcl-2 that ensures survival of B-cell 
progenitors. Grants: CIHR MOP - 84526 
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Hematopoietic stem cells (HSCs) develop into B cells by first 
differentiating to multipotent progenitors and common lymphoid 
progenitors (CLPs). Entry of the CLPs into the B cell lineage depends on 
the transcription factors E2A, EBF1 and Pax5. E2A and EBF1 are essential 
for early specification of the B cell lineage by activating the expression of 
several B-cell-specific genes including Pax5. Pax5 in turn restricts the 
broad developmental potential of lymphoid progenitors to the B cell 
pathway by repressing B-lineage-inappropriate genes and simultaneously 
activating B-cell-specific genes (Nutt et al., Nature 401, 556-562; Cobaleda 
et al., Nat. Immunol. 8, 463-370). Consistent with its B cell commitment 
function, Pax5 is exclusively expressed in the B-lymphoid lineage, where 
its function is continuously required throughout B cell development. Pax5 
furthermore regulates the contraction of the immunoglobulin heavy-chain 
(IgH) locus, which facilitates distal VH-DJH recombination in pro-B cells 
(Fuxa et al., Gene Dev. 18, 411-422). We have recently performed 
chromatin profiling of Pax5-regulated genes by ChIP-chip analysis, 
demonstrating that Pax5 regulates its target genes by inducing active 
chromatin at promoters and enhancers. These studies furthermore resulted 
in the identification of novel regulatory elements in the distal VH gene 
cluster, which are likely implicated in IgH locus control. In my 
presentation, I will report recent highlights of these studies. 
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During B lymphopoiesis, the interplay of signals propagated through the 
pre-B cell antigen receptor (pre-BCR) and the interleukin 7 receptor (IL-7R) 
coordinate pre-B cell expansion with subsequent Igκ recombination. 
Recently, we have demonstrated that pre-BCR mediated Ras-MEK-Erk 
activation coordinates cell cycle exit with Igκ recombination by both 
repressing Ccnd3 transcription (encoding cyclin D3) and by upregulating 
free E2A which enhances Igκ transcription (Nat Immunol 2009, 10:1110). 
IL-7R-mediated STAT5 activation opposes this pathway by promoting 
Ccnd3 transcription and by binding directly to the Igκ intronic enhancer 
(Eκi) and preventing E2A recruitment. These data revealed a novel role for 
STAT 5 as an important transcriptional repressor. We now demonstrate that 
STAT 5 inhibits Igκ transcription by binding to a site (iκS2) adjacent to the 
κE1 E-box site and preventing E2A binding. In vitro, introducing spacers 
between iκS2 and κE1 enables both transcription factors to bind and 
abrogates Igκ repression. In vivo, STAT 5 binding maintains Eκi histone 3 
K27 trimethylation and prevents the acquisition of the markers of open 
chromatin (H3K4me1 and H4Ac) associated with entry into the small pre-B 
cell pool. These data demonstrate that STAT 5 mediates a comprehensive 
program of repression at the Eκi. 
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E2A AND CBP/P300 ACT IN SYNERGY TO PROMOTE CHROMATIN 
ACCESSIBILITY OF THE IMMUNOGLOBULIN Κ LOCUS IN 
NONLYMPHOID CELLS 
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V(D)J recombination of immunoglobulin (Ig) and T cell receptor (TCR) 
genes is strictly regulated in a lineage- and stage-specific manner by the 
accessibility of target gene chromatin to the recombinase, RAG1 and RAG2 
proteins. It has been shown that enforced expression of the basic helix-loop-
helix protein, E2A, together with RAG1/2 in a nonlymphoid cell line 
BOSC23 can induce V(D)J recombination in endogenous Igκ and TCR loci 
by increasing chromatin accessibility of target gene segments. In this study, 
we demonstrate that ectopically expressed E2A proteins in BOSC23 cells 
have the ability to bind directly to the promoter and recombination signal 
sequence of Vκ genes and to recruit histone acetyltransferase CBP/p300. 
Overexpression of CBP/p300 in conjunction with E2A results in 
enhancement of E2A-induced histone acetylation, germline transcription 
and Igκ rearrangement. Conversely, knockdown of endogenous CBP/p300 
expression by small interfering RNA leads to a decrease in histone 
acetylation, germline transcription and Igκ rearrangement. These 
observations indicate that E2A plays critical roles in inducing Igκ 
rearrangement by directly binding to and increasing chromatin accessibility 
at target gene segments. 
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Introduction and Objectives: Activation of T cells results in antigen-
specific clonal expansion and also differentiation to effector and/or memory 
cells. To maintain homeostasis, the majority of activated T cells must be 
removed after elimination of the invading pathogen or during chronic 
stimulation. Two main mechanisms control the contraction of these cells, 
namely activation-induced cell death (AICD) and activated T cell 
autonomous death (ACAD). Toll-like receptors (TLRs) present on the 
surface of antigen-presenting cells are potent modulators of both innate and 
adaptive immune responses. As TLRs can also be expressed by T cells it 
became reasonable to assume that TLRs may directly regulate activation, 
differentiation, proliferation and death of these cells. Thus, the main goal of 
this research is to investigate the influence of TLR ligands on AICD of T 
lymphocytes. Methods and Results: DO11.10 T cell hybridoma was 
stimulated with anti-CD3 antibodies (AICD), in the presence or not 
different TLR agonists, namely Pam3CSK4 (TLR1/2), Poly(I:C) (TLR3), 
LPS (TLR4), Flagellin (TLR5) and Imiquimod – R837 (TLR7). Apoptosis 
was measured by flow cytometry analysis of DNA content and/or 
phosphatidylserine externalization. Among all TLR ligands used, 
imiquimod significantly reduced cell death rates when added during anti-
CD3 stimulation of T cells (AICD). Decreased AICD was correlated with a 
de-regulated FASL expression. This result was confirmed in mouse CD4 T 
cell blasts. Conclusions: Our results suggest that TLR7 stimulation in T 
lymphocytes may directly modulate FASL expression and AICD. Financial 
Support: CNPq, FAPESP. 
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In our search for factors that propagate the transcriptional programs of T 
helper (Th) lineages, we found that the Polycomb group (PcG) proteins, 
which are known as transcriptional silencers, function unconventionally and 
differentially, in primary Th1, Th2, and Th17 cells and in established Th 
cell lines, as transcriptional activators of the hallmark cytokine genes. 
Moreover, the PcG protein Mel-18 was necessary to recruit NFAT1 and T-
bet to the Ifng promoter in Th1 cells. However, our results also indicate that 
the PcG proteins can act as transcriptional silencers, for example, of Tbx21 
in Th17 cells. This dual function of the PcG proteins may participate in the 
mechanisms underlying the commitment and plasticity of the Th 
phenotypes.  
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iNKT cells are innate-like T lymphocytes that upon activation respond 
rapidly by cytokine production. They play increasing importance in immune 
regulation, antimicrobial protection and allergy. iNKT cells bear semi-
invariant TCRs that recognize glycolipid antigens in the context of the non-
classical MHC class I-like molecule CD1d. Thymic selection of iNKT cells 
is accomplished by cortical DP thymocytes which present endogenous 
glycolipids, as opposed to the selection of conventional thymocytes 
mediated by cortical thymic epithelial cells which present endogenous 
peptides. BCL11B is a transcription factor expressed in T lymphocytes, 
including iNKT cells. Here we provide genetic and biochemical evidence 
that BCL11B deficiency leads to an early block in iNKT cell development 
caused by an intrinsic defect in glycolipid presentation by cortical DP 
thymocytes, as well as by an inherent defect in early thymic iNKT 
precursors. The glycolipid presentation defect is associated with enlarged 
late endosomal/lysosomal compartment and accumulation of several 
glycolipid species, suggesting that the presentation defect could be 
attributed to a glycolipid storage disorder. Mechanisms underlying the 
failure of BCL11B-deficient DP thymocytes to efficiently present 
glycolipid are shown, together with the mechanisms responsible for the 
inherent defects in iNKT cells. These findings identify BCL11B as one of 
the major transcription factors for iNKT cell lineage development, not only 
by controlling early iNKT precursors, but also being intrinsically required 
for glycolipid presentation by cortical DP thymocytes, a process which is 
poorly understood. 
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Modulation of the host signaling events at the level of initiation as well as 
during course of infection represents a critical factor for the suppression of a 
generalized inflammatory response and possible persistence of 
mycobacteria within the host. In this intricate process, modulation of 
cyclooxygenase-2 (COX-2) levels, a key enzyme catalyzing the rate-
limiting step in the inducible production of Prostaglandin E2 (PGE2) by 
mycobacteria like Mycobacterium bovis BCG act as an important factor 
influencing the overall host immune response. PGE2 is known to exert 
immunosuppressive functions as inhibition of human T lymphocyte 
activation and proliferation, production of Th1 cytokines like IL-2 & IFN-γ 
but not of Th2 cytokines IL-4 & IL-5, induction of IL-10 production etc. 
Current study demonstrates that M. bovis BCG triggered TLR2-dependent 
signaling leads to COX-2 expression and PGE2 secretion in vitro in 
macrophages and in vivo in mice. Further, the presence of PGE2 could be 
demonstrated in sera or CSF of tuberculosis patients. Additionally, TLR2 
agonist like Phosphatidyl-myo-inositol dimannosides (PIM2), an integral 
component of the mycobacterial envelope, could drive COX-2 expression. 
The induced COX-2 expression is dependent on NF-κB activation, which is 
mediated by iNOS/NO dependent participation of the members of Notch1-
PI3K pathway or iNOS/NO independent signaling events. Importantly, loss 
of iNOS activity either in iNOS null macrophages or by pharmacological 
intervention in wild type macrophages severely abrogated M. bovis BCG 
ability to trigger Notch1-PI3K signaling axis as evidenced by deficiency in 
generation of Notch1 intracellular domain (NICD) as well as activation of 
PI3K signaling cascade. Notably, pharmacological inhibition of the 
biosynthesis of TLR2 ligand PIM2, markedly compromised M. bovis BCG 
ability to trigger Notch1 activation and COX-2 expression. Overall, we 
propose the involvement of iNOS/NO as one of the obligatory early 
proximal signaling signature in mycobacteria induced COX-2 expression in 
macrophages. 
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Class switch recombination is a transcription coupled DNA cleavage and 
religation process, which begins with germline transcription through donor 
and acceptor switch (S) regions. Here we show that knocking down of 
histone chaperon FACT (facilitates chromatin transcription), comprised of 
SSRP1 and SPT16, completely inhibited CSR, although transcription of 
AID and germline transcripts remained intact. Knock down of FACT 
components drastically reduced γH2AX formation and DNA cleavage in 
switch regions. Depletion of FACT dramatically altered the chromatin 
structure of S-region by changing the nucleosome occupancy and histone 
ratio, leading to a defect in trans-histone modification cascade and 
enhancement of cryptic germline transcripts. Decreased nucleosomal barrier 
facilitated transcription, but the altered state of histone modification halted 
recombination. We propose FACT is essential for continued reassembly of 
nucleosomes during transcription through S-region, thereby preserving a 
dynamic structural integrity of the S-region chromatin, which is required for 
AID induced DNA cleavage. 
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Nuclear factor of activated T cells (NFAT) was first described as a 
transcription factor involved in the activation and differentiation of T 
lymphocytes. The NFAT proteins are primarily regulated upon T cell 
receptor engagement at the level of their subcellular localization through the 
calcium/calmodulin-dependent phosphatase calcineurin. In addition, recent 
studies suggest different roles for NFAT family members in the regulation 
of proliferation and differentiation or apoptosis. Moreover, NFAT 
transcription factors appear to be involved in cell cycle control, thereby 
influencing tumor growth and survival. To address the role of NFAT in 
dendritic cells (DCs), we took advantage of mice having individual NFAT 
family members deleted or knocked down NFAT by lentivirally transduced 
shRNA. Here, we demonstrate that NFATc1 and NFATc2 exert contrary 
functions on dendritic cell (DC) generation, proliferation and maturation. 
Thus, during GM-CSF induced bone marrow differentiation towards 
myeloid dendritic cells (BMDCs), NFATc1 supports cell cycle progression 
and maturation, while NFATc2 inhibits proliferation. Different from T and 
B cells, in BMDCs only promoter 2 of NFATc1 is transcriptionally active 
and no positive feed-back to promoter 1 could be observed. When BMDCs 
are activated though, e.g. through Toll-like receptors, both NFATc1 and 
NFATc2 are silenced. At that point and in response to the β-Glucan receptor 
Dectin-1 another NFAT family member, namely NFATc3, is essential for 
the expression of pro-inflammatory IL2, IL12, IL13 and TNFα. 
Furthermore, NFATc3 counteracts the production of immune-suppressive 
IL10. Taken together, these results suggest opposing roles of NFATc1 and 
NFATc2 in the development of myeloid dendritic cells, while NFATc3 
plays a crucial role in the cytokine expression pattern of activated cells. 
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Zeb2 (also known as Zfhx1b and Sip1) is a DNA-binding multi-zinc-finger 
transcription factor found to play a significant role in the development of 
cells both early in neuronal differentiation and in cancer metastasis. By 
binding dual E2 box enhancer elements, Zeb2 acts primarily as a 
transcriptional repressor and may inhibit E-protein DNA binding, although 
it is known to act also as a transcriptional activator. While the closely 
related family member, dEG1/Zfhx1a/Zeb1, is known to plays an early role 
in lymphocyte development, the function of Zeb2 in T lymphocytes remains 
unknown. We find that Zeb2 is upregulated in activated T cells and 
hypothesize that it influences differentiation of mature cytotoxic T 
lymphocytes during an immune response. We are currently assessing the 
interplay between Zeb2 and E-proteins in differentiation of naïve CD8 T 
cells to cytotoxic effector cells. 
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Our laboratories are interested in understanding of complex interactions 
between activation receptors of natural killer (NK) cells, their target structures 
at tumor cell surface, and intracellular activation pathways resulting in the 
activation of NK cell effector functions at molecular and cellular level. To 
identify high afinity ligands, we produce stable recombinant soluble forms of 
NK cell receptors such as NKR-P1, CD69, and NKG2D (1,2), and use them in 
binding, inhibition and precipitation studies based on standard biochemical 
assays and oligosaccharide arrays. High affinity ligand mimetics are constructed 
by attachment of the active compounds to polyamidoamine or calix[4]arene 
cores, or by dimerization of the ligand through a defined chemical linker (3,4). 
GlcNAc-coated polyamidoamine dendrimers induce upregulation of antibody 
formation that triggered by their interaction with mNKR-P1C (5). GlcNAc-
coated calix[4]arene downregulated the expression of GlcNAc transferases 
MGAT3 and MGAT 5, increased the susceptibility of tumor cells to natural 
killing, and increased the expression of mNKG2D through the activation of 
PI3K–ERK but not phospholipase C-g -JNK pathway (6). GlcNAc dimers can 
provide permanent protection in 70 % of mice bearing syngeneic B16S 
melanomas. This is due to activation of NKT lymphocytes, and subsequent 
infiltration of tumors by CD8+ cytotoxic lymphocytes. The exceptional 
signaling efficiency of GlcNAc dimers is explaned by sequential cooperative 
engagement of mNKR-P1A leading to the formation of large signaling 
complexes of about 20 MDa containing G proteins, b-arrestin, phosphorylated 
dynamin, Src kinase, Vav, Rac1, Grb2, and Ras (4). Use of combined ligand 
mimetics results in engagement of several target receptors, and efficient 
activation of NK cell effector functions due to effective receptor cross-talk.  
(1) Bezouška K. et al. (1994) Nature (2) Vaněk O. et al. (2008) FEBS J (3) 
Bezouška K et al. (2010) Bioorg Med Chem (4) Křenek K et al., unpublished (5) 
Hulíková K. et al. (2009) Int Immunopharmacol (6) Benson V. et al. Int Immunol 
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There exists a synergistic relationship between HIV and Mycobacterium 
tuberculosis. Tuberculosis develops in an HIV patient as a result of 
exposure to the pathogen or reactivation of latent TB due to decrease in the 
strength of immune system. HIV is one of the most important factors for 
susceptibility and reactivation of tuberculosis. Once TB takes over, it results 
in the enhanced replication of HIV either as a result of immune response of 
the host to the Mycobacterium tuberculosis infection by production of 
proinflammatory cytokines or directly as a result of interaction of 
mycobacterial components with the host immune cells. 
In the current study we show the up-regulation of HIV transcription by a 
member of PPE protein family (Rv1168c) of Mycobacterium tuberculosis. 
The protein is expressed on the surface of Mycobacterium tuberculosis. We 
show that this protein specifically interacts with Toll Like Receptor 2 
(TLR2) on the macrophage surface resulting in the activation of NF-κB 
transcription factor. The latter then rapidly translocates to the nucleus 
thereby binding to the specific NF-κB binding sites in the HIV-1 LTR 
promoter element resulting in the activation of transcription (independent of 
Tat transactivator protein). Blocking of the TLR2 using the blocking 
antibody resulted in the abrogation of Rv1168c mediated HIV-1 LTR 
activation. Furthermore, infection of macrophage having stably integrated 
HIV-1 LTR linked to CAT reporter gene with Mycobacterium smegmatis 
transformed with Rv1168c protein resulted in up-regulation of HIV-1 LTR 
activity. Rv1168c interacts with the LRR domain of TLR2 (also recognized 
by Pam3CSK4) activating NF-κB but not to the LRR 10~15 known to 
induce anti-inflammatory signaling. Our results suggest that binding of 
some of the PPE proteins to the different domains of TLR2 results in the 
differential activation of NF-κB signaling cascade resulting in the activation 
of HIV-1 LTR. Furthermore, we first time show the involvement of a PPE 
protein in the activation of HIV-1 LTR. This study may be helpful in 
understanding the molecular mechanism of pathogenesis of HIV-1 during 
Mycobacterium tuberculosis co-infection. 
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Plasmacytoid dendritic cells (pDCs) mature in the bone marrow and migrate 
to peripheral organs and lymphoid tissues, from where they can migrate to 
sites of infection or inflammation and locally produce type 1 interferons. 
Here we demonstrate that the transcription factor interferon regulatory 
factor 5 (IRF-5) is required for proper pDC colonization of these peripheral 
sites. IRF5 expression is first induced in the dendritic cell lineage as 
common myeloid progenitors differentiate into common dendritic cell 
progenitors. Although progenitor frequencies are normal, mature IRF5-/- 
pDC numbers are slightly expanded in the bone marrow relative to wild 
type controls and are reduced by nearly 90% in the spleen, lymph node, and 
blood. Competitive bone marrow reconstitutions of wild type and IRF5-/- 
recipients have demonstrated that this defect is intrinsic to IRF5-/- pDCs. 
Chemotaxis assays showed that IRF5-/- pDCs not only failed to migrate 
toward CXCL12 and CCL3, but also showed no background levels of 
migration in the absence of added chemokines, suggesting a defect in 
cellular motility. Microarray comparisons of IRF5-/- pDCs and wild type 
pDCs are consistent with this interpretation, as a number of genes 
associated with cytoskeletal rearrangement are dysregulated in IRF5-/- 
pDCs. Thus, the pDC and IRF-5, a cell type and a gene whose functions 
have independently been associated with systemic lupus erythematosus, are 
linked at the level of cellular migration and egress from the bone marrow. 
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Class Switch Recombination (CSR) in B lymphocytes is initiated by introduction of 
multiple DNA double-strand breaks (DSBs) into switch (S) regions that flank 
immunoglobulin heavy chain (IgH) constant region exons. CSR is completed by 
joining a DSB in the donor Sμ to a DSB in a downstream acceptor S region (e.g. 
Sγ1) by end-joining. In normal cells, many CSR junctions are mediated by classical 
non-homologous end-joining (C-NHEJ), which employs the Ku70/80 complex (Ku) 
for DSB recognition and the XRCC4/DNA ligase 4 (Lig4) complex for ligation. 
During IgH class switch recombination (CSR) in B lymphocytes, switch (S) region 
DSBs are joined by C-NHEJ to form junctions either with short micro-homologies 
("MH-mediated" joins) or no homologies ("direct" joins). Multiple DSBs are 
introduced into Sμ during CSR, with some being re-joined or joined to each other to 
generate internal switch deletions (ISDs). In addition, S region DSBs can be joined 
to other chromosomes to generate translocations, the level of which is increased by 
absence of a single C-NHEJ component (e.g. XRCC4). In the absence of XRCC4 or 
Lig4, substantial CSR occurs via "alternative" end-joining (A-EJ) that generates 
largely MH-mediated joins. Because upstream C-NHEJ components remain in 
XRCC4- or Lig4-deficient B cells, residual CSR might be catalyzed by C-NHEJ 
using a different ligase. To address this, we have assayed for CSR in B cells 
deficient for Ku70, Ku80, or both Ku70 and Lig4. Ku70- or Ku80-deficient B cells 
have reduced, but still substantial, CSR. Strikingly, B cells deficient for both Ku 
plus Lig4 undergo CSR similarly to Ku-deficient B cells, firmly demonstrating that 
an A-EJ pathway distinct from C-NHEJ can catalyze CSR end-joining. Ku-deficient 
or Ku- plus Lig4-deficient B cells are also biased towards MH-mediated CSR joins; 
but, in contrast to XRCC4- or Lig4-deficient B cells, generate substantial numbers 
of direct CSR joins. In addition, we find, unexpectedly, that B cell activation for 
CSR generates substantial ISD in both Sμ and Sγ1 and that ISD in both is greatly 
increased by absence of C-NHEJ. IgH chromosomal translocations to the c-myc 
oncogene are also augmented in the combined absence of Ku70 and Ligase 4. Our 
findings suggest that more than one form of A-EJ can function in CSR and we are 
currently screening for A-EJ factors using an “in vitro” system.  
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Dendritic Cells (DCs) have a short life-span and need to be continuously 
replenished from hematopoietic stem and progenitor cells. Previously we 
found that Flt3 receptor expression on early dendritic cell progenitors and 
Flt3 tyrosine kinase signalling efficiently supports and is indispensable for 
DC development in mice and men. Flt3 is also expressed on mature steady-
state lymphoid organ DCs; however its function on mature cells remains to 
be determined. Interestingly we found that depletion of DCs in CD11c-DTR 
mice by administration of diphtheria toxin lead to elevated levels of Flt3L 
in the serum without a change in expression of Flt3L mRNA, which 
strongly indicates that Flt3 expressed on DCs might be acting as a sink for 
Flt3L. Therefore DCs might play a regulatory role in the maintenance of 
Flt3L milieu. Flt3 ligand (Flt3L) is produced by stromal cells and some 
hemato-lymphoid cells; however, the relative contribution of stroma versus 
hemato-lymphoid cells to Flt3L levels in steady-state and in ongoing 
immune reactions is unknown. Our recent findings suggest that stromal cell 
produced Flt3L helps to maintain steady state DC homeostasis, while Flt3L 
produced by the hematopoietic cells helps in faster replenishment of DCs 
during an ongoing immune response and in combating foreign pathogens by 
enhancing the antigen presentation process. Further more, enhanced cDC 
development upon Treg depletion involves Flt3L produced by activated 
CD4 T cells. These key observations provide insight into regulation of DC 
homeostasis and function via tailored adaptation of the Flt3L cytokine 
milieu during steady state and under pathogenic stress. 
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Timely acquisition of cell-fates and the elaborate control of growth in 
numerous organs depend on Notch signaling1. RBP-J transcription factor 
plays a dual role in regulating Notch target genes2. RBP-J actively 
represses target genes in the non-Notch receiving cells while it induces 
expression of target genes in cells receiving the Notch signal. Therefore, 
Notch signaling acts as a switch that reverses RBP-J-mediated repression of 
target genes. We hypothesize that histone methylation plays a key role in 
this dynamic regulation of Notch target genes.  
 
Here, we show that the histone demethylase KDM5A is an integral, 
conserved component of Notch/RBP-J gene silencing. Methylation of 
histone H3 lysine 4 is dynamically erased and reestablished at RBP-J-sites 
upon inhibition and re-activation of Notch signaling. KDM5A physically 
interacts with RBP-J, this interaction is conserved in Drosophila and crucial 
for Notch-induced growth and tumorigenesis responses.  
 
Together these findings indicate that dynamic regulation of histone 
methylation plays a key in the Notch target gene expression. With the in 
vivo evidence of Drosophila lid/KDM5A in Notch-induced tumorigenesis, 
this study suggests a pathway-specific tumour-suppressor role of KDM5A 
in cancer and provides the basis for studies in novel strategies to manipulate 
Notch-mediated carcinogenesis. 
 
References: 
1) Kopan, R, Ilagan, M (2009) Cell 137(2):216-33. (Review) 
2) Borggrefe, T. and Oswald, F. (2009). Cell. Mol. Life Sci. 66(10):1631-
46. (Review) 
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The immune system is constantly replenished by a rare population of 
hematopoietic stem cells (HSC) residing in the bone marrow of adult 
organisms. E-proteins, the widely expressed basic helix-loop-helix (bHLH) 
transcription factors, appear to contribute to HSC activity, but their specific 
cell intrinsic functions remain undefined. In contrast to a recent report, we 
show that E47 is dispensable for the short-term myeloid differentiation of 
HSCs. In our quantitative assays, E47 deficient progenitors show competent 
myeloid production in vitro and in vivo as well as under burden of a 
pathogen mimic. We also show that long-term myeloid and lymphoid 
differentiation is compromised due to the progressive loss of the self-
renewal potential of HSCs in vivo. Compromised self-renewal of E47 null 
HSCs is associated with over-proliferation and premature exhaustion under 
replication stress. These observations suggest that cell-intrinsic E47 is 
dispensable for the short-term myeloid repopulation activity of HSCs and, 
by contrast, that E47 plays an essential cell-autonomous role in the self-
renewal of HSCs by preventing hyperproliferation-associated exhaustion 
following replication stress. 
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The vitamin D receptor gene (VDR) is one of the candidate genes implicated 
in genetic susceptibility to tuberculosis (TB). Genetic variants in the 
primary promoter, in exon 2 and the 3’ end of the VDR were found to be 
associated with TB. The alleles or haplotypes of SNPs reported to be linked 
to TB predisposition are inconsistent between populations. The objective of 
the current study was to investigate the role of epigenetics in this 
phenomenon. The methylation status of the 3’ VDR CpG island (CGI 1060) 
was characterized considering ethnicity, sex, the geno- or haplotype of 
SNPs it contain and TB status. DNA from EBV-transformed B lymphocytes 
originating from Caucasians (n=30) and Yoruba (YRI; n=30) as well as 
DNA from whole blood collected from TB cases (n=32) and matched 
controls (n=29) from the Venda Population, Limpopo Province, South 
Africa, were used. Bisulfite conversion and/or pyrosequencing facilitated 
quantification of CpG methylation and genotyping of SNPs in CGI 1060, 
including ApaI (rs7975232) and TaqI (rs731236). The significance of 
methylation differences was analysed using SPSS parametric and non-
parametric tests. TaqI coincided with the methylatable ‘C’ of a CpG 
dinucleotide in CGI 1060 and directly influenced its methylation by 
introducing or removing a CpG ‘C’ that appeared to be always methylated 
when present (TC 50%, CC 100%). Presence of TaqI ‘C’ and coincident 
site-specific methylation increased regional methylation of CGI 1060 in 
African populations to levels significantly above levels in the absence of 
‘C’ (P < 0.001, One-way ANOVA and Mann-Whitney U), but not 
significantly so in Caucasians. Despite a notably higher TaqI ‘C’ allele 
frequency in Caucasians (38% ‘C’) compared to YRI (21% ‘C’) and 
consequent higher site-specific methylation of the TaqI CpG (Caucasians 
35% methylation vs. YRI 20% methylation, P ≤ 0.05, Mann-Whitney U), 
CGI 1060 regional methylation was significantly higher in YRI than 
Caucasians (P < 0.05, One-way ANOVA). This difference was driven by 
higher site-specific methylation at 6/17 CpGs (P < 0.05, One-way ANOVA 
and Mann-Whitney U). Two of these CpG sites, immediately downstream 
of the TaqI CpG, were also significantly more methylated in Venda TB 
cases compared to controls (P < 0.03, One-way ANOVA and Mann-
Whitney U). Epigenetics, specifically DNA methylation, may confound 
comparisons of alleles/haplotypes of 3’ VDR SNPs found associated with 
TB in different populations. Hepitype analysis, combining haplotype and 
epitype, may reveal more powerfully genetic and environmetal factors 
contributing to disease predisposition. 
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The MHC-II locus spans nearly 700 kb and encodes a dense cluster of 
genes, the majority of which function to present antigens to CD4+ T cells 
and initiate adaptive immune responses. MHC-II and the accessory genes 
encoded within the locus are regulated in a cell type dependent manner; 
while other genes within the locus are constitutively expressed in many cell 
types. Ten chromatin insulator CTCF binding sites were identified that 
divide the MHC-II locus into apparent evolutionary domains such that pairs 
of MHC-II genes are separated from each other by surrounding CTCF sites. 
Using RNAi, CTCF was found to be required for the expression of all 
MHC-II and MHC-II related genes but not the other genes within the locus. 
Knockdown of Rad21, a cohesin protein found at all 10 CTCF sites, 
diminished MHC-II gene expression. 3C assays were conducted across the 
MHC-II locus and defined two CTCF-dependent chromatin architectural 
states, each with multiple configurations and interactions. Independent of 
MHC-II gene expression, the 10 CTCF sites interacted with each other in a 
distance dependent manner. The CTCF sites also interacted with the 
promoter proximal regions of the MHC-II genes themselves. This 
interaction was only associated with MHC-II gene expression and 
dependent on the presence of CIITA, the MHC-II transactivator, bound to 
the proximal regulatory region of the MHC-II genes. CIITA-dependent, 
CTCF-site selection was also distance dependent, but it was found that 
CIITA-bound regions could interact with multiple CTCF sites. Disruption 
of the CTCF-dependent rearranged states eradicated expression. Using 
homologous recombination strategies, CTCF sites in an MHC-II locus 
encoding BAC were mutated and assessed for their activity. Preferences for 
interactions among the sites and promoters were observed in the minimal 
system, suggesting that such preferences may occur normally. Thus, CTCF 
and cohesin organize the MHC-II locus into a novel basal architecture of 
interacting foci and loop structures that dynamically rearrange in the 
presence of the transcriptional regulator CIITA to activate MHC-II gene 
expression. These results therefore define a non-traditional role for CTCF as 
an organizer of gene expression and display a unique dynamic set of 
chromatin organizational structures. 
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The transcription factors Gata3 and Thpok, together with Runx-family 
members Runx1 and Runx3, are required for the proper differentiation of 
CD4 and CD8 lineages, respectively, in the thymus. We and others 
previously proposed that Thpok serves as a ‘commitment’ factor and is not 
actually required to induce gene expression programs specific of CD4-
lineage cells. However, this hypothesis had not yet been tested in cells with 
intact Runx activity. Here, we used a combination of genetic analyses and 
assessments of gene expression and histone modifications to analyze the 
role of Thpok in CD4-lineage ‘commitment’, understood as the repression 
or termination of CD8-specific gene expression programs, vs. 
‘specification’, i.e. the onset of CD4-lineage specific gene expression. Our 
results indicate that Thpok is not required for 'CD4 specification' in MHC 
II-restricted thymocytes with an otherwise intact transcriptional circuitry, 
and we will discuss new observations delineating the respective 
contributions of Gata3 and Thpok to CD4-lineage differentiation. In 
addition, we will present experiments assessing the respective roles of 
Thpok and epigenetic DNA marking in repressing CD8-lineage gene 
expression in post-thymic CD4 T cells. Similarities and differences with 
Cd4 silencing in CD8 cells will be discussed. 
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As well as being pervasive in regulating gene expression, the RNase III 
enzyme Dicer functions in establishing and maintaining transcription 
dependent barrier activity and controlling site specific recombination 
events. Lymphocytes exhibit differentiation blocks in the absence of Dicer; 
these blocks occur at developmental transitions dependent upon successful 
VDJ recombination and/or antigen receptor induced cellular proliferation. 
Lck-Cre:Dicerflox/flox mice exhibit reduced thymic cellularity and a partial 
block in development between the DN and DP stages. This phenotype is 
consistent with a role for dicer in TCRβ recombination, proliferation, and/or 
survival. To distinguish amongst these possibilities, we generated and 
analyzed Lck-Cre:Dicerflox/flox mice containing a pre-assembled endogenous 
Vβ1DJβ1.4 rearrangement (the Vβ1NT allele). Repetitive DNA sequences 
upstream of the Vβ1DJβ1.4 exon mark a boundary between accessible 
(Vβ10) and inaccessible (Vβ4, Vβ16) germline Vβ segments. Vβ 
accessibility is characterized by cell surface expression, rearrangement over 
the pre-assembled Vβ1DJβ1.4 join, bi-directional transcription, and low 
CpG methylation of the promoter and coding sequences. Dicer deletion in 
Vβ1NT thymocytes provides a defined system that allows us to assess 
potential functions of Dicer in boundary activity, accessibility, and 
recombination at the TCRβ locus. Vβ1NT expression in Dicer-/- thymocytes 
leads to increased thymic cellularity compared to Dicer-/- cells; Dicer 
deletion in Vβ1NT thymocytes results in partial loss of the accelerated 
DN3/DN4 transition driven by expression of pre-assembled TCRβ genes. 
Dicer inactivation does not affect Vβ4/Vβ16 accessibility, indicating that 
Dicer is not required for barrier activity of Vβ16-Vβ10 intergenic 
sequences. Dicer deletion does result in decreased expression, transcription, 
and increased CpG methylation of Vβ10, all of which are consistent with 
reduced Vβ10 accessibility and/or loss of cells attempting Vβ10 
rearrangements, possibly due to incomplete or aberrant DNA repair in the 
absence of Dicer. To begin to distinguish between these two possibilities, 
we have generated and begun to analyze Lck-
Cre:Dicerflox/flox:Vβ1NT/NT:Rag1-/- mice. Initial experiments reveal that Rag1 
deletion leads to reemergence of the accelerated DN3/DN4 transition driven 
by Vβ1NT expression. Collectively, our data suggest that Dicer function is 
required for normal activation of cellular checkpoint(s) upon RAG mediated 
DNA cleavage in developing thymocytes. 
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Cell cycle control is critical for homeostasis in an antibody response. Upon 
stimulation by antigen and cytokines, resting mature B cells enter the cell 
cycle from the G0/G1 boundary, replicate and undergo clonal expansion. 
The D-type cyclins are known to promote cell cycle reentry and progression 
in cooperation with cyclin-dependent kinases (Cdk) 4 and 6, but their 
function in the antibody response is unknown. We now show that cyclin D2 
is dispensable for the T-independent (TI) antibody response due to 
functional redundancy with cyclin D1 and cyclin D3. By contrast, ablation 
of cyclin D2 compromises the expansion of germinal center B cells and the 
generation of low affinity plasma cells in the T-dependent (TD) response 
because of incomplete compensation by cyclin D3 activation. Cyclin D1 
apparently plays no role in the TD response, since cyclin D1 protein is not 
expressed despite the synthesis of cyclin D1 mRNA. Together, these data 
suggest that cyclin D2 is uniquely required to mediate specific physiologic 
signals for cell cycle activation in the TD response. In search of such 
signals, we have discovered that BAFF and IL-4 synergistically induce 
resting B cells to enter the cell cycle, leading to DNA replication and cell 
division, while IL-4 alone can not activate the cell cycle and BAFF induces 
only partial G1 progression. BAFF and IL-4 both are known to promote B 
cell survival in vivo and ex vivo. Induction of cell cycle entry by BAFF and 
IL-4 requires cyclin D2, through rapidly and selectively activation of cyclin 
D2 transcription that requires STAT6, but not cyclin D3 or D1 transcription. 
Our findings provide the first direct evidence that the D-type cyclins are 
differentially required for TI and TD antibody responses, and demonstrate 
an extraordinary specificity with which physiologic signals such as BAFF 
and IL-4 regulate D-type cyclins for homeostatic cell cycle control of the 
antibody response. 
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The tumor necrosis factor receptor-associated factors (TRAFs) have been 
found to function as signaling intermediates for the TNF receptor 
superfamily, and are believed to orchestrate cytoplasmic signaling events 
downstream of receptor activation. In this study, we show that TRAFs 1-7 
are present within the nucleus of Neuro2a cells, and that TRAF2 and 
TRAF3 translocate into the nucleus within minutes of CD40L-stimulation. 
Once in the nucleus, TRAF2 and TRAF3 very rapidly bind to chromatin, 
and more specifically to the nuclear factor-kappa B consensus element. 
Analysis of the transcriptional regulatory potential of TRAFs 1-7 by 
luciferase assay revealed that each of the TRAFs functions as a co-activator, 
co-repressor, or even as a transcription factor, in a cell- and target protein-
specific manner. Our findings demonstrate for the first time that the TRAF 
proteins are not only intermediate signaling molecules, but also direct 
effectors by modulating transcriptional activity. 
 39 
REGULATION OF BASAL AND INDUCIBLE EXPRESSION OF THE 
TRANSCRIPTIONAL CO-ACTIVATOR BOB.1/OBF.1 IN B VERSUS T 
CELLS 
 
Kerstin Müller, Jasmin Quandt, Melanie Kilzheimer, Thomas Wirth, 
Cornelia Brunner  
 
University Ulm, Institut of Physiological Chemistry, Albert-Einstein-Allee 
11, Ulm, 89081, Germany 
 
The transcriptional co-activator BOB.1/OBF.1 is recruited to the DNA via 
protein–protein interaction with Oct1 or Oct2 and thereby enhances 
octamer-dependent transcription. BOB.1/OBF.1-deficient mice show severe 
defects at several stages of B cell development in maturation and function. 
The main characteristic of these mice is the complete failure to form 
germinal centers. In T cells, BOB.1/OBF.1 contributes to the maintenance 
of the balance between TH1 and TH2 cells. BOB.1/OBF.1 is continuously 
expressed throughout B cell development albeit at different levels. In 
addition, the expression of BOB.1/OBF.1 can be further upregulated by 
stimuli like αCD40+IL-4 or LPS. In T cells no basal expression of 
BOB.1/OBF.1 could be detected. However, it is inducible expressed by 
treatment of T cells with PMA/Ionomycin or antigen receptor engagement. 
The aim of the present study is to identify regulatory elements within the 
BOB.1/OBF.1 promoter as well as transcription factors involved in the 
basal an inducible BOB.1/OBF.1 expression in B versus T cells.  
In silico analyses revealed, beside the known transcription factor binding 
site, a combined NF-AT/NF-κB site as well as an additional TATA-box 
within the BOB.1/OBF.1 promoter. Interestingly, we have also identified a 
combined NF-AT/NF-κB motif within the potential Oct2 promoter. 
Moreover, by using several different inducers and inhibitors, a co-regulation 
of Oct2 and BOB.1/OBF.1 could be observed. An array of genetic as well 
as biochemical analyses revealed an involvement of NF-κB and NF-AT 
transcrption factors in the transcriptional regulation of the BOB1/OBF.1 
promoter activity. 
Insights into the regulation of BOB.1/OBF.1 expression enable us to learn 
more about the transcriptional network necessary for proper B and T cell 
function. 
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The response to self and foreign antigens requires a network of signals 
between antigen presenting cells and responding T lymphocytes. In our 
studies, we demonstrate that the ability to access the TNFR-ligand CD70 
confers a competitive advantage to CD8+ T cells in response to foreign 
antigen. Specifically, adoptive transfer studies have demonstrated that 
CD8+ T cells sufficient for CD27 are able to suppress the expansion of 
endogenous antigen-specific CD8+ T cells to a greater extent than CD27-
defficient CD8+ T cells. To dissect the mechanism by which the expression 
of CD27 confers a competitive advantage to CD8+ T cells, we utilized in 
vitro and in vivo assays in which we were able to demonstrate that dendritic 
cell surface expression of CD70 is reduced in the presence of CD27+ T 
cells, but not CD27-deficient T cells. Furthermore, preliminary studies 
indicate that upon engagement of CD27 by CD70, CD27 is proteolytically 
cleaved from the surface of CD8+ T cells and captured by CD70 expressing 
dendritic cells, effectively masking CD70 from being recognized by 
neighboring responding T cells. These data indicate that CD8+ T cells of 
the same or different antigen specificities can compete against one another 
by directly regulating the access of T cells to CD70. Our data predicts that if 
access to TNFR-ligands were limited, then the responding population of 
antigen-specific T cells would be selected for high affinity clones. 
Consistent with this hypothesis, antigen-specific CD8+ T cells from 
immunized CD27-/- mice have an increased affinity for peptide:MHC 
complexes compared to WT T cells. Collectively, our data indicate that T 
cells compete against each other for access to the TNF ligand CD70 on the 
surface of antigen presenting cells, and that regulation of interactions 
between CD27 and CD70 shapes not only the magnitude, but also the 
repertoire of responding CD8+ T cells. 
 
This work supported by the Irvington Institute-Cancer Research 
Institute/Eugene V. Weissman Memorial Fellowship 
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Mature B-cell lymphomas represent the major class of human lymphomas 
overall, and the treatment of these diseases is a serious challenge in medicine. 
Biochemical and genetic analysis have firmly established that constitutive NF-
κB signaling and deregulation of cMyc expression are recurrent events in the 
ABC subgroup of Diffuse Large B-cell Lymphoma (ABCDLBCL), and in 
Multiple Myeloma (MM). However, it remains to be determined whether 
constitutive NF-κB signaling and deregulated cMyc expression cooperate to 
induce B-cell transformation and consequently are at the origin of ABC-
BLBCL and/or MM. 
 
To test this hypothesis we used conditional targeted mutagenesis in the mouse, 
to express a constitutively active IKK2 molecule (IKK2ca) and/or cMyc (MYC) 
in CD19pos B-cells through tamoxifen-induced Cre-mediated elimination of a 
STOP cassette. The genetic system of conditional targeted mutagenesis used in 
this work is unique in two ways. First, transgene activation occurs only in a 
small fraction of CD19pos B-cells (3-5%) through transient Cre expression, 
mimicking the sporadic nature of oncogenic events. Second, due to incomplete 
Cre mediated recombination in individual cells, this CD19pos B-cell population 
is constituted by IKK2capos/MYCpos, IKK2capos/MYCneg and IKK2caneg/MYCpos 
expressing cells, providing all possible “oncogene” combinations in the same 
mouse at the same time.  
 
While the KK2caneg/MYCpos B-cells decayed over time, IKK2capos/MYCneg B-
cells remained constant over time, in agreement with our previous results 
showing that constitutive NF-kB signaling per se, promotes B-cell survival but 
not proliferation. By contrast, there was a steady increase of the 
IKK2capos/MYCpos population, and eventually, 100% of the mice succumbed to 
a plasma cell neoplasia derived from this population, with a median survival of 
192 days. Tumor cells were present in bone marrow, spleen, and 75% of the 
mice exhibited liver metastasis.  
 
Thus, using a conditional targeted mutagenesis system that recapitulates the 
sporadic nature of oncogenic events, we demonstrate that constitutive NF-κB 
signaling cooperates with deregulated cMyc expression to induce B-cell 
transformation and MM in the mouse. These results suggest that this oncogene 
combination represents a primary event in MM rather than ABCDLBCL. 
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Among the most prominent microRNAs in the hematopoietic system are 
two microRNAs generated from a single microRNA precursor, namely 
miR-142-5p and -3p. These two microRNAs are highly abundantly and 
almost exclusively expressed in the hematopoietic lineage. As their seed 
sequences differ from each other, they are predicted to target different 
groups of molecules. To investigate the functional role of these 
microRNAs, we generated a conditional allele to be able to delete miR-142 
in a cell type specific manner. So far, we have analyzed mice in which miR-
142-5p and -3p have been deleted in the germline. This resulted in 
splenomegaly, a dramatic reduction of T cells in spleen and blood, impeded 
B cell maturation in bone marrow and spleen, loss of B1 cells, and an 
increased proportion of granulocytes in spleen. These results and ongoing 
experiments will be discussed. 
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Mice bearing a knockdown mutation in the Ikaros gene (IkL/L) develop 
spontaneous T-cell lymphomas/leukemias that exhibit strong activation of 
the Notch pathway. How and which members of the Notch pathway 
contribute to T-cell transformation in vivo remain unclear. We investigated 
the role of Notch1, Notch3 and RBP-Jk in the progression of T-cell 
leukemias in IkL/L mice by a genetic approach. Deletion of RBP-Jk 
markedly delays tumor initiation, indicating that the Notch pathway is 
essential for the development of Ikaros-deficient T-cell tumors. Deletion of 
Notch3 did not affect survival, suggesting that Notch3 is not required for 
tumor progression. Unexpectedly, deletion of Notch1 via its 5' 
promoter/exon1 significantly accelerated tumor progression. These Notch1-
deleted tumors were inhibited in their growth by gamma-secretase 
inhibitors, showed strong activation of Notch target genes, and accumulated 
cleaved Notch1 proteins containing 3' PEST mutations. In addition, the 
tumor cells contained Notch1 transcripts that were initiated from a cryptic 
intragenic promoter and encode proteins lacking the extracellular domain. 
These results suggest that the combined loss of Ikaros and the conserved 
Notch1 promoter results in the synthesis of novel Notch1 oncogenic 
proteins. 
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Allelic exclusion allows only one functional Tcrb V-to-DJ rearrangement 
per thymocyte. This process is initiated by asynchronous recombination and 
maintained by feedback inhibition. Asynchronous recombination could 
result from either strictly ordered recombination of alleles, or by infrequent 
recombination of both alleles. Association with repressive nuclear 
compartments could potentially suppress Tcrb recombination efficiency. 
Two well characterized repressive compartments are the nuclear lamina and 
pericentromeric heterochromatin. Previously we used 3D immunoFISH to 
localize TCR genes and demonstrated that Tcrb alleles frequently and 
stochastically colocalize with the lamina. V-to-DJ recombined Tcrb alleles 
were more often located centrally, which could result either from infrequent 
V-to-DJ recombination of lamin-associated alleles or recombination of 
lamin-associated alleles followed by their dissociation from the lamina. We 
used 3D immunoFISH to label Tcrb alleles, the lamina, and DSB repair 
protein 53BP1 to analyze the location of recently rearranged Tcrb genes. 
We found that recently recombined alleles are underrepresented at the 
lamina. Therefore Tcrb loci do not substantially relocalize following 
recombination, and association with the lamina reduces recombination 
efficiency. Because some recombination events do occur at the lamina, we 
further investigated the conformation of lamin-associated alleles using a 
program capable of measuring the distance between the centers of Tcrb and 
53BP1 foci and the surface of the lamina. We found that the 5’ end and the 
3’ end of most Tcrb alleles were equidistant from the inner edge of the 
lamina. However Tcrb 53BP1 foci were clearly farther from the lamina than 
5’ Tcrb foci. This indicates that recombination of peripheral Tcrb alleles 
may occur on a subset of alleles that adopt a conformation in which a 
portion of the locus preferentially dissociates from the lamina. Therefore 
both the location and orientation of the Tcrb locus relative to the lamina 
likely play roles in asynchronous V-to-DJ recombination. 
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The interferon regulatory factor 5 (IRF5) transcription factor is activated in 
response to pathogens that activate Tank-binding kinase-1 (TBK-1), Tumor 
necrosis factor receptor-associated factor-6 (TRAF6), or Receptor 
interacting protein-2 (RIP2). We compared the individual effects of these 
activators on the ability of IRF-5 to induce the interleukin-12 (IL-12) p40 
promoter and interferon promoters. Compared with TRAF6 or TBK1, RIP2 
was the most effective activator of IRF-5 transcriptional activation. The role 
of RIP2 in signaling by nucleotide-binding oligomerization domain (NOD)-
like-receptors suggests that IRF5 may play a preferred role in NOD-like-
receptor signaling under physiological conditions. Mass spectrometry was 
used to identify two specific serine residues phosphorylated on IRF-5 by 
TBK-1. Introducing phosphomimetic Asp substitutions for these residues 
confers constitutively active IRF5, suggesting phosphorylation on these 
residues facilitates TBK-1-mediated IRF5 function. TRAF6, an E3 
ubiquitin ligase, stimulates the ubiquitination of IRF-5 and IRF-5 mediated 
induction of the IL-12 promoter. This induction is senstitive to the 
deubiquitinating activity of A20 as is the induction by RIP2. Our studies 
indicate that IRF-5 plays a primary role in innate immune responses to 
pathogens that activate the NOD-like receptor inflammasome, specific 
cytokine gene induction, and subsequently cell death. 
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IL-12 and IL-23 are produced by activated antigen-presenting cells but the 
two induce distinct immune responses by promoting Th1 and Th17 cell 
differentiation, respectively. IL-23 is a heterodimeric cytokine consisting of 
two subunits: p40 that is shared with IL-12 and p19 unique to IL-23. In this 
study, we showed that the production of IL-23 but not IL-12 was negatively 
regulated by protein phosphatase 2A (PP2A) in dendritic cells (DC). PP2A 
inhibits IL-23 production by suppressing the expression of the IL-23p19 
gene. Treating DC with okadaic acid that inhibits the PP2A activity or 
knocking down the catalytic subunit of PP2A with siRNA enhanced IL-23 
but not IL-12 production. Unlike PP2A, MAP kinase phosphatase-1 or 
CYLD did not show an effect on IL-23 production supporting the 
specificity of PP2A. PP2A-mediated inhibition requires a newly made 
protein that is likely responsible for bringing PP2A and IKKβ together upon 
LPS stimulation which then results in the termination of IKK 
phosphorylation. Thus, our results uncovered an important role of the 
protein phosphatase in the regulation of IL-23 production and identified 
PP2A as a novel inhibitor of IL-23p19 expression in DC. 
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The NF-κB signaling pathway in the cytoplasm, the release of NF-kB 
dimers from IkB complexes, and the subsequent translocation into the 
nucleus and gene activation by NF-kB have been well studied. However, 
one central issue that remains unresolved is the precise mechanism by 
which each member of the NF-kB family differentially regulates the 
expression of a diverse array of genes in different cell types and in response 
to different stimuli. The five evolutionarily conserved NF-kB proteins 
(named RelA [p65], RelB, c-Rel, p50, and p52) contain an N-terminal 300-
amino acid Rel homology region (RHR) that is responsible for DNA 
binding and dimerization. The NF-kB family members p65 and c-Rel 
recognize similar DNA sequences through identical DNA contact residues, 
yet the phenotypes of mutant mice suggest that these proteins regulate 
distinct sets of genes. 
Previously, we showed that c-Rel is required for the induction of Il12b 
transcription upon lipopolysaccharide (LPS) stimulation of bone marrow-
derived macrophages (S. Sanjabi et al. PNAS, 2000). We demonstrated that 
46 unique residues within an 86-residue segment of the RHR of c-Rel are 
responsible for the c-Rel requirement for Il12b induction (S. Sanjabi et al., 
Genes and Dev. 2005). Although the residues of c-Rel and p65 that contact 
specific bases and the DNA backbone within the NF-kB recognition 
sequences are identical, homodimers of c-Rel and of a chimeric p65 protein 
containing the critical c-Rel residues bound with high affinity to a broader 
range of NF-kB recognition sequences than did wild-type p65 homodimers. 
These results demonstrate that the unique functions of closely related 
transcription factor family members can be dictated by differences in the 
range of DNA sequences recognized at high affinity, despite having similar 
binding site consensus sequences and DNA contact residues.  
These findings highlighted our limited knowledge of the unique DNA-
binding properties of each homodimeric and heterodimeric NF-kB species. 
To better define the similarities and differences in DNA-binding properties, 
we have critically analyzed binding kinetics of eight dimeric species 
through the use of surface plasmon resonance. Combined with detailed 
studies of consensus recognition sequences performed in collaboration with 
the lab of Martha Bulyk, our results have provided important insights that 
are likely to help explain the different physiological roles and mechanisms 
of action of the individual NF-kB family members and dimers.  
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The immunoglobulin heavy (IgH) chain locus is subject to several tightly 
regulated processes, such as VDJ joining, somatic hypermutation and class 
switching (CSR). One of two key cis regulatory elements in the IgH locus, 
the 3' regulatory region (3'RR) contains multiple enhancers (hs3a, hs1,2, 
hs3b and hs4) and is required for IgH expression and class switching. 
Additional DNase I hypersensitive sites are located downstream of hs4. The 
chromosome conformation capture (3C) assay has revealed that the 3'RR 
physically interacts with the VH promoter region and with I regions, 
forming a scaffold on which IgH expression and CSR can occur. My 
experiments focus on examining the regulation of the 3'RR by various 
binding factors: these include CTCF, a protein that binds to hs4 downstream 
sequences and is associated with all mammalian insulators; cohesin, which 
colocalizes with most of the CTCF binding sites in the genome and thereby 
contributes to insulator activity; and transcription factors YY1 and Pax5, 
which are known to influence IgH-specific processes. Chromatin immuno-
precipitation (ChIP) assays revealed dynamic binding of these factors to 
3'RR elements during B cell development and during LPS stimulation for 
CSR. My experiments show that YY1 acquires binding to hs1,2 after 48 hrs 
of LPS stimulation. Pax5 binds to hs4 in resting and 96 hr LPS-activated B 
cells but not at 48 hrs when germ line transcripts are expressed. In addition, 
stimulation of normal B cells, while adding anti-IgM (which prevents 
switching), changes Pax5 binding, further suggesting a role for Pax5 in 
CSR. Binding of CTCF to hs3b and hs4 of the 3'RR is modest throughout 
LPS stimulation. However, cohesin binds to hs3b and hs4 at 0 hrs and 96 
hrs but not at 48 hrs. Hence, cohesin binding is independent of CTCF. Such 
regulated binding of these factors at hs3b and hs4 indicate their potential 
roles in switching and germ line transcription as hs3b and 4 are critical for 
these events. As an approach to identify the function of CTCF in the 
regulation of IgH, we knocked down CTCF with shRNA in pre-B, B and 
plasma cell lines. Initial experiments showed that CTCF was not essential 
for IgH loop formation in plasma cells. Interestingly, CTCF appears to 
contribute to the regulation of Pax5 binding in the 3'RR. In CTCF-depleted 
cell lines, Pax5 acquired binding to specific 3’RR sites. In addition, during 
B cell development, Pax5 binding to hs1.2 decreases while CTCF binding 
to hs1.2 increases. In further support of this reciprocity, EMSA shows that 
CTCF can compete with Pax5 binding in vitro. The mechanisms by which 
transcription factor binding to the 3'RR is regulated are under study. (NIH 
AI13509) 
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Mammalian microRNAs (miRNAs) are emerging as key regulators of the 
immune system. Here we report a strong but transient induction of miR-155 
in mouse bone marrow after injection of bacterial lipopolysaccharide (LPS) 
correlated with granulocyte/monocyte (GM) expansion. Demonstrating the 
sufficiency of miR-155 to drive GM expansion, enforced expression in 
mouse bone marrow cells caused GM proliferation in a manner reminiscent 
of LPS treatment. MiR-155 expressing mice also exhibited marked 
splenomegaly and extramedullary hematopoiesis. Extending relevance to 
human disease, mir-155 levels were 4.5 times higher in the bone marrow of 
acute myeloid leukemia (AML) patients as compared to normal, and 8 times 
higher in M4/M5 AML patients as compared to normal. To determine 
which genes mir-155 regulates, Raw 264.7 cells were stably transfected 
with a mir-155 expressing vector, and a microarray showed downregulation 
of 1080 genes. Of these, 89 contained conserved mir-155 binding sites as 
determined by Targetscan 4.0. Among these were eleven genes relevant to 
hematopoiesis and myeloproliferation. We knocked each of these genes 
down in the mouse hematopoietic system using retroviral vectors expressing 
small interfering RNAs (siRNAs), and found that specific knockdown of 
SHIP1 results in a myeloproliferative disorder (MPD) that is strikingly 
similar to that observed in miR-155 expressing mice. We used gain and loss 
of function approaches to show that miR-155 represses SHIP1 through 
direct 3’UTR interactions that have been conserved throughout evolution. 
Repression of endogenous SHIP1 by miR-155 occurred following sustained 
overexpression of either mouse or human miR-155 in hematopoietic cells 
both in vitro and in vivo, and resulted in increased activation of the kinase 
AKT during the cellular response to LPS. Furthermore, SHIP1 was also 
repressed by physiologically regulated miR-155, which was observed in 
LPS treated wild type versus miR-155-/- primary macrophages. Taken 
together, our study unveils a molecular link between miR-155 and SHIP1, 
and provides evidence that miR-155 repression of SHIP1 contributes to the 
pathogenesis of the myeloid diseases MPD and AML. 
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Lymphocyte development is driven by V(D)J recombination, a process by which 
antigen receptor gene segments are rearranged to create a vast repertoire of antigen 
receptor specificity. Because V(D)J recombination entails the cleavage and joining 
of widely dispersed gene segments many millions of times each day, the antigen 
receptor loci are particularly dynamic regions of the genome, and even a miniscule 
error rate would still carry considerable risk of translocation. Indeed, leukemias and 
lymphomas are among the most common malignancies in humans, and 
chromosomal translocations involving the antigen receptor loci are a common 
underlying mechanism. Multiple mechanisms regulate sequential accessibility of the 
loci to the recombinase machinery including changes in histone modifications and in 
nuclear compartmentalization. Our lab is focused on investigating the mechanisms 
by which recombination is coordinated on the individual alleles of antigen-receptor 
loci during B and T cell development. Our recent analyses of the Immunoglobulin 
loci suggest a new model for recombination whereby the V(D)J recombinase and 
DNA damage response machinery coordinate DNA cleavage and nuclear 
positioning to initiate allelic exclusion and preserve genomic integrity during 
recombination (Hewitt et al, 2009). Homologous Ig alleles physically pair up in a 
stage-specific manner that parallels the sequential stages of their recombination. We 
also found, surprisingly, that this interallelic association is mediated by the V(D)J 
recombinase and the introduction of a double-strand break at one Ig allele induces 
ATM-dependent repositioning of the other allele to pericentromeric heterochromatin 
to prevent further cleavage. An absence of ATM leads to biallelic RAG-mediated 
cleavage, which results in breaks and translocations.We are now investigating how 
the recombination process of the Tcra locus is regulated in developing thymocytes. 
This locus is of interest because: i) the Tcrd locus is embedded within Tcra, and is 
recombined in early double-negative T cells, whereas Tcra is recombined later at the 
double-positive T cell stage, and ii) Tcrd is the only antigen receptor locus that is not 
allelically excluded. Using 3D-DNA in situ hybridization and immunofluorescence, 
we focused on understanding how the recombinase machinery, ATM and other 
components of the DNA double stranded break repair pathway, and environmental 
signaling pathway, coordinate the regulation of Tcra recombination. Our data 
suggest that a dialog between recombination and repair pathways, as well as 
environmental signals influence accessibility of the Tcra locus. 
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Signal transducers and activators of transcription (STATs) are latent 
proteins that are activated in response to different cytokines and hormones 
and transduce signals from the cytoplasm to induce gene expression in the 
nucleus. There are seven members in this family in mammals and STAT6 
transcription factor is essential for the development of protective immunity, 
however the consequences of its activity can also contribute to the 
pathogenesis of autoimmune disease. It is activated by tyrosine 
phosphorylation in response to cytokine stimulation, but the mechanisms by 
which it enters the nucleus have not been defined. We used live cell 
imaging techniques (fluorescence recovery after photobleaching and 
fluorescence loss in photobleaching) to demonstrate the continual nuclear 
import and export of STAT6 is independent of tyrosine phosphorylation. 
The protein domain required for nuclear entry includes the coiled coil 
region of STAT6 and was found to function similarly before or after 
cytokine stimulation. The dynamic nuclear shuttling of STAT6 appears to 
be mediated by the classical importin-α-importin-β1 system. Although 
STAT6 is imported to the nucleus continually, it accumulates in the nucleus 
following tyrosine phosphorylation due to its ability to bind DNA. These 
findings will impact both diagnostic strategies and strategies to block the 
deleterious effects of STAT6 in autoimmunity. 
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NF-κB family transcription factors are critical regulators of gene 
transcription. Akt is known to contribute to the activation of numerous 
downstream pathways including NF-κB. Using an NF-κB enriched 
microarray we found that many NF-κB regulated genes were upregulated 
after T cell activation of which only a subset were affected by Akt 
inhibition. These genes include TNF-α, Tnfsf14, Csf2, Il6, Il10 etc. In this 
study we further investigated the role of Akt in NF-κB-mediated TNF-α 
gene expression. The chromatin immuno-precipitation assay showed that 
recruitment of the NF-κB p65 subunit to the promoter of TNF-α was 
reduced by inhibition of Akt. The DNA binding activity of p65 was also 
decreased by Akt inhibition. Similar results were demonstrated on TNF-α 
production in a Th2 cell line, bone marrow derived macrophages and 
primary Th1 cells and human whole blood in the presence of Akt inhibitor. 
Taken together, these data provide compelling evidence for the role of Akt 
in NF-κB mediated TNF-α gene expression. 
 
Supported by NIH grant GM080398. 
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Induction of G1 cell cycle arrest by the Cdk4/6 inhibitor p18INK4c (p18) is 
critical for the generation of non-cycling end-stage plasma cells. In the 
absence of p18, CD138+ plasmacytoid cells continue to cycle but are rapidly 
eliminated by apoptosis in situ. These findings provide the first direct 
evidence for cell cycle control of plasma cell differentiation in vivo, and 
suggest that cell cycle attenuation by p18 imposes a final homeostatic 
checkpoint in plasma cell differentiation. We now show that p18 selectively 
acts in a rare population of rapidly cycling and apoptotic CD138hi/B220hi 
intermediate plasma cells (iPCs). iPCs are poised to differentiate to IgG-
secreting plasma cells, while retaining activated B cell signatures such as 
CD40, CD22 and GL7. p18 is required for the generation or maintenance of 
the iPC pool and promotes timely differentiation to plasma cells. 
Conversely, CD40 signaling accelerates the cell cycle in opposition to p18 
in iPCs and enhances apoptosis. Consistent with cell cycle control of 
apoptosis, the iPC pool is expanded by the loss of the pro-apoptotic Bim or 
overexpression of the anti-apoptotic Bcl-xL. p18 is dispensable for the 
expression of transcription factors that are essential for germinal center 
formation or plasma cell differentiation. Blimp-1 and Bcl-6 are expressed 
fully and mutually exclusively in individual iPCs, except for a minor 
proportion expressing both. These Blimp-1+/Bcl-6+ iPCs are preferentially 
protected by p18 and Bcl-xL. On this basis, we propose that p18 targets 
iPCs, which are dynamic and transient intermediates between activated B 
cells and plasma cells, for homeostatic control of terminal plasma cell 
differentiation by cell cycle-coupled apoptosis. 
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Translocations in tumors are considered to represent very low frequency 
events that are strongly selected at the cellular level. However, we have 
recently demonstrated that mechanistic factors have the ability to 
substantially influence the frequency of recurrent translocations. Such 
mechanistic factors include the frequency of DSBs at two loci, the spatial 
proximity of the two loci, and the repair pathways functionally available to 
carry out the actual joining. To gain further insights into mechanisms that 
promote translocations, we are developing high-throughput methods to 
identify translocation partners from fixed DNA DSBs in a genome-wide 
fashion. By targeting I-SceI recognition sequences into the γ1 switch region 
or into the c-myc locus we were able to ask for translocations appearing in 
cycling primary B cells from a defined DSB site.  
Our preliminary analysis showed that in WT or H2AX deficient cells a 
defined DSB does not translocate to a very limited number of chromosomal 
loci, as suggested from some tumor studies, but rather has a relatively broad 
distribution to many sites on most chromosomes. On the other hand, there 
are areas that appear to be targeted more frequently for translocations, 
including sites along the same chromosome. Ongoing analyses which seek 
to saturate translocation maps and compare translocations frequencies in 
different genetic backgrounds (e.g. deficient in particular DSB response or 
repair factors) should help to more clearly define the role in primary B cells 
of various factors, including nuclear organization, DNA sequence, and 
repair pathways in suppressing and/or enhancing recurrent translocations.  
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Interleukin (IL)-4 is an important survival factor for hematopoietic cells 
such as lymphocytes. Mechanisms of anti-apoptotic signaling induced by 
IL-4 apart from PI3K-Akt activation are not clear. Previous work identified 
PARP-14 as a protein with intrinsic ADP-ribosyltransferase activity that is 
highly expressed in B cells and interacts with the IL-4-induced transcription 
factor Stat6. ADP-ribosyltransferases and PARPs catalyze mono- and poly-
ADP-ribosylation, transferring ADP from NAD+ to target proteins. ADP-
ribosylation is a post-translational modification which influences gene 
transcription, DNA repair and apoptosis. Although there are 17 PARP 
family members, almost nothing is known about biological roles or 
mechanisms of mammalian PARPs other than PARP-1. We now show that 
roles of PARP-14 in mediating IL-4 induction of metabolic functions of B 
lymphocytes are central to a requirement for PARP-14 in IL-4-induced 
survival signaling. The evidence indicates that a coordinate enhancement of 
glycolysis and mitochondrial function is orchestrated by PARP-14 in B 
cells and is crucial for the protective role of IL-4. In addition, AMP-
activated protein kinase (AMPK) activity regulated by IL-4 and metabolic 
fitness are pre-conditions for PARP-14-dependent survival signaling. 
Consistent with a vital biological role, PARP-14 regulates energy 
metabolism in B cells from Eμ-Myc transgenic mice and contributes to 
pathogenesis of Eμ-Myc-induced lymphoma. Together, these results reveal 
a novel function of a mammalian ADP-ribosyltransferase in mediating 
cytokine-regulated metabolic activity and survival of lymphocytes. 
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The berberine (BBR), an isoquinoline alkaloidal component of Coptidis 
Rhizoma, became known to have anti-inflammatory, anti-oxidative and 
anti-diabetic effects. The molecular mechanism, however, involved in the 
anti-inflammatory effect of BBR is not fully understood. In this study, we 
found that berberine suppressed the prostaglandin E2 (PGE2) and nitric 
oxide (NO) production in LPS-activated RAW 264.7 cells. Interestingly, 
BBR decreased the enzyme activity of COX-2 but failed to inhibit the 
COX-2 expression. Meanwhile, NO reduction by BBR was due to the 
inhibition of inducible nitric oxide (iNOS). Moreover, our results revealed 
that the repression of iNOS but not COX-2 expression may come from the 
activation of Akt, downstream of the PI3K signal cascade. The treatment 
wortmannin, PI3K inhibitor, protected the BBR-induced reduction of iNOS 
expression. In summary, our data indicated that BBR exhibits the anti-
inflammatory properties via differential inhibitory effect on COX-2 and 
iNOS activities in LPS-activated RAW 264.7 cells.  
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CD8+ cytotoxic T lymphocytes (CTLs) play a major role in defense against 
intracellular pathogens. While effector CTLs eliminate the infection, a small 
population of memory cells are retained that yields more rapid and robust 
response upon re-infection. Antigen presenting cells secrete an array of 
innate cytokines including IL-12 and IFN-α after recognition of pathogens. 
Both IL-12 and IFN-α have been shown to act as the third signal regulating 
the development of CTLs. We have shown that these two cytokines have a 
non-redundant effect in generation of human effector vs memory CTL. IL-
12 alone is sufficient for effector CTL genesis marked by IFN-γ and TNF-α 
production, as well as increased cytolytic activity. In contrast, human CTLs 
activated in the presence of IFN-α developed central memory phenotype. 
Using microarray analysis we have investigated how IL-12 and IFN-α 
differentially regulate the genetic programming pathways that give rise to 
effector vs central memory among multiple human donors. We have also 
analyzed the gene expression patterns of cells sorted out of peripheral blood 
that display surface markers of effector and memory CTL. With this 
approach, we will determine the unique pathways that are upregulated in 
response to either IL-12 or IFN-α, which eventually leads to stably 
expressed gene expression in memory cells. 
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Interferons (IFN) are produced by most cells in the body in response to viral 
infection and induce the expression of many diverse genes with anti-viral, 
anti-tumor and immunoregulatory functions. Because IFNs have such 
diverse physiological roles they have been used clinically for the treatment 
of Hepatitis C virus infection, cancer and Multiple Sclerosis. However, 
there are many cellular suppressors that can reduce the efficacy of IFN 
therapy. Our previous work has shown that activation of the Ras/MEK 
pathway allows viral replication even in the presence of IFN-α. In addition, 
we have recently shown that activation of the Ras/MEK pathway in NIH 
3T3 mouse fibroblast cells inhibits transcription of the STAT2 gene, an 
essential mediator of the IFN-α pathway, to significantly, but partially, 
reduce the IFN-α response. Here we sought to identify additional genes, 
which are necessary for an effective IFN-α response, whose expression is 
repressed by the Ras/MEK pathway. Using global gene expression analysis 
we identified IFN-inducible genes that are upregulated by treatment with 
MEK inhibitor U0126 (MEK-downregulated IFN-inducible (MDII) genes). 
The expression levels of five anti-viral genes (STAT2, GBP2, Ptx3, IRF7 
and Iigp2) in response to U0126 and/or IFN treatment were confirmed by 
quantitative RT-PCR. We hypothesize that a common transcriptional 
regulator controls expression of many of the MDII genes to globally reduce 
IFN-α signaling. To identify this unknown transcriptional regulator, we 
have analyzed the promoter regions of a number of these genes using 
luciferase reporter constructs and identified potential regulatory regions that 
respond to U0126 treatment. Further in silico analysis of the promoter 
regions followed by ChIP experiments to analyze promoter occupancy by 
putative transcription factors will be performed to identify the transcription 
factor responsible for regulating expression of the MDII genes. 
Identification of a transcriptional regulator used by cellular suppressors of 
the IFN pathway may reveal additional therapeutic strategies to restore IFN-
responsiveness to cell types that are resistant to IFN therapy. 
 
Funding provided by CIHR and to SLC by a CIHR post-doctoral fellowship 
and a trainee award from The Beatrice Hunter Cancer Research Institute 
with funds provided by CRTP. 
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The demands for energy substrates in a eukaryotic cell rise as the cell 
transitions from a resting state to an activated state. This process is well 
documented in lymphocytes undergoing mitogenic responses. In these cells, 
the increasing energy requirements are met by increasing production of 
ATP either by glycolysis or by oxidative phosphorylation (OXPHOS), both 
processes being regulated by signaling from antigen receptors and 
costimulatory molecules. Scattered evidence suggests that these demands on 
cellular bioenergetics correlate with mitochondrial biogenesis. However, the 
molecules that regulate mitochondrial biogenesis in response to lymphocyte 
activation remain unknown. 
 
We have reported that stomatin-like protein 2 (SLP-2), a mitochondrial 
inner membrane protein, is up-regulated in human T lymphocytes during 
activation and this correlates with enhanced T cell function. The mechanism 
by which SLP-2 modulates T cell activation is currently unknown. Our 
work indicates that SLP-2 interacts with prohibitin-1 and 2 and binds to the 
mitochondrial inner membrane phospholipid cardiolipin. Up-regulation of 
SLP-2 expression increases de novo synthesis of cardiolipin and the cellular 
cardiolipin content as well as the formation of metabolically active 
mitochondrial membranes. Up-regulation of SLP-2 is also associated with 
an increase in the expression of the nuclear transcriptional co-activator 
PGC-1α (required for mitochondrial biogenesis) and in mitochondrial DNA 
replication. Altogether, these events translate into increased intracellular 
ATP stores, increased mitochondrial uptake of calcium, and enhanced 
resistance to apoptosis through the mitochondria-dependent intrinsic 
pathway, the end result being increased T lymphocyte effector responses. 
We have generated a conditional T cell knockout mouse for SLP-2 and 
preliminary data corroborate the functional phenotype in vivo. 
 
Based on these results, we propose that SLP-2 modulates T cell activation 
by recruiting prohibitins to cardiolipin-enriched microdomains in the 
mitochondrial inner membrane and regulating mitochondrial biogenesis. 
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Pax5, a B-cell specific transcription factor, is crucial for normal B-cell 
development and is also overexpressed through chromosomal translocations 
in a subset of B-cell neoplasms. Previously, we had shown that activation of 
ITAM proteins and B-cell receptor signaling by Pax5 contributes to B-
lymphomagenesis (Cozma et al, J Clin Invest, 2007). However, the 
molecular basis of its transforming activity is not fully understood. In 
particular, it is not known whether and how Pax5 interacts with other 
oncogenic transcription factors. Our new data demonstrate that 
overexpression of Pax5 increases c-Myc protein stability and steady-state 
levels. This was discovered using Pax5-negative plasmacytoma cell lines 
and Myc5, a c-Myc-induced murine lymphoma with spontaneous silencing 
of Pax5 (Yu et al, Blood, 2003; Johnson et al, Nat Immunol, 2004). 
Consequently, the ability of c-Myc to bind to and inhibit the promoter of the 
tumor suppressor miR15a/16-1 (Chang et al, Nat Genet, 2008) was 
markedly enhanced in presence of Pax5. Conversely, Pax5 knockdown 
decreased c-Myc protein expression in Myc5 and P493-6 cells, where c-
Myc expression is driven by the retroviral LTR and the synthetic tetO7-TP 
promoter, respectively. This suggested a promoter-independent, post-
translational mechanism of c-Myc regulation. After analyzing several Pax5 
effectors in Pax5-negative cells, we found that constitutive ITAM signaling 
does not rescue c-Myc levels, while CD19, a B cell-specific co-receptor, 
was a potent inducer of c-Myc protein. This effect was due at least in part to 
the restoration of AKT signaling and inhibition of GSK3-beta function. 
Moreover, ectopic CD19 expression in murine plasmacytoma and Myc5 
cells was sufficient to boost cell expansion both in vitro and in vivo. Thus, 
Pax5 and its downstream effector CD19 could be considered major 
regulators of c-Myc oncogenic activity in B-cell neoplasms. This work was 
supported by the Leukemia & Lymphoma Society fellowship #5259-09 to 
EYC and the National Institutes of Health grant R01CA102709 to A.T.-T.  
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IL-17-producing T lymphocytes have recently been shown to comprise a 
discrete lineage of proinflammatory helper T cells, termed Th17 cells. 
While important for the clearance of a variety of pathogens at mucosal 
surfaces, Th17 cells have also been implicated as major contributors to 
tissue inflammation and autoimmunity. Our group has identified the orphan 
nuclear receptor RORγt as a key transcription factor (TF) regulating Th17 
development, being both required and sufficient for the generation of IL-17-
producing cells. Other nuclear factors, namely STAT3 and IRF-4, have also 
been demonstrated to be essential for this process. The objective of this 
study is to delineate the otherwise obscure mechanisms by which RORγt 
regulates transcription, and how RORγt collaborates with STAT3 and IRF-4 
to mediate changes in chromatin structure and gene expression at target 
loci. To this end, we will employ chromatin immunoprecipitation followed 
by high throughput sequencing (ChIP-Seq) to compile genome-wide maps 
of direct TF binding and of histone modifications in naive T cells activated 
under Th17-polarizing conditions. This strategy will be coupled with 
transcriptome analysis of wild-type and TF-deficient Th17 cells to define 
factor-dependent expression profiles, and distinguish activated versus 
repressed targets. Preliminary analyses reveal a high degree of overlap in 
Th17-associated TF binding, suggesting coordinate regulation of gene 
expression. This work will provide mechanistic insight into the function of 
RORγt, STAT3, and IRF-4 in Th17 cells and, moreover, delineate the 
transcriptional regulatory network that underlies Th17 lineage specification 
and function.  
 
Supported by a fellowship from the Leukemia & Lymphoma Society to 
M.C.; and funds from the Howard Hughes Medical Institute (D.R.L.) and 
the HudsonAlpha Institute (R.M.M.). 
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The closely linked IL-3 and GM-CSF genes are located within a cluster of 
cytokine genes co expressed in activated T cells. Their activation in 
response to TCR signaling pathways is controlled by specific inducible 
upstream enhancers.  
To study the developmental regulation of this locus in T lineage cells we 
created a transgenic mouse model encompassing 130 kb of the human IL-3 
and GM CSF genes plus the known enhancers. We demonstrated that the IL 
3/GM-CSF locus undergoes progressive stages of activation. Looking first 
at immature T cells, we found that the IL-3/GM-CSF locus was 
epigenetically and transcriptionally silent in CD4/CD8 double positive 
thymocytes, thereby minimizing the potential for inappropriate activation 
during the course of TCR selection. Thymocytes lacked all of the tissue-
specific and inducible DNaseI Hypersensitive Sites (DHSs) associated with 
regulatory elements, with the exception of the insulator that segregates the 
two genes. Intra-cellular FACS staining of mature T cells revealed that the 
IL-3 and GM-CSF genes are differentially regulated with stepwise increases 
in active modifications and the proportion of cytokine-expressing cells, 
throughout the course of T cell differentiation. Freshly isolated spleen T 
cells exhibited essentially no inducible IL-3 expression and only 6% of cells 
could express GM-CSF. The locus did not reach its maximal transcriptional 
potential until after T cells had undergone blast cell transformation to 
become fully activated proliferating T cells. In stimulated T blast cell 
cultures, 24% of cells expressed both IL-3 and GM-CSF, 37% expressed 
just GM-CSF, almost no cells expressed IL-3 alone, and 40% of cells 
expressed neither gene. Hence, there appears to be stochastic activation of 
this locus, as has been observed for the IL-4 and IL-13 genes. The transition 
from thymocytes to T blast cells was accompanied by the acquisition of 
active histone modifications within tissue-specific DHSs located far 
upstream and downstream of the locus, and the ability to induce DHSs at 
enhancers. The ability to express IL-3 was dependent not on the previously 
defined proximal IL-3 enhancer, but on a novel powerful enhancer located 
37 kb upstream. We also found that memory CD4 positive T cells, but not 
naïve T cells, maintain a remodelled chromatin structure resembling that 
seen in T blast cells. 
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In addition to IL-17A and IL-17F, mouse Th17 cells also produce the IL-
10-related cytokine IL-22. IL-22 plays a non-redundant role in immunity to 
pathogenic bacteria such as Klebsiella pneumoniae and Citrobacter 
rodentium. Similar to IL-10, both pro and anti-inflammatory effects have 
been described for IL-22. Th17 cell-derived IL-22 has been shown to 
mediate IL-23-induced skin inflammation in models of psoriasis, indicating 
a proinflammatory function of IL-22. However, IL-22 has also potent anti-
inflammatory activities in models of acute hepatitis and inflammatory 
bowel disease. These studies showed that, although IL-17 and IL-22 are 
coexpressed by inflammatory Th17 cells in the mouse, these cytokines 
could have diverging activities on inflammatory responses depending on the 
tissue and the model studied. Recent reports have suggested that human IL-
22 producing CD4+ T cells may represent a separate T helper cell subset.  
We have determined which human CD4+ T cell subsets secrete IL-22 and 
how IL-22 expression is regulated during CD4+ T cell differentiation. We 
found that in peripheral blood, similar to IL-17, most of the IL-22-secreting 
T cells were memory cells expressing the chemokine receptor CCR6. 
Analysis of cytokine production at the single cell level revealed than only 
one third of Th17 cells also produced IL-22 whereas the major IL-22-
secreting cell populations were a subset of Th1 cells and “Th22” cells that 
produce neither IL-17 nor IFN-γ. Finally, we identified a small population 
of CD4+ T cell producing the 3 cytokines. Thus, our results indicate that IL-
22-producing CD4+ T cells represent a heterogeneous cell population. 
We were then interested in the molecular mechanisms involved in the 
differentiation of IL-22 producing T cells. We found that in cord blood-
derived naïve CD4+ T cells, T cell receptor signaling was sufficient to 
induce IL-22 expression, and this could be inhibited by cyclosporine A. 
Addition of pro-inflammatory cytokines increased IL-22 expression, while 
TGF-β and IL-4 strongly decreased IL-22 production.  
In conclusion, we found that only a minority of Th17 cells secrete this 
cytokine suggesting that IL-22 is not a Th17 “signature” cytokine in 
humans. Our results indicate that different human CD4+ T cell subsets can 
produce IL-22. This heterogeneity could explain the dual role observed for 
IL-22-producing cells, which may depend on the additional cytokines they 
produce. Our current work addresses the epigenetic modifications at the 
IFNG/IL26/IL22 locus that could determine this heterogeneity in cytokine 
gene expression. 
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The accumulation of large numbers of neutrophils in the lungs and airways is 
common to many forms of inflammatory lung disease, and large numbers of 
neutrophils accumulate in the lungs and airways during acute lung injury. 
Phenotypic changes and gene expression changes that neutrophils undergo as 
they leave the peripheral circulation and migrate into the airspaces have not 
been explored in the context of chemotactic signaling, and in relation to 
transmigration in other immune cell types. In experimental models, neutrophils 
rapidly enter the pulmonary parenchyma and then migrate into the alveolar 
space after systemic or pulmonary administration of bacteria or bacterial 
products, such as endotoxin (i.e., lipopolysaccharide or LPS). The importance 
of neutrophils in contributing to the development and severity of ALI is 
demonstrated by studies in which lung vascular permeability and other indices 
of lung injury are attenuated following endotoxin challenge or other 
pathophysiologic insult in neutropenic animals.  
 
We employed a human model of Acute Lung Injury based on bronchoscopic 
instillation of endotoxin in a lung subsegment followed 16 hours later by repeat 
bronchoscopy and lavage, yielding from 35 to 500 million neutrophils. 
Functional assays including survival, cytokine release, respiratory burst, and 
chemotaxis were performed, and this data and the gene expression data were 
contrasted with peripheral blood neutrophils isolated from the same individual 
in order to isolate population variability.  
 
Overall, these experiments demonstrate that neutrophils undergo profound 
alterations in gene expression and functional properties when they migrate from 
the peripheral circulation into the lung in response to an endotoxin challenge. 
Statistically significant changes in gene expression occur in approximately 15% 
of the neutrophil transcriptome. Pulmonary neutrophils have greatly diminished 
chemotactic abilities, a reduced priming index, and enhanced superoxide anion 
release in response to fMLP stimulation. These alterations are unlikely to have 
been acquired through direct exposure of the neutrophils to endotoxin, as 
endotoxin is rapidly cleared from the lungs, but rather as a result of contact with 
pulmonary cell populations, such as endothelial and epithelial cells, encountered 
during migration from the blood to the lung as well as through exposure to the 
proinflammatory milieu induced in the alveoli by endotoxin stimulated 
macrophages and epithelial cells. 
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Our laboratory has recently identified a novel human oncoprotein, 
designated as Cancerous Inhibitor of PP2A (CIP2A). CIP2A is 
overexpressed in common human malignancies and promotes breast cancer 
aggressiveness (Junttila et al :, Cell 2007 ; Come et al., Cancer Research 
2009). In cancer cells, CIP2A promotes malignant growth but its 
physiological role remains to be determined. The work presented in this 
abstract suggests that CIP2A is involved in the development and responses 
of the immune system. 
To address the physiological role of CIP2A, we have generated a CIP2A 
deficient and a transgenic mouse model constitutively expressing the 
protein. In addition to testis, bone marrow, spleen, lymph nodes and thymus 
are among the very few organs expressing CIP2A in human or mouse 
tissues. Moreover, CIP2A is expressed at significant levels in germinal 
center cells, both in the spleen and lymph nodes, indicating a role for 
CIP2A in lymphocyte activation. This idea is reinforced by the fact that ex-
vivo activated B and T cells strongly upregulate CIP2A. 
Under SPF conditions, CIP2A deficient mice present a normal apparent 
phenotype and lifespan. However, loss of CIP2A alters B cell numbers, 
suggesting a role for CIP2A in lymphocyte homeostasis. In order to study 
this possible link between CIP2A and lymphocyte activation, we are 
planning to immunize mouse models deficient or constitutively expressing 
CIP2A and compare their immune response to the one of normal mice. 
Finally, to investigate whether CIP2A is involved in lymphomagenesis, we 
have crossed our knock-out mice with the Eμ-Myc lymphoma model. 
Results of these in vivo studies will be presented.  
The selective profiles of CIP2A in the immune system and lymphocytes 
suggests it to be an important regulator of the immune system. We aim at 
determining the precise role of this recently discovered protein in the 
development of immune system and response. 
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The pro inflammatory cytokine IL-6 has been shown to promote the 
development of activated CD4+ T cells into T follicular helper cells (TFH) 
during an immune response. TFH cells secrete IL-21, and collaborate with B 
cells in the formation of germinal centres (GC) during T-cell-dependent 
antibody responses. Dendritic cells and macrophages have been implicated 
in supplying IL-6 to the activated CD4+ T cells. Here, we demonstrate that 
B cells are also a source of IL-6. We observed that IL-6 expression in B 
cells was dependent on the transcription factor Oct2 and it’s co-activator 
OBF-1 in toll-like-receptor ligand stimulated in vitro cultures, as well as in 
B cells derived from influenza infected mice. IL-6 expression in follicular B 
cells in the draining lymph node was an early event during an influenza 
response, peaking on day two of infection.  
 
To study the molecular regulation of IL-6 expression by Oct2 or OBF-1 we 
analyzed the IL-6 locus for putative binding sites (octamer motifs). We 
identified several octamer sites within the IL-6 promoter region in silicio 
and were able to show direct interaction of the transcription factors with a 
subset of the sites.  
 
Finally, the IL-6 secreted by activated B cells was sufficient to promote the 
differentiation of IL-21-secreting CD4+ T cells in an in vitro co-culture 
system. The induction of IL-21-secreting CD4+ T cells required OBF-1 in 
the activated B cells. This study demonstrates the dependence of IL-6 
expression in B cells on the transcription factors Oct2 and OBF-1, and 
suggests a role for B cell-derived IL-6 in the formation of IL-21 producing 
T helper cell subsets. 
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The SRF cofactor SAP-1, a member of the Ternary Complex Factor (TCF) 
subfamily of Ets domain proteins, is an ERK target required for thymocyte 
positive selection. Although SAP-1 is the predominant TCF in thymocytes, 
the other family members, Elk-1 and Net, are also expressed, and we 
therefore tested their role in selection. Elk-1 deletion did not impair positive 
selection, but exacerbated the SAP-1 defect. In contrast, the Netδ mutation, 
a putative null, had no deleterious effect either alone or in combination with 
SAP-1 deficiency, and triply deficient thymocytes were no more defective 
than SAP-1-/- Elk-1-/- cells. Inactivation of the other TCFs did not affect 
SAP-1-independent processes, including β-selection, Treg selection and 
negative selection, although reduced marginal-zone B cells were observed 
in SAP-1-/- Elk-1-/- animals. SAP-1 target genes in TCR-stimulated DP 
cells whose transcription was further impaired by Elk-1 inactivation, 
including Egr-1 and Egr-2, were identified by array analysis as probable 
SAP-1 effectors in positive selection. Although chromatin 
immunoprecipitation revealed subtle differences in promoter targeting 
specificity between the TCFs, ectopic expression of Elk-1 could rescue the 
SAP-1 selection defect, indicating that it is the expression level of SAP-1 in 
thymus relative to Elk-1, rather than any specific functionality, that 
underlies its critical role in thymocyte development. In contrast, ectopic Net 
expression did not rescue the SAP-1 null selection defect, which may reflect 
differences in target gene selection by this TCF.  
Inactivation of SRF itself results in a complete block in thymocyte positive 
selection. We used retroviral expression of SRF mutants in an SRF null 
background to investigate this phenomenon in more detail. Wildtype SRF 
rescued the positive selection defect. In contrast, a SRF V194E, a point 
mutant that is incapable of interaction both with the TCFs and a second 
family of SRF co-activators, the MRTFs, failed to rescue the selection 
defect, indicating that cofactor interaction is essential for SRF activity in 
this context. Fusion of the TCF regulatory domain to SRF SRF V194E 
restored its activity, and this required the integrity of its ERK 
phosphorylation sites. The major role of SRF in thymocyte development is 
thus to provide a platform for TCF recruitment, enabling ERK mediated 
activation of target genes essential for the selection process. 
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The immune system relies on a tightly regulated balance to ensure proper 
activation against pathogens while minimizing the risks of an autoimmune 
attack that could result in disease. While many aspects of central and 
peripheral tolerance mechanisms have been elucidated, important questions 
related to adaptive immunity to self antigens remain to be evaluated. One 
area that remains poorly studied is the effect of oxidative damage in altering 
self proteins, how these modified epitopes can be recognized by the 
immune system and what are the outcomes of this recognition. Oxidative 
stress induced by aging, smoking, pathogens, tumors and inflammatory 
responses can lead to oxidative modifications of proteins and peptides and 
therefore tilt the balance within the immune system. Our lab has developed 
an in vivo mouse model to study tissue-specific autoimmunity by analyzing 
the immune response against modified antigens coming from the retina. 
Carboxyethylpyrrole (CEP) is an oxidation product of docosahexaenoic 
acid (DHA), a fatty acid highly concentrated in the outer retina, and has 
been implicated in the pathogenesis of age-related macular degeneration 
(AMD): CEP-adducted proteins and anti-CEP autoantibodies are elevated in 
AMD patients. Similar to the human disease, immunization of mice with 
CEP-MSA (mouse serum albumin) results in autoantibodies and AMD-like 
pathology. Ex vivo restimulation of splenocytes results in the activation of 
CD4+ T cells (associated with IL-17 and IFN-gamma production) as well as 
CD8+ T cells, suggesting the generation of immunological memory against 
these antigens. In addition, we have observed immunogenicity against other 
lipid oxidative modifications, such as carboxyalkylpyrroles (CAP). Our 
results provide proof of principle that oxidative stress-induced modification 
of self antigens can produce an adaptive immune response and establish our 
system as an ideal model to investigate this underestimated type of 
immunity. This work will lead to a better understanding of the basic 
signaling events that are required for maintenance of tolerance and could 
have important clinical implications for age-related disorders, 
immunotherapy and cancer. 
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Promiscuous expression of tissue-restricted antigens (TRAs) in medullary 
thymic epithelial cells (mTECs) is essential for central T cell tolerance. The 
molecular regulation of this unusual gene expression, in particular the 
interplay between genetic and epigenetic mechanisms, is only poorly 
understood. By studying promiscuous expression of the mouse casein locus, 
we report that transcription of this locus develops gradually and starts with 
the casein beta and gamma genes during ontogeny. With increasing age of 
the embryo we observe an increase in the percentage of mature TECs, first 
expressing single and subsequently multiple TRAs. Transcription is 
preceded by promoter demethylation in immature mTECs followed by local 
locus decontraction and introduction of active histone marks upon mTEC 
maturation. Promiscuous transcription of the casein cluster however does 
not correlate with locus-wide epigenetic marks. Moreover, analysis of an 
additional locus showed that promiscuous expression is transient in single 
mTECs and we observed mono- and biallelic expression patterns. Transient 
or fluctuating gene expression could conceivably add to the diversity of 
self-antigen display in a confined microenvironment and thus enhances the 
efficacy of central tolerance. 
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V(D)J recombination in lymphocytes proceed via double-strand breaks 
generated by the RAG1/2 endonuclease. This recombination mechanism has 
long been thought to be involved in genomic instability leading to cancer. In 
fact, because antigen-receptor gene rearrangement entails breaking and 
rejoining the chromosome several times before a complete immunoglobulin 
or TCR molecule can be expressed at the cell surface, V(D)J recombination 
has been termed a "disaster waiting to happen." 
Analysis of RAG1 and RAG2 mutants has demonstrated that the RAG post-
cleavage complex normally prevents V(D)J recombination-associated DSBs 
from accessing alternative end joining pathways and promoting aberrant 
rearrangements.  
To test the consequences of a mutant RAG complex in vivo, we generated a 
knock-in mouse model harboring a RAG2 truncation (RAG2tr) and 
examined lymphocyte differentiation, genomic stability and tumorigenesis 
in this setting. Significant mature B and T cell numbers are generated in 
RAG2tr/tr knock-in mice, showing that the mutant RAG recombinase retains 
in vivo function. We found that, as compared with p53 null mice, 
RAG2tr/tr/p53-/- animals more rapidly develop tumors (mean survival: 
RAG2tr/tr/p53-/- = 14 weeks as compared with p53-/- = 23 weeks; p < 5.8e-7). 
Also, in contrast to p53-/- animals, RAG2tr/tr/p53-/- mice virtually all die of 
thymic lymphomas associated with recurrent translocations frequently 
involving chromosomes that harbor antigen receptor loci. These results 
indicate that the tumorigenic events were initiated by the mutant 
RAG1/RAG2tr endonuclease. To test whether recombination defects exist 
in RAG2tr/tr thymocytes, we assayed for Tcrα locus integrity by three-
dimensional interphase DNA-fluorescent in-situ hybridization (FISH). We 
found that RAG2tr/tr thymocytes have a three- to six-fold increase in the 
number of cells harboring aberrant Tcrα locus as compare with wild type 
thymocytes, indicating that RAG2 is required for the stability of the Tcrα 
locus. 
Thus, our study provides the first in vivo evidence for a role of RAG2 in 
maintenance of genome stability and tumor suppression during V(D)J 
recombination. 
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We studied monocyte heterogeneity and the factors that regulate 
mycobacterial growth in human Mycobacterium tuberculosis (M. tb) 
infection. In 5 healthy donors, M. tb H37Rv grew 5.6-fold higher in human 
CD14+CD16- macrophages compared to CD14-CD16+ macrophages (7.9 ± 
2.6 x 106 vs 1.4 ± 0.7 x 106 CFU per well, p=0.002). CD14+CD16- 
monocytes from 13 healthy donors produced higher amounts of IL-10, 
compared to CD14-CD16+ monocytes upon culturing with γ-irradiated M. 
tb (329.8 ± 61.0 vs 1.8 ± 0.9 pg/ml, p=0.0002). Expression of mRNA for c-
maf, a transcription factor, was upregulated in M. tb-stimulated 
CD14+CD16- monocytes, compared to CD14-CD16+ monocytes, as 
measured by real time PCR (3.1 ± 0.8 vs 0.7 ± 0.07 arbitrary units, p=0.03). 
c-maf siRNA inhibited IL-10 production by CD14+CD16- monocytes, 
compared to control siRNA (134.5 ± 76.7 vs 532.2 ± 190.3 pg/ml, p=0.02). 
Similarly, c-maf siRNA inhibited M. tb H37Rv growth in CD14+CD16- 
macrophages compared to control siRNA (2.6 ± 1.0 x 106 vs 10.33 ± 1.5 x 
106 CFU per well, p=0.0005). In 5 healthy donors, recombinant IL-10 
marginally enhanced M. tb growth in CD14-CD16+ macrophages (5.9 ± 0.8 
x 106 vs 2.5 ± 0.3 x 106 CFU per well, p=0.01) and had no effect on M. tb 
growth in CD14+CD16- macrophages (13.6 ± 2.5 x 106 vs 20.0 ± 3.2 x 106 
CFU per well, p=0.13) suggesting that c-maf dependent M. tb growth is not 
dependent on IL-10. To determine the c-maf dependent mechanisms that 
regulate M. tb growth, we compared gene expression of γ-irradiated M. tb-
cultured CD14+CD16- and CD14-CD16+ monocytes, using microarray 
analysis. In CD14+CD16- cells, mRNA expression for 230 genes was >1-
fold higher than in CD14-CD16+ cells. Of these genes, 22 have a c-maf 
binding site in their promoter region. Among these genes, we first selected 
hyaluronan synthase1 (HAS1) that was previously shown to regulate 
extracellular M. tb growth in lungs. Expression of HAS1 mRNA was up 
regulated in CD14+CD16- monocytes compared to CD14-CD16+ 
monocytes upon culturing with γ-irradiated M. tb, as measured by real time 
PCR (8.7 ± 2.1 vs 1.5 ± 0.13 arbitrary units, p=0.02). c-maf siRNA 
inhibited HAS1 expression in M. tb-stimulated CD14+CD16- monocytes, 
compared to control siRNA (1.1 ± 0.3 vs 4.8 ± 1.2, p =0.02). Studies are 
underway to determine the effect of HAS1 siRNA on intracellular survival 
of M. tuberculosis in CD14+CD16- macrophages. 
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Ezh2 and Ezh1 lysine methyltransferases are the key enzymatic components 
of the PRC2 complex, an essential epigenetic regulator of gene expression 
during development, conserved from fly to man. Our earlier findings 
revealed an unexpected role of Ezh2 in T cell antigen receptor (TCR) 
signaling. We found that Ezh2 is present in the T cell cytosol where it 
interacts with Vav, a potent signal transducer downstream of the TCR and 
co-stimulatory receptors. Here we report an extension of these studies 
where we show an essential and selective role of Ezh2 and Ezh1 in TCR 
induced T cell activation. We will present data showing a nucleus 
independent function of Ezh2/Ezh1 in T cell signaling and immunity. We 
will also report on the role of nuclear Ezh2 in the regulation of T cell 
differentiation and maintenance of T cell identity. 
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Cell survival decisions are fundamental to immune homeostasis and 
regulation. Cell metabolism is becoming increasing recognized as an 
important input to cell survival and T cell memory differentiation. 
Glycolysis can be upregulated and oxidative phosphorylation suppressed by 
active hypoxia-inducible factors (HIFs). We used a genetic approach to 
modify T cell metabolism by deleting VHL, the major negative regulator of 
the HIFs. We observe perturbations in cell survival, proliferation, and 
response to infection of peripheral T cells null for VHL. Further study of 
the mechanisms and signaling pathways underlying these perturbations may 
yield insights into how metabolism affects T cell survival decisions and 
memory differentiation. 
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Signals from the bone marrow microenvironment are critical for the 
development of lymphohematopoietic progenitors (LHP). Previous studies 
established that the receptor tyrosine kinase, Flt3 and its ligand, Flt3-ligand 
(FL) regulate LHP development. Mice deficient in FL exhibit striking 
reductions in Flt3+/hi LHP and B cell precursors (BCP), and evidence 
decreased lymphoid lineage priming. Currently, the mechanism by which 
Flt3 signaling regulates lymphocyte development is unknown. In this study, 
we investigated the role of Flt3 signaling in the proliferation, 
differentiation, and survival of LHP and common lymphoid progenitors 
(CLP). Unexpectedly, we found that mono-allelic expression of FL (FL+/-) 
resulted in a dose-dependent reduction in LHP and CLP. Thus, Flt3 
signaling sets a threshold for bone marrow lymphopoiesis. This finding is 
further supported by limiting dilution analysis, which revealed that LHP 
from FL+/- mice have reduced B cell precursor frequency. In vivo 
bromodeoxyuridine incorporation studies established that Flt3 signaling is 
not essential for the proliferation of LHP. However, Annexin V staining 
showed that Flt3 signaling is important for the survival of LHP. Additional 
evidence supportive of the role of Flt3 signaling in the survival of LHP was 
obtained by FL withdrawal from FL-dependent EBF-/- and E2A-/- cell 
lines, which revealed increased Bim transcripts. To examine the role of Flt3 
signaling in differentiation, we sorted GMLP and LMPP from FL+/- mice. 
Real-time PCR showed reduced rag1 and ebf1 transcripts and increased id1 
and id2 transcripts in these subsets. The increases in id1 and id2 transcripts 
were recapitulated in the cell line FL withdrawal experiments. Id1 and Id2 
are E2A antagonists and inhibitors of B lymphopoiesis. Id1 is expressed in 
primitive hematopoietic progenitors and downregulated in LHP and flow 
cytometric analysis of Id1-/- mice revealed increased frequencies of CLP. 
To determine if Flt3 signaling regulates LHP by limiting Id1 expression, we 
generated FL-/- x Id1-/- mice. However, analysis of compound knockouts 
revealed that loss of Id1 did not restore the deficiency in LHP in FL-/- mice, 
suggesting downregulation of Id2 may be involved. Taken together, these 
data provide the first mechanistic insight into the roles of Flt3 signaling in 
LHP and B cell development: survival and differentiation. 
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Ubiquitin modification represents a versatile mechanism to control cellular 
functions. It is a reversible process that is counteracted by the activity of 
ubiquitin deconjugating enzymes (DUBs). More than 90 different DUBs are 
encoded in the human genome including around 50 members that belong to 
the family of the ubiquitin specific proteases (USPs). Despite their high 
number and diversity, the physiological function and biological relevance of 
individual DUBs in discrete cell types is poorly defined. 
Using cre-loxP-mediated gene targeting, we have generated mice with a T-
cell-specific deletion of USP8 (ΔT-USP8). In T-cells many key signalling 
molecules are controlled by ubiquitin-mediated mechanisms. For instance, 
the stability of the E3-Ligase “gene related to anergy in lymphocytes” 
(GRAIL) has been shown to be controlled by USP8. Deletion of USP8 in T-
cells caused severe autoimmune inflammatory bowel disease leading to 
premature death of the animals. CD4+ cells in the periphery are highly 
activated demonstrating an essential function of USP8 in the prevention of 
aberrant T-cell responses in vivo. In addition, the numbers of CD4+ and 
CD8+ single positive cells in spleen, lymphnodes and thymus of ΔT-USP8 
mice are strongly reduced due to an impaired transition from the 
CD4+CD8+ double positive to the CD8+ and CD4+ single positive stage of 
thymocyte development.  
Using yeast two-hybrid screening, we have identified USP8-interacting 
molecules including potential substrates. The molecular mechanisms that 
underlie USP8 function are currently under investigation and will be 
discussed. 
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CD4 co-receptor expression is negatively regulated through activity of the 
Cd4 silencer in CD4–CD8– DN thymocytes and CD8+ cytotoxic lineage T 
cells. Cd4 silencing in committed CD8+ T cells is maintained through 
epigenetic processes once it is established by the silencer. We previously 
demonstrated that members of the Runx family of transcription factors are 
required for Cd4 silencing both in DN thymocytes and CD8+ T cells. 
However, additional factors cooperating with Runx proteins for 
establishment of Cd4 silencing remain unknown. To identify such factors 
contributing to Cd4 silencing, we used microarray and RNAi-based 
approaches and identified a bHLH-ZIP transcription factor, AP4, as a 
molecule contributing to Cd4 gene regulation. In AP4-deficient mice, DN 
thymocytes de-repressed CD4 expression. In contrast, AP4-deficient CD8+ 
T cells appeared to normally downregulate CD4 expression. However, AP4 
deficiency resulted in a significant increase in the frequency of CD4-
expressing CD8+ T cells in mice harboring point mutations in the Cd4 
silencer. These observations suggest that AP4 modulates Cd4 silencing both 
in DN and CD8+ cytotoxic lineage T cells. 
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CD4/CD8 lineage specification of thymocytes is linked with coreceptor 
expression. Previously, the transcription factor MAZR was identified as an 
important regulator of Cd8 gene expression. To further investigate the 
physiological function of MAZR during T cell development, MAZR–/– 
mice were generated. Here we demonstrate that MAZR functions at two 
distinct stages of T cell development. We show that variegated CD8 
expression by loss of Cd8 enhancers is reverted in MAZR-deficient mice, 
confirming that MAZR negatively regulates the Cd8 loci during the DN to 
DP transition. Moreover, loss of MAZR led to a partial redirection of MHC 
class I-restricted thymocytes into CD4+ helper-like T cells. By using either 
MHC class I-restricted TCR transgenic mice or MAZR–/– BM chimeric 
MHC class II-deficient mice, we demonstrate that MAZR-deficiency led to 
a partial redirection of MHC class I-restricted thymocytes into CD4+ helper-
like T cells. This correlated with derepression of ThPOK, an essential 
molecule for helper lineage differentiation, in MHC class I-signaled DP and 
CD4+CD8lo MAZR–/– thymocytes. MAZR bound the ThPOK locus, 
suggesting a direct control of ThPOK expression. Thus, our data provide 
genetic evidence that MAZR is a part of the transcription factor network 
that controls CD4/CD8 cell fate decision of DP thymocyte by regulating 
ThPOK expression. 
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Antiviral immunity depends largely on the ability of infected cells to 
activate expression of type I interferon (IFN) and interferon inducible 
genes. Strict regulation of virus-dependent IFN expression is essential for 
immune system homeostasis, as attenuated or excessive IFN production is 
associated with immune deficiencies or autoimmunity, respectively. IFN 
genes are dormant in non-infected cells, but become transcriptionally active 
upon encounter with the virus. Although, many of the events and factors 
that lead to activation of IFNs have been identified, mechanisms of 
silencing IFNs have not been characterized. Here, we identify di-
methylation of histone H3 lysine 9 (H3K9me2) as a potent regulator of Ifnβ 
expression. We found that the repressed state of Ifnβ depends on H3K9me2, 
which is catalyzed by the histone methyltransferase G9a. In turn, activation 
of Ifnβ expression in response to viruses is associated with rapid 
demethylation of H3K9me2. We found that the deficiency in G9a or 
overexpression of Jumonji family demethylases resulted in more rapid and 
robust Ifnβ transcription and greatly enhanced cell resistance to viral 
infection. Therefore, the Ifnβ promoter exists in a repressed chromatin state 
prior to virus-induced activation and demethylation of H3K9me2 is an 
important step towards transcriptional activation. In summary, we identified 
a novel control mechanism of Ifnβ expression that may facilitate the 
treatment of immune disorders associated with aberrant Ifnβ production. 
 79 
ROLE OF THE CTCF/COHESIN COMPLEX IN V(D)J 
REARRANGEMENT 
 
Stephanie C Degner1, Timothy P Wong1, Roy Riblet2, Yin Lin3, Cornelis 
Murre3, Ann J Feeney1  
 
1The Scripps Research Institute, Department of Immunology and Microbial 
Science, 10550 N. Torrey Pines Rd, La Jolla, CA, 92037, 2Torrey Pines 
Institute for Molecular Studies, Division of Genetics, 3550 General Atomics 
Court, San Diego, CA, 92121, 3University of California, San Diego, 
Division of Biological Sciences, 9500 Gilman Drive, La Jolla, CA, 92093 
 
The creation of a diverse antibody repertoire requires efficient utilization of the 
large number of VH and Vκ genes. The >100 functional VH genes are spread 
over 2.5 Mb region and need to have access to the single DJH rearrangement. 
Likewise, ~100 functional Vκ genes are spread over 3.1 Mb, and all need to 
efficiently recombine to one of 4 Jκ genes within a 1.5 kb region. In order for 
VH genes and for Vκ genes throughout the loci to rearrange efficiently, the large 
V regions need to contract so that all of the V genes can obtain access to the 
small D-J portion of the locus. 3D-FISH studies have shown that this 
contraction occurs via the formation of multiple loops, forming a rosette-like 
structure within the VH locus. CTCF is a transcription factor associated with 
insulators and boundary elements that regulates gene expression by long-range 
chromosomal looping. We therefore hypothesized that CTCF may be crucial for 
the contraction of the Ig loci.  
We performed ChIP-chip, and more recently ChIP-seq, to determine if CTCF 
was a candidate for being involved in creating the loops at the Ig loci, and 
demonstrated many CTCF sites in the VH and Vκ loci (and also in the TCRβ 
and TCRα/δ V loci). However, CTCF binding in the Igh locus was largely 
unchanged throughout differentiation, suggesting that CTCF binding alone 
cannot be responsible for stage-specific locus compaction. Because cohesin can 
co-localize with CTCF, we performed ChIP/qPCR for the cohesin subunit 
Rad21 and found lineage and stage-specific higher level recruitment of Rad21 
to CTCF. Interestingly, although we found many CTCF/cohesin sites within the 
VH portion of the Igh locus, there were only two other locations of CTCF 
binding within the rest of the Igh locus: one large region in the 3’ enhancer 
which had been previously described, and, importantly, 2 close sites just 5’ of 
the end of the DH gene cluster. This is the ideal location to have a boundary 
element separating the VH portion of the locus from the DH and JH portion, and 
thus we propose that these CTCF sites may act as a boundary/insulator 
preventing premature accessibility of the VH locus at the time when D-J 
rearrangement is occurring. This is being tested by 3C analysis. We propose 
that these DFL-flanking sites begin to bind to CTCF/cohesin sites located 
throughout the VH locus during the stage of VH to DJH rearrangement, thus 
resulting in the formation of multiple loops. Knockdown of CTCF in pro-B cells 
followed by 3D-FISH is being done to demonstrate whether CTCF plays a 
functional role in locus compaction. In addition, due to its boundary function, 
CTCF may control the spread of epigenetic changes within the large Ig loci. 
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Epstein-Barr virus (EBV) preferentially infects human B cells and 
establishes a lifelong persistence in long-living memory B cells. The virus 
is associated with different lymphoproliferative malignancies, like Burkitt´s 
lymphoma and Hodgkin lymphoma. During primary infection the virus 
expresses nine viral proteins, referred to as latency III, leading to the 
immortalization of B cells. These viral proteins code for six nuclear 
antigens (EBNA 1-6) and three membrane proteins (LMP1, LMP2A and 
LMP2B). However in vivo cytotoxic T cells recognize infected cells and 
eliminate these cells. Hence, expression of the viral proteins is 
downregulated and viral persistence is established in the memory B cell 
compartment. In the quiescent state no viral protein or only EBNA1, which 
is not recognized by the immune system, is expressed (latency I/0). In most 
cases of EBV-associated tumors the virus does not exist in latency III but in 
latency I or in latency II, which is characterized by the expression of LMP1, 
LMP2A and EBNA1. Thus the latency II expression profile was found in 
EBV positive Hodgkin tumor cells (HRS). To study the influence of LMP1 
and LMP2A on tumor development, we transfected expression vectors for 
LMP1, LMP2A and LMP1/LMP2A into an EBV conditionally 
immortalized human B cell line (EREB2-5), in which EBNA2, the main 
regulator of latency III, can be regulated by estrogen. After estrogen 
withdrawal we investigated the ability of LMP1 and LMP2A to immortalize 
B cells as well as the signaling pathways activated by both proteins. The 
analysis revealed that in the absence of EBNA2 the co-expression of LMP1 
and LMP2A induces limited proliferation and improved survival of EREB 
cells but is not sufficient to maintain B cell immortalization. 
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The present study uses two independent genetic strategies to explore the 
requirement for Phosphoinositide dependent kinase-1 (PDK1) in the 
development of T cell subpopulations from CD4/8 double positive 
thymocytes. The data show that there is a selective requirement for PDK1 
catalytic activity for the development of NKT cells in the thymus. These 
cells use a Vα14 invariant T cell antigen receptor to recognise glycolipids 
presented by CD1d molecules and play a role in immune surveillance and 
immune homeostasis. CD4/8 double positive thymocytes that do not 
express PDK1 or express a catalytically inactive PDK1 mutant lack even 
the earliest Vα14 NKT progenitors, although these cells can differentiate 
into conventional CD4, CD8 or regulatory T cell subsets. PDK1 
phosphorylates the activation loop of numerous AGC kinases, including 
Protein Kinase B (PKB, also called Akt). The PDK1 requirement for iNKT 
cell development reflects that these cells require PKB for proliferative 
expansion in response to Interleukin 15 or antigen receptor stimulation. 
These data identify PDK1 as a kinase that integrates cytokine and antigen 
receptor signaling to support the proliferative expansion of iNKT cells in 
the thymus. The data also reveal that there is constitutive PDK1 signaling in 
conventional SP α/β T cells that fine-tunes expression of coreceptors and 
adhesion molecules and is essential to allow SP thymocytes to populate the 
periphery.  
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Marginal zone (MZ) B cells of the spleen and peritoneal B1 cells are 
specialized B cell subsets implicated in bridging the innate and adaptive 
immune responses, categorizing these cells as “innate-like B cells”. Besides 
their separate localization in distinct regions of secondary lymphoid organs 
and the peritoneal as well as the pleural body cavities, these cells differ 
from conventional, recirculating follicular (Fo) B cells by their attenuated 
Ca2+ mobilization, fast kinetics of antibody secretion and increased cell 
adhesion.  
Here we identify a gene, termed Mzb1, as a determinant of the specialized 
functions of MZ B and B1 cells. In these B cell subsets, Mzb1 is expressed 
at high levels, and we show that Mzb1 protein is localized in the lumen of 
the endoplasmatic reticulum (ER). Proteomic analysis revealed an 
association of Mzb1 with ER-localized chaperones and oxidoreductases 
being important regulators of the oxidative folding of integrins and the ER 
Ca2+ store content, respectively. Knockdown of Mzb1 in a B cell line and in 
primary MZ B cells results in increased Ca2+ mobilization and cell 
proliferation. Moreover, Mzb1 knockdown in MZ B cells decreases LPS-
induced antibody secretion and integrin-mediated adhesiveness by a defect 
in generating an active conformation of integrins. Taken together, these data 
suggest that Mzb1 is a determinant for the diversification of the immune 
functions of MZ B and B1 cells by regulating key features such as ER Ca2+ 
stores, antibody secretion and surface expression of integrins. 
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Cells of the immune system communicate and transfer information among 
them to coordinate immune responses. Cytokines are important mediators 
of this complex intercellular communication network. Understanding such 
complex interactive networks may be facilitated by studying simpler 
modules which occur abundantly throughout the network. This approach 
was found highly useful in studying intracellular molecular networks. Here, 
we present an extension of those methods to study modules of intercellular 
communication networks.  
Autoregulation, or autocrine feedback, occurs when a cell expresses 
receptors to a cytokine that it secretes. This is the simplest module of the 
intercellular cytokine communication network, and is abundantly found 
throughout the network. We study extracellular feedback in the context of 
T-cell activation, where IL-2 is secreted by T-cells upon stimulation of their 
T-cell receptor (TCR), and expression of the alpha subunit of the IL-2 
receptor (IL-2R) is up-regulated upon IL-2 induced signaling. We present 
here a mathematical model which describes this extracellular feedback, and 
study its behavior. Unknown model parameters are determined from 
quantitative measurements of expression levels of key proteins involved, 
under well defined inputs to TCR and IL-2R.  
We apply the model to analyze a system of T-cells that are activated and are 
interacting with each other via IL-2, for example two T-cells of different 
TCR specificities entering a lymph node and being activated. The model 
shows a variety of dynamic behaviors including cooperation between the 
two clones under some conditions, and clonal competition under others. Our 
modeling results suggest another, yet un-described, role for cytokines in T 
cell activation dynamics, introducing temporal considerations into the 
process of T cell activation and inter-clonal interactions. Specifically, a cell 
with higher TCR signal wins only if it enters the competition in an early 
stage, but looses if it arrives too late. Therefore, we hypothesize that one of 
the roles of cytokine mediated extracellular positive feedback might be to 
serve as a time window, limiting the time available for clones to become 
activated. Limitation by cytokines of the time for response might accelerate 
the immune response, even if the most avid clone is not selected, thus 
balancing response accuracy and time to initiation. Our model suggests a 
unified explanation for a variety of experimentally observed phenomena 
such as clonal dominance and bystander effects, and may have implications 
for vaccine design and autoimmunity. 
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Activation-induced cytidine deaminase (AID) is a DNA mutator that is 
essential for somatic hypermutation (SHM), immunoglobulin gene 
conversion (GCV), and class switch recombination in activated B cells. 
High levels of mutagenic events occur predominantly in immunoglobulin 
genes, while the remainder of the genome remains protected.  
Using chicken DT40 cells as our model system, we previously identified a 4 
kb regulatory region (named 3′RR for its location) in the Ig light chain locus 
that contains a targeting element for AID-mediated sequence diversification 
and a transcriptional enhancer. Using gene targeting and a systematic 
deletion strategy a distinct mutation enhancer element (MEE), 1.3 kb in 
size, was found within the 3′RR that when deleted completely abrogates 
SHM and GCV, while transcription remains largely unaffected. Cross-
complementation approaches are currently ongoing to identify such cis-
acting elements in the murine Ig loci. Preliminary evidence suggests that the 
two major regulatory elements in the murine Igκ locus are not sufficient for 
targeting, while strongly supporting transcription. Overall, this finding 
suggests that two distinct types of regulatory sequences exist in Ig loci: 
transcriptional enhancers and mutational enhancers. The identification of 
specific binding sites and the corresponding trans-acting factors are in 
progress.  
 
This research was supported by the Intramural Research Program of the 
National Institute on Aging / National Institutes of Health.  
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Eukaryotic cells have been shown to regulate gene expression post-
transcriptionally through the binding of proteins and small RNA species to 
sequences within the 3’ untranslated region (UTR) of mRNAs. In the 
cytoplasm RNA binding proteins may act to confer stability to the 
transcript, to destabilise the mRNA or to affect translation and there is 
evidence that they may also have a role in the nucleus and affect RNA 
processing events such as polyadenylation site choice. The Tis11 family of 
proteins consists of Tis11, Tis11B, and Tis11D all of which have a tandem 
CCCH zinc finger structure that has been shown to bind to AU-rich 
elements (ARE) of mRNAs.  
 
In order to study the role of Tis11 family proteins in lymphocyte 
development our lab developed transgenic mouse strains with floxed alleles 
of Tis11B and Tis11D for deletion by cell type specific Cre recombinases. 
Simultaneous deletion of Tis11B and Tis11D in lymphocyte progenitors in 
mice using CD2 Cre gives rise to a block in B-cell development around the 
pro-B cell stage and very few pre-B cells are formed in the bone marrow of 
these mice. The mice also develop acute T-cell lymphoblastic leukaemia 
due to expansion of the CD8+ immature single positive T-cell population. A 
microarray of the thymus of these mice showed an increase in Notch-1 
mRNA which may be responsible for T-cell leukaemia and the reduction in 
number of B-cells that develop.  
 
To assess the role of Tis11B and Tis11D in B-cell development I have 
carried out FACS sorts to collect pre-pro-B cells and pro-B cells from the 
Tis11Bfl/fl, Tis11Dfl/fl CD2 Cre and wild-type mice and compared the 
abundance of potential target transcripts by quantitative RT-PCR. The 
results suggest that there may be a reduction in rag-1 and rag-2 expression 
in the Tis11Bfl/fl, Tis11Dfl/fl CD2 Cre pre-pro-B cells and pro-B cells 
compared to wild-type mice. I plan to continue to analyse the phenotype of 
Tis11Bfl/fl, Tis11Dfl/fl CD2 Cre mice and identify Tis11B and Tis11D 
target mRNAs in B-cell progenitors.  
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Chromosome translocations at the 11q23 locus occur in a majority of infant 
acute lymphocytic leukemia (ALL) cases as well as a significant percentage 
of adult acute leukemia cases. These translocations disrupt the Mixed 
Lineage Leukemia (MLL) gene and frequently result in the production of 
chimeric fusion oncoproteins, most commonly MLL-AF4 in the infant ALL 
cases. Gene expression and immunophenotype data support the concept that 
MLL-AF4 immortalizes an early B-cell precursor with myeloid stem cell 
features. To dissect the pathways leading to the development of B-cells that 
may be under wild-type Mll regulation, we performed the following studies 
using conditional mutagenesis and developmentally regulated Cre 
expressing mouse models. 
We have previously reported that Mll supports steady-state hematopoiesis 
through its role in maintaining hematopoietic stem cells (HSCs) and 
multiple progenitors in the bone marrow. By using the developmentally-
regulated pan-hematopoietic Vav-Cre transgene to excise Mll, we 
demonstrate that the developmentally regulated excision of Mll results in 
defective B lymphopoiesis in addition to other multi-lineage defects. To 
more precisely assess the role of Mll during commitment to the lymphocyte 
lineages, we excised Mll using the Rag1-Cre knock-in model. Despite 
efficient excision of Mll in all early lymphocyte progenitors, we again 
found a selective B-cell reduction in peripheral and bone marrow 
populations of Rag1-Cre; Mll F/F animals. The reduction in peripheral B-
cells in these animals was preceded by a significant and age-dependent 
reduction in developing B-cells in the bone marrow. In particular, a block in 
the transition from the pro-B to pre-B stage represented the largest fold 
difference between control and Rag1-Cre; MllF/F animals. Dysregulated 
surrogate light chain and μ chain expression in the Mll-deficient B cells 
suggest the pre-B cell receptor checkpoint as the major Mll-dependent step 
during B-cell differentiation. Further analysis of Mll-/- B-cells revealed a 
defective IgH rearrangement and reduction of intracellular heavy chain 
proteins. In periphery, the reduced B-cell output from the bone marrow 
resulted in a parallel reduction in B-cells at all stages of maturation. In 
contrast, peripheral and thymic T-cell numbers were largely normal at all 
ages tested, although a partial block at the DN3-DN4 stage was observed in 
two week-old animals. These results elucidate an important role for Mll in 
B-cell development and suggest a possible mechanism for the proclivity of 
MLL-drive ALL for the B-cell lineage. 
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miRNAs regulate numerous physiologic processes and also contribute to 
diseases such as cancer. Our goal is to identify miRNAs involved in the 
regulation of B cell development or that contribute to the oncogenic 
transformation of B cells by the Abelson Murine Leukemia Virus (AMuLV) 
and to identify the targets and processes they regulate. The 
chemotherapeutic agent STI-571 (Gleevec) specifically inhibits the 
oncogenic tyrosine kinase expressed by AMuLV. We observed previously 
that STI-571 treatment of Abelson pro-B leukemia cells results in their exit 
from the cell cycle and differentiation to a pre-B cell-like state. We used 
this system to conduct a microarray-based screen for miRNAs regulated by 
v-Abl activity.  
 
We observed the upregulation of a group of miRNAs once v-Abl was 
inactivated and B cell progression was allowed; a smaller subset of 
miRNAs were downregulated with this treatment. When individually 
overexpressed in Abelson pro-B cells, two of these regulated miRNAs 
result in the induction of germline kappa transcription, a key aspect of the 
normal pro-to-pre-B cell transition. We are in the process of examining 
potential miRNA targets that may result in the observed regulation of 
germline kappa transcription. Our goal is to elucidate the pathway through 
which these miRNAs regulate germline kappa transcription, and to test 
whether such a pathway is similarly regulated during primary B cell 
development.  
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Nuclear architecture and chromatin reorganisation have recently been 
shown to orchestrate gene expression and act as key players in 
developmental pathways. The formation of chromatin loops has been shown 
to involve direct interactions between distant regulatory elements such as 
LCRs, enhancers and promoters. Direct in vivo evidence to support the 
looping model has come from studies in the β-globin and other loci. In 
order to investigate how regulatory elements in the mouse CD8 gene locus 
are arranged in space and in relation to each other, the 3C technique was 
employed to identify long range interactions between the different elements 
during T cell development. In order to compare the spatial organisation of 
the CD8 locus in cells where the CD8α and CD8β genes are expressed 
(CD8+), with cells in which they are silenced (CD4+) or have never been 
transcribed (B cells), lymphocytes from spleens of wild type C57Bl/6 mice 
were sorted and used for 3C analysis. Our data are consistent with an 
interpretation that the cis-regulatory elements of the CD8α and CD8β genes, 
as well as the two genes, spatially cluster together in CD8 expressing cells, 
where the locus is active, to form an ACH. In contrast, in cells that have 
silenced (CD4+ cells) or have never activated the locus (B cells) the 
interactions are much weaker, indicating a more linear, non structured 
chromatin conformation in these cells. These observations confirm the 
dynamic state of chromatin during developmental state decisions. 
 89 
THE TRANSCRIPTION FACTOR ETS-1, BUT NOT THE CLOSELY 
RELATED FACTOR ETS-2, INHIBITS ANTIBODY-SECRETING CELL 
DIFFERENTIATION 
 
Shinu A John1, Lisa Russell1, Shu Shien Chin1, Robert Oshima2, Lee Ann 
Garrett-Sinha1  
 
1State University of New York at Buffalo, Biochemistry, 701 Ellicott Street, 
Buffalo, NY, 14203, 2Burnham Institute, Tumor Development Program, 
10901 North Torrey Pines Road, La Jolla, CA, 92037 
 
B cell differentiation into antibody-secreting plasma cells (ASCs) is a 
tightly-regulated process under the control of multiple transcription factors. 
We have previously shown that one such transcription factor, Ets-1, blocks 
the transition of B cells to ASCs via two separate activities: (1) stimulation 
of target genes that promote B cell identity such as Pax-5 and (2) 
interference with the functional activity of the transcription factor Blimp-1, 
which is required for ASC formation. Ets-1 is a member of a multigene 
family, several of whose members are expressed within the B cell lineage, 
including the closely-related protein Ets-2. We demonstrate that Ets-1, but 
not Ets-2, can block ASC formation. This is despite the fact that Ets-1 and 
Ets-2 are highly homologous, bind to identical DNA sequence motifs and 
are thought to regulate overlapping sets of target genes in vivo. We further 
demonstrate that several regions of the Ets-1 protein are required for 
maximal activity in inhibiting ASC formation including the highly-
conserved Ets DNA binding domain as well as less conserved regions 
within the N-terminus of the protein. However, known post-translational 
modifications at the N-terminus of Ets-1 are not required for its activity. 
Mutation of key arginine residues in the DNA binding domain of Ets-1 
abolish Ets-1 DNA binding, but result in proteins with partial activity in 
blocking ASC formation. This suggests that DNA binding contributes to 
Ets-1 function, but is not the exclusive mechanism by which this protein 
functions. Current experiments are geared towards identifying a mutation of 
Ets-1 that can disrupt its physical interaction with Blimp-1 so that we can 
further validate the relevance of this pathway in regulating ASC 
differentiation. Together, our results support a model in which Ets-1 had 
unique effects on ASC differentiation both by regulating target genes and 
by interactions with the master regulator of ASC formation, Blimp-1. 
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Activation-induced cytidine deaminase (AID) is a mutator enzyme that 
initiates class-switch recombination and somatic hypermutation of 
immunoglobulin genes (Ig) in B lymphocytes. However, AID also produces 
off-target DNA damage, including mutations in oncogenes and double 
stranded breaks that can serve as substrates for oncogenic chromosomal 
translocations. AID is strictly regulated by a number of mechanisms, 
including phosphorylation at serine 38 and threonine 140, which increase 
activity. Here we show that phosphorylation can also suppress AID activity 
in vivo. Serine 3 is a novel phospho-acceptor which, when mutated to 
alanine, leads to increased class switching and c-myc/Igh translocations 
without affecting AID levels or catalytic activity. Conversely, increasing 
AID phosphorylation specifically on serine-3 by interfering with 
serine/threonine protein phosphatase 2A (PP2A) leads to decreased class 
switching. We conclude that AID activity and its oncogenic potential can be 
down-regulated by phosphorylation of serine 3, and that this process is 
controlled by PP2A. 
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Activation-induced deaminase (AID) is a B cell enzyme that initiates 
somatic hypermutation in variable and switch regions of immunoglobulin 
genes. Two contrasting mechanisms have been proposed for AID to act on 
either RNA or DNA. Biochemical and genetic data strongly support 
deamination of cytosine to uracil in DNA, but no physical evidence of 
increased uracils in B cell DNA has been reported. To find the rogue uracil, 
we used three techniques: Southern, PCR, and ligation-mediated PCR 
assays. Activated B cells were collected from mice deficient for uracil-DNA 
glycosylase (UNG), which would retain any uracils in the DNA. DNA was 
prepared and digested in vitro with UNG and abasic endonuclease. If uracils 
are present, the DNA would be cleaved and produce a loss of signal in 
Southern and PCR assays. Our results show a decrease of intact DNA from 
the variable and switch regions but not the constant regions of 
immunoglobulin genes. This mechanism is specific to AID as there was no 
decrease in variable or switch region DNA from Ung-/- Aid-/- B cells. 
Furthermore, we found that deamination in the switch region occurs early 
after activation, prior to cell division. After division, there were fewer 
uracils, which had presumably been repaired during replication. Finally, we 
mapped the position of uracils in the variable region by ligation-mediated 
PCR and sequencing. DNA was digested with UNG and endonuclease, and 
linkers were ligated to the breaks and amplified. The majority of linkers 
were found at cytosine residues in hotspot motifs, in accord with the DNA 
deamination theory. 
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Mice with a homozygous point mutation in the rc3h1 gene that encodes the 
Roquin protein develop severe autoimmune disease (Vinuesa et al., 2005, 
Nature 435, 452-8). It has been shown that Roquin represses ICOS by 
promoting mRNA decay and increased ICOS expression in the mutant mice 
contributes significantly to pathology (Yu et al., 2007, Nature, 450, 299-
303).  
We investigated the molecular mechanism by which Roquin represses 
ICOS. Knockdown approaches revealed that ICOS expression is placed 
under the control of Roquin in Th1 and Th2 cells. In a deletion mutagenesis 
we identified a carboxy-terminal sequence in Roquin with a high content of 
asparagine and glutamine residues that is functionally important and 
specifies localization of Roquin to P bodies, but is not required for 
enrichment of Roquin in stress granules. Similarly, we determined that 
Roquin-mediated ICOS repression does not require the essential stress 
granule protein TIA-1, instead functionally depends on the P body 
component Rck. We genetically tested a requirement for cellular RNAi by 
using Dicer-deficient mouse embryonic fibroblasts clones, which are 
incapable of microRNA biogenesis, and by using mouse embryonic stem 
cells with gene deletion of argonaute 1-4, which are unable to form 
microRNA-induced silencing complexes (miRISC). Our data show no 
requirement for microRNAs and miRISC formation in Roquin-mediated 
ICOS repression. Instead, we demonstrate direct physical interaction of 
Roquin protein with ICOS mRNA in vitro and binding of Roquin to ICOS 
mRNA in primary T cells. Our experiments uncover a novel mode of RNA-
protein interaction, in which the amino-terminal ROQ domain cooperates 
with its adjacent zinc finger. Analyzing Roquin-interacting proteins we find 
specific and RNase-insensitive interactions of Roquin with Rck and Edc4 
proteins in mouse T cells, which are critical factors in P body-associated 
mRNA-decay. We therefore propose that Roquin prevents autoimmunity 
through interaction with ICOS mRNA and by coordinating assembly of 
functional messenger ribonucleoprotein complexes that downregulate ICOS 
expression posttranscriptionally. 
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Macrophages and dendritic cells use a panoply of receptors to detect 
microbial pathogens. These receptors generate diverse intracellular signals 
that combine to define the nature of the net inflammatory response. Some 
receptors, such as Toll-like receptors, primarily trigger inflammatory 
cytokine and chemokine production, while other receptors additionally 
trigger direct anti-microbial responses such as phagocytosis and a 
respiratory burst. While the former are useful even if a cell is not in direct 
contact with a microbe, the latter require contact to be effective. Dectin-1 
detects β-glucans in fungal cell walls and is a central player in the anti-
fungal response. Detection of β-glucan-containing particles (e.g. yeast) by 
Dectin-1, which signals via an ITAM-like motif, triggers phagocytosis and 
an oxidative burst, in addition to the production of inflammatory mediators. 
In contrast, soluble β-glucans, which are too small to trigger phagocytosis, 
fail to activate Dectin-1 signaling. Using confocal microscopy we found 
that upon β-glucan particle binding by Dectin-1, membrane tyrosine 
phosphatases are segregated away from the receptor. Our data indicate that 
“phagocytic synapse” formation is required to initiate Dectin-1 signaling, 
and that the inability of soluble β-glucans to trigger such reorganization 
accounts for their failure to activate Dectin-1. 
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Interleukin(IL)-12 plays a key role in the polarization of CD4 T cells into 
Th1 effector cells producing interferon (IFN)-γ. A closely related cytokine, 
IL-23, was shown to promote the activity of Th17 cells, which are 
responsible for auto-immune inflammation in several experimental models. 
IL-27, a third member of the IL-12 family emerged as an important 
regulator of innate and adaptive immune responses. As these cytokines 
dramatically influence the outcome of the immune response, it is crucial to 
identify the early regulatory mechanisms that control the IL-23/IL-12/IL-27 
balance. We analysed transcriptional regulation of the genes encoding the 
different subunits in response to TLR agonists. We assessed the role of the 
MyD88-, TRIF- and IFN-dependent pathways. We found that expression of 
both IL-12p35 and IL-27p28, but not of IL-12/23p40, IL-23p19 or EBI3 
requires the TRIF/IRF3 pathway. Transcriptional activation of these 2 genes 
also depends on MyD88-dependent activation and IFN-dependent 
upregulation of IRF1. Furthermore, we demonstrated that expression of the 
IL-27p28 gene is dependent on a secondary recruitment of the ISGF3 
complex to a proximal ISRE site. This event was not involved in IL-12p35 
gene activation. We confirmed this result on splenic dendritic cells in vivo 
in the course of experimental endotoxemia. We also observed that both 
IRF3-/- and IRF9-/- mice developed an exacerbated form of experimental 
autoimmune encephalomyelitis (EAE) associated with increased antigen-
specific Th17 responses. We conclude that besides their role in the 
induction of type I IFNs and anti-viral responses, IRF3 and ISGF3 also 
modulate the balance between IL-12 family members and thereby could 
influence autoimmune inflammation. 
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The eight Src kinases harbor a conserved tyrosine in the SH2 domain that is 
not found in other SH2 domains. Phosphorylation of this residue in Lck and 
Src (Lck Y192 and Src Y215) has previously been shown to alter the 
peptide binding specificity of these SH2 domains. Here we report that the T 
cell specific adapter protein (TSAd) promotes phosphorylation of Lck Y192 
in Jurkat T cells transiently expressing TSAd. Moreover, co-expression of 
TSAd and the inducible Tec kinase Itk further increased the Lck Y192 
phosphorylation, whereas expression of Itk alone was not sufficient. Since 
phosphorylation of Lck Y192 seems to be associated to the expression of 
TSAd, and the SH2 domain of kinases influences the substrate of choice, 
we propose that TSAd promotes alteration of the Lck substrate preference. 
As TSAd displays three interaction sites for the Lck-SH2 domain, we first 
examined whether the affinity of Lck-SH2 for TSAd phosphopeptides was 
affected by phosphorylation of Lck Y192. The tyrosine phosphorylation of 
Lck Y192 was mimicked by an acidic residue (E) at the tyrosine position. 
We observed that isolated intact Lck-SH2 domains with the Y192E 
substitution led to reduced binding to the classic Lck-SH2 domain motives 
TSAd Y305 and the HMT peptide. In contrast, the TSAd pY290 peptide 
which is not a typical Lck-SH2 motif, had a 15 fold higher affinity for the 
Lck-SH2-Y192E domain than to the Lck-SH2 domain. Furthermore we 
wanted to explore whether the affinity of the Lck-SH2 domain to other Lck 
ligands were positively affected by phosphorylation of Lck Y192. A custom 
made peptide spot array including 431 phosphopeptides, representing 
previously reported phosphorylated tyrosines (PhosphoSite) in Lck 
interacting molecules (Human Protein Reference Database), were tested for 
binding to the intact or mutated Lck-SH2 domain. Several of the 
phosphopeptides displayed altered binding specificity of the Lck-SH2 and 
Lck-SH2-Y192E. One of these proteins was Itk that showed higher binding 
of Lck-SH2-Y192E to both pY180 and pY511, both of which are sites 
known to regulate Itk activity. We have recently shown that TSAd promotes 
Lck-mediated phosphorylation of Y511 in Itk. Whether activated Itk may 
phosphorylate either TSAd or Lck is under investigation in our lab. Our 
current working hypothesis is that TSAd functions as a scaffold for Lck and 
Itk, allowing Lck and Itk to reciprocally transphosphorylate each other. 
Since Lck Y192 is a predicted Itk phosphorylation site we propose that 
TSAd ensures that Lck alters its ligand preference through transient 
phosphorylation of its SH2 domain by Itk. 
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During B lymphocyte development, the cells have to pass several 
checkpoints verifying the functionality of their antigen receptors. 
Expression of a pre-B-cell receptor (pre-BCR) with membrane-bound Ig 
heavy chain protein associated with surrogate light chain (SLC) proteins is a 
critical checkpoint that monitors for functional heavy chain rearrangement. 
Signaling from the pre-BCR induces survival and clonal expansion, thereby 
driving the preferential expansion and differentiation of cells with high 
quality heavy chains. The proliferation has of course to be limited, and pre-
BCR signaling turns also off transcription for the SLC proteins and the co-
receptor CD19. Later in the development, the BCR is used to select cells for 
receptor editing, select cells allowed to leave the bone marrow and select 
against autoreactive cells. To optimize the initial wave of antibody defense 
against infections, the B-cells with highest antigen affinity are selected to 
generate the extrafollicular plasmablast responses. B-cells with less strong 
antigen binding are selected for the germinal center (GC) where they 
undergo somatic hypermutation (SH) and the GC B-cells with highest 
affinity are selected for plasma cell differentiation. Such cells typically have 
5-10 mutations in their Ig genes. They have increased their antigen binding 
strength with many orders of magnitude through several rounds of SH. Each 
round leads to one or a few mutations, followed by selection for increased 
affinity. After a number of cycles, the B-cells with highest affinity are 
selected for plasma cell differentiation and thereby antibody production. 
BCR signaling has therefore to be able to detect improvements in antigen 
affinity, even if relatively small, over an extremely broad range of affinities. 
Here we have examined whether this ability could be due to an effect of 
BCR signaling on the BCR signalosome itself. We show that both the pre-
BCR and the BCR are subject to general negative feedback regulation. 
Activation of signaling leads to down-regulation of the receptor proteins as 
well as many co-receptors and proteins participating in signal pathways 
from the receptors. Thus, the down-regulation of the pre-BCR is much 
broader than previously anticipated, and the BCR can down-regulate itself 
to enable sensitive detection of successive improvements in antigen affinity 
of the receptor over a very large span of affinities during somatic 
hypermutation. We show also that the mechanism of the feedback inhibition 
for most of the proteins of the BCR signalosome, and most other up- and 
down-regulations of genes upon BCR stimulation, is through inhibition of 
the transcription factor E2A by Ca2+/calmodulin. 
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The Ataxia Telangiectasia-mutated protein (ATM) detects DSBs, stabilizes 
broken ends, and activates repair pathways and checkpoints and is also involved 
in DSB joining during V(D)J recombination; however, in the absence of ATM, 
V(D)J recombination still occurs at substantial levels and lymphocyte 
development is only modestly affected. The XRCC4-like factor (XLF, also 
called Cernunnos) was isolated based on its mutation in human immune-
deficient patients. Mice that lack XLF show general genomic instability 
associated with a DNA repair defect, but in contrast to deficiency for classical 
non-homologous end joining (C-NHEJ) proteins, like XRCC4, XLF deficient 
mice show very modest defects in V(D)J recombination and lymphocyte 
development. However, we now show that mice with a dual deficiency for both 
ATM (ATM-/-) and XLF (XLFΔ/Δ) have a block of lymphocyte development at 
the progenitor B and T cell stages similar to that observed in C-NHEJ deficient 
backgrounds. Moreover, we show that ATM-/-XLFΔ/Δ A-MuLV transformed 
pro-B lines, reminiscent of XRCC4-deficient pro-B lines, appear nearly 
completely deficient for ability to join ends during attempted V(D)J 
recombination of chromosomal substrates, apparently due to defective V(D)J 
recombination associated with severely compromised NHEJ. We further show 
that the synergy between ATM and XLF in end joining during V(D)J 
recombination involves the ATM kinase activity and implicate several ATM 
substrates (e.g. H2AX and 53BP1) as also having synergistic functions with 
XLF. Thus, our findings reveal a much more major end-joining role for ATM in 
V(D)J recombination, and potentially general DSB repair, than previously 
anticipated because the role was masked by synergistic functions of XLF. 
Conversely, by studying the requirement for XLF in ATM deficient cells, we 
have now also demonstrated a major role for XLF in end-joining during V(D)J 
recombination. Consistent with the synergy between ATM and XLF likely 
being required to allow C-NHEJ, ATM-/-XLFΔ/Δ mature B cells (generated via 
IgH and IgL knock-in alleles) are not substantially more impaired for IgH class 
switch recombination than either deficiency alone, apparently due to the ability 
of alternative end-joining to still catalyze joining of broken ends during CSR. 
New studies on overlapping functions of ATM substrates with XLF and 
potential differential requirements for XLF plus ATM on chromosomal versus 
extra-chromosomal V(D)J recombination will also be presented. 
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The functional immunoglobulin heavy chain genes are generated by 
regulated recombination of variable (VH), diversity (DH) and joining (JH) 
gene segments. Prior to initiation of recombination activation-specific 
histone modification are largely restricted to the DH-Cμ domain, providing a 
plausible explanation for DH recombination occurring before VH 
recombination. We have previously shown that deletion of the intronic 
enhancer, Eμ, results in a partially active locus that is characterized by loss 
of histone acetylation but less effect on other form of epigenetic activation. 
Here we demonstrate that Eμ is also involved in nuclear location and 
chromosome conformation of the IgH. 
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Notch1 signaling is essential for the development of T cells and blocks B 
cell development in the bone marrow when deregulated. Notch2 is 
dispensable for T cell development, but has a pivotal role in marginal zone 
(MZ) B cell lineage decision. However, the contribution of Notch2 to MZ B 
cell development has still not been completely elucidated. In this work, we 
have characterized a conditional transgenic mouse strain that expresses a 
constitutive active Notch2 receptor (Notch2IC) specifically in B cells. 
Notch2IC expression from the pro-B cell stage dependent on mb1-Cre 
blocked early B cell development, and led to the formation of ectopic T 
cells in the bone marrow. Activation of Notch2IC dependent on CD19-Cre 
strongly shifted B2 cells to the MZ B cell compartment at the expense of 
follicular (Fo) B cells. Thereby, most MZ B cells appeared to branch from 
the T1 transitional B cell stage, and displayed enhanced PI3K and MAPK 
signaling, but reduced NF-κB activation. Favoured MZ B cell generation 
was achieved even in the absence of CD19, which has been shown to be 
essential for MZ B cell development. Our findings not only underline the 
differences in the outcome of Notch2 signaling depending on the B cellular 
differential stage, but point to an instructive role of Notch2 during MZ B 
cell lineage decision. Moreover, our data indicate that Notch2 is sufficient 
to induce MZ B cell development. 
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Mouse NKR-P1B/D:Clrb and NKR-P1F:Clrg receptor : ligand pairs are 
important components of the receptor “zipper” that occurs at the contact 
between natural killer cells and its target cell [1], and represent a recently 
discovered example of lectin – lectin interactions important for recognition 
of immune cell subsets. Previously, immunologists have brought evidence 
for the involvement of the NKR-P1F:Clrg pair in cellular activation such as 
T cell proliferaction [2], while the NKR-P1B/D:Clrb pair has been shown to 
inhibit natural killing [3]. In order to study the above interactions by 
biochemical techniques, we have amplified the individual cDNA clones for 
the above receptors by RT-PCR using spleens from B6/BL mice as the 
starting material. DNA fragments coding for the extracellular ligand 
binding domains of the two receptors were transferred into pET-30 bacterial 
expression vectors. After induction of protein production with IPTG, the 
protein precipitated into inclusion bodies, from which they could be 
refolded in vitro using standard refolding protocols. The quality of the 
refolding for both receptors was confirmed checking the disulfide bonding 
which fitted into the pattern expected for C-type lectins. Thus, using ion 
cyclotron resonance mass spectrometry with both MALDI and LC-ESI 
ionization [4], we have found that in NKR-P1F, the first cysteine is paired 
with the second one, the third with the sixths, and the fourth with the fifth. 
In Clrb the cysteine pairing was proved to be identical except the fourth and 
fifth cysteine, which were both missing in this receptor. In order to increase 
the stability of NKR-P1D, the third cysteine which does not fit into the 
pattern usual for this family of receptors was substituted for serine. The 
resulting C118S NKR-P1D, just as the Clrb, was shown to be monomeric in 
solution. Using gel filtration and analytical ultracentrifuge we were unable 
to prove the interaction between Clrb and NKR-P1D in these monomeric 
forms. Experiments to prove this interaction by SPR are underway. Efforts 
to prepare the receptors in dimeric forms in which they appear on the 
membrane, and experiments to see if these forms interact will follow. 
Supported by grants from Ministry of Education of Czech Republic 
(MSM_21620808 and 1M0505), and from The Grant Agency of Czech 
Rep. (GAČR 305/09/H008 and 303/09/0477).  
[1] Vivier E et al (2008) Nat Immunol 9, 503 [2] Tian et al (2005) Cell 
Immunol 234, 39. [3] Carlyle JR et al (2004) PNAS 101, 3527 [4] Pompach 
P et al (2009) J. Mass Spectrom 44, 1571. 
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SATB1 is a nuclear matrix/scaffold- associated DNA binding protein that 
participates in the maintenance of chromatin architecture and regulates 
expression of many genes. SATB1 is predominantly expressed in 
thymocytes and SATB1 mRNA expression peaks at the DP stage. In order 
to investigate whether SATB1 is involved in TCRα rearrangement we 
generated SATB1 conditional knockout mice in which SATB1 is deleted at 
the long term HSC stage by a vav-cre transgene. These mice have a reduced 
number of total thymocytes but a relatively normal DN to DP transition. We 
analyzed TCRα recombination by assessing the distribution of Jα usage in 
SATB1-deficient thymocytes and found that usage of 3’ Jα segments 
decreases dramatically compared with wild type thymocytes. Therefore 
secondary rearrangement is impaired in SATB1-deficient thymocytes. Short 
DP life-span or failure of Rag re-induction in DP thymocytes can impair 
secondary rearrangement. Expression of anti-apoptotic genes Bcl2 and Bcl-
xl are comparable in wild-type and SATB1-deficient DP thymocytes. 
Moreover Bcl2 transgenic mice did not eliminate the difference in Jα usage 
between wild-type and SATB1-deficient mice. However we did detect 
substantial reductions in the expression of Rag1 and Rag2 in SATB1-
deficient DP thymocytes. Rag re-induction in DP thymocytes depends on 
the ability of a distant anti-silencer to counteract the effects of the Rag 
silencer. In order to investigate the reason for failed re-induction of Rag in 
SATB1-deficient DP thymocytes, we analyzed histone modifications and 
RNA Pol II occupancy across the Rag locus. Consistent with reduced 
transcription, H4 acetylation and H3K4 di/trimethylation of Rag1 and Rag2 
are diminished in SATB1-deficient thymocytes. Pol II occupancy was high 
at four sites in the wild type locus: Rag1 promoter, Rag2 promoter, silencer 
and anti-silencer. SATB1-deficient DP thymocytes show reduced Pol II 
occupancy at the Rag1, Rag2 promoter and silencer, but normal occupancy 
at the anti-silencer. We hypothesize that SATB1 deficiency may regulate 
chromatin conformation and Pol II access to Rag1 and Rag2. 3C analyses of 
long distance interactions in the Rag locus are currently underway. 
 102 
ACTIVATION OF THE TCRA LOCUS GERMINAL TRANSCRIPTION 
AT Β-SELECTION BY AN INDUCIBLE ENHANCEOSOME 
 
Del Blanco Beatriz, Hernández-Munain Cristina  
 
Instituto de Parasitología y Biomedicina López-Neyra (CSIC), Cellular 
Biology and Immunology, Avda. del Conocimiento s/n, Armilla (Granada), 
18100, Spain 
 
The T-cell receptor α locus (Tcra) enhancer (Eα) is essential to activate 
germinal transcription at the Tcra locus during β-selection and V(D)J 
recombination in double-positive (DP) thymocytes. We have studied the 
molecular requirements for induction of these transcripts in cell models for 
pre-TCR signaling and primary mouse thymocytes. Concordantly with an 
essential role for pre-TCR-induced signaling for this activation, Tcra 
germinal transcription was dependent on constant phospholipase Cγ 
signaling that suggests a crucial role for binding of inducible transcription 
factors to Eα. Furthermore, Tcra transcription was strongly dependent on 
calcineurin-dependent calcium and MAPK/ERK signaling indicating that 
NFAT factors, among other inducible factors, are crucially involved in this 
function. We found that both NFAT and AP-1 can bind to multiple sites 
within Eα. Furthermore, NFAT factors are part of the Eα enhanceosome 
assembled in vivo during β-selection. Transient transfection experiments 
indicate that Eα is responsible for activation by calcium signaling through 
calcineurin. All these experiments together indicate that binding of 
inducible factors, such as NFAT and AP-1 factors, are part of an active Eα 
enhanceosome that it is essential for Tcra transcriptional activation during 
β-selection. Future efforts will address the study of Eα activity control by 
signaling transduced by pre-TCR versus TCR along thymocyte maturation 
and in peripheral Tαβ cells. 
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T cell fate is associated with mutually exclusive expression of CD4 or CD8 
in helper and cytotoxic T cells, respectively. RUNX transcription factors 
simultaneously activate the Cd8 locus, silence the Cd4 locus, and repress 
the ThPOK locus, which encodes a transcription factor required for CD4 
expression, but coordination of these disparate activities has been difficult 
to unravel. Here we find that interplay among members of this transcription 
factor circuitry alters nuclear organization; RUNX mediates association of 
Cd4 and Cd8 while Th-POK keeps the loci apart. Moreover, targeted 
deletions within Cd4 modulate CD8 expression and pericentromeric 
repositioning of Cd8. We propose that communication between Cd4 and 
Cd8 enables long-range epigenetic regulation in trans so that expression of 
one excludes the other in mature SP cells. 
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Signal-induced alternative splicing is a primary, but poorly understood, 
mechanism for regulating protein isoform expression in response to 
changing cellular environments. In T cells, signal-induced alternative 
splicing controls the relative expression of the five isoforms of the 
transmembrane tyrosine phosphatase CD45 in response to cellular 
activation. CD45 is essential for TCR signaling and exon skipping upon 
activation leads to reduced CD45 activity and T cell attenuation. However, 
the signaling pathway leading to activation-induced exon exclusion remains 
elusive. Here we show that in resting T cells the splicing regulatory protein 
PSF is held in an inactive complex with TRAP150, which is regulated by 
direct GSK3-mediated phosphorylation. Reduced GSK3 activity upon T cell 
activation releases PSF from TRAP150, thereby allowing it to bind splicing 
regulatory elements in CD45 and repress variable exon inclusion. 
Pharmacological inhibition or knock-down of GSK3 in resting T cells both 
induce a CD45 splicing pattern resembling that of activated T cells, clearly 
implicating GSK3 as a new signal responsive regulator of alternative 
splicing in T cells. This was observed in the JSL1 T cell line and in primary 
human T cells, confirming in vivo relevance. We propose a model in which 
de novo synthesis of PSF in the absence of GSK3 activity is required to 
induce CD45 exon skipping. Our data provide evidence for a new signaling 
pathway leading from TCR engagement to reduced GSK3 activity, RNA 
binding of PSF, CD45 exon exclusion and finally T cell attenuation. 
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IL-17 functions at the interface of the adaptive and innate arms of 
immunity, as it is produced by T helper 17 (Th17) cells but drives 
inflammatory responses in mesenchymal and epithelial cell types. This 
functional coordination is crucial for host defense against extracellular 
pathogens such as Candida albicans and, conversely, for the pathogenic 
effects of autoimmunity. The inflammatory program initiated by IL-17 
signaling occurs downstream of the IL-17 receptor (IL-17R), which is 
comprised of two subunits: IL-17RA and IL-17RC. While IL-17RA signals 
as part of a pre-assembled multi-subunit complex, IL-17RA homodimers 
are not sufficient for functional IL-17 signaling. Rather, IL-17RC, a distinct 
member of the IL-17R family, is an essential component of the IL-17R 
complex. However, the specific molecular and cellular contributions of the 
IL-17RC subunit to IL-17 signaling and immunity remain unclear. 
Therefore, we aimed: (1) to define regions within the IL-17RC cytoplasmic 
tail that are integral to IL-17 signaling and (2) to define contributions of IL-
17RC to IL-17-dependent immune responses in vivo. To delineate specific 
regions of the IL-17RC cytoplasmic tail required for proper IL-17 signal 
transduction, IL-17RC receptor truncation mutants were created and 
evaluated for downstream signaling activities. We found that functional IL-
17 signaling requires the IL-17RC SEFIR domain, a conserved signaling 
motif found on all IL-17R family members. However, an additional 
downstream sequence is also necessary for target gene expression. We show 
further that IL-17RC interacts with the adaptor/E3 ubiquitin ligase Act1, 
and that the functional IL-17RC mutants containing the extended SEFIR 
region interact specifically with a phosphorylated isoform of Act1. The IL-
17RC cytoplasmic tail, however, is not required for co-association with its 
partner, IL-17RA. Finally, we found that IL-17RC is required for IL-17-
dependent responses during oral mucosal infections caused by the 
commensal fungus Candida albicans. These results show that IL-17RC is 
critical for IL-17-dependent responses both in vitro and in vivo. Further 
insight into the functional contribution of IL-17RC will shed light on its 
role in modulating IL-17-dependent inflammatory responses and may 
provide an avenue for therapeutic intervention in IL-17 dependent diseases 
and host defense. 
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Isotype determination by class switch recombination (CSR) is an integral 
step in the development of an immune response. The mechanism of CSR is 
still not well understood. A different recombination event in B cells, VDJ 
recombination, has been examined by fluorescence in situ hybridisation 
(FISH) and has revealed the events occurring at both alleles. We have 
undertaken a study using FISH to analyse the events involved in CSR in 
human B cells. 
 
The heavy chain locus is a highly repetitive region of DNA, making the 
individual heavy chain genes difficult to identify using FISH. We have 
developed a novel approach using bioinformatics to analyse this region. 
Utilising this technique we have created unique probes that can identify 
CSR from µ to γ/ε or γ to ε heavy chain genes in a single human B cell. The 
combination of immunocytochemistry and FISH provides a powerful tool to 
examine the nuclear architecture and microenvironment in which the heavy 
chain locus resides. It has allowed us to differentiate between the two alleles 
and the events that are occurring independently on each allele. 
 
We have examined the colocalisation of the heavy chain locus with proteins 
involved in CSR including AID, UNG and Ku70. We have also identified 
the chromatin marks at the different alleles using a panel of antibodies 
against histone markers, including acetylated H3 and H3K4 trimethylation 
(markers of active gene transcription), as well as H3K9 trimethylation and 
H3K27 trimethylation (markers of active gene repression). Utilising these 
techniques we are dissecting the mechanism of CSR switching to IgE in 
human B cells. 
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TIS11b and TIS11d are RNA-Binding proteins that regulate the expression 
of target mRNA transcripts. They interact with AU-rich sequences in the 
3’untranslated region (3’UTR) of target transcripts and induce mRNA 
deadenylation, destabilization and translational inhibition. We have 
generated conditional knockouts of both these genes and crossed them to 
CD2Cre mice which effect deletion early in T and B cell development. 
Single knockout mice show interesting but modest defects in B cell 
development. In anticipation of functional redundancy between TIS11b and 
TIS11d we intercrossed the single knockout mice. Remarkably these double 
knockout mice develop T lymphoblastic Leukaemia (T-ALL) and die 
around the age of 3-5 months. B cell development is arrested at the pro-B 
stage. Haemaopoietic stem cells purified from bone marrow and cultured on 
the OP9-DL1 stromal line show increased proliferation and differentiation 
to double positive T cells. Microarray performed on thymus from 5 week 
old mice (prior to development of leukaemia) revealed elevation of several 
mRNAs including Notch-1. This was confirmed by RT-PCR and elevated 
Notch-1 proteins was demonstrated by FACS. The B cell arrest and 
leukaemic phenotype in the TIS11b/d double knockout mice is almost 
identical to that seen in previously published Notch-1-over-expressing mice. 
Furthermore, the Notch-1 3’UTR contains a region of high interspecies 
conservation within which sit three predicted binding sites for TIS11b/d. 
Luciferase reporter assays confirm repressive activity of TIS11b/d upon 
these regions. Furthermore, this repression is abolished by point mutation 
within the RNA-binding domain. When cultured in vitro, proliferation and 
survival of tumour cells is Notch dependent and is suppressed by a gamma 
secretase inhibitor.  
 
This suggests a novel mode of regulation of Notch-1 expression at the post-
transcriptional level mediated by RNA binding proteins and is the first 
direct evidence of a role for RNA-binding proteins in the development of 
malignancy. Ongoing work aims to identify corresponding mutations in 
human cases of T-ALL and to attempt to rescue the murine phenotype using 
in vivo notch1 inhibition.  
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The nuclear matrix refers to the highly branched non-chromatin network 
and granules inside of the nuclear lamina, which has long been proposed as 
the centers for various biological reactions, such as DNA replication, RNA 
transcription, and RNA splicing. Pax5 is an important regulator for B 
lineage cell development, which controls the B lineage gene expression 
program involving hundreds of positive and negative target genes. Here, we 
show that majority of the endogenous Pax5 proteins in human and murine B 
lineage cells are associated with the nuclear matrix; where they occupy the 
centers for transcription as indicated by co-localization with the RNA 
polymerase II and the TATA box binding protein (TBP). Detailed analyses 
identified that the partial homeodomain (HD) and lysine 67, 87, and 89 
residues within the PRD domain of Pax5 are required for its association 
with the nuclear matrix. Mutation of these lysine residues disrupts Pax5 
mediated activation and repression of hundreds target genes. Based on these 
results, we propose an experimental model that Pax5 controls the B lineage 
gene expression through recruitment of the target genes to the transcription 
center associated with the nuclear matrix. 
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The mouse nuclear hormone receptor retinoic acid-related orphan receptor-
γt (RORγt) is necessary and sufficient for the differentiation of interleukin 
17 (IL-17)-producing T helper (Th17) cells, which comprise one of the 
distinct effector T cell lineages involved in the regulation of host defenses, 
particularly against extra-cellular bacteria and fungi. Recent studies from 
numerous laboratories indicate that the Th17 cells have key pro-
inflammatory roles in various autoimmune diseases and in cancer. For 
example, mice lacking IL-17 or the p19 subunit of IL-23, which is required 
for the expansion of Th17 cells in vivo, were resistant to various animal 
models of diseases, including experimental autoimmune encephalomyelitis 
(EAE), collagen-induced arthritis (CIA), and inflammatory bowel disease 
(IBD). In accordance with these observations, previous work in our 
laboratory has also shown that interrupting RORγt function prevents 
progression of autoimmune diseases in mice, suggesting that it may be a 
good therapeutic target for these diseases.  
 
Despite the potential of RORγt as a target for anti-inflammatory drugs, 
ligands and other factors that regulate its activity have yet to be identified. 
We have developed an activity-based assay system in Drosophila S2 cells 
to perform genome-wide loss-of-function and small-molecule chemical 
compound screens, which may allow us to identify chemical/genetic 
modulators, including components involved in the ligand biosynthetic 
pathway. At least two different classes of small molecule compounds 
identified from the screens function as specific inhibitors for RORγt to 
selectively block both mouse and human Th17 cell differentiation in vitro. 
Moreover, treatment of animals with these compounds not only delays 
onset, but also reduces severity of EAE progression in both active and 
passive EAE induction models. We also identified multiple Drosophila 
genes involved in several interesting biological pathways that positively or 
negatively regulate the function of RORγt. Regulatory roles of their 
mammalian orthologues in Th17 cell differentiation are currently being 
tested and ensuing results will be presented.  
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Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized 
by pruritic and eczematous skin lesions. AD is caused by complex 
pathogenic factors including gene susceptibility, skin barrier dysfunction, 
bacterial infection and immunological factors. Eosinophils and Th2 type 
cytokines including IL-4, IL-5, IL-10, IL-13 and IL-31 play important role 
in the development and progression of AD. Although many studies 
elucidated the pathogenesis of AD, little information is available for the 
genetic factors associated with AD development and pathogenic processes. 
Recently, we have found that Ets1 knock out (KO) mice developed 
spontaneous AD and were more susceptible to induce experimental AD. To 
elucidate underlying mechanisms of exuberant AD symptoms in Ets1 KO 
mice, we investigated functional characteristics of T and B cells related with 
AD pathogenesis. The alterative genetic program in Ets1 KO mice resulted 
in upregulation of IL-5, IL-9, IL-10 and IL-31 expression, hyper-
plasmacytosis and hyper-production of IgE levels, which contributed to AD 
pathogenesis. In T cells, Ets1 negatively regulated a set of AD pathogenic 
genes including IL-5, IL-10 and IL-31 by direct binding on each promoter 
region. Moreover, Ets1 concomitantly acted as a transcriptional activator of 
Pax5 gene but as a transcriptional repressor of Blimp1 gene through direct 
binding on each promoter region of each target genes. Conclusively, our 
findings suggest that Ets1 acts as the master regulator in AD pathogenesis 
in which transcription factor Ets1 modulates effector function of T and B 
cells by regulating multiple target genes resulting in prevention of AD 
development and progression. This research was supported by grants from 
the regional technology innovation program of the MOCIE (No. RTI05-01-
01), the Korea Healthcare Technology R&D Project, Ministry for Health, 
Welfare and Family Affairs (A080588-5) and by systems biology 
infrastructure establishment grant provided by GIST. 
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T cells, the major player of adaptive immunity, are generated from 
hematopoitic stem cells (HSCs) through a line of differentiation steps. 
Whereas later steps serving as checkpoints for the quality of T cell receptor 
have been well defined, mechanisms of earlier steps where pluripotent 
HSCs are restricted to unipotent T cell progenitors are poorly understood. 
We have previously shown that progenitors developing in the thymus are 
determined to T cell lineage by shutting-off the potential to produce 
myeloid, dendritic and NK cells, at the midst of c-kit+CD25+ (DN2) stage, 
termed “DN2-determination step”. Here we show that this DN2-
determination step is serving as a critical developmental checkpoint. We 
firstly demonstrate that, by culturing murine prethymic progenitors on 
immobilized DLL4 protein in the presence of cytokines including IL-7, 
cells differentiated towards T cell lineage were arrested just before the 
DN2-determination step, and the arrested cells undergo self-renewal cycle 
keeping non-T lineage potentials. These arrested DN2 cells were induced to 
be determined to T cell lineage by simply reducing the IL-7 concentration, 
eventually giving rise to CD4+CD8+ αβT cells. We further show that, a very 
similar arrest and self-renewal of progenitors were observed in thymocytes 
of Bcl11b-/- mice, and the DN2-arrest in the DLL4/IL-7 culture did not 
occur in progenitors in which Bcl11b is enforced to express. Our study thus 
revealed a novel Bcl11b-dependent checkpoint of T cell development, the 
blockage of which induces self-renewal of arrested progenitors, providing a 
clue to elucidate the molecular mechanisms establishing T cell lineage 
identity. 
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Recent studies suggested a role of miRNAs in regulation of the pathogen-
host interaction. The pathogens, including some viruses, were found to 
produce miRNAs. Conversely, host response to pathogens is associated 
with changes in the pattern and levels of miRNA expression. The execution 
of the miRNA function is mediated by the Ago family of proteins. We 
argue that multiplicity of the Ago proteins in mammalian cells as well as in 
cells of other organisms may reflect the differential ability of individual 
Ago’s to regulate response to distinct pathogens. To test this hypothesis we 
studied the antiviral response of mouse cells deficient in Ago1, Ago2, 3 or 4 
proteins. At this point, we found that deficiency in Ago2 boosts the levels of 
virus or synthetic nucleic acid-induced IFNβ production. An increase 
expression of IFNβ by Ago2 deficient cells is associated with higher, as 
compared to wild-type cells, resistance to the cytopathic effect of RNA 
viruses such as Influenza A and Vesicular Stomatitis Virus (VSV). These 
data revealed a previously unknown negative role of Ago2 in regulation of 
antiviral response. We will present the data that address the mechanism of 
Ago2 involvement in antiviral response. 
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V(D)J recombination is a somatic recombination event that enables 
enormous diversity to be created from a limited number of gene segments. 
It is critical that this process is restricted to non-cycling cells to prevent 
replication from occurring over broken or unrepaired DNA. IL-7, a cytokine 
that is secreted within the local environment of developing B and T cells, 
provides essential proliferation and survival signals to lymphocytes while 
also guiding their development. IL-7 is required for promoting the 
accessibility of select antigen receptor loci, thereby promoting their 
recombination. In apparent contradiction, recent data demonstrates that IL-7 
represses the expression of the Rag genes, essential components of the 
recombination process. It has remained unclear how IL-7 can both promote 
and inhibit recombination within a single cell population such as pro-B 
cells. We provide evidence that pro-B cells are heterogeneous in terms of 
IL-7R expression in a manner that is directly related to cell cycle. In 
addition, cycling cells have lower levels of Rag transcripts than cells in 
G1/GO. Decreased Rag transcription correlates with increased association 
with pericentromeric heterochromatin (PCH), a repressive compartment 
within the nucleus, providing a potential mechanism for repression. 
Interestingly, the Igh locus (a target whose accessibility has been positively 
linked to IL-7) does not alter its association with PCH according to cell 
cycle status. We propose a model in which IL-7 acts as a “gate-keeper” to 
restrict recombination to non-cycling cells by actively inhibiting RAG 
expression via altered nuclear compartmentalization. 
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Development of thymocytes from the CD4+CD8+ double positive (DP) to 
the CD4+ or CD8+ single positive (SP) stage is a tightly regulated and 
obligatory step for the production of mature αβ T cells. This developmental 
transition is initiated upon proper expression of a T cell receptor (TCR) and 
proceeds through a variety of differentiation events, including the decision 
for cells to enter either the CD4 or CD8 T cell lineage. Current 
understanding of the underlying transcriptional regulation directing DP to 
SP development reveals a complex network of factors required for 
interpreting TCR selection signals, controlling cell survival, and 
determining lineage fate. Among the known players in these processes, the 
E-protein transcription factors HEB and E2A have been shown to be critical 
for both positive selection of DP thymocytes and DP cell survival. 
However, data from these studies suggested that the extent of E-protein 
function during the DP to SP transition does not end there. Here we 
investigate an additional role for E-proteins in directing CD4 vs. CD8 
lineage choice. To analyze the function of E-proteins during DP to SP 
development, we utilize a double conditional knockout mouse model that 
results in deletion of the genes encoding HEB and E2A at the DP stage. T 
cells generated in these mice are predominantly CD8 lineage with only a 
small proportion of CD4 lineage cells. Elimination of the pro-apoptotic 
factor Bim, critical for negative selection of thymocytes, was unable to 
rescue this CD4 lineage defect. Furthermore, CD8 lineage T cells continued 
to be generated even in the presence of a major histocompatibility complex 
(MHC) class II restricted TCR transgene (which usually drives CD4 
development). These results suggest that CD4 lineage cells fail to develop 
in the absence of E-proteins and instead are diverted to the CD8 lineage. 
The resulting mature, E-protein deficient T cells were able to proliferate and 
produce cytokines upon stimulation, demonstrating that the functions of E-
proteins downstream of TCR signaling may be unique and specific to 
thymocyte development during maturation from the DP to SP stage. 
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Immune homeostasis is dependent upon tight control over the size of a 
population of regulatory T (Treg) cells capable of suppressing over-
exuberant immune responses. The Treg cell subset is comprised of cells that 
commit to the Treg lineage by up-regulating the transcription factor (TF) 
Foxp3 either in the thymus (tTreg) or in the periphery (iTreg). Considering 
a central role for Foxp3 in Treg differentiation and function, we 
hypothesized that conserved non-coding DNA sequence (CNS) elements at 
the Foxp3 locus encode information defining the size, composition and 
stability of the Treg population. Here, we demonstrate that each of three 
Foxp3 CNSs (CNS1-3) has a distinct non-redundant function in Treg cell 
fate determination. We demonstrate a critical cell-intrinsic role for c-Rel in 
Foxp3 induction. The pioneer element CNS3, which acts to potently 
increase the frequency of Treg cells generated in the thymus and the 
periphery, binds cRel in in vitro assays. In contrast, CNS1, which contains a 
TGF-β/NFAT response element, is superfluous for tTreg differentiation, but 
plays a prominent role in iTreg generation in gut-associated lymphoid 
tissues (GALT). Finally, CNS2, while dispensable for Foxp3 induction, is 
required for continuous Foxp3 expression in the progeny of dividing mature 
Treg cells. Intriguingly, Foxp3-containing protein complexes bind to CNS2 
in a CBFβ/Runx1 and CpG DNA demethylation-dependent manner, 
suggesting that Foxp3 recruitment to this “cellular memory module” 
facilitates the heritable maintenance of the active state of the Foxp3 locus 
and, therefore, Treg lineage stability. Together, our studies demonstrate that 
the composition, size, and maintenance of the Treg cell population are 
controlled by Foxp3 CNS elements engaged in response to distinct cell-
extrinsic or -intrinsic cues. 
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NF-κB family transcription factors are critical for the regulation of many 
genes important for both innate and adaptive immunity. Common to all 
receptors that induce the classical NF-κB pathway is the activation of the 
trimeric inhibitor of κB kinase (IKK) complex. This complex consists of 
two catalytic subunits (IKK1/IKK2 or IKKα/IKKβ) and a scaffolding or 
adaptor subunit known as IKKγ or NF-κB essential modulator (NEMO). 
Here we demonstrate, using live cell confocal microscopy with fine spatial 
and temporal resolution, that the IKK complex is recruited to early sites of 
T cell receptor for antigen (TCR) signaling known as microclusters. 
Furthermore, we show that IKK is specifically recruited to microclusters 
containing the tyrosine kinase ZAP-70, but not those with the adaptor SLP-
76. Using a panel of Jurkat T cell variants lacking specific signaling 
proteins, we have determined which elements of the TCR signaling 
machinery are required for IKK localization to the microclusters. Finally, 
we have performed structure/function analysis of IKKγ itself to determine 
which domains within IKKγ mediate its recruitment to TCR microclusters, 
and will present the results of this analysis. 
Funding: NIGMS/NIAID 
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Activation of inflammatory immune responses during granuloma formation 
by the host upon infection of mycobacteria is one of the crucial steps that is 
often associated with tissue remodeling and breakdown of the extracellular 
matrix. In these complex processes, matrix metalloproteinase-9 (MMP-9) 
plays significant role in tissue remodeling. In this study, we investigated the 
molecular mechanisms underlying Phosphatidyl-myo-inositol dimannosides 
(PIM2), an integral component of the mycobacterial envelope, triggered 
MMP-9 expression in macrophages. PIM2 triggers the activation of 
Phosphoinositide-3 Kinase (PI3K) and Notch1 signaling leading to MMP-9 
expression in a Toll-like receptor 2 (TLR2)-MyD88 dependent manner. 
Notch1 signaling perturbations data demonstrate the involvement of the 
cross-talk with members of PI3K and Mitogen activated protein kinase 
pathway. Enforced expression of the cleaved Notch1 in macrophages 
induces the expression of MMP-9. PIM2 triggered significant p65 nuclear 
factor -kB (NF-kB) nuclear translocation that was dependent on activation 
of PI3K or Notch1 signaling. Furthermore, MMP-9 expression requires 
Notch1 mediated recruitment of Suppressor of Hairless (CSL) and NF-kB 
to respective promoters. Taken together, these data implicate PI3K and 
Notch1 signaling as obligatory early proximal signaling events during PIM2 
induced MMP-9 expression in macrophages. 
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Immunoglobulin (Ig) class switch recombination (CSR) uses a distinct 
nonhomologous end joining (NHEJ) pathway to repair DNA double strand 
break (DSB) intermediates. During CSR the Igh locus is dependent on 3D 
chromatin architecture mediated by long range intra-chromosomal 
interactions between distantly located enhancers to create a looped 
structure. 53BP1 is a DNA damage response protein which is rapidly 
recruited to sites of chromosomal DNA double strand breaks (DSBs) and is 
essential for CSR. Based on two key observations it has been suggested that 
within the Igh locus, 53BP1 facilitates synapsis of distant broken DNA ends 
that are located in switch (S) regions. First, in 53BP1 deficient- but not WT 
B cells enhanced intra-S region rearrangement is detected. Second, 53BP1 
deficiency is associated with genome instability at the Igh locus upon 
induction of DSBs implying that 53BP1 is involved in tethering distantly 
located DSBs. We have used the chromosome conformation capture (3C) 
technique to assess the contribution of 53BP1 to the spatial organization of 
the Igh locus in the presence and absence of DSBs. In B cells deficient for 
53BP1 or AID there was modest impact on multiple long range interactions 
during CSR. Unexpectedly, intra-chromosomal interactions were 
profoundly reduced in B cells doubly deficient for 53BP1 and AID, 
suggesting that prior to the induction of DSBs, 53BP1 is a crucial 
contributor to the spatial organization of the Igh locus. Chromatin 
immunoprecipitation (ChIP) assays using two independent antisera, indicate 
that 53BP1 is resident on S regions in resting B lymphocytes from WT and 
AID deficient B cells indicating that 53BP1 occupancy is independent of 
DSB induction. ChIP analyses also demonstrate the presence of H4K20me2 
modifications in S region of resting B cells. The H4K20me2 mark is 
recognized by the 53BP1 tudor domain and functions to anchor the protein 
to chromatin. Others have shown that in mice doubly deficient for Suv4-
20h1 and Suv4-20h2, the absence of H4K20me modifications is correlated 
with delayed recruitment of 53BP1 to DSBs, reduced CSR and instability of 
chromosome 12 at the Igh locus. Replication protein A (RPA) is also found 
in S regions and is an interaction partner with 53BP1 suggesting that the 
combined presence of H4K20me2 and RPA might target 53BP1 to S 
regions in resting B cells. Our findings provide evidence that 53BP1 is 
specifically recruited to the Igh locus independent of the presence of DSBs 
and is a key organizer of chromatin architecture during CSR. This work was 
supported by the National Institutes of Health, USA (RO1AI052400 to A. 
L. K.) 
 119 
ROLE OF SHORT NON-CODING RNAS IN B CELL DEVELOPMENT 
 
Sergei B Koralov1, David Riess1, Tirtha Chakraborty1, Kari Jensen1, Robert 
Blelloch4, Mark Chong2,3, Dan Littman2, Klaus Rajewsky1  
 
1Harvard Medical School/Children's Hospital Boston, Program in Cellular 
and Molecular Medicine, 200 Longwood Ave, Boston, MA, 02115, 2NYU, 
Skirball Institute, 540 First Avenue, New York, NY, 10016, 3The Walter 
and Eliza Hall Institute, Autoimmunity and Transplantation Division, 1G 
Royal Parade, Parkville, 3052, Australia, 4 UCSF, Department of Urology, 
Box 0525, San Francisco, CA, 94143 
 
In order to explore the role of miRNAs and other small interfering RNAs in 
B cell survival and orchestration of the B lymphocyte developmental 
program we undertook a global approach, ablating all Dicer dependent short 
RNAs by conditionally deleting Dicer at the earliest stage of B cell 
development. We found that B cell specific ablation of Dicer resulted in an 
essentially complete developmental block in the bone marrow at the pro-B 
to pre-B cell transition. By introducing a pro-survival EμBcl2 transgene or 
by knocking out one of the genes targeted by miRNAs throughout B cell 
development, Bim (a pro-apoptotic BH3 family member), we achieved 
considerable rescue of Dicer null B cells. Rescue of B cell development in 
the absence of short non-coding RNAs allowed us to investigate the role of 
these short RNAs in lymphocyte proliferation, V(D)J rearrangement and B 
cell receptor expression. While we found the basic mechanism of V(D)J 
recombination was intact in the absence of short non-coding RNAs, there 
was a discernable impact on Ig repertoire because of a shift in DH element 
accessibility at the heavy chain locus and aberrant N nucleotide addition 
among Ig light chain joints (Koralov, Muljo et al Cell 2008). 
We are now comparing Dicer, Drosha and DGCR8 deficient B cells, 
rescued in a similar manner as above with EμBcl2 transgene, to distinguish 
the role of miRNAs from other short non-coding RNAs throughout B cell 
development. In particular we are investigating the role of local Ig 
transcripts in DH element accessibility. We also uncovered a role of short 
non-coding RNAs in Ig expression in mature cells. Dicer null B cells 
exhibit a surface Ig low phenotype and appear to have undergone repetitive 
gene rearrangement at their kappa loci, characterized by elevated Jκ4/5 
usage, increased IRS/RS recombination and striking skewing towards 5’ Vκ 
gene usage. We are currently examining the possible role of short non-
coding RNAs in Ig locus accessibility and downstream BCR signaling to 
identify what pathway may be responsible for the Ig low phenotype in Dicer 
null B cells. Combining an Ig transgene with transgenic Bcl2 leads to 
complete rescue of B cell development, allowing us to study the role of 
short non-coding RNAs on other B cell intrinsic processes that may involve 
this element of regulation – somatic hypermutation and class switch 
recombination.  
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Somatic hypermutation (SHM) and gene conversion (GCV) are two closely 
related processes that increase the diversity of the primary immunoglobulin 
(Ig) repertoire. Both processes are initiated by the activation-induced 
cytidine deaminase (AID) that converts cytosine residues to uracils in a 
transcription-dependent manner and processed by direct replication and 
error-prone DNA repair. It is unknown how this mutagenic activity is 
targeted almost exclusively to Ig loci.  
To identify cis-acting elements involved in targeting SHM and GCV to the 
chicken Ig light chain (IgL), we used DT40 cells and systematically deleted 
non-coding sequences from the IgL locus using standard gene targeting 
strategies. We identified a novel as of yet uncharacterized regulatory region 
(named 3′RR) in the chicken IgL gene, containing a classical transcriptional 
enhancer and also cis-acting DNA elements essential for targeting AID-
mediated sequence diversification. We are continuing our systematic 
deletion strategy to identify the minimal sequence required for targeting and 
to determine the trans-acting factors that bind to it. To identify similar 
targeting elements in the murine Igκ locus, we use a cross-complementation 
approach replacing the 3′RR in DT40 cells with murine Igκ sequences. 
Previous mouse transgenic studies indicated that both iEκ and 3'Eκ were 
necessary for the SHM of Igκ transgenes, and we are currently testing the 
ability of these enhancers to restore SHM/GCV in the chicken locus.  
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Intestinal mucosal surface is constantly exposed to a complex and dynamic 
community of microorganisms. Therefore, it is crucial that host organism 
monitors and regulates microbial interactions with intestinal epithelial 
surfaces using gut-associated immune system (GALT). GALT represents 
complex network of various lymphoid structures, such as Peyer’s Patches 
(PPs), isolated lymphoid follicles (ILFs)and lamina propria lymphocytes. 
Recently, lymphoid tissue-inducer cells are reported as crucial cell type for 
development of PPs and ILFs. Previously, TNF and lymphotoxin α (LTα) 
and beta (β) were shown as critical factors for development of these 
structures, although cellular sources of these cytokines remain largely 
unknown. To study role of TNF, LTα and LTβ expressed by LTICs, mice 
with floxed TNF, LTα and LTα genes were crossed with mice bearing Cre-
recombinase under Rorγt-promoter. LTα and LTβ produced by LTICs are 
crucial for PPs and LN development, while TNF expressed by LTICs has 
critical, non-redundant functions in PPs development. Analysis gut IgA 
production revealed no role of LTICs – derived LTβ in IgA production, 
while ablation of LTα in LTICs resulted in complete absence of IgA from 
feces, implying critical role of soluble LTα (sLTα) in the control of T-cell 
independent IgA production in the gut. In addition, gut IgA levels were only 
impaired in TNFR1 KO mice, suggesting that sLTα mediates its effects via 
both TNFR1 and TNFR2. Taken together, our data revealed distinct, non-
redundant functions of TNF/LT expressed by LTICs in mucosal immunity. 
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The functional architecture of the interphase nucleus has recently become a 
focus of interest. Chromatin modifications and nuclear spatial organisation 
seem to function in concert to co-ordinate the responses of a cell to 
environmental and intracellular signals that lead to the establishment of a 
gene expression program. The positioning of a gene in relation to its 
chromosome territory (CT) has been studied extensively in recent years. In 
our study, we followed the repositioning of the CD8α gene in relation to its 
chromosomal backbone during the developmental program of T cells, from 
DN thymocytes to DP and then CD4 SP and CD8 SP in the thymus and 
eventually to mature CD4+ and CD8+ cells in the spleen, and compared it 
to B cells where the gene has never been expressed. As the CD8 gene is 
located on mouse chromosome 6, its repositioning was studied in relation to 
its sub-chromosomal territory (sCT), defined by specific mcb fragments that 
were generated by micro-dissection of chromosome 6 resulting in a library 
of 8 overlapping fragments. The distance of the gene was measured both 
from the centre and from the nearest edge of its sCT. Our results suggest 
that during T cell development the CD8 gene in CD8 expressing cells 
relocates from an inner core of its chromosomal domain to a nuclear 
location where transcription becomes possible. As this is also true for the 
CD4 gene, this gene motility appears to be a more general feature of gene 
regulation during T cell development.  
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Th17 cells are a potentially pathogenic T helper subset in autoimmunity. 
Th17 cells are characterized by secretion of IL-17A, IL-17F and IL-22 and 
are largely dependent of the transcription factor RORγt and the cytokine IL-
23. Although Th17 cells were shown to be highly pathogenic in animal 
autoimmune models, our recent data show that for CNS autoimmunity the 
major cytokines produced by Th17 cells such as IL-17A, IL-17F and IL-22 
are dispensable. Recent data showed that Tregs as well as Th17 cells share 
flexibility in response to the surrounding cytokine milieu. To investigate the 
stability and the fate of differentiated Th17 cells we created a new mouse 
strain that allows for cell fate experiments. In these mice the IL-17F 
expressing cells are irreversibly marked by Cre mediated excision of a loxP-
flanked-STOP cassette of the Rosa-EYFP transgene. We found that sorted 
EYFP positive Th17 cells are highly plastic whether generated in vitro or in 
vivo. Adoptively transferred Th17 cells largely lost IL-17 expression in a 
lymphopenic environment and expressed IFNγ. In contrast, 
encephalitogenic Th1 cells stayed stable IFNγ expressers although some 
Th1 cells of lymph nodes became double positive for IL-17A and IFNγ. 
Additionally our data show that Th17 cells do not become longterm bone 
marrow resident memory cells. This flexibility questions whether Th17 
cells can be put into one line of stable T helper subsets as Th1 or Th2 cells. 
Th17 might rather constitute a state of T cells under the influence of a pro-
inflammatory milieu. 
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Compartmentalization of the mammalian genome within the nucleus is 
considered to regulate various processes such as transcription, RNA 
processing, DNA repair and recombination. The murine IgH locus has been 
shown to be associated with the nuclear lamina in multi-potential 
hematopoietic progenitors, T-lineage cells and fibroblasts and repositioned 
within the nucleoplasm during early B cell development. We have proposed 
that such compartmentalization may restrict access of the IgH locus to the 
transcriptional and recombination machinery in T-lineage cells. Consistent 
with this proposal, repositioning of active genes to the lamina can result in 
their transcriptional repression. Recently, targeted DNA methylation 
(DamID) has been used to map lamina-associated domains (LADs) in 
human fibroblasts that span nearly forty percent of the genome and 
preferentially contain inactive chromatin. We have used high resolution 
DamID and chromatin crosslinking to analyze the interaction of the germ-
line IgH locus with the lamina and to delineate and characterize LADs in 
chromosomes of mouse fibroblasts. Such analysis reveals that the entire IgH 
locus (~3Mb) constitutes a LAD. Using DNA sequences from the IgH locus 
and another developmentally regulated LAD (Cyp3a) we demonstrate the 
presence of lamina-associating sequences (LASs) that, upon ectopic 
integration in fibroblasts, reposition loci to the nuclear lamina. The 
interaction of LASs as well as the endogenous IgH and Cyp3a loci with the 
lamina is disrupted by inhibition of histone deacetylase (HDAC) activity. 
Unlike detachment, re-association of LASs with the nuclear lamina is 
dependent on cell division. These results suggest that both DNA sequence 
elements and chromatin structure are required for cell cycle dependent LAD 
assembly and maintenance. Thus as is the case for proteins, chromosomal 
loci contain nuclear address signals that are important for gene location and 
activity. Future experiments are focused on delineating the nature of the 
sequence elements and factors that target the IgH locus to the nuclear 
lamina. 
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TET2 is a close relative of TET1, an enzyme that we recently showed 
converts 5-methylcytosine to 5-hydroxymethylcytosine in DNA. TET2 
mutations and chromosomal deletions spanning the TET2 locus are 
frequently found associated with myelodysplastic syndromes (MDS), 
myeloproliferative disorders (MPD) and frank myeloid malignancies (acute 
myeloid leukemia, AML, and chronic myelomonocytic leukemia, CMML). 
The mutations have been assumed to be loss-of-function mutations since 
both alleles of TET2 are generally affected. Here we show that TET2 
expression in cells causes loss of 5-methylcytosine staining in parallel with 
increased staining with an antibody to 5-hydroxymethylcytosine and an 
increased level of 5-hydroxymethylcytosine in genomic DNA. This activity 
is abolished or severely impaired by engineered mutations predicted to 
impair catalytic activity, as well as by leukemia-associated mutations in 
residues predicted to play a role in catalysis. The mutational status of the 
TET2 locus, determined by SNP analysis and sequencing, correlated well 
with the level of 5-hmC in genomic DNA from patients with MDS, MPD 
and other myeloid malignancies. These findings indicate that appropriate 
hydroxymethylation of DNA is critical for suppressing myeloid 
tumorigenesis. 
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Cohesin-mediated sister chromatid cohesion is essential for chromosome 
segregation and post-replicative DNA repair. An additional role for cohesin 
in the regulation of gene expression has recently been recognized based on 
findings in model organisms and in patients with Cornelia de Lange 
syndrome. This non-canonical role of cohesin in gene regulation has been 
rationalized, at least in part, by findings that cohesin is recruited to 
mammalian chromosomes by the insulator protein CTCF and that cohesin 
knockdown perturbs long-range chromosomal interactions. Here we take a 
genetic approach to determine the impact of cohesin on cell lineage-specific 
and developmental stage-specific gene expression in developing T cells. 
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ImmGen is a collaborative group of Immunology and Computational Biology 
labs which aims to determine, on a broad scale, the patterns of gene expression 
and genetic regulatory networks of immune system cells in the mouse. We will 
illustrate some of the results and computational predictions, which arrive at an 
unusual perspective on transcriptional regulation. 
In the first phase, which is well under way, ImmGen participants are generating 
under carefully standardized conditions a “complete” compendium of whole-
genome microarray datasets. This will encompass most defined cell populations 
of the adaptive and innate immune systems, at major stages of their 
differentiation and activation (lymphoid, myeloid, stroma; ~250 populations 
overall). Each participating lab is addressing questions relevant to particular 
lineages of interest (relationships between cells populations, transcript flow 
through differentiation or cell migration, regulatory structures). The global data 
are also used for computational reconstruction of regulatory networks, grouping 
genes into modules of genes that are coregulated by the same regulatory factors 
(transcription or signaling factors), generating predictions of their regulatory 
elements, some of which are shared across the entire system, others being 
lineage-specific. 
In the second phase, we are beginning to use “perturbations” (natural or induced 
genetic variation, drug treatment, TF transfections) to test the 
variability/robustness of transcriptional control, and to validate and refine the 
computational predictions of regulatory relationships. 
ImmGen data are made publicly available through usual public databases and 
through a project-specific website (www.immgen.org), for which we are 
exploring novel ways to display expression data and its organization in gene 
families and modules, or throughout the physical genome. In addition, ImmGen 
is open to suggestions from the community, either for defined cell types not 
previously included, or as add-on experiments that might benefit from 
ImmGen’s standardized processing. 
Supported by NIAID R24, in partnership with eBiosciences, Affymetrix and 
Expression Analysis. 
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Histone mimics are short stretches of amino acid residues that are 
homologous or identical to the N-terminal portion of histone H3. Histone 
mimics are present in numerous proteins of human, mouse, viral or bacterial 
origin. However, function of these mimics remains unknown. We have 
identified the presence of a histone mimic within the functionally important 
influenza protein NS1. We show that similar to histones, the NS1 histone 
mimic could be modified by acetylation, methylation and phosphorylation. 
Furthermore, similar to the modified histones, the NS1 histone mimic 
controls expression of genes in mammalian cells. These findings suggest a 
possible role of the virally encoded histone mimic in regulation of the host 
gene expression during influenza infection. I will present the data that 
address the structural and functional features of the influenza histone 
mimic. I will also discuss the results of the experiments that utilize synthetic 
histone mimics to control gene expression in immune cells. 
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Each cell type is associated with a distinct epigenome that is characterized 
by a set of distinct chromatin modifications. We previously showed that 
while TCR-inducible genes are poised by chromatin modification in resting 
T cells, significant changes in histone modifications accompany T helper 
cell differentiation. Signature cytokine genes exhibit either active or 
repressive chromatin modifications as expected for their expression status; 
however, key transcription factors such as Tbx21 and Gata3 associate with 
bivalent modifications in non-expressing lineages. The epigenetic 
mechanisms underlie the T cell specificity and plasticity. To understand 
how the epigenetic patterns are established, we analyzed the genome-wide 
distribution of GATA3, a key transcription factor required for double 
positive cell and Th2 differentiation, in all well-defined T cell lineages. Our 
data indicate that GATA3 regulates critical components of multiple 
signaling and transcription pathways by mediating epigenetic modifications. 
(* indicates authors contributed equally; contact: jfzhu@niaid.nih.gov; 
zhaok@nhlbi.nih.gov). 
 
References: Wei et al., Immunity v30, p155-167 (2009); Barski et al., 
Genome Research v19, p1742-1751 (2009) 
 
Funding: Division of Intramural Research of NHLBI, NIH 
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Conditional knock-out of transcription factor YY1 in the B cell lineage 
results in pro-B cell arrest. The PcG protein EZH2 shows a similar 
phenotype. We deleted a 25 amino acid YY1 domain (the REPO domain) 
that is necessary and sufficient for YY1 PcG function. We used this mutant, 
and wild-type YY1 retroviral constructs, to transduce bone marrow from 
YY1 conditional knock-out mice and transferred these cells into irradiated 
recipient mice. While wild type YY1 rescued B cell development, the 
REPO deletion mutant failed to rescue the B cell lineage with dramatic 
reduction in immature B cells. We also found that Ig kappa rearrangement 
was reduced in the REPO mutant background. We used the YY1 REPO 
domain to isolate interacting proteins and found that the REPO domain 
interacts with proteins from the condensin complex. We found that YY1 
and condensin proteins co-localize at numerous sites across the Ig kappa 
locus and that RNAi knock-down of condensin subunit SMC4 inhibits Ig 
kappa rearrangement. Our results suggest that YY1 and condensin proteins 
are involved in Ig locus contraction and rearrangement. 
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During immunoglobulin heavy chain (Igh) V(D)J recombination, D-to-J 
precedes V-to-DJ recombination in an ordered manner, controlled by 
differential chromatin accessibility of the V and DJ regions, and essential 
for correct antibody assembly. However, with the exception of the intronic 
enhancer Εμ, which regulates D to J recombination, cis-acting regulatory 
elements have not been identified. We have assembled the sequence of a 
strategically located 96kb V-D intergenic region in the mouse Igh, and 
analysed its activity during lymphocyte development. We show that Εμ-
dependent D antisense transcription, proposed to open chromatin before D 
to J recombination, extends into the V-D region for more than 30 kb in B 
cells before, during and after V(D)J recombination and in T cells, but 
terminates 40kb from the first V gene. Thus, subsequent V antisense 
transcription before V to DJ recombination is actively prevented and must 
be independently activated. To find cis-acting elements that regulate this 
differential chromatin opening, we identified six DNase I hypersensitive 
sites (HS) in the V-D region. One conserved HS upstream of the first D 
gene locally regulates D genes. Two further conserved HSs near the D 
region mark a sharp decrease in antisense transcription, and both HSs bind 
CTCF in vivo. Further, they both possess enhancer-blocking activity in 
vivo. We propose they are enhancer-blocking insulators preventing Εμ-
dependent chromatin opening extending into the V region. Thus they are the 
first elements identified that may control ordered V(D)J recombination and 
correct assembly of antibody genes. 
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The immunoglobulin heavy-chain (Igh) locus is organized in distinct 
regions that contain multiple variable (VH), diversity (DH), joining (JH) 
and constant (CH) coding elements. In previous studies we have determined 
the 3D-structure of the Igh locus in pre-pro-B and pro-B cells. These 
findings indicated that the Igh locus undergoes large-scale conformational 
changes upon developmental progression. We have extended these findings 
and examined how Igh locus contraction is established in developing B 
cells. As a first approach to resolve this questions, we have isolated 
hematopoietic progenitor cells that carry an inducible Id2 construct. These 
cells upon withdrawal of Id2 these progenitor cells readily differentiate to 
become committed to the B cell lineage. We observed in this in vitro system 
that Igh locus contraction occurs prior to Igh VDJ gene rearrangement. 
Additionally, we observed that the Igh locus consists of three compartments 
at the pre-pro-B cell stage but that the compartments merge within a five 
days period upon withdrawal of Id2. Collectively, these data indicate that 
the Igh locus undergoes distinct topologies during the development of B-
lineage cells, to ultimately establish distinct topology that allows long-range 
genomic interactions to occur with relatively high frequency. We have used 
multicolor 3D-FISH to confirm the 3D-topology as resolved by trilateration. 
Based on the observations obtained by others as well as our own, we 
propose that Igh locus topology as observed in pre-pro-B cells is a general 
feature of the eukaryotic chromatin fiber.  
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Cancer initiating translocations such as those associated with lymphomas 
require formation of paired double strand breaks (DSBs). Activation-
induced cytidine deaminase (AID) produces widespread mutation in mature 
B cells by introducing U:G mismatches in target DNA. These lesions can be 
processed to produce DSBs in IgH and more rarely in c-myc but the extent 
of genome instability produced by AID and whether this leads to 
translocation associated malignancy is unknown. We have shown that de-
regulated expression of AID causes widespread chromosomal damage, 
which alone is insufficient to induce B cell lymphoma; transformation 
requires concomitant loss of the tumor suppressor p53. Mature B cell 
lymphomas arising as a result of de-regulated AID expression harbor clonal 
reciprocal translocations involving a diverse group of Ig and non-Ig genes 
that are direct targets of AID, including miRNA142, a previously unknown 
target, which is translocated in human B cell malignancy. We conclude that 
AID produces DSBs throughout the genome, some of which lead to 
lymphoma associated chromosome translocations in mature B cells.  
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Immunoglobulin class switch recombination (CSR) is initiated by the 
specific targeting of activation induced cytidine deaminase (AID) to 
transcribed switch (S) regions and the subsequent generation of double 
stranded DNA breaks (DSBs). AID targeting during CSR correlates with 
the induction of epigenetic modifications at S regions, including 
trimethylation of lysine 9 of histone H3 (H3K9me3), and has been 
suggested to be mediated by the C-terminus of AID. Although this domain 
is required for the specific function of AID in CSR, its actual role and the 
interactions it mediates are poorly understood. Here we show that the C-
terminus of AID associates with KAP1 (KRAB-associated protein 1)) and 
that AID can form a complex with KAP1 and HP1 (heterochromatin protein 
1), which is recruited to transcribed S regions in vivo during CSR. 
Furthermore, we show that conditional inactivation of KAP1 in B cells does 
not affect somatic hypermutation but results in defective CSR, a defect due 
to reduced levels of DSB formation at transcribed S regions. Finally we 
show that CSR requires the in vivo association between KAP1 and HP1. 
We propose that AID associates with KAP1 and HP1 and that this complex 
is tethered to transcribed S regions bearing the H3K9me3 mark, thus 
providing a targeting mechanism that links for the first time the C-terminus 
of AID to epigenetic modifications induced during CSR. 
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Histone H3K4 trimethylation is a chromatin mark of transcription initiation 
and is mediated by a number of MLL-like complexes; however, to what 
extent these complexes promote gene expression important for immune 
function is unknown. The BRCT domain-containing PTIP protein is a 
component of the MLL3/MLL4 methyltransferase complex and, 
interestingly, also accumulates at sites of DNA damage. Using Ptip 
conditional deletion mice, we investigated PTIP function in B lymphocytes, 
whose programmed DNA rearrangements require transcription and DNA 
repair. Here we show that activated B cells deficient for PTIP proliferate 
and survive normally but display impaired H3K4me3 most significantly at 
the immunoglobulin heavy-chain (Igh) switch regions, with very few other 
changes genome-wide. Further experiments reveal that B cells lacking PTIP 
have severe immunoglobulin class-switching defects because of impaired 
transcription initiation through downstream Igh switch regions, marked by 
loss of histone acetylation and RNA Polymerase II (Pol II) association. As a 
separate function, we show that PTIP accumulation at DNA breaks also 
contributes to class-switch recombination (CSR) and genome stability 
independently from Igh switch transcription. Our experiments demonstrate 
that PTIP promotes histone modifications and Pol II association critical for 
initiation of Igh switch region transcription and AID accessibility while also 
having a minor function in the repair of CSR-associated DNA breaks, 
suggesting a non-redundant role for the MLL3/MLL4 complex in altering 
antibody effector function. 
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Mature B cells upon encountering antigens undergo class switch 
recombination (CSR), a deletional recombination reaction that replaces the 
constant region of the expressed immunoglobulin molecule so that the B 
cell changes from expressing IgM to IgG, IgE or IgA. CSR requires the 
generation of DNA double-strand breaks (DSBs) at repetitive DNA 
elements, called switch (S) regions in the immunoglobulin locus, followed 
by ligation of DSBs between two different S regions. It is now clearly 
established that the activity of the DNA deaminase AID at S regions leads 
to the generation of DSBs. However, the mechanism that targets AID 
activity specifically to the S regions and the process by which the DSBs 
thus generated are ligated to complete CSR are outstanding unresolved 
questions. Using a combination of biochemical screens for AID interactors 
and short-hairpin-mediated knock-down in B cells, we have identified the 
splicing regulator polypyrimidine tract binding protein 2 (PTBP2) as a 
factor that promotes binding of AID to S regions to activate CSR. We also 
show that DNA-end processing factor CtIP plays a significant role in the 
joining of DSBs during the completion phase of CSR. Our results have 
implications on how AID activity is targeted to the immunoglobulin locus 
and how the classical non-homologous end-joining and the “alternative” 
end-joining pathways mediate ligation of DSBs at S regions during CSR. 
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Recurrent translocations in tumors are often considered to represent very 
low frequency events that are strongly selected at the cellular level. 
However, we have recently demonstrated that mechanistic factors have the 
ability to substantially influence the frequency of recurrent translocations. 
Such mechanistic factors include the frequency of DSBs at two loci, the 
spatial proximity of the two loci, and the repair pathways functionally 
available to carry out the actual joining. To gain further insights into 
mechanisms that promote translocations, we are developing high-
throughput methods to identify translocation partners from fixed DNA 
DSBs in a genome-wide fashion. One of the systems employs RAG1/2 or I-
SceI endonuclease generated DSBs introduced into the genome of Abelson 
Murine Leukemia virus-transformed pro-B cell lines arrested in the G1 
phase of the cell cycle. The other system employs cycling primary B cells in 
which I-SceI mediated DSBs were generated either at the site of the γ1 
switch region or into the c-myc locus. While we are still relatively early in 
our analysis, several preliminary conclusions have been suggested. First , 
analyses of independent starting DSBs in different chromosomes of ATM 
or H2AX deficient cells show that a defined DSB does not translocate to a 
very limited number of chromosomal loci, as suggested from some tumor 
studies, but rather has a relatively broad distribution to many sites on most 
chromosomes. On the other hand, there are areas that appear to be targeted 
more frequently for translocations, including sites along the same 
chromosome, as well as regions of the same or different chromosomes that 
undergo high frequency breaks. Ongoing analyses which seek to saturate 
translocation maps and compare translocations frequencies in different 
genetic backgrounds (e.g. deficient in particular DSB response or repair 
factors) should help to more clearly define the role of various factors, 
including nuclear organization, DNA sequence, and repair pathways in 
suppressing and/or enhancing recurrent translocations. The implications of 
our findings in the context of DSB repair mechanisms and models for 
factors that promote translocations will be discussed. 
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We are interested in the mechanism and regulation of V(D)J recombination, 
the reaction that assembles and diversifies immunoglobulin and T cell 
receptor genes. We have developed chromatin immunoprecipitation (ChIP) 
methodology to study the binding of the RAG1 and RAG2 proteins to 
antigen receptor loci during lymphocyte development. Using this 
methodology and mice expressing an active site mutant of RAG1 (D708A 
RAG1), we find that RAG protein binding occurs in a highly focal manner 
to a small region of active chromatin encompassing Igκ and Tcrα J gene 
segments and Igh and Tcrβ J and J-proximal D gene segments. Formation of 
these small RAG-bound regions, which we refer to as recombination 
centers, occurs in a developmental stage- and lineage-specific manner. 
Interestingly, each RAG protein is independently capable of specific 
binding within recombination centers. While RAG1 binding is restricted to 
regions containing recombination signal sequences (RSSs), RAG2 binds to 
thousands of sites in the genome in a pattern that mirrors that of 
trimethylated lysine 4 of histone 3 (H3K4me3). In the Tcrα locus, RAG1 
binding requires the presence of the Tcrα enhancer and is strongly 
influenced by the TEA promoter and transcription elongation. We propose 
that V(D)J recombination is initiated within recombination centers in the 
following steps: 1) accessibility control elements such as enhancers and 
germline promoters create small regions of highly active chromatin 
spanning J (and where present, proximal D) gene segments; 2) the RAG 
proteins are recruited into these regions via RAG-RSS, RAG2-H3K4me3, 
and RAG1-RAG2 interactions, leading to the formation of a stable 
RAG1/RAG2/RSS complex; 3) partner RSSs compete for capture by the 
RAG proteins in the recombination center, with successful capture being a 
low probability event that leads to formation of a 12RSS-23RSS synaptic 
complex and DNA cleavage. Recombination centers provide an attractive 
means of regulating the initiation of V(D)J recombination, enforcing allelic 
exclusion, and facilitating DNA repair and reaction fidelity. 
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During their development, B lymphocytes undergo several rounds of V(D)J 
recombination to form a novel antigen receptor gene. The uniqueness of the 
antigen receptor is crucial: each lymphocyte must express only one antigen 
receptor specificity so as to avoid cross-reactivity and autoimmunity. To 
ensure that only one antibody specificity is produced, recombination is 
completed at only one allele per locus. This “allelic exclusion” ensures 
monoallelic gene expression, much as X chromosome inactivation ensures 
that only one X chromosome is active in females. Because D-J 
rearrangement takes place first, on both Igh alleles, allelic exclusion 
established at the V to DJ stage clearly relies on some sort of feedback 
mechanism. But how it is established has remained a major enigma. 
Another major question has been how genomic stability is maintained 
during rearrangement, given the multiple double-strand breaks produced at 
each chromosomal locus.  
We recently found that the answer to both questions involves pairing of 
homologous alleles. Multiple mechanisms allow alignment and pairing of 
chromosomes, but they can be divided into those that require double strand 
break formation and those that do not—the preferred mechanism varies 
with the organism. In the case of V(D)J recombination, RAG expression 
initiates a phase of Igh pairing, while RAG cleavage triggers the DNA 
damage response, recruiting ATM to the site of the break. ATM then 
mediates relocation of the uncleaved allele to pericentromeric 
heterochromatin, likely to halt further recombination attempts while the first 
allele is undergoing repair. In the absence of ATM, cleavage (as indicated 
by the formation of γH2AX foci) occurs at significantly higher frequencies 
on both Igh alleles. We conclude that pairing of homologous alleles during 
V(D)J recombination not only helps establish allelic exclusion but serves to 
stabilize the chromosome being repaired and reduce the chance of 
translocations by halting RAG cleavage on the second allele. 
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Developing lymphocytes generate millions of RAG-mediated DNA double 
strand breaks (DSBs) each day as they attempt to assemble antigen receptor 
genes. These breaks are generated in G1-phase cells and are normally repaired 
by the non-homologous end joining (NHEJ) pathway of DNA DSB repair. Cells 
with un-repaired RAG DSBs are channeled into cell death pathways preventing 
these breaks from being resolved as potentially dangerous lesions such as 
chromosomal translocations. In response to DNA DSBs, Atm phosphorylates 
the histone variant H2AX, forming γ-H2AX, in chromatin flanking the breaks 
with γ-H2AX functioning to recruit many DNA damage response proteins to 
DNA break sites. Mice with combined deficiencies of H2AX and p53 have an 
increased incidence of lymphoid tumors with translocations involving antigen 
receptor loci consistent with the notion that H2AX functions in the repair of 
RAG-mediated DNA DSBs. However, developing H2AX-deficient 
lymphocytes do not exhibit overt defects in V(D)J recombination. We 
demonstrate that H2AX, and specifically γ-H2AX, regulates the 
endonucleolytic and exonucleolytic processing of un-repaired broken DNA 
ends generated by RAG cleavage. In this regard, hairpin-sealed coding ends in 
H2AX-deficient cells are efficiently opened and resected in the absence of 
Artemis, the nuclease normally required for opening hairpin-sealed coding ends. 
This Artemis-independent processing of coding ends is dependent on Atm and 
CtIP and is inhibited by γ-H2AX and MDC-1, which normally binds to γ-H2AX 
in chromatin at the DSB site. Although some of the hairpin-opened coding ends 
in Artemis-/-:H2AX-/- cells form coding joints, these joints have significant 
deletions that would preclude the generation of a functional antigen receptor 
gene. Moreover, in contrast to normal coding joints, they exhibit a more 
extensive use of micro-homologies. Strikingly, a large fraction of coding ends 
persist un-repaired in Artemis-/-:H2AX-/- cells even though the hairpin-sealed 
coding ends have been opened. Moreover, these coding ends engage pathways 
normally activated during homologous recombination (HR) in cells at post-
replicative stages of the cell cycle. We propose that H2AX prevents un-repaired 
RAG DSBs generated in G1-phase cells from being processed in ways that 
preclude their repair by NHEJ and promote their access to alternative repair 
pathways that could lead to their aberrant resolution as potentially dangerous 
chromosomal translocations rather than pathways that would promote cell 
death. 
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Selective activation of lymphocyte subsets plays an important role in the 
pathogenesis of human allergy and chronic inflammatory and autoimmune 
diseases. Immune response is also crucial in host defense against cancer. 
We aim at understanding the molecular mechanisms of signaling pathways 
and transcriptional and epigenetic regulation that lead to the differentiation 
of distinct lymphocyte subsets. Moreover, we aim at revealing the key 
points of convergence and divergence between these pathways, thereby 
identifying new targets through which cell differentiation can be 
appropriately manipulated.  
 
We have used systematically the state-of-the art genome-scale measurement 
technologies together with effective computational methods to investigate 
the complicated networks and the molecular mechanisms involved in 
human Th cell differentiation. Our genome wide analysis of regulation 
during the early stages of  
human Th cell differentiation provides an insight into a dynamic network 
that regulates and gives rise to the complex Th cell selective phenotypes. 
Our data shows differential regulation of both known genes coding for 
components of certain pathways and novel genes with unknown functions. 
In addition, we have exploited siRNA-mediated knockdown experiments 
followed by genome-wide transcriptome analysis combined with ChIP-chip 
studies to reveal potential upstream key factors involved in the regulation of 
Th differentiation.The data indicating a role of SATB1 and ATF3 in 
regulating human Th cell differentiation will be presented in detail.  
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Toll-like receptors (TLRs) are innate immune receptors that recognize 
pathogen-associated molecular patterns found on microbes. In particular, 
TLR3 mediates immune response to viruses by recognizing double-stranded 
RNA and initiating signaling via the adaptor TRIF. We demonstrate that 
Bruton’s tyrosine kinase (BTK) plays a critical role in TRIF-dependent 
signaling and acts downstream of TRIF but at a nodal point before the 
bifurcating of the NFkB and IRF3 pathways. In the absence of BTK, TLR3-
stimulated macrophages failed to secrete IFN-β and other inflammatory 
cytokines such as IL-6 and TNF-α. BTK-deficient mice were also less 
susceptible to poly(I:C)-induced septic shock and death. Biochemically, 
BTK signaling is required for TLR3-induced RIP1 ubiquitination that leads 
to NFkB activation as well as for TBK-1 induction that is important for 
IRF3 phosphorylation. Thus, BTK is an essential mediator of TRIF-
dependent signaling downstream of TLR3. 
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Toll like receptors mediate recognition of conserved microbial structures. 
Engagement of TLR has been shown to initiate an inflammatory cascade in 
innate immune cells that in turn orchestrate and instruct effector adaptive 
immune responses. B cells hold a particular position in the immune system 
displaying characteristics of both adaptive and innate immune cells. On one 
hand they elicit antigen-specific responses and produce high affinity 
antibodies, whereas by virtue of their expression of pattern recognition 
receptors, including TLR, they are equipped to sense and rapidly respond to 
microbes. Here we show that MyD88, a major signaling adaptor 
downstream most TLR, can also have anti-inflammatory functions through 
B cells. We found that mice lacking MyD88 selectively in B cells suffered a 
more severe chronic form of experimental autoimmune encephalomyelitis 
(EAE) - a mouse model of multiple sclerosis. In contrast, MyD88 deficient 
mice were resistant to disease. The exacerbated disease observed in mice 
with MyD88-deficient B cells correlated with increased autoreactive Th1 
and Th17 cells, suggesting that MyD88 in B cells promoted disease 
resolution by limiting inflammatory T cell responses. The suppressive 
function of B cells required TLR2/4 but not TLR9, indicating that distinct 
TLR differentially contribute to disease development and resolution. The 
agonists triggering the protective TLR on B cells were likely derived from 
Mycobacterium tuberculosis present in the adjuvant used to induce disease, 
rather than commensal flora. Absence of MyD88 in B cells was dispensable 
for germinal centre formation and antigen-induced antibody production, 
arguing against a requirement for MyD88 in B cell activation. However it 
resulted in strikingly reduced titers of natural IgM. Using mice deficient for 
secreted IgM, we found that IgM had a protective function in EAE that 
interfered with the development of autoreactive Th1 and Th17 responses 
and controlled disease onset and severity. Altogether, these findings 
demonstrated a dual role for MyD88 in immune responses: MyD88 
signaling in cells other than B cells, presumably DC and macrophages, is 
critical for the initiation of inflammation and T cell responses, whereas 
MyD88-signalling in B cells antagonizes this effect, thereby controlling 
overt inflammatory responses. 
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Bcl-6 (B cell lymphoma 6) regulates germinal center formation and 
differentiation of B cells into high affinity antibody-producing plasma cells. 
The double negative regulatory circuit between Bcl-6 and Blimp-1 has been 
well established. We now reveal new mechanisms how Bcl-6 prevents 
plasma cell differentiation. We show that Bcl6 directly promotes the 
expression of Bach2, a known suppressor of Blimp-1. Moreover, Bcl-6 
suppresses Blimp-1 expression through direct binding to IRF4 gene, as well 
as by promoting the expression of MITF, a known suppressor of IRF4. We 
also provide evidence that Bcl6 is needed for the expression of AID and 
UNG, the indispensable proteins for somatic hypermutation and class-
switch recombination, and UNG appears to be a direct target of Bcl-6 
regulation. Together our findings reveal a complex regulatory network, in 
which Bcl-6 acts as a key element dictating the transition from B cells to 
plasma cells. 
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The ability of the first primordial cell, endowed with innate immunity, to 
survive and proliferate its background of high ionizing radiation, raises the 
question of what evolutionary mechanism increased humankind’s sensitivity to 
radiation. Perhaps it was the development of the adaptive immune system. A 
sudden exposure to high dose radiation results in the production of reactive 
oxygen species (ROS) from radiolysis of the 70-80% body water content. 
Damaging radicals destroy biomolecules giving strong signals to Toll-like 
receptors (TLR). Mediated by the TLR activation of those mitogen-associated 
protein kinases (MAPKs) that cause pro-inflammatory cytokine secretion, and 
generate an exacerbated adaptive immune response, the level of oxidative stress 
and damage to body tissues is significantly greater. Innate cell responders 
(neutrophils and macrophages) to these detected damage-associated molecular 
patterns, recruit adaptive immune cells (lymphocytes), all secreting ROS, and 
conferring a self-repetitive pro-inflammatory status to the affected tissues. 
Among the ROS, is the intermediate, hydrogen peroxide, H2O2 , that impacts on 
cell signaling pathways in a highly concentration-dependent manner. It 
contributes to biomolecular damage by oxidizing certain highly susceptible 
amino acids on proteins causing their fragmentation. The TLR would detect 
these fragments as threats. H2O2 is a regulator of the inflammatory process. 
Together with TNF-α, and NF-κB, it interacts synergistically creating a pro-
inflammatory loop; absent NF-κB and TNF-α, H2O2 restores homeostasis to the 
affected tissues by signaling the gene expression of heme oxygenase (HO) that 
catabolizes heme, with carbon monoxide (CO) as a second messenger. Cells 
experiencing low CO concentrations secrete ROS, termed ‘oxidative 
conditioning’, that may be responsible for homeostatic restoration. H2O2 
deactivates phosphatases by removing a thiol group from the central core of 
cysteine-based phosphatases. Such inhibition promotes phosphorylation that 
influences cell signaling. Phosphorylation and de-phosphorylation positively or 
negatively regulate mechanisms within the pathways and are likely involved in 
crosstalk between NF-κB and JNK/AP pathways that affect the life or death 
destinies of cells. Pre-treatment with low non-toxic concentrations of H2O2 
could generate a controlled adaptive immune response and protect individuals 
from the massive tissue damage from a terrorist nuclear attack. It is time for 
immunologists and radiobiologists to collaborate on such a worthwhile venture. 
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Mammalian target of rapamycin (mTOR) is an important mediator of 
phosphoinositol-3-kinase (PI3K) signaling. PI3K signaling regulates B cell 
development, homeostasis and immune responses however the function and 
molecular mechanism of mTOR mediated PI3K signaling in B cells has not 
been fully elucidated. Here we show that Sin1, an essential component of 
mTOR complex 2 (mTORC2), regulates B cell development. Sin1 
deficiency results in increased IL-7 receptor (il7r) and RAG recombinase 
(rag1 & rag2) gene expression leading to enhanced pro-B cell survival and 
augmented V(D)J recombinase activity, respectively. Sin1 deficiency 
disrupts mTORC2 integrity and abolishes Akt hydrophobic motif (Ser473) 
phosphorylation in B cells. We identify Akt2 as the specific mediator of 
Sin1/mTORC2 dependent suppression of il7r and rag gene expression in 
developing B cells. Furthermore, we show that FoxO1 phosphorylation is 
impaired in both the Sin1 and Akt2 deficient B cells, and impaired FoxO1 
phosphorylation correlates with increased expression of the FoxO1 target 
genes il7r, rag1 and rag2. Finally, we provide evidence showing that the 
mTOR inhibitor rapamycin induces rag gene expression and promotes 
aberrant V(D)J recombination in developing B cells. Our study reveals that 
the Sin1/mTORC2-Akt2 signaling axis is a key regulator of FoxO1 
transcriptional activity in B cells and shows that genetic or pharmacologic 
disruption of mTORC2 function results in the aberrant over-expression of 
key genes that regulate cell survival and immunoglobulin gene 
recombination in developing B cells. 
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T-cell immunoglobulin and mucin 3 protein (Tim-3) is a type-I 
transmembrane protein expressed on murine T-helper type 1 (Th1) cells 
which regulates Th1 cell proliferation and development of tolerance. Tim-3 
has six tyrosine residues in the cytosplasmic tail, two and three tyrosines 
residues are clustered in proximal and distal region of the cytoplasmic tail 
respectively. We demonstrated that deletion of the cytoplasmic tail region 
containing the distal tyrosine residues (Y250, Y251, Y253) slightly 
increased NFAT/AP1 and NF-κB-Luciferase reporter activity, while 
deletion of the region containing both distal and proximal (Y235, Y242) 
tyrosine residues abolished the reporter activity to basal level in Jurkat cells. 
Point mutation of both Y235 and Y242 decreased NFAT/AP1 and NF-κB 
reporter activity close to basal level while single point mutation of Y235 or 
Y242 did not result in significant changes in reporter activity. SH2 domain 
screen and co-immunoprecipitation identified P85 interaction with Tim-3. 
We conclude that phosphorylation of Y235 and Y242 residues of Tim-3 are 
responsible for potentiation of signal transduction initiated by the TCR, 
upstream of NFAT/AP1 and NF-κB pathways, in a redundant manner. 
Finally, Tim-3 signal transduction may be mediated in part by recruitment 
of P85 to the phosphotyrosine of Tim-3. 
 148 
MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2 CONTROLS 
A PROTEIN KINASE C - NF-ΚB PATHWAY IN T HELPER TYPE 2 
CELL DIFFERENTIATION 
 
Keunwook Lee1, Prathyusha Gudapati1, Nigel Killeen2, Mark Magnuson3, 
Mark Boothby1  
 
1Vanderbilt University, Microbiology & Immunology , 1161 21st Ave. S, 
Nashville, TN, 37232, 2University of California-San Francisco, 
Microbiology & Immunology , 513 Parnassus Avenue, San Francisco, CA, 
94143, 3Vanderbilt University, Cell & Developmental Biology, 1161 21st 
Ave. S, Nashville, TN, 37232 
 
Mammalian target of rapamycin (mTOR) is an essential serine/threonine 
kinase involved in cell growth, proliferation, and differentiation. Many 
cellular function of the rapamycin-sensitive mTOR complex 1 (mTORC1) 
have been defined, but relatively little is known about the biology of an 
alternative complex, mTORC2. Recently, we have found that mTORC2 
selectively promotes helper T cell (Th) differentiation into a subset of CD4 
effector types via regulation of protein kinases B and C. We further 
examined the relative role of mTORC2 in the axis of PKC/NF-κB pathway 
during Th2 differentiation. In the absence of rictor, an essential subunit of 
mTORC2, we detected impaired nuclear localization of NF-κB and 
decreased NF-κB-responsive promoter activity induced by antigen receptor 
and costimulation. The defect of NF-κB activity was reversed by 
transduction of a constitutively active PKCθ mutant. Importantly, the active 
PKCθ enhanced GATA-3 expression and restored normal Th2 
differentiation of mTORC2-deficient T cells, whereas it was not sufficient 
to revert the defects of Th1 differentiation. In agreement with the evidence 
that PKCθ stabilizes the intercellular interaction of integrin LFA-1 to 
ICAM-1 shortly after antigen recognition, we also observed a decrease in T 
cell activation-dependent binding of ICAM-1. Our results provide evidence 
that a crucial mechanism by which mTORC2 regulates helper T cells is 
transduced via a PKC relay to signaling by NF-κB. 
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Upon encountering pathogens, mature B cells undergo class switch 
recombination (CSR), a deletional recombination reaction that replaces the 
constant region of the expressed immunoglobulin molecule so that the B 
cell changes from expressing IgM to IgG, IgE or IgA. CSR requires the 
generation of DNA double-strand breaks (DSBs) at repetitive DNA 
elements, called switch (S) regions in the immunoglobulin locus, followed 
by ligation of DSBs between two different S regions. It is now clearly 
established that the activity of the DNA deaminase AID at S regions leads 
to the generation of DSBs. However, the mechanism by which the DSBs are 
ligated to complete CSR is not clearly understood. The non-homologous 
DNA end-joining (NHEJ) pathway was implicated to be required for CSR, 
but significant CSR still occurs in the absence of NHEJ components, 
suggesting the participation of additional processes, including a poorly 
characterized pathway, which is microhomology-mediated. To directly 
determine the requirement of this pathway in CSR, we have used the 
shRNA technique to knock-down a key player, CtIP, in the murine B-cell 
lymphoma line CH12. Additionally, we have knocked-down CtIP in 
combination with NHEJ components. The modified cells were then 
analyzed for CSR and for the nature of the S junctions. Our results provide 
interesting clues to the interplay of NHEJ and MMEJ pathways in CSR.  
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The Mixed Lineage Leukemia (MLL) gene is disrupted by chromosomal 
translocation in childhood and secondary leukemias. Its association with 
Menin, a tumor suppressor encoded by the multiple endocrine neoplasia 
(MEN1) gene, has been reported in cell line models. Importantly, this 
interaction is essential for MLL fusion oncogenes to transform 
hematopoietic cells; thus targeting this interaction has been proposed 
strategy for rational drug design. Our studies have demonstrated that Mll 
gene excision in a murine conditional knockout model results in defects in 
steady-state hematopoiesis. A similar experimental approach using a 
conditional Menin knockout mouse model revealed overlapping phenotypes 
particularly in maintenance of HSC function and homeostasis in the B cell 
lineage. If MLL is similarly dependent on Menin in stem cells and B cells, 
targeting the Menin-MLL interface may not prove an effective therapeutic 
strategy for selective leukemia targeting. 
To determine the importance of Menin and Mll interaction to sustain 
hematopoiesis, we have undertaken a genetic analysis using compound 
conditional knockout mutants in the setting of an inducible Cre transgene 
(Mx1-Cre) or a developing lymphocyte Cre knock-in model (Rag1-Cre). 
We predicted that if MLL requires menin interaction for steady-state 
hematopoiesis, we may observe phenotypes in the double heterozygotes. In 
the Mx1-Cre system, normal HSC-enriched population and normal B cell 
progenitors were observed in animals lacking one copy of Menin and one 
copy of Mll (MeninΔ/+;MllΔ/+). Stress hematopoiesis with 5-fluoro-uracil 
treatment exhibited similar recovery kinetics. Furthermore, we removed 
both alleles of Menin on a sensitized Mll heterozygous background 
(MeninΔ/Δ;MllΔ/+). Animals in which homozygous Menin deficiency was 
induced exhibited a reduction in B cells starting at the pro-B cell stage, as 
previously reported. However, Menin deficiency on the Mll heterozygous 
background did not result in reduction in HSCs or further reduction in B 
cells, an observation difficult to reconcile if Menin is a requisite component 
of the MLL complex. Ongoing experiments focus on Menin-Mll genetic 
interactions within developing lymphocyte populations using the Rag1-Cre 
knock-in to identify common or distinct Menin and MLL dependent 
pathways during lymphopoiesis. 
In summary, our genetic evidence argues that Menin and MLL may act 
independently during steady-state hematopoiesis, suggesting that targeting 
this protein-protein interaction may be a promising strategy to treat 
leukemia. 
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The organization and dynamics of receptors and other molecules in the 
plasma membrane are not well understood. Here we analyzed the spatio-
temporal dynamics of T cell antigen receptor (TCR) complexes and linker 
for activation of T cells (LAT), a key adaptor molecule in the TCR 
signaling pathway, in T cell membranes. Using high-speed photoactivated 
localization microscopy (hsPALM), dual-color fluorescence cross-
correlation spectroscopy (dcFCCS) and transmission electron microscopy 
(TEM), we have found that both the TCR and LAT are preclustered into 
distinct, separate and spatially stable membrane domains (protein islands) 
on quiescent T cells. After antigen recognition, these protein islands 
transiently concatenate. The concatemers are identical to the previously 
described microclusters. Concatenation takes place without any substantial 
change in the size and number of the component domains. Surprisingly, no 
co-localization or mixing of TCR and LAT occurs on a molecular level. 
These data showed for the first time that the architecture of the plasma 
membrane is not only important for the exclusion or accumulation of T cell 
signaling molecules (for example, through rafts) but also controls the 
signaling process by the segregation and controlled association of particular 
membrane domains. This separation versus physical juxtapositioning of 
receptor domains and domains containing downstream signaling molecules 
in quiescent versus activated T cells may be a general feature of plasma 
membrane–associated signal transduction. 
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Transmembrane immunoglobulin and mucin 1 (Tim-1) belongs to a family 
of cell surface proteins with roles in immune regulation. Tim-1 cross-
linking has been shown to enhance CD4+ T cell activation and 
differentiation. We and others have also demonstrated that Tim-1 cross-
linking leads to interaction with important signaling molecules, including 
p85 PI3k, as well as induction of NFAT/AP-1 transcription, which is 
dependent on Tim-1 tyrosine 276 phosphorylation. However, the exact 
mechanisms by which Tim-1 alters T cell activation and differentiation 
remain mostly unknown.  
We hypothesize that Tim-1 co-stimulation may impact T cell activation and 
differentiation by directing a unique signaling network after tyrosine 
phosphorylation and adopting a distinct pattern of localization upon 
activation. Work in this study focuses on identifying downstream targets of 
Tim-1 signaling as well as understanding Tim-1 localization during T cell 
activation.  
Putative Tim-1 binding proteins were identified by motif scanning as well 
as pull-down with a phosphorylated 13 amino acid peptide based on the 
Tim-1 cytoplasmic tail. Confocal microscopy was used to visualize Tim-1 
localization during immunological synapse and microcluster formation. We 
recently found that Tim-1 can recruit PLCγ1 in a phosphotyrosine-
dependent manner. Furthermore, the downstream effects of Tim-1 on 
NFAT/AP-1 and markers of early activation may be mediated through 
PLCγ1. In addition, we have demonstrated that Tim-1 is diffusely expressed 
on the surface of resting T cells, and that it appears to be excluded from the 
immunological synapse after APC interaction. Understanding how Tim-1 
signaling and localization are regulated will be important in establishing the 
underlying mechanisms by which Tim-1 specific ligands and antibodies 
modulate immune responses in autoimmunity and allograft tolerance.  
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The γ-secretase complex is a protease complex responsible for the final 
intramembrane cleavage of various type I transmembrane proteins. It is 
composed of 4 proteins: APH1, PEN2, Presinilin and Nicastrin. The most 
renowned substrates are the amyloid precursor protein (APP) and Notch 
from which γ-secretase liberates amyloid β peptide and intracellular active 
form (ICN) respectively. The role of γ-secretase activity in the 
lymphopoiesis is well known through its effect on Notch signaling that 
specify T cell over B cell commitment. However the role of γ-secretase 
activity in hematopoietic stem cells (HSC) is unknown. To explore potential 
role of γ-secretase activity in HSC we generated a conditional knock-out 
mouse model of the Nicastrin gene. We show that lack of γ-secretase 
activity in HSC leads to a severe myeloproliferative disorder (MPD). We 
also show that this MPD arise through upregulation of a skewed myeloid-
differentiation genetic program in HSC. Using a genetic model of 
conditional deletion of Notch1 and Notch2 genes in HSC, we show that the 
γ-secretase deficiency induced MPD is mediated by loss of Notch signaling 
and that restoring Notch signaling, using a conditional ICN1 knock-in 
mouse, is able to counteract Nicastrin deletion and inhibit myeloid 
commitment of HSC. We then further characterize the mechanism of 
Notch-induced myeloid inhibition by showing that this mechanism is 
mediated by the canonical Notch target gene, Hes1. We show that upon 
Notch activation, Hes1 is expressed in an early multipotent progenitor 
population and can directly bind the promoters and repress the expression of 
key genes involved in myeloid differentiation: Cebpa and Pu.1. 
These findings indicate that Notch signaling negatively regulates myeloid 
commitment of HSC by inhibiting a critical genetic program involved in 
myeloid differentiation. Our study also unravels a new tumor suppressor 
role of γ-secretase activity/Notch in the hematopoietic system as loss of 
Notch signaling induces a severe myeloproliferative disorder. 
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Immunological tolerance ensures that lymphocytes with specificity for self 
are prevented from initiating immune responses, and is maintained by 
“central” and “peripheral” mechanisms. In the case of T cells, central 
tolerance occurs in the thymus wherein differentiating thymocytes are 
exposed to a repertoire of self-antigens (Ags) that reflects those normally 
encountered in the periphery. This is accomplished by the expression and 
presentation of a large array of Ags on the surface of a subset of thymic 
medullary epithelial cells (MECs). The expression of these peripheral-tissue 
Ags (PTAs) is in large part under the control of the transcription factor 
Aire. Aire is a protein with several conserved domains typically found in 
transcription factors, and induces the transactivation of thousands of genes 
in vitro. However, the molecular mechanisms by which it induces PTA 
expression in vivo are not well understood. Our lab has recently 
demonstrated that Aire forms many functional interactions with proteins 
involved in DNA repair, chromatin remodeling, and RNA 
splicing/processing. Aire also has affinity for unmethylated lysine residues 
on histone H3 (e.g. H3K4) mediated by a PHD domain (PHD1). For this 
study, we chose to concentrate on the function of Aire’s RING domain 
(previously called PHD2). RING domains often act as E3 ubiquitin ligases; 
however, the function of the RING domain of Aire has not been 
demonstrated in vivo.  
Through the use of a previously described inducible-Aire double transgenic 
system, we are determining what effect loss of the RING domain has on the 
function of Aire in MECs in mice by expressing a RING-less (ΔRING) Aire 
transgene in otherwise Aire-deficient mice. We are comparing the repertoire 
of PTAs expressed in MECs as well as the incidence and severity of 
autoimmune disease in ΔRING Aire transgenic mice compared with WT 
Aire transgenic mice. As a complement to our in vivo studies using 
transgenic mice, we are determining by quantitative mass spectrometry 
whether the RING domain is required to form any of the previously 
described/novel protein-protein interactions. Preliminary experiments have 
shown that a ΔRING Aire mutant is stable and localizes similarly to WT 
Aire when expressed in a human thymic epithelial cell line (4D6).  
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Foxp3+ regulatory T (Treg) cells represent a distinct cell lineage of T 
lymphocytes for maintaining immunological tolerance to “self” and 
restraining pathogenic immune responses to pathogens and commensal 
microorganisms. A class of short regulatory non-coding RNAs known as 
microRNAs (miRNAs) was recently shown to be pivotal in the 
development and function of Treg cells. Selective ablation of miRNAs in 
Treg cells resulted in the early onset autoimmune lethality indistinguishable 
to those were observed in mice devoid of Treg cells. Distinct miRNA 
expression profiles, of which many were directly targeted by Foxp3, in Treg 
cells further suggested specific miRNAs could control different facets of 
Treg biology. We found that elevated miR-146a expression in Treg cells is 
essential for effective control of a particular class of immune responses 
(TH1) dominated by IFNg Further studies suggested that miR-146 controls 
TH1 responses through targeting signal transducer and activator 
transcription 1 (STAT1), the key transcription factor involved in initiation 
of effector TH1 responses. Loss of miR-146a in Treg cells resulted in 
increased levels of both total and phosphorylated STAT1. As a 
consequence, mice harboring miR-146a-deficient Treg cells succumbed to 
IFNg dependent immunopathology. Our results provided strong evidence 
suggesting that specific aspects of Treg suppression function can be 
controlled by a single miRNA. Furthermore, our studies imply that miRNA-
dependent post-transcriptional regulation enable Treg cells to control a 
particular type of effector immune responses. 
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Pre-B cell expansion is driven by signals from the IL-7 receptor (IL-7R) 
and the pre-B cell receptor (pre-BCR) and is dependent on the cell cycle 
regulators cyclin D3 and c-Myc. We have shown previously that interferon 
regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to 
suppress pre-B cell proliferation. However, the molecular mechanism 
through which Ikaros and Aiolos exert their growth inhibitory effect is still 
not clear. Here, we provide evidence that Aiolos and Ikaros bind to c-Myc 
promoter in vivo and directly suppress c-Myc expression in pre-B cells. 
Downregulation of c-Myc is critical for the growth inhibitory effect of 
Aiolos, as sustained c-Myc expression antagonizes Aiolos-mediated growth 
inhibition. Aiolos also induces expression of p27 and downregulates cyclin 
D3 in pre-B cells, and growth inhibitory effect of Aiolos is compromised in 
the absence of p27. A time-course analysis further reveals that 
downregulation of c-Myc by Aiolos precedes p27 induction and cyclin D3 
downregulation. Moreover, our results show that downregulation of c-Myc 
by Aiolos is necessary for the induction of p27 and downregulation of 
cyclin D3. Collectively, our studies identify a pre-B cell receptor signaling 
induced inhibitory network, orchestrated by Ikaros and Aiolos, which 
functions to terminate pre-B cell expansion. 
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Various members of tripartite motif (TRIM) protein family display antiviral 
properties, targeting retroviruses in particular. The potential activity of 
TRIM19, better known as promyelocytic leukemia protein (PML) against 
several viruses has been well documented, yet it’s role in HIV-1 infection 
remains elusive.  
One of the most important cellular partners of HIV-1, P-TEFb kinase 
complex, composed of CDK9 and CyclinT1 plays a crucial role in 
regulation of HIV-1 transcription. We have previously demonstrated that 
both members of P-TEFb interact with PML protein and localize inside the 
PML Nuclear Bodies (PML NB). In particular, we found that the acetylated 
and enzymaticaly inactive form of CDK9 binds PML and can be separated 
with PML in the insoluble chromatin fraction. Our ChIP analysis revealed 
that acetylated form of CDK9 localizes to the integrated and 
transcriptionally silent viral genome, thus indicating that PML might have 
yet unidentified role in regulation of HIV-1 infection and latency. 
In latently infected Jurkat clones, integrated viral genome was marked by 
H3K4Met3 at the promoter level and PML and KAP-1 proteins, both bound 
to the body of silent viral genome. Transcriptional activation of the provirus 
with TNF-α led to the displacement of PML and KAP-1 proteins. By three-
dimensional immuno-fluorescent in situ hybridization (3D Immuno DNA 
FISH) we visualized the silent viral genome in close proximity to PML NB, 
at the distance of less that 0.6 Microns in 40-45% of the cells. Recently 
described KAKA foci, characterized by the presence of KAP-1 (or Trim28) 
and KRAB-Zinc Finger proteins, were also found to be spatially related to 
the silent viral genome, at a distance of 0.9 microns in 40% of the cells. 
Thus, silent viral genome resides in the close proximity to either PML NBs 
or to KAKA foci, that both might represent a repressive nuclear 
neighborhood. To verify this, we disrupted PML NBs by arsenic trioxide 
treatment or we stably knocked-down PML protein, and we observed a 
significant increase in the levels of viral transcription (from 8-15 times over 
a silent control). However, only a portion of cells with silenced PML 
showed an increased viral expression, whereas almost half of the cells still 
remained silenced. In these cells viral genome remained associated to the 
KAKA bodies. Double knock-down of both PML and KAP-1 proteins is 
expected to further increase the levels of viral gene expression.  
Nuclear neighborhood seems to strongly influence viral gene expression, 
and we are currently monitoring the changes in spatial organization of the 
nucleus in CD4+ cells during the establishment of latent infection.  
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Long-standing evidence indicates that quiescent human peripheral blood T 
lymphocytes (PBLs) do not support efficient HIV infection. In resting 
PBLs, reverse transcription of viral RNA takes longer than in activated 
cells, partially because formation of the late products of reverse 
transcription is decreased by RNA binding by apolipoprotein B mRNA–
editing enzyme, catalytic polypeptide-like 3G (APOBEC3G). In a 
subsequent step, integration of the viral complementary DNA that is 
eventually formed is markedly impaired. Here we show that cellular c-Jun 
N-terminal kinase (JNK), an enzyme that is lacking in resting CD4+ T cells, 
regulates permissiveness to HIV-1 infection, and we unravel a novel, 
sequential post-translational pathway of protein modification that regulates 
viral DNA integration. We found that, in activated T lymphocytes, viral 
integrase, which mediates HIV-1 cDNA integration into the host cell 
genome, is phosphorylated by JNK on a highly conserved serine residue in 
its core domain. Phosphorylated integrase, in turn, becomes a substrate for 
the cellular peptidyl prolyl-isomerase enzyme Pin1, which catalyzes a 
conformational modification of integrase. These concerted activities 
increase integrase stability and are required for efficient HIV-1 integration 
and infection. Lack of these modifications restricts viral infection in 
nonactivated, primary CD4+ T lymphocytes. 
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To identify key host response genes to mycobacterial diseases in cattle, a 
functional genomics approach was undertaken to investigate bovine 
macrophage gene expression patterns in response to stimulation with 
Mycobacterium bovis, attenuated M. bovis bacillus Calmette-Guérin (BCG) 
and M. avium subsp. paratuberculosis (MAP) – the causative agent of 
Johne’s disease. Purified monocyte-derived macrophages (MDM) from 
seven unrelated Holstein-Friesian females were used for separate in vitro 
challenge experiments using the three bacterial species (MOI – 2:1). Total 
cellular RNA was extracted from challenged MDM samples at intervals of 2 
h, 6 h and 25 h post-infection and prepared for pan-genomic gene 
expression analyses using the high-density Affymetrix® GeneChip® 
Bovine Genome Array with features representing more than 23,000 gene 
transcripts. These gene expression data can be used for systems biology 
reconstruction of macrophage cellular pathways underlying host 
interactions with M. bovis, M. bovis-BCG and MAP. Important gene 
expression changes can be identified and validated using real time 
quantitative reverse transcription PCR (qRT-PCR). Analyses of these data 
will: (1) provide a panel of candidate resistance/susceptibility genes that can 
be used for subsequent population resistance/susceptibility studies in field-
infected and control animals; (2) offer a greater understanding of the host 
responses against these mycobacteria; (3) lead to improvements in disease 
diagnostics; and (4) enhance vaccine development. Here we present 
preliminary analyses and results from these experiments. 
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Mutations in Artemis, the nuclease that opens hairpin coding ends during 
V(D)J recombination, result in radiosensitive severe combined immune 
deficiency (RS-SCID) syndrome. Radiosensitivity and genomic instability 
of Artemis deficient cells suggest its role in Non-Homologous End Joining 
(NHEJ), hence DNA double strand break (DSB) repair. We wanted to 
explore novel protein interactions of Artemis with the long term goal of 
understanding its multiple roles in V(D)J recombination and DNA DSB 
repair. We have discovered a direct interaction of Artemis with Ligase IV, a 
DNA ligase that plays essential roles in both NHEJ and V(D)J 
recombination. This interaction is observed with endogenous proteins in the 
physiological setting of developing B cell lines and is mediated by Artemis’ 
Carboxy-terminal region and the DNA binding domain (DBD) of Ligase 
IV. It is a highly specific interaction since the DBD regions of other DNA 
ligases do not interact with Artemis, both in vivo and in vitro. Point mutants 
of Artemis that disrupt this interaction show impaired V(D)J recombination 
and increased sensitivity to ionizing radiations. Our data thus provides an 
important function for the uncharacterized C-terminal region of Artemis in 
both V(D)J recombination and post-irradiation cell survival through its 
interaction with Ligase IV. Previously identified hypomorphic disease 
mutants of Artemis that result in truncation of the Artemis C-terminal 
region showed undetectable Ligase IV interaction. Therefore, in vivo 
relevance of this interaction sheds light on the mechanism of 
immunodeficiency and development of lymphomas observed in these 
patients. Furthermore, by bringing processing and repair factors together, 
this interaction offers alternate models of NHEJ in which, in the presence of 
Artemis, a large protein complex might assemble, permitting highly 
efficient repair of DNA double strand breaks, both during V(D)J 
recombination and general DNA repair. 
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The transcription factor early B cell factor-1 (Ebf1) is expressed in B 
lineage cells, in addition to adipocytes and cells of the nervous system. Ebf1 
is a key component of a transcription factor network that is necessary for 
the specification and commitment of B cell progenitors, including the 
restriction of alternative lineage choices. In an effort to identify both direct 
and functional targets of Ebf1, and to gain insight into the molecular basis 
of Ebf1 function in early-stage B cells, we utilized a genome-wide ChIP 
sequencing approach in combination with both gain- and loss-of-function 
transcriptome analyses. Among over 500 genes that are both occupied and 
regulated by Ebf1, we identified large sets involved in (pre)B cell receptor 
and Akt signaling. Moreover, we found that Ebf1 controls expression of 
multiple regulatory and structural components of cell adhesion and 
migration. Ebf1 binding was also detected at more than a third of previously 
described Pax5 targets, suggesting a functional synergy between Ebf1 and 
Pax5. In addition to Ebf1-activated and -repressed genes, we identified 
targets in which Ebf1 induces changes in chromatin structure that poise the 
genes for expression at subsequent stages of differentiation. Thus, multiple 
functions of Ebf1 contribute to the combinatorial gene control underlying B 
cell specification and commitment. 
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The nonstructural protein 1 (NS1) of the human influenza virus is expressed 
early after viral infection and is used by the virus to counteract the anti-viral 
response mounted by the infected cell. We identified the presence of a 
histone H3K4-like sequence (histone mimic) within the carboxy-terminal 
domain of NS1. We showed that similar to histone H3, the histone mimic of 
the NS1 is methyated and acetylated in vivo in the nucleus of influenza 
virus-infected human cells. Using non-modified and modified cell 
permeable NS1 histone mimics, we identified the role of this sequence in 
negative regulation of type I IFN and IFN inducible gene expression. 
Consistently, the influenza virus that carries the mutated histone mimic is 
less virulent. We hypothesize that the presence of the histone mimic in NS1 
allows the influenza virus to compete effectively with the host cell 
epigenome for transcriptional regulators of antiviral genes. 
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Mature naïve B lymphocytes, upon encountering antigens in the peripheral 
lymphoid organs, can undergo two mechanisms of secondary 
immunoglobulin gene diversification: class switch recombination (CSR) 
and somatic hypermutation (SHM). Upon activation B cells begin to 
express the DNA editing enzyme activation-induced cytidine deaminase 
(AID), which is required for both SHM and CSR. AID initiates both of 
these mechanisms by deaminating cytosine residues to uracils, thus creating 
U:G mismatches. In SHM, transcription through the variable region, 
followed by AID activity and subsequent repair of the U:G mismatches by 
error-prone DNA repair proteins, leads to the introduction of point 
mutations throughout the variable region, and results in the generation of 
antibodies with higher affinity for antigen. In CSR, transcription through 
the highly repetitive switch (S) regions within the IgH constant region, 
followed by AID activity, results in DNA double-strand breaks and the 
exchange of the primary constant region, Cμ, for a downstream constant 
region and the excision of the intervening DNA sequence. Thus, CSR leads 
to the generation of antibodies with new effector functions. 
 
CSR and SHM are independent processes, and it is unknown how AID is 
differentially targeted to distinct regions of the immunoglobulin locus to 
initiate either reaction. In order to address this enigma, we employed a 
murine B cell lymphoma line called CH12s, which have a propensity to 
switch from IgM to IgA upon stimulation with antiCD40, IL-4 and TGF-β. 
Since Cα is the final constant region in the murine IgH locus, we term IgA+ 
CH12s “terminally switched”, meaning they can no longer undergo 
“classic” CSR. Using a purified population of IgA+ CH12s, we analyzed 
AID expression and targeting in stimulated “terminally switched” cells as 
compared to freshly stimulated CH12s. We also analyzed AID activity in 
stimulated “terminally switched” cells by looking at mutation rates at the 
VDJ, Cα and Sμ – Sα junction regions and comparing them to rates in 
unstimulated IgA+ cells. Despite seeing AID expression in stimulated 
“terminally switched” cells, we were only able to see AID recruitment and 
activity within the remaining switch region and never within the VDJ region 
of the locus. Using this system we conclude that either 1) the remaining 
switch region is acting as an AID sink, sequestering AID away from the 
VDJ or 2) a factor needed for AID targeting to the VDJ is not present in this 
system, either because of the stimulation used or the nature of the CH12 cell 
line. 
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Activation induced cytidine deaminase (AID) initiates immunoglobulin 
class switch recombination (CSR) and somatic hypermutation (SHM) by 
deaminating transcribed double stranded DNA to produce U:G mismatches. 
Subsequent error prone repair serve to process AID induced lesions to 
produce SHM or CSR. Normally AID activity is targeted to the 
immunoglobulin locus however, AID induced lesions can produce off site 
DNA damage including double stranded breaks and chromosome 
translocations. Therefore, strict regulation of AID is important for 
maintaining genomic stability. Transcriptional regulation, nuclear export 
and phosphorylation have all been shown to modulate AID activity and it 
has been suggested that phosphorylation can facilitate interaction of AID 
with partner proteins. Furthermore, AID phosphorylation doesn’t affect 
AID catalytic activity as measured in E coli, but augments AID function in 
vivo, providing evidence that post-translational modification facilitates AID 
interaction with partners. We have taken a proteomics approach to identify 
proteins that interact with AID. To ablate artifacts from overexpression and 
assay AID interactions in a normal physiological state where AID is 
properly phosphorylated, we created epitope tagged, Flag-AID, knockin 
mice. B cells from these mice develop normally and can undergo class 
switch recombination to IgG1 following stimulation by LPS and IL-4 in 
vitro. We identified candidate AID partners by detecting co-purifying 
molecules from B cells extracts. The Flag tag was used to purify AID and 
interacting proteins were identified via mass spectrometry. This approach 
identified several candidate proteins and AID interaction was confirmed via 
co-immunoprecipitation. The success of this approach and the current 
progress in assessing the role of these candidate partners in AID function 
will be discussed.  
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HIV infection of the thymus results in a decreased output of naive T-cells. 
The HIV Nef protein functions as an adaptor protein to interfere with the 
trafficking of several surface molecules and intersects with intracellular 
signaling cascades. We previously showed that expression of the Nef 
protein alone is sufficient to disturb human thymopoiesis. Structure-
function studies with mutant Nef alleles showed that Nef-sites, critical for 
disturbing intracellular signaling cascades are crucial for Nefs effect on T-
cell development. Our recent studies with mutant HIV-1 Nef alleles that 
selectively disrupt the interaction with PAK2 (i.e. NA-7, F191R, SF2 
F195A) showed that Nef-PAK2 is especially important for interfering with 
T cell development. In an attempt to unravel the exact mechanism by which 
this interaction disturbs human thymopoiesis, we evaluated these Nef alleles 
for their ability interfere with the signaling of CXCR4 and the IL-7 
receptor, given their importance in regulating T-cell development.  
 
Wild-type (WT) Nef alleles and Nef mutants were cloned into a retroviral 
vector expressing Nef and EGFP from a single bicistronic mRNA (NEF-
IRES-eGFP). Primary CD4+ T-cells were transduced with these Nef 
constructs and analysed for the expression of CD4, CXCR4, and CD127 
(IL-7 receptor α-chain) by flow cytometry. The effect of Nef on 
thymopoiesis was studied by transducing CD34+ hematopoietic progenitor 
cells and subsequent FTOC.  
 
Primary CD4+ T-cells and CD34+ thymocytes, transduced with wild-type 
NA-7 and SF2 Nef showed a reduced surface expression of CD4, CXCR4 
and CD127 (IL-7 receptor α-chain). As expected NA-7 and SF2 Nef 
severely impaired T-cell development in FTOC. Interestingly, F191R and 
F195I mutations, which completely abolish the interaction with PAK2, 
impair Nefs abilty to downregulate CXCR4 and CD127 and result in normal 
T-cell development. Treatment of FTOC with human recombinant IL-7 and 
SDF1α partially restored the effect of WT Nef on T-cell development. Our 
results show that Nefs ability to disturb human T-cell development is 
associated with the ability to downregulate CXCR4 and the IL-7 receptor, 
and support our hypothesis that Nef disturbs T-cell development by 
interfering with signalling of these receptors.  
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MicroRNAs (miRNAs) are an abundant class of conserved non-coding 
RNAs that control gene expression by targeting mRNAs for degradation or 
translational repression. Several human diseases have now been associated 
with dysregulated miRNA expression, however, it is unclear what influence 
miRNAs have on other diseases such as asthma. The balance between 
different inflammatory cytokines is an important determinant for asthma 
development and severity, and several cell types can contribute directly or 
indirectly to it. Among these are various subsets of CD4+ T lymphocytes 
(such as Th1, Th2 and Th17, each characterized by the ability to produce a 
specific panel of cytokines) as well as mast cells, which are central effector 
cells in asthmatic responses. It is now becoming clear that miRNAs may 
have fundamental roles in regulating immune cells differentiation and 
cytokine production, thereby also potentially influencing the cytokine and 
cellular milieu responsible for asthma. The molecular network that regulates 
mast cell differentiation and functions has not been investigated as widely 
as it has been in other hematopoietic cells. Such information could be used 
to determine potential therapeutic targets for the control of mast cell 
activation in disease. We identified a family of two miRNAs, miR-221-222, 
that is upregulated following acute activation of differentiated mast cells. 
We found that these miRNAs have pleiotropic effects, regulating mast cells 
proliferation, survival and effector functions, and we are now investigating 
a possible role also in cell differentiation. Since an alteration of the balance 
between Th1 and Th2 lymphocytes can lead to autoimmune diseases, 
allergy and asthma, we also analyzed the role of miRNAs in regulating the 
critical balance between these two cell types. We previously reported that 
very few miRNAs are differentially expressed between Th1 and Th2 cells in 
the mouse, indicating that they might be involved in fate determination of 
these cells. Indeed, our recent data now show that one particular miRNA 
has an important role in regulating T cell plasticity and Th1-Th2 balance in 
both human and mouse. Besides being of fundamental relevance to our 
understanding of cell differentiation and gene regulation, elucidation of the 
molecular mechanisms that control mast cells and T lymphocytes 
differentiation and activation have substantial potential to find new points 
of entry for clinical application in the treatment of asthma and allergy. 
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Here we investigated the regulation of NF-κB activity by posttranslational 
modifications upon reconstitution of NF-κB p65-deficient cells with the 
wildtype protein or phosphorylation-defect mutants. Quantitative analysis 
of NF-κB target gene expression showed that p65 phosphorylations alone or 
in combination function to direct transcription in a highly target gene-
specific fashion, a finding discussed here as the NF-κB barcode hypothesis. 
High resolution microscopy and surface rendering revealed serine 536 
phosphorylated p65 predominantly in the cytosol, while serine 468 
phosphorylated p65 mainly localized in nuclear speckles. TNF stimulation 
resulted in the translocation of the cytosolic p65 kinase IKK to the nucleus 
and also to PML nuclear bodies. This inducible IKK translocation was 
dependent on p65 and was prevented by the oncogenic PML-RARα fusion 
protein. Chromatin immunoprecipitation experiments revealed the inducible 
association of IKK to the control regions of several NF-κB target genes. In 
the nucleus, the kinase contributes to the expression of a subset of NF-κB-
regulated genes, thus revealing a novel role of IKK for the control of 
nuclear NF-κB activity. 
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We and others recently identified a novel lymphocyte population in the 
lamina propria of the murine small intestine characterized by the expression 
of the transcription factor retinoic orphan receptor γ t (RORγt) and 
activating natural killer (NK) cell receptors (e.g., NKp46, NKG2D and 
NK1.1).  
Similar to lymphoid tissue inducer (LTi) cells NKR+RORγt+ lymphocytes 
required RORγt for their development. Whether this innate lymphocyte 
subset is part of the NK cell or lymphoid tissue inducer (LTi) cell lineage or 
rather defines an independent third lineage of innate lymphocytes remains 
controversial and constitutes an important gap in the hematopoietic lineage 
maps.  
We investigated the developmental relationship of LTi, NKR+RORγt+ and 
NK cells by using genetic fate mapping, in vitro differentiation and 
adoptive transfer assays. We demonstrate that NK cells and LTi cells are 
distinct and separate innate lymphocyte lineages. LTi cells were the direct 
progenitors of NKR+RORγt+ cells which constituted differentiated LTi 
cells. NKR+RORγt+ cells further differentiated into NKR+RORγt- cells and 
RORγt expression determined their responsiveness to the IL-12 and γc 
family of cytokines. RORγt+ cells produced high levels of IL-22 in response 
to IL-23 whereas RORγt- produced high levels of IFN-γ in response to IL-
12. IFN-γ-producing LTi-derived NKR+ lymphocytes but not NK cells were 
central mediators of experimental colitis.  
These data provide direct evidence for the existence of two developmentally 
and functionally distinct lineages that constitute the pool of innate NK cell 
receptor-expressing lymphocytes in humans and mice and reveal previously 
unappreciated plasticity within the LTi cell lineage. 
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MicroRNAs are small, endogenous, single stranded RNA that represent a 
novel group of non-protein coding gene products. MicroRNAs play 
important gene-regulatory roles by influencing transcription, degradation or 
activation of mRNA produced by classical genes. It is estimated that 
microRNA dependent regulation of all classical gene expressions spans at 
least third of entire genome. MicroRNAs have also been demonstrated as a 
important regulatory principle in the immune system. However, a detailed 
role of miRNA in regulation of autoimmunity remains unclear. The aim of 
this study was to analyze microRNA involvement during the development 
of autoimmune demyelination. To this end we have performed a systematic 
miRNA profiling using global microarray analysis as well as individual 
miRNA assays. Sorted CD4 T cell from lymph nodes of C57Bl/6 mice 
immunized with MOG peptide 35-55 as well as T helper (Th) cell from 
MOG-TCR transgenic mice (2D2) were used for the analyses. We have 
found a very selective expression of miRNA in Th cell highlighting three 
miRNA that were consistently upregulated: mmu-miR155, mmu-miR21 and 
mmu-miR301a. Mmu-miR155, mmu-miR21 and mmu-miR301a have all 
also been selectively upregulated in brain infiltrating mononuclear cells 
isolated from animals with different stages of experimental autoimmune 
encephalomyelitis (EAE). The changes in the above miRNA correlated with 
both in vitro and in vivo Th17 differentiation. Blockage of microRNA 
function influenced the critical pathways of Th17 development. Search of 
potential targets of positively highlighted miRNA with both bioinformatics 
and microarray profiling approaches revealed a number of immune genes 
that could be regulated by miRNA in a process of myelin autoantigen 
recognition. Our results provide evidence for specific and selected role of 
several miRNA in the process of myelin antigen recognition and 
autoreactive Th cell activation suggesting a new venues for a possible 
therapeutical intervention for the autoimmune demyelination. 
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Protein kinase Ds are a conserved family of serine/threonine kinases that 
includes PKD1, PKD2 and PKD3. PKDs are expressed ubiquitously but are 
particularly abundant in lymphocytes where they are selectively activated 
by triggering of antigen receptors. T lymphocytes express PKD2 and PKD3. 
Mice that lack PKD2 or express a catalytically inactive PKD2 can produce 
peripheral T cells but these cells have defects in antigen receptor induced 
proliferation and show an abnormal transcriptional program in response to 
engagement of their antigen receptor. In particular the cells are defective in 
the production of key cytokines including Interleukin 2 and Interferon 
gamma. We looked at the combined impact of PKD2/PKD3 gene loss In T 
cells by backcrossing PKD2-/- mice with PKD3fl/fl mice and mice 
expressing Cre recombinase specifically in the T cell lineage under the 
control of the p56lck promoter. In PKD2-/- PKD3fl/fl lck cre mice there is 
normal development of T cells in the thymus but a depletion of peripheral T 
cells in the blood, and peripheral lymphoid tissues such as the spleen and 
lymph nodes. Previous studies had noted that PKDs were activated by the 
pre T cell receptor in T cell progenitors and by the mature T cell receptor in 
peripheral T cells. The T cell phenotype of PKD2-/- PKD3fl/fl lck cre mice 
is consistent with the model that PKDs are dispensible for the preTCR 
function but important for the TCR signals that control mature T cell 
homeostasis. 
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The intestinal mucosa is a dynamic environment of complex interactions 
between the host and the gut microbiota. Maintaining an effective barrier 
function against pathogens through pathogen-associated molecular patterns 
(PAMPs) ensures integrity of the gut mucosa. Certain protein domains such as 
leucine-rich repeats (LRRs) have been found to be key for sensing microbes as 
evidenced by Toll-like receptors (TLRs) which detect PAMPs through their 
LRR domain.  
Although members of the TLR-family and their roles in pathogen recognition 
and innate immune signaling have been well-studied, the function of a large 
number of LRR proteins remains unknown. Where biological information or 
annotation is available through database interrogation and literature mining, 
broad functional diversity can be observed across LRR proteins. Because these 
varied functions are often determined by non-LRR domains in the protein, LRR 
proteins are typically grouped based on these non-LRR domains. This results in 
proteins with LRR-only domains being placed together in an isolated group 
unrelated to any specific function. Since most of these LRR-only proteins 
remain functionally uncharacterized, our aim is to devise a method for grouping 
LRR proteins such that LRR-only proteins would be distributed among those 
with non-LRR domains.  
By employing an automated approach that uses pattern recognition and Hidden 
Markov models, we cataloged 375 human LRR proteins and classified them by 
LRR repeat-class composition. With few exceptions, human LRR proteins, in 
general, contain repeats of predominantly one class. We also observe a 
statistically significant co-occurrence of certain LRR repeat classes (when 
featured predominantly in the protein) with transmembrane domains or with 
non-LRR protein domains, eg. F-box, CARD or PYRIN domains. This provides 
a useful basis on which to classify LRR proteins of unknown function that co-
cluster with better characterized members.  
With this base classification for human LRR proteins, we were interested to 
identify from this, a subset that might have important roles in immunity and 
host defense pathways. We examined expression signatures for LRR genes 
across tissue types and identified about 80 LRR genes that are immune 
enriched, including NOD-like receptor and TLR genes. To identify bacterial-
responsive LRR genes, we examined expression profiles of LRR genes in 
primary macrophages infected with a number of pathogenic bacteria including 
M. tuberculosis. LRR genes exhibiting both immune enrichment and induction 
by pathogens, eg MFHAS1 was found to be involved in key immune pathways 
including NF-kB-dependent signaling in epistasis and siRNA experiments. 
 172 
SILAC DNA-PROTEIN INTERACTION SCREENING- A REVERSE 
CHIP APPROACH FOR IDENTIFICATION OF SEQUENCE SPECIFIC 
DNA BINDING FACTORS 
 
Trung T Ngo, Gerhard Mittler  
 
Max Planck Institute for Immunbiology, Mol. & Cel Immunology, 
Stuebeweg 51, Freiburg, D79108, Germany 
 
Mammalian genomes contain roughly 20000 protein-coding genes. 
However, in given cell types only about more than 5000 of these genes are 
expressed at detectable level. In order to understand this, much scientific 
effort has been focused on deciphering the gene regulatory network that 
consists of DNA sequence specific binding of transcription factors (TF), 
which are able to read the regulatory information. We have already reported 
a fast, scalable and sensitive MS based methodology (SILAC DNA-protein 
DNA interaction screening) that allow to identify protein-DNA interaction 
in an unbiased manner complementary to ChIP technology. Here we applied 
our reverse ChIP to discover the proteins, which bind to a novel 
evolutionary conserved mammalian core promoter-associated cis-element 
(termed M4) harboring the consensus sequence 
RRACTACANNTCCCRRNRNRC. A combination of biochemical and 
cellular in vitro studies recapitulates our MS data unequivocally 
demonstrating that the hematopoietic master regulator Ikaros and the 
pluripotency factor THAP11/Ronin are directly interacting with M4. We 
can further show that Ikaros is essentially required to recruit the NF-kappa 
B/rel family members p50, p52 to the M4 and that THAP11/Ronin is 
necessarily involved in bringing the epigenetic cell cycle regulator HCF1 
(host cell factor 1) to M4 bearing genes. Since our reporter assays reveal 
that Ikaros binding is functional, we are continue to study biological role of 
M4 binders by knock-down experiments followed by global gene 
expression analysis. 
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Regulatory T (Treg) cells form a distinct cell lineage and act in a dominant 
manner to maintain immune homeostasis. Deficiency of Treg cells is 
associated with the fatal lymphoproliferative disease, immune dysregulation 
polyendocrinopathy enteropathy X-linked (IPEX) syndrome in humans and 
the corresponding scurfy phenotype in mice. Despite this immunoregulatory 
role, Treg cells have been demonstrated to co-express transcription factors 
normally expressed in effector cells, together with the lineage specifying 
transcription factor, Foxp3, and the Treg cell T cell receptor repertoire is 
skewed towards autoreactivity. Together, this suggests that instability of the 
Treg cell lineage could have pathogenic consequences. To assess the stability 
of Treg cells in vivo, we utilized a mouse model in which Foxp3 expressing 
cells could be inducibly labeled with a stable YFP reporter and tracked over 
time. We demonstrate that, in the steady state, expression of Foxp3 and the 
associated Treg cell phenotype is maintained for up to six months post 
labeling. Further, Treg cells remained stable in vivo despite a variety of 
immunologic challenges, including irradiation-induced lymphopenia, 
infection with Listeria monocytogenes and treatment with CD40 agonistic 
antibody. Minimal loss of Foxp3 was observed in vivo following 
withdrawal of IL2. We report that, under homeostatic and inflammatory 
conditions, Foxp3 expression is stably maintained in Treg cells, conferring 
faithful lineage identity. 
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Activation-induced deaminase (AID) is a B-cell specific cytidine deaminase 
that is required for class-switch recombination (CSR) and somatic 
hypermutation (SHM), resulting in the diversification of antibodies in 
germinal centers. Due to its potent mutagenic potential AID must be tightly 
regulated and specifically targeted to the Ig locus. Deregulated and 
mistargeted AID activity has been implicated in the ontogeny of a large 
number of mature B cell lymphomas in mice and humans. However, the 
mechanism via which this regulation and targeting is achieved is unknown. 
In order to gain insight into the regulation and targeting of AID, we have 
performed a screen for AID-interacting proteins using in vivo biotinylation 
tagging. This was accomplished by stably transfecting a B cell line (CH12) 
with an Escherichia coli biotin ligase (BirA) and AID containing a short 
sequence tag (biotag), which can be biotinylated by BirA in vivo. The 
biotinylated AID was then pulled down as a complex with its interactors in 
the context of CSR using streptavidin beads. Putative AID interacting 
proteins were subsequently identified by mass spectrometry. This screen 
identified the splicing factor polypyrimidine tract binding protein 2 
(PTBP2) as an AID-interacting protein. We have verified this interaction in 
primary B cells using AID antibodies for co-immunoprecipitation. PTBP2 
is an RNA-binding protein that plays a role in alternative splicing in 
neuronal cells but has not been studied in the immune system. We have 
shown that at least in vitro, PTBP2 can bind to the germline transcript at 
switch regions. We have also shown that knockdown of PTBP2 by shRNA 
in CH12s and primary B cells results in a significant defect in CSR. This 
decrease in CSR is not due to a defect in AID expression, cellular 
proliferation, transcription at the Ig locus or splicing of the germline 
transcript. However, we have shown by chromatin immunoprecipitation that 
shRNA knockdown of PTBP2 results in decreased AID binding to the 
switch regions after stimulation for CSR in CH12s and primary B cells. 
This defect in stable binding of AID to the switch regions could explain the 
defect in CSR observed in PTBP2 knockdown cells. This is the first study 
to show a direct role for splicing factors in the binding of AID to the switch 
regions.  
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Activation of dendritic cells through TLR stimulation is a key component 
bridging the innate recognition of foreign entities to the induction of 
adaptive immune responses. Covalent conjugation of TLR7 agonists to 
protein antigens is an efficacious vaccine formulation that enhances the 
immunogenicity of the antigen and elicits adaptive immune responses. This 
study identifies divergent effects of two crucial cytokines induced by the 
TLR7 agonist-protein conjugate, IFNα and IL-12, in leading to efficient 
priming of CD8+ T cells. Here, we demonstrate that TLR7-driven CTL 
responses require not one, but both IFNα and IL-12. We found that 
signaling through the IFN-αβR was required for the timely recruitment and 
accumulation of activated dendritic cells in the draining lymph nodes. 
Surprisingly, we found that TLR7 induction led to cross-presentation of the 
conjugated protein by Langerhans cells. In contrast, IL-12 had no effect on 
the capacity of dendritic cells to respond to the conjugate. Instead, IL-12 
appears to be crucial for the activation and expansion of CD8+ T cells. 
Collectively, the data suggest that TLR7-driven CD8+ T cell responses are 
dependent on IFNα for inducing migration and cross-priming in Langerhans 
cells, and IL-12 for eliciting the expansion of CD8+ T cells. 
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Notch signaling is a well conserved signaling pathway involved in cell fate 
decisions, proliferation, apoptotic cell death of various cell lineages, 
including myeloid lineage cells such as macrophages and dendritic cells. It 
also plays important roles in regulating effector functions of these cells in 
the periphery. In macrophages, activation of Notch signaling pathway 
regulates expression of pro-inflammatory genes, resulting in inflammatory 
responses upon TLR agonist-mediated activation. Inhibition of Notch 
signaling using pharmacological agents or genetic deletion of its DNA-
binding partner, RBP-J, resulted in blunting of pro-inflammatory responses. 
Contributions of individual Notch receptors in this setting, however, were 
largely unknown. In this study, we specifically silenced expression of 
Notch1 in macrophage-like cell line, RAW264.7. Unexpectedly, knock 
down of Notch1 resulted in spontaneous activation phenotypes of 
macrophages. Increased expression of iNOS, TNFα, IL-12p40 and IL-10 
were observed even in the absence of any TLR and/or IFNγ stimulation. 
Nitric oxide and TNFα productions correlated well with the mRNA 
expression. The microbiacidal activities of these Notch1 knock-down 
macrophages were also significantly higher, compared to the control cells, 
suggesting that Notch1 silencing leads to spontaneous activation of 
macrophages. The expression of one of target genes of the Notch signaling 
pathway, deltex, was significantly increased in the absence of any 
stimulation, indicating that Notch signaling pathway is activated when 
Notch1 is silenced. The expression of Notch ligands, i.e. Dlk1, Dlk4 and 
Jagged1, were also upregulated in these cells. Taken together, we proposed 
that silencing Notch1 leads to activation of the Notch signaling pathway and 
macrophage activation, via upregulation of Notch ligands. The molecular 
mechanisms underlying the upregulation of the Notch ligands are under 
investigation. 
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T regulatory cells (Tregs) have a fundamental role in maintaining immune 
homeostasis. There is much interest in defining their unique properties in 
order to understand their mechanisms of action and identfy new therapeutic 
approaches to modulating their activity in vitro or in vivo. We previously 
found that Tregs have a reduced capacity to activate the PI3K/Akt pathway 
downstream of the TCR, and that low activity of Akt was necessary for 
their suppressive function. In order to define the molecular basis for their 
unique molecular phenotype, we investigated Treg expression of 
phosphatases that regulate the PI3K/Akt pathway: PTEN, SHIP and 
PHLPP. Although ex vivo Tregs and conventional T cells expressed similar 
amounts of the lipid phosphatases PTEN and SHIP, Tregs expressed 
significantly higher levels of PHLPP, a novel Ser/Thr protein phosphatase 
that negatively regulates Akt. Knock-down of PHLPP using siRNA 
completely restored TCR-mediated activation of Akt in Tregs. Moreover, 
knock down of PHLPP in naive T cells significantly impaired their capacity 
to develop into induced Tregs under the influence of TGF-β, indicating that 
PHLPP-mediated suppression of Akt is necessary for peripheral Treg 
development. To investigate the functional significance of PHLPP in Tregs, 
we analyzed T cells from PHLPP1-/- mice. Differentiation of peripheral 
Tregs was impaired in mice genetically deficient for PHLPP1, and the 
suppressive capacity of ex vivo Tregs was significantly reduced. These data 
define a novel mechanism used by T cells to control the Akt pathway and 
provide the first evidence for a molecular mechanism underlying the 
functionally essential reduction of Akt activity in Tregs. 
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The Autoimmune Regulator (AIRE) protein is expressed in thymic 
medullary epithelial cells, where it promotes the ectopic expression of 
tissue-restricted antigens. Expression of tissue-specific antigens is needed 
for efficient negative selection of developing thymocytes. Mutations in 
AIRE cause Autoimmune Polyendocrine Syndrome type 1 (APS1) , which 
is characterized by a breakdown of self-tolerance. The molecular 
mechanism by which AIRE increases the expression of a variety of different 
genes remains unknown. We have studied AIRE-regulated genes using 
whole genome expression analysis and chromatin immunoprecipitation. We 
show that AIRE preferentially activates genes that are tissue-specific and 
characterized by low levels of initial expression in stably transfected cell 
model but also in mouse thymic medullary epithelial cells. In addition, the 
AIRE-regulated genes lack active chromatin marks, such as histone H3 
trimethylation (H3K4me3) and acetylation (AcH3), on their promoters. We 
also show that during activation by AIRE, the target genes acquire histone 
H3 modifications associated with transcription and RNA polymerase II. In 
conclusion, our data show that AIRE is able to promote ectopic gene 
expression from chromatin associated with histone modifications 
characteristic to inactive genes. 
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The transcription factor T-bet (T-box expressed in T cells, TBX21) is a key 
regulator of Th1 cell development. Similar to the Th1-specific genes IL-
12Rb2 and IFN-g, T-bet is not expressed in naïve CD4+ T cells, but is 
readily induced during Th1 cell differentiation. However, despite its crucial 
role in Th1 lineage commitment, the mechanisms controlling Th1-specific 
expression of this factor are incompletely understood. 
We have investigated how T-bet expression is controlled at early time 
points following stimulation of naïve human CD4+ T cells. To identify 
potential cis-elements that control T-bet expression we mapped DNase I 
hypersensitive sites (HS) at this locus in naïve CD4+ T cells and in cells 
developing along a Th1 or Th2 pathway. Using conventional hypersensitive 
site assays we identified two strong HS in Th1 and Th2 cells. HS2 contains 
an NFAT binding site and was not detected in naïve CD4+ T cells, whereas 
HS3 was already present in naïve cells and represents the core promoter. 
Since we did not detect any Th1-specific HS within the 16.7kb surrounding 
the mRNA start site, we screened for potential Th1-specific HS using 
Quantitative Chromatin Profiling (QCP), a PCR-based approach, which is 
not limited by the presence of convenient sites for restriction enzymes. 12kb 
upstream of the transcription initiation site we identified an additional HS in 
Th1 cells (HS1), containing a STAT binding consensus sequence. 
TCR/CD28 signaling induced rapid histone H4 acetylation at these elements 
and binding of NFAT to HS2 in vivo. H4 acetylation, NFAT binding and T-
bet expression were strongly reduced when cells were stimulated in the 
presence of cyclosporine A (CsA), suggesting that TCR-induced NFAT 
activation and binding to the T-bet locus was required to initiate T-bet 
expression in naïve CD4+ T cells. IFN-g and IL-12 signaling alone were not 
sufficient to induce T-bet expression in naïve CD4+ T cells, but cytokine 
signaling enhanced T-bet expression in TCR/CD28-stimulated cells. We 
found that IL-12 signaling induced binding of STAT4 at HS1 and showed 
that siRNA-mediated knock-down of STAT4 expression reduced expression 
of T-bet and of IFN-g. 
Collectively, our data suggest that T-bet locus remodeling and gene 
expression are initiated by TCR-induced NFAT recruitment and amplified 
by IL-12-mediated STAT4 binding to distinct distal regulatory elements 
during human Th1 cell differentiation. 
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JAK family members are promising new drug targets for the treatment of 
inflammatory disorders. Here, we describe the use of KinobeadsTM, our 
unique kinase-fingerprinting platform, for screening and selectivity 
profiling of JAK family inhibitors, using advanced clinical compounds 
CP690,550 and INCB018424 as examples. Using Kinobeads™ we can 
screen libraries of up to 100,000 compounds against native kinases directly 
in lysates from JAK expressing cell lines. For this purpose we have 
developed a primary assay based on KinobeadsTM that allows us to measure 
the potency of all four JAK family members (1, 2, 3, and Tyk2) by antibody 
detection on reversed phase microarrays. Subsequently, in lead 
optimization, we use KinobeadsTM as a primary assay system to drive 
optimization of the binding potency of candidate molecules towards the 
target, and selectivity over other, related kinases. Additionally, broad mass 
spectrometry based profiles against the protein and lipid kinome are 
performed on key molecules to confirm their selectivity in several different 
cell lines and tissues. Later in the drug discovery process, KinobeadsTM 
experiments can be used to determine the extent of target engagement in 
cells, organs and patient blood samples in efficacy and clinical studies. 
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The identification of specialized subsets of effector CD4+ T cells has 
provided a paradigm to understand immunity and immunopathology. IL-17 
producing T cells (Th17) have been first characterized in the mouse as a 
distinct lineage of CD4+ T cells that can differentiate from uncommitted 
naive T cell precursors under the aegis of the master transcription factors 
RORγt and the polarizing cytokines TGF-β, IL-6 and IL-23. IL-17 has been 
shown to mediate protection against extracellular pathogens by promoting 
neutrophil recruitment but also to cause immunopathology in different 
models of autoimmunity. Although it has been shown that neutrophils can 
infiltrate sites of bacterial infection and contribute to activation of T cells 
through induction of a pro-inflammatory environment, there is no evidence 
for a direct cross-talk between neutrophils and autoreactive Th17 cells. We 
will report on neutrophil dynamics in mice developing auitoimmune 
diseases and on how these cells contribute to shape T cell immune 
responses. 
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Activating Fc receptors and inflammatory cytokine production by 
macrophages have been implicated in the development and pathology of 
arthritis. However, the molecular components that mediate these events are 
not well characterized. Here we identify Bruton’s tyrosine kinase (BTK) as 
an essential player not only in B-cell dependent but also in myeloid-cell 
dependent inflammatory arthritis using a novel highly specific small 
molecule inhibitor of BTK (BTK SMI). In rodent models of collagen-
induced arthritis, treatment with BTK SMI inhibits disease by at least two 
mechanisms: preventing autoantibody production and suppressing 
inflammatory cytokine production. Specifically, BTK SMI treatment 
prevents signaling and inflammatory cytokine production in response to 
immune complex activation in macrophages. Pathways found in rodents 
translate to human as BTK SMI prevents Fc receptor induced cytokine 
production in human monocytes. These data indicate that BTK SMI may be 
beneficial for the treatment of rheumatoid arthritis and that BTK contributes 
substantially to myeloid cell-dependent disease pathogenesis. 
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Notch signaling based culture system have become indispensable for studying 
T-cell development in vitro. Using the OP9/DL1 coculture system murine and 
human haematopoietic progenitors can be induced to engage towards T-cell 
differentiation in vitro. Transfer of murine T-cell precursors generated in vitro 
on OP9/DL1 into NOD/SCID/γc-/--mice (NSG) promoted reconstitution of the 
T-cell compartment. While most Notch based culture systems consist of stromal 
cells transduced with either DL1 or DL4, so far there is little evidence whether 
DL1 or DL4 alone can drive hematopoietic progenitors towards a T-cell fate in 
vitro. It was recently suggested that exposure of CD34+ HSC to Delta4 is 
sufficient to promote human T-cell differentiation in vitro. We applied this 
approach to further characterize early steps of Notch dependent induction of 
human T-cell differentiation.  
We exposed human CD34+ progenitors to immobilized Delta4. Within 7 days a 
population of CD34+/CD7+ and CD34-/CD7++ T-cell precursors emerged in 
the presence of DL4. After 7 days the CD34+/CD7+ population subsequently 
declined while further amplification of the CD34-/CD7++ population was 
observed. Within the CD34-/CD7++ population, two distinct progenitor subsets, 
CD5+ and CD5-, emerged. The CD5+ subset partially acquired CD1a and thus 
adopted the phenotype corresponding to an intermediate between an early 
thymic progenitor (ETP) and a prethymocyte (pre-T), corresponding to the 
murine DN2/DN3 stage. The CD34-CD7++CD5- cells acquired a Natural Killer 
cell (NK) phenotype. Conversely to what observed in OP9/DL1-coculture, T-
cell development did not progress beyond the pre-T stage. We neither observed 
more advanced stages of T-cell development nor TCR-rearrangements. 7-day 
exposure to immobilized Delta-lika-4 induced a 90-fold increase of T-precursor 
frequency in CD34+ progenitors (1/8800 vs. 1/90). All T-cell precursor activity 
was restricted to cells expressing CD34, CD7 or both (frequency: 1/9), whereas 
the CD34-CD7- population did not contain any detectable T-cell precursor. In 
vitro generated T-cell precursors were transferred into NSG to study their 
potential to enhance thymic reconstitution. Results of the in vivo-experiments 
are pending.  
Our results provide further evidence that human T-cell development can be 
induced in vitro by a simple exposure to immobilized Notch-ligand DL4. In 
contrast to the OP9/DL1 system, T-cell development induced by immobilized 
DL4 is blocked at the preT-stage, suggesting that further signals distinct to 
Notch and not provided by the cultured human progenitors themselves are 
required for T-differentiation beyond the DN-stage.  
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CYLD is a tumor suppressor gene mutated in familial cylindromatosis, an 
autosomal-dominant condition that predisposes to multiple skin tumors. 
CYLD exhibits deubiquitinating activity and acts as a negative regulator of 
NF-B signaling. 
To analyse the function of CYLD in vivo we used the CYLDex7/8 mice, 
which are characterized by loss of the full-length transcript and 
overexpression of a short splice variant of cyld (sCYLD). 
In CYLDex7/8 mice the overexpression of sCYLD resulted in splenomegaly 
and lymphadenopathy. Additionally, the B cell population in spleen and 
lymph nodes is increased at the expense of T cells. 
Analysis of CYLDex7/8 T cells showed a significant reduction of CD4 single 
positive (SP) and CD8 SP T cells in the thymus and in the periphery. In 
vitro as well as in vivo we could show that CD4+ T cells display a 
hyperactive phenotype, proliferating to a better extent than wild type (wt) 
cells and expressing high amounts of inflammatory cytokines like IL-6 and 
IL-17. Western blot analysis of steady state thymocytes and peripheral 
CD4+ T cells were performed, showing that the alternative NF-B pathway 
was highly upregulated visualized by the expression levels of RelB and 
p100/p52. In order to investigate the contribution of CYLD in positive and 
negative selection in the thymus in vivo, the HY-TCR transgene (HYtg) was 
crossed to CYLDex7/8 mice. The analysis of CYLDex7/8 HYtg males revealed 
an increase in CD4+CD8+ DP as well as in CD8 SP thymocytes, suggesting 
a less pronounced negative selection in CYLD mutant mice compared to 
HYtg control mice. Interestingly, the impaired negative selection in the 
thymus was accompanied by a strong colitis phenotype even at early age (4 
weeks). 
Since medullary TECs (mTECs) play an important role in the late stage of T 
cell development by negatively selecting autoreactive thymocytes, the 
levels of mTECs in the medullary compartment was investigated. 
Interestingly, low numbers of mTECs were observed, combined with 
decreased expression levels of the mTEC markers UEA-1, keratin-5, 
claudin-3 and claudin-4. The reduction of mTECs in the medullary 
compartment could explain the inflammatory phenotype of CD4+ T cells in 
CYLDex7/8 mice. Taken together, these results show an important role of 
sCYLD in T cell development as well as in NF-B signaling of T cells. 
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Thymic stromal lymphopoietin (TSLP) is a type I cytokine that plays 
essential roles in allergic/inflammatory skin and airway disorders, in 
helminth infections, and in regulating intestinal immunity. TSLP signals via 
IL-7Rα and a specific TSLPR subunit that is highly related to the common 
cytokine receptor γ chain, γc. Although TSLP has effects on a broad range 
of hematopoetic cells and can induce STAT5 phosphorylation, TSLP was 
reported to not signal via JAK kinases, and the mechanism by which TSLP 
regulates STAT5 phosphorylation has been unclear. We now demonstrate 
that TSLP activates JAK1 and JAK2 in mouse and human primary CD4+ T 
cells, in contrast to the known activation of JAK1 and JAK3 by the related 
cytokine, IL-7. We show that just as JAK1 interacts with IL-7Rα, JAK2 is 
associated with TSLPR protein, and both JAK1 and JAK2 are indispensable 
for TSLP-mediated STAT5 phosphorylation. These findings clarify the 
basis for TSLP-mediated signaling and establish the first example wherein a 
cytokine uses JAK1 and JAK2 to mediate the activation of STAT5. 
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IL-1β is a pleiotropic cytokine produced following cleavage of pro-IL-1β by 
interleukin-1 converting enzyme (caspase-1), which in turn is activated by 
the inflammasome. This cytokine has been shown to play a role in several 
inflammatory immune disorders in humans and in experimental animal 
models, including mouse experimental autoimmune encephalomyelitis 
(EAE). More recently, IL-1β was proposed to be involved in the 
differentiation of inflammatory Th17 cells. We observed that mice deficient 
for a component of the inflammasome (the apoptosis-associated speck-like 
protein containing a caspase recruitment domain, also known as ASC) did 
not develop EAE following immunization with MOG in CFA. However, T 
cells from ASC-KO mice could differentiate into Th17 cells in vitro and in 
vivo upon s.c immunization, indicating that in these conditions IL-1β is not 
required for priming of mouse Th17 cells. We hypothesized that IL-1β, or 
other inflammasome-generated cytokines, may be required in the effector 
phases of EAE. Consistent with this hypothesis we found that microglial 
cells and CNS-resident myeloid cells expressed caspase-1 and released 
active IL-1β upon stimulation with inflammatory cytokines or TLR agonists 
in vitro. To further investigate the role of IL-1β in Th17-mediated diseases 
we set up a different EAE model. Rag1 KO mice were adoptively 
transferred with 2D2 transgenic MOG-reactive T cells following induction 
of brain inflammation by head irradiation. After 4 weeks mice developed 
EAE, which was associated with a large infiltrate of inflammatory 
leukocytes including MHC class II+ microglia/inflammatory monocytes in 
the brain. We are now using this model in ASC-KO or IL-1 β KO mice. 
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Antibodies are a major part of the immune system and consist of 
immunoglobulin heavy and light chains, which are encoded by rearranged 
genes assembled from subsets of V (variable), D (diversity, only heavy 
chains) and J (joining) gene segments. Antibody repertoire diversity, 
potentially of 108 or more unique molecules in a single individual, build the 
basis of antibody-based antigen recognition and protection. The diversity of 
antibody repertoires is further increased by somatic recombination and 
hypermutation to achieve high specificity and selectivity in the detection of 
foreign antigens. In some autoimmune disorders, as well as other diseases, a 
bias in V-gene usage has been reported and different patterns of V(D)J 
recombination are suggested. In an initial study we could verify that not 
only elevated levels of VH4-34 usage makes a difference between 
rheumatoid arthritis patients and healthy individuals, but a certain V(D)J 
recombination pattern is increasingly found.  
To obtain a deeper insight into the nature of human antibody repertoires, we 
started developing a pyrosequencing method on a Roche Genome 
Sequencer FLX System yielding large sets of rearranged antibody 
sequences. We envisage to acquire V(D)J recombination patterns of heavy 
and light chains of all immunoglobulin classes in diseased and healthy 
individuals. To handle these datasets, engineering of a new database is 
ongoing, which will hold all collected sequence information as well as 
cover specific questions about antibody repertoires. We envisage that our 
study will conclude in new ways for sequencing and analysis of antibody 
repertoires in humans.  
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CD4+ T helper (Th) lymphocytes play a central role in cell-mediated 
adaptive immunity. Upon encounter with the antigen, naïve CD4+ T cells 
can differentiate into various sub-types of effector cells including Th1 and 
Th2 cells, which are characterized by their cytokines profile (IL-4, IL-5 and 
IL-13 for Th2 cells, and IFN-γ by Th1 cells). MicroRNAs (miRNAs) are 
small, non-coding RNA molecules (22-24 nt in length) that typically 
function as negative regulators of the expression of protein-encoding genes. 
MiRNAs are transcribed in a PolII or PolIII-dependent manner and are 
processed in the nucleus from primary transcript (pri-miRNA) to a hairpin 
precursor (pre-miRNA). In the cytoplasm, mature miRNAs interact with 
target mRNA transcript, interfering with their translation into protein. Over 
the last few years, miRNAs has been shown to play key roles in regulating 
various immunological processes such as thymocytes maturation, 
differentiation of effector T cells (including Tregs), affinity maturation and 
selection of B cells in germinal centres. These findings suggest that 
miRNAs and the miRNA machinery may be crucial in the regulation of 
immunological response, development, function, and homeostasis. Since an 
alteration of the balance between cellular immunity (Th1) and humoral 
immunity (Th2) can lead to autoimmune and atopic diseases, we decided to 
analyze the role of miRNAs in regulating the critical balance between Th1 
and Th2 lymphocytes. We previously reported that very few miRNAs were 
differentially expressed between Th1 and Th2 cells in the mouse, indicating 
that they might be involved in fate determination of these cells. Indeed, our 
recent data now show that one particular miRNA has an important role in 
regulating T cell plasticity and Th1-Th2 balance in both human and mouse. 
Specifically, in a Jurkat T cell line, miRNA overexpression leads to an 
increased sensitivity to activation inducing cell death (AICD), and altered 
IL-2 production. Most interestingly, in primary T cells from both human 
and mouse, the cytokine profile of miRNA-overexpressing cells was 
skewed towards a Th1-like phenotype, with increased IL-2 and IFN-γ 
production and reduced IL-4 production. Besides being of fundamental 
relevance to our understanding of cell differentiation and gene regulation, 
elucidation of the molecular mechanisms that control T lymphocyte 
differentiation and activation have substantial potential to find new points 
of entry for clinical applications. 
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Th17 cells are a subset of CD4+ T- helper cells important in autoimmunity. 
Although the cytokine environment required for Th17 differentiation and 
the transcription factors they activate have been widely studied; the 
signaling pathways that are responsible for Th17 differentiation are not 
fully understood. Recently we demonstrated that Itk, a Tec family tyrosine 
kinase involved in signaling after T-cell receptor engagement, helps 
modulate TCR signaling to ensure differential regulation of IL17A and 
IL17F. Th17 CD4+ T-cells lacking Itk showed decreased expression of 
IL17A resulting from a defective activation of NFATc1 due to impaired 
TCR-mediated activation of PLC-g1 and Ca2+ mobilization in the absence 
of Itk. Importantly, there was no change in expression of the master 
transcription factor RORgT or production of IL17F in CD4+ T cells from 
Itk -/- mice. Given that Itk couples TCR signaling to IL17A expression, we 
are examining differences in TCR-induced transcriptional complexes to 
understand how Itk-mediated pathways may regulate the differential 
expression of IL17A and IL17F. 
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Notch signaling is essential during early stages of T cell development and can 
control peripheral T cell immunity with context-dependent effects. We have 
identified Notch as a new, critical regulator of donor-derived alloreactive T cells 
mediating graft-versus-host-disease (GVHD) after allogeneic bone marrow 
transplantation. To inhibit Notch-mediated transcriptional activation, we 
conditionally expressed the pan-Notch inhibitor DNMAML in mature CD4+ and 
CD8+ T cells (ROSADNMAMLf x Cd4-Cre+ mice). Notch-deprived alloreactive T 
cells were able to proliferate and to expand in major histocompatibility complex 
(MHC)-mismatched hosts, as well as in minor histocompatibility antigen-
mismatched recipients. However, DNMAML T cells failed to differentiate into 
potent effector T cells, leading to reduced GVHD severity and markedly 
improved survival. Upon ex vivo restimulation with anti-CD3 and anti-CD28 
antibodies, alloreactive DNMAML CD4+ T cells produced markedly decreased 
amounts of multiple cytokines, including IFN-γ, IL-4, TNFα, IL-17 as well as 
IL-2. Similar effects were observed in MHC-mismatched recipients upon 
systemic administration of γ-secretase inhibitors or after conditional inactivation 
of Rbpj, encoding CSL/RBP-Jκ, a transcription factor mediating the canonical 
effects of Notch signaling. Alloreactive DNMAML CD4+ and CD8+ T cells had 
preserved expression of the master transcription factors, Tbx21 (encoding T-bet) 
and Eomesodermin. When alloreactive DNMAML CD4+ T cells were 
restimulated with PMA and ionomycin, bypassing proximal steps of signaling, 
Ifng mRNA was completely restored, and Il2 mRNA was partially rescued. 
These observations differed from past observations of Notch signaling in 
mature T cells and were not consistent with classical CD4+ helper or CD8+ 
effector T cell differentiation defects. Our findings identify Notch as a novel, 
potent regulator of alloreactive T cell responses mediating GVHD and a 
promising therapeutic target after allogeneic bone marrow transplantation. 
 191 
IDENTIFICATION OF TARGET GENES OF DC-STAMP/LUMAN 
PATHWAY IN DENDRITIC CELLS  
 
Anna Sanecka, Dagmar Eleveld-Trancikova, Marleen Ansems, Maaike 
Looman, Bastian Jansen, Gosse Adema  
 
NCMLS, Radboud University Nijmegen Medical Centre, Tumor 
Immunology, Geert Grooteplein 28, Nijmegen, 6525GA, Netherlands 
 
Dendritic cells (DC) are the highly specialized antigen-presenting cells that 
play a key role in regulating immune response. DC can efficiently initiate 
immune responses or induce tolerance. Regarding this dual function DC are 
studied in immunotherapy directed against cancer and autoimmune 
diseases. Characterization of DC-specific genes leading to better 
understanding of DC immunobiology will help to optimally apply DC in a 
clinical setting.  
Dendritic Cell Specific TrAnsMembrane Protein (DC-STAMP) previously 
discovered in our lab, is a protein preferentially expressed by dendritic cells. 
Its expression is upregulated during differentiation and downregulated upon 
maturation of DC. DC-STAMP in immature DC localizes to the 
endoplasmic reticulum (ER). Interestingly, upon maturation it is transported 
out of ER towards a Golgi compartment. We identified a physically 
interacting partner of DC-STAMP in the endoplasmic reticulum (ER), 
called LUMAN (also known as CREB3 or LZIP). LUMAN was previously 
described as an ER-resident transcription factor with unknown function. It 
is activated in a process called regulated intramembrane proteolysis (RIP), 
which involves translocation to the Golgi and subsequent proteolytic 
cleavage. The proteolytically activated form of the protein then translocates 
to the nucleus. Our data suggest that DC-STAMP plays an important role in 
the modulation of LUMAN activity in DC.  
To understand the importance of DC-STAMP/LUMAN pathway in DC 
immunobiology we set out to identify the target genes of LUMAN in DC. 
We introduced the active form of LUMAN into the mouse DC-like cell line 
D2SC1 and screened the altered gene expression in time using microarray. 
Two genes were selected as LUMAN specific targets and validated by 
qPCR in two independent experiments in D2SC1 cell line as well as in 
mouse bone marrow derived DC’s (BMDC’s). Currently, we are 
investigating the role of the DC-STAMP/LUMAN pathway, including the 
luman target genes, in DC. 
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CTLA-4 is an essential regulator of T cell immune responses whose 
mechanism of action is poorly understood. Whilst it has been proposed that 
ligation of CTLA-4 delivers an inhibitory signal to T cells, evidence for this 
process is hard to obtain. Indeed, T cells activated in the presence of natural 
ligands, all express CTLA-4, yet undergo robust cell division. Furthermore, 
studies of T cells lacking CTLA-4 fail to reveal obvious defects in T cell 
behaviour. In contrast, recent evidence increasingly supports the view that 
CTLA-4 can act cell-extrinsically to regulate the activity of T cells. This is 
consistent with a role for CTLA-4 as an effector of suppression on 
regulatory T cells. However, CTLA-4 expression (and presumably its 
functions) are not restricted to Treg cells. Using a model CHO cell system 
we have identified that a central molecular feature of CTLA-4 is its ability 
to capture and internalise the co-stimulatory ligand CD86 by a process of 
trans-endocytosis. Based on this observation we have found that all T cells 
expressing CTLA-4, including activated T cells and Treg and CTLA-4 -
transfected Jurkat cells, have the ability to remove CD86 molecules 
resulting in impaired T cell costimulation by antigen presenting cells. 
Efficient removal of CD86 from target cells requires the C-terminal region 
of CTLA-4, which is responsible for protein trafficking and the removal 
process is stimulated by TCR engagement. Blocking lysosomal degradation 
reveals an accumulation of internalised ligand inside the T cell, suggesting 
that the fate of internalised ligands is lysosomal degradation.  
Together, these results provide a new mechanism of immune regulation that 
uses CTLA-4 as a “ligand depleting pump” to remove costimulatory 
molecules from antigen presenting cells, thereby inhibiting T cell activation. 
Importantly, this model of CTLA-4 function accounts for many of the key 
features of the CD28-CTLA-4 system providing a cogent explanation for 
the sharing of ligands between CTLA-4 and CD28, the highly conserved 
nature of CTLA-4 endocytosis and the constitutive presence of CTLA-4 on 
regulatory T cells. Moreover, this model offers a simple intuitive 
mechanism of immune regulation that applies equally to all CTLA-4 
expressing cells. 
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Recent studies have established the important role of chromatin modifiers in 
controlling the stage-specific networks of transcription factors regulating 
lymphoid cell differentiation. The vertebrate specific Krüppel-Associated 
Box-Zinc Finger Protein (KRAB-ZFP) family comprises more than 400 
transcriptional repressors, which seem to be differentially expressed in a 
lineage-specific manner. Whereas the gene targets of these regulators 
remain mostly unknown, it has been demonstrated that they act through 
sequence-specific DNA binding and recruitment of their KAP1 (KRAB-
Associated Protein 1) universal cofactor, which in turns recruits chromatin 
remodellers and induces heterochromatin formation.  
In order to investigate the role of KRAB/KAP1-mediated regulation in the 
lymphoid lineage, we developed two conditional KAP1 knockout mouse 
lines by crossing KAP1flox2 mice with strains expressing the Cre-
recombinase under the control of either the CD4 or the CD19 promoters. 
Cytofluorimetric analyses of the resulting progeny indicate that CD4-
Cre/Kap1flox2 mice exhibit a significant accumulation of CD8+SP cells in 
the thymus and a reduction of the same population in the periphery. Also, in 
these mice, naturally occurring T regulatory and gd cell populations are 
expanded. CD19-Cre/ KAP1flox2 exhibit a significant reduction of the 
marginal zone B cells and the B1 cell compartment. We are currently 
testing the function of the affected populations and performing 
transcriptome analyses to determine the molecular bases of the observed 
phenotypes. This work will shed interesting light on the role of epigenetic in 
the control of immune differentiation and function.  
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53BP1 is a well known mediator of the cellular response to DNA damage. 
Two alternative mechanisms have been proposed to explain 53BP1's 
interaction with DNA breaks (DSBs), one by binding to methylated histones 
and the other via an RNF8 E3 ligase-dependent ubiquitylation pathway. The 
formation of RNF8 and 53BP1 irradiation induced foci are both dependent 
on histone H2AX. To evaluate the contribution of the RNF8 dependent 
pathway to 53BP1 function we generated RNF8 knockout mice. We report 
that RNF8-deficiency results in defective class switch recombination (CSR) 
and accumulation of unresolved immunoglobulin heavy chain (IgH) 
associated DNA breaks. The CSR DSB repair defect is milder than that 
observed in the absence of 53BP1 but similar to that found in H2AX-/- 
mice. Moreover, similar to H2AX but different from 53BP1 deficiency, 
RNF8-/- males are sterile, and this is associated with defective 
ubiquitylation of the X-Y chromatin. Combined loss of H2AX and RNF8 
does not cause further impairment in CSR, demonstrating that the two genes 
function epistatically. Importantly, although 53BP1 foci formation is RNF8-
dependent, its binding to chromatin is preserved in the absence of RNF8. 
This suggests a two-step mechanism for 53BP1 association with chromatin, 
in which constitutive loading is dependent on interactions with methylated 
histones, whereas DNA damage inducible RNF8-dependent ubiquitylation 
allows its accumulation at damaged chromatin. 
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Bone marrow progenitor cells continuously replenish all blood lineages thus 
maintaining a functional immune system throughout adult life. The lineage 
negative, Sca+, Kit+ (LSK) subset of the bone marrow can be further 
resolved into long-term hematopoietic stem cells (HSC) and multipotent 
progenitors (MPP). The transition from HSCs to downstream MPPs is 
marked by loss of long-term self renewal as cells progress towards a more 
differentiated downstream progenitor. It is critical for HSCs to cycle at a 
steady yet low rate to continuously seed the marrow and at the same time 
keep their numbers constant. Insufficient stem cell renewal can lead to 
hematopoietic failure. In addition, disruption of mechanisms involved in 
controlling HSC proliferation can promote formation of cancer stem cells. 
Previous work from our lab has recently shown that HSCs from mice 
lacking E47 exhibit increased proliferation, loss of quiescence and 
decreased expression of the cell cycle inhibitor p21. These findings suggest 
that p21 is a possible downstream target of E47 in restraining the 
proliferative activity of bone marrow stem cells. However, formal evidence 
establishing a genetic interaction between E47 and p21 is lacking. We have 
generated E47+/-p21+/- compound heterozygotes to test this hypothesis. 
While there are no detectable differences in the frequencies of LSKs, flk2- 
LSKs, flk2+LSKs, common lymphoid progenitors and B cell progenitors 
from compound heterozygote mice compared to WT or single heterozygote 
controls, we found significant alterations in proliferative activity. In vivo 
BrDU incorporation assays reveal an increase from ~55% BrdU+ LSKs in 
each WT and animals heterozygous for either gene, versus 65% BrdU+ 
LSKs in the compound HETs. Sensitive resolution of individual HSC and 
MPP subsets within LSKs showed even more profound effects. 
Approximately 43% of E47+/- p21+/- flk2- LSKs are proliferating compared 
to 31-35% in WT or single heterozygotes. A significant increase from ~67% 
BrDU+ flk2+ LSKs from each WT and single HETS to 79% BrDU+ 
flk2+LSKs from compound heterozygotes was also observed (p<0.05, t-
test). Consistent with the increased proliferation, total LSKs, flk2- LSKs, 
and flk2+ LSK numbers from compound heterozygotes were more sensitive 
to 5-FU, a drug that is toxic to cycling cells. These results indicate that there 
is an increase in the proliferation of uncommitted progenitors in mice 
haploinsufficient in E47 and p21, providing evidence of a direct genetic 
link. 
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Either disruption of the tonic signal transmitted by an innocuous BCR or 
strong engagement of the BCR with antigen results in receptor editing and 
apoptosis in immature B cells. Inhibition of PI3K signaling promotes both 
of these outcomes. Expression of mRNA encoding the proapoptotic family 
of Foxo transcription factors is reduced by PI3K signaling in mature B cells, 
suggesting that changes in Foxo levels may also occur in and have 
functional consequences for immature B cells. anti-IgM stimulation was 
shown to upregulate Foxo family mRNA expression in primary immature B 
cells and WEHI 231 cells. Disruption of the tonic signal with PI3K 
inhibitors also increased Foxo mRNA. Since expression of Foxo3 was 
increased to a greater extent than that of Foxo1 or Foxo4 in primary cells, 
we examined its role in the response of immature B cells to BCR 
crosslinking. Overexpression of Foxo3 promoted BCR-induced cell death in 
WEHI 231 cells, while immature B cells from Foxo3-/- mice demonstrated 
reduced apoptosis in response to anti-IgM. In contrast, Igλ usage was 
normal, if not enhanced, in the absence of Foxo3 suggesting that receptor 
editing is unimpaired. This is consistent with previous studies 
demonstrating a role for Foxo1 in BCR-induced Rag expression. These 
results support a model in which Foxo3 and Foxo1 mediate apoptosis and 
receptor editing, respectively, in immature B cells expressing a non-
functional or autoreactive BCR.  
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Regulating RAG activity in B lineage cells is crucial to prevent deleterious 
events that can be caused by the presence of DNA double strand breaks. To 
identify negative regulators of Rag expression, we conducted an unbiased 
cDNA library screen in Abelson murine leukemia-virus transformed pro-B 
cells. We found that overexpression of the transcriptional repressor Gfi-1b 
downregulates RAG expression in pro-B cell lines and primary B lineage 
cells from bone marrow. Gfi-1b binds directly to a region of the RAG locus 
upstream of the B-cell specific Erag enhancer and its activity depends on its 
association with chromatin modifying cofactors. In addition, Gfi-1b’s effect 
on RAG levels appears to be mediated in part by repression of Foxo1, a 
recently identified positive regulator of RAG expression. Gfi-1b-deficient 
cell lines exhibit increased RAG levels as well as an increase in the overall 
number of DNA double strand breaks per cell when compared to their 
wildtype counterparts, suggesting that Gfi-1B may be critical to maintain 
genome integrity. Moreover, microarray experiments revealed that Gfi-1b 
controls the expression of a suite of B lineage-specific genes, including the 
immunoglobulin kappa locus and the transcription factor SpiB. We identify 
Gfi-1B as a novel regulator of RAG expression that may also be involved in 
the execution of genetic programs that govern B cell development. 
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IN NAÏVE T CELLS THE CTLA-4 GENE IS EMBEDDED IN A 20KB 
REGION ENRICHED IN H4AC WITH POCKETS OF H3K9ME2; 
POISED FOR TRANSCRIPTION, EARLY ACTIVATION INVOLVES A 
COMPETITION BETWEEN POSITIVE AND NEGATIVE 
REGULATORS FOR THE USAGE OF THE NFAT AND OCTAMER 
BINDING SITES 
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Activation of CD4(+) Foxp3(-) T cells by Antigen Presenting Cells relies on the 
integration of both positive and negative signals. CTLA-4 is a negative 
regulator of T cell activation, expressed de novo after the integration of 
TCR/costimulation related signals. CTLA-4 is required for T cell homeostasis 
and tolerance and exerts its function by T-cell intrinsic and extrinsic 
mechanisms. Although multiple pathways have been shown to modulate T cell 
activation, in addition to TCR-mediated signals, the role of CD28 as positive 
and CTLA-4 as negative mediators remain critical.  
 
Given the central role of CTLA-4 in regulation of T cell activation, surprisingly 
little is known about the regulation of Ctla-4 transcription. We uncovered the 
presence of a positive regulatory cluster composed of NFAT- and Octamer-
binding sites in the promoter element. In addition, we found that Ctla-4 lies in 
an extended region enriched for H4Ac histones, with no much H3Ac, but with 
pockets of H3K9me2. Interestingly, this poised chromatin appears to have an 
added layer of negative regulation in that gene expression requires that the 
positive regulators NFAT and Octamer binding proteins out-compete negative 
regulators present in the naïve T cells that utilized the same binding sites.  
 
In vitro, the Ctla-4 promoter can be activated in an Octamer-dependent 
mechanism even in the absence of NFAT binding. Moreover, during the first 
hours of T cell activation, endogenous Ctla-4 expression appears to occur in 
waves of transcription that seemed linked to differences in the NFAT family 
members present at the promoter. These observations are consistent with a key 
role for NFAT primarily in the “turn on” signal, and suggest a role for Octamer-
binding proteins in the “maintenance of expression” (i.e. after NFAT activating 
signals have ceased). Finally, we uncovered a miR155 target site in the 3`UTR 
of the Ctla-4 mRNA that in vitro decreases reporter protein levels, thus perhaps 
involved in “turning off” gene expression. 
 
Altogether, these observations are consistent with a model where the 
transcription of the Ctla-4 gene in T cells is regulated by NFAT-dependent and 
–independent mechanisms that out-compete negative regulators and miR155- 
rather than by extensive regulation of accessibility to the locus, which seems 
poised for transcription. 
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Triggering of B cell receptor by anti-IgM antibodies (α-IgM Ab) induces a massive 
synthesis of NFATc1 in primary splenic B cells. This concerns mainly the short 
isoform NFATc1/αA which lacks a C-terminal peptide of approximately 245 aa 
residues and differs from other NFATc1 proteins by its N-terminal α-peptide. By the 
inactivation of the Nfatc1 gene in B cells and re-expressing NFATc1/αA we show 
that NFATc1 levels are critical for the activity and survival of murine splenic B cells 
and chicken DT40 B lymphoma cells upon α-IgM Ab stimulation. While moderate 
NFATc1 levels support the proliferative capacity of splenic B cells, high 
concentrations induce their Activation Induced Cell Death (AICD) by stimulating 
the expression of pro-apoptotic Fasl/CD95 Ligand, Pdcd1/PD-1 and Tnfsf14/LIGHT 
genes. The diminished proliferative capacity of NFATc1-deficient B cells appears to 
be due to a decreased Ca++ mobilization and influx, and of calcineurin activity. 
NFATc1 ablation in bone marrow B cells did not markedly affect the differentiation 
of B cells in bone marrow and spleen, but suppressed the generation of peritoneal 
B1a cells and of germinal centre (GC) B cells upon immunization with sheep red 
blood cells. In addition, upon immunization with specific antigens NFATc1-
deficient B cells produce less IgM antibodies and show a defect in switch to the 
production of other Ig classes. Ectopic expression of NFATc1/αA in NFATc1-
deficient DT40 B induced Bcl-6 and Bach-2 but suppressed Blimp-1 expression, i.e. 
markers of GC reaction or plasma cell formation. These data find support in the 
constitutive nuclear expression of NFATc1/αA in GC B centrocytes expressing IgM. 
Incubations of NFATc1-deficient splenic B cells with T cells in mixed lymphocyte 
reactions or, upon loading of OTII T cells expressing an Ova-specific with 
transgenic TCR with an Ova323-339 peptide showed a marked decrease in the capacity 
of B cells to stimulate the proliferation and IL-2 secretion of T cells. All these 
findings indicate that NFATc1-/- B cells acquire an anergy-like phenotype. 
Therefore, NFATc1 affects the strength and duration of immune responses, and its B 
cell-specific ablation impairs immune reactions in vitro and in vivo. This is shown 
for the mild clinical course of Experimental Autoimmune Encephalomyelitis (EAE) 
upon injection of EAE-inducing MOG35-55 peptide into mice bearing NFATc1-/- B 
cells. Taken together, our data indicate a crucial role for NFATc1 in the control of 
immune reactions. In addition, they suggest that NFATc1 and NFATc2, the two 
most prominent NFAT factors in peripheral lymphocytes, control the two features of 
the adaptive immune system, namely immunity (NFATc1/αA) or anergy (NFATc2). 
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Specification of T cells requires signaling through the Notch receptor, 
which is mediated by Delta-ligand interactions. The endocytosis of Delta 
(Delta-like in mammals) in the signal-sending cell is thought to induce 
Notch activation in the signal-receiving cell. This work focuses on 
investigating the role of Delta-like 1 (Dll-1) and Dll-4 endocytosis in Notch 
activation and T cell development using the OP9-DL1 (and -DL4) stromal 
cells.  
 
To address whether endocytosis of Delta-like is a requirement during T cell 
development, we have created different Delta-like mutants to specifically 
target Delta-like endocytosis to better understand its role in Notch 
activation. OP9 stromal cells retrovirally transduced to express the Dll-1 
construct that lacks the intracellular domain (OP9-DL1-delta-ICD) or Dll-1 
extracellular (ECD) domain fused to the transmembrane and cytoplasmic 
domain of CD25 (OP9-DL1-CD25), do not support T cell development nor 
do they inhibit B cell development. In contrast, OP9-DL4-delta-ICD and 
OP9-DL4-CD25 stromal cells retain the ability to support T cell 
development, but to a lesser degree compared to full-length Dll-4. In 
addition, quantitative PCR analysis revealed a differential induction of 
downstream Notch target genes. Constructs to promote endocytosis of Dll-1 
or Dll-4 were created and over-expressed on OP9 stromal cells, by fusing 
the ECD of DL1 (or DL4) to the transmembrane and intracellular domain of 
the transferrin receptor (OP9-DL1-TFR1 or OP9-DL4-TFR1) and their 
ability to support T cell development was also analysed. Surprisingly, cell 
surface expression of both full length DL4 and DL4-delta-ICD are reduced 
compared to their respective DL1 constructs, suggesting that indeed Dll4 is 
able to support T cell development more efficiently than Dll1 and that it 
does not solely depend on endocytosis as a mechanism in which to initiate a 
Notch signal. To assess if the DSL domain of Dll4 has a greater affinity for 
Notch1 and is therefore better able to induce a Notch signal than Dll1, we 
swapped the DSL domains of Dll1 and Dll4 and over-expressed them in 
OP9 stromal cells and assessed their ability to support T cell development.  
 
These studies not only demonstrate the importance of the endocytosis of 
Delta-like during hematopoiesis and its role in T cell specification, but also 
suggest the differential potential mechanism of Dll1 and Dll4 in this 
process.  
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The Tcra/d locus is composed of Dδ, Jδ and Cδ gene segments embedded 
between large arrays of Vα/δ and Jα gene segments. During T cell 
development, Tcrd gene segments recombine in DN thymocytes, whereas 
Tcra gene segments recombine in DP thymocytes. Notably, in DN 
thymocytes the Dδ-Jδ cluster has a single chance to recombine to widely 
separated Vδ gene segments, whereas in DP thymocytes, Tcra undergoes 
multiple rounds of Vα-to-Jα rearrangement and preferentially recombines 
proximal Vα gene segments first. The contraction of antigen receptor loci is 
thought to promote long-range interactions of V(D)J gene segments for 
synapsis and recombination. To investigate the changes in the conformation 
of the Tcra/d locus during T cell development, we used the 3-dimensional 
fluorescence in situ hybridization (3D-FISH) method with four DNA probes 
targeted to the distal V, central V, proximal V and 3’end of the Tcra/d 
locus. We found that the 3’ portion of Tcra/d locus is highly contracted in 
both DN and DP thymocytes as compared to B cells. This result is 
consistent with the concept that locus contraction is necessary for Tcrd and 
Tcra rearrangement in DN and DP thymocytes, respectively. Remarkably, 
the 5’ portion of the Tcra/d locus is highly contracted in DN thymocytes, 
but then decontracts in DP thymocytes. A potential explanation for this 
difference is that a highly contracted 5’ conformation is essential for one-
chance Tcrd rearrangement, involving proximal and distal V gene segments 
in DN thymocytes, whereas the relatively decontracted 5’ conformation 
benefits Tcra rearrangement that is biased to more proximal V segments in 
DP thymocytes. In Murre’s previous studies, the contracted conformation of 
the Igh locus in pro-B cells places all VH gene segments a similar distance 
from the DH-JH cluster, thereby providing all VH gene segments the 
opportunity for recombination. We suggest that the Tcra/d locus adopts a 
similar strategy in DN thymocytes, but a distinct strategy that is uniquely 
suited to promote multiple rounds of Tcra rearrangement in DP thymocytes. 
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Brassica rapa species (Brassicaceae) constitute one of the most important 
sources of food. We previously found that three indole acetonitrile 
compounds, namely, caulilexin, indole-3-acetonitrile, and arvelexin, 
comprise the active components of B. rapa. In the present study, arvelexin 
was found to have the most potent inhibitory effect on prostaglandin E2 
(PGE2) and nitric oxide (NO) in LPS-stimulated RAW264.7 cells. 
Furthermore, arvelexin reduced levels of cyclooxygenase-2 (COX-2), 
inducible nitric oxide synthase (iNOS), and inflammatory cytokines (TNF-
α, IL-6, and IL-1β) in LPS-stimulated cells. COX-2 and iNOS promoter 
activity assay revealed that arvelexin inhibited LPS-induced PGE2 and NO 
production through the repression of their gene expression. In addition, 
arvelexin attenuated LPS-induced DNA binding and the transcriptional 
activities of nuclear factor-kappa B (NF-κB), which was associated with the 
prevention of the IκB kinase (IKK) phosphorylations and the inhibitor κBα 
(IκBα) degradation and consequently with decreased nuclear NF-κB protein 
levels. In rats, arvelexin (25 and 100 mg/kg, p.o.) inhibited carrageenan-
induced paw edema, neutrophil migration, and PGE2 production. These 
results demonstrate that arvelexin has an anti-inflammatory effect, which 
results from the inhibition of NF-κB activation in macrophages, thereby 
decreasing expression of COX-2, iNOS and pro-inflammatory cytokines. 
These findings showing inhibition by arvelexin on paw oedema as well as 
inflammatory gene induction will help to understand its pharmacology and 
mode of action. 
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PRDM1 (Positive Regulatory Domain zinc finger protein 1) is a DNA-
binding transcription factor, originally identified as a suppressor of 
interferon-beta in virally-infected human osteosarcoma cells. It is most 
widely recognized as a key regulator of B-cell terminal differentiation into 
antibody-producing plasma cells. More recently, several reports have 
described functions in T-cell homeostasis and effector lineage 
differentiation. Here, we demonstrate that PRDM1 has a functional role in 
human natural killer (NK) cells. Using microarray profiling of primary NK 
cells stimulated with IL-2, IL-12 and IL-18, we observed strong induction 
of PRDM1 transcripts. Further characterization revealed high levels of 
expression predominantly in the CD56dimCD16+ subset in response to 
stimulation. Chromatin immunoprecipitation experiments reveal binding to 
novel regulatory sites in the IFNG and TNF loci in primary NK cells. 
Knockdown of PRDM1 leads to enhanced levels of IFNG and TNF mRNA 
and protein. Conversely, adenoviral-mediated over-expression of PRDM1 is 
sufficient to abrogate stimulation-induced IFNG and TNF transcription in 
cell lines. Furthermore, ChIP-on-chip analysis using promoter tiling arrays 
has allowed us to identify numerous novel PRDM1 target genes which may 
be relevant to NK function. The list of target genes identified thus far is 
quite divergent from genes previously shown to be regulated by PRDM1 in 
B and T cells, suggesting a unique functional role for PRDM1 in NK cells. 
Collectively, these data provide the first description and functional analysis 
of PRDM1 in NK cells, further extending the functional repertoire of this 
highly-conserved transcription factor. 
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Homologous pairing has been thought to have limited utility in higher 
eukaryotes. We recently discovered, however, that developing B cells 
undergo pairing during V(D)J recombination: homologous Ig alleles pair 
just prior to recombination, and monoallelic cleavage triggers ATM-
dependent repositioning of the uncleaved allele to pericentromeric 
heterochromatin (PCH), halting further recombination until the first allele is 
repaired. Since genomic stability must also be maintained during class 
switch recombination (CSR) in B cells, we asked whether common 
processes regulate both recombination events. Not only do we find that Igh 
alleles pair during CSR, mediated by AID and the 3’ enhancer, and that 
ATM repositions one allele to PCH, but our data suggest that AID and 
UNG provide a scaffold for the recruitment of repair proteins. 
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It is now well established that different combinations of histone post-
translational modifications influence the transcriptional activity of a given 
gene. However, how these epigenetic changes correlate with the regulation 
of gene expression during the process of cell differentiation has not been 
extensively studied. In order to address this issue, we have analysed locus-
wide changes in gene expression and marks for “active” (H3K4me1/2/3, 
H3K36me3) and “repressive” (H3K9me2, H3K27me3) chromatin, at two 
critical stages of early T-cell differentiation, using primary cells from 
mouse model systems. We found that gene regulation was not associated 
with clear-cut switches between “active” and “repressive” marks. Instead, 
gene expression regulation between the two developmental stages resulted 
in a locus-specific combination of epigenetic marks at both proximal and 
distal regulatory regions. Importantly, both epigenetic priming and memory 
appears to be widespread properties of regulatory elements targeted by the 
pre-TCR signalling. Finally, we also describes the epigenetic dynamics at 
the complex TCR genes and highlight novel regulatory features related to 
the regulation of V(D)J recombination at these loci. In conclusion, our 
results show that gene regulation correlates with combinatorial changes of 
the epigenetic marks at both proximal and distal regulatory elements, with 
the strength of these modifications depending on the intrinsic features of 
each individual gene and associated regulatory elements. 
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Previous work has shown that mature B cells depend upon survival signals 
delivered to the cells by their antigen receptor (BCR). To identify the 
molecular nature of this survival signal, we have developed a genetic 
approach in which ablation of the BCR is combined with the activation of 
specific, BCR dependent signaling cascades in mature B cells in vivo. 
Using this system, we provide evidence that the survival of BCR deficient 
mature B cells can be rescued by a single signaling pathway downstream of 
the BCR, namely PI3-Kinase (PI3K) signaling, with the FOXO1 
transcription factor playing a central role. 
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During B cell differentiation after immunization or infection, activation-
induced cytidine deaminase (AID) initiates diversification of 
immunoglobulin (Ig) genes, initiating mutations within the antigen binding 
variable regions (somatic hypermutation), and recombination events 
resulting in a switch from one class of antibody to another (class switch 
recombination). Upon subsequent selection, mutations can improve the 
affinity of antibodies, and class switch recombination (CSR) leads to 
replacement of the μ constant region of the Ig heavy (H) chain (present in 
IgM) with another constant region, resulting in improved ability of the 
antibodies to remove the pathogens. AID initiates CSR by deaminating 
cytosines in special tandemly repeated switch (S) region sequences (ranging 
from 1 - 10 kb in length) located upstream of each of the IgH chain genes. 
The resulting dU bases are excised by uracil DNA glycosylase (UNG), 
which results in abasic sites that are converted to single-strand breaks 
(SSBs) by AP endonucleases. If the SSBs occur sufficiently near each other 
on opposite DNA strands, this can lead to the double-strand DNA breaks 
(DSBs) required for the deletional recombination occurring during CSR. S 
regions have numerous repeats of a sequence motif (WGCW), where W=A 
or T, which is a preferential target for AID. However, it is unknown if 
physiological levels of AID initiates DSBs at other sites in the genome, and 
if so, whether these DSBs can lead to genomic instability resulting in the 
translocations, deletions and amplifications found in B cell malignancies. 
AID has been shown to initiate mutations at non-Ig genes in Peyer’s patch 
B cells, a location in which Ig variable region genes have undergone 
numerous rounds of SHM, but whether AID activity also leads to DSBs at 
sites other than IgH S regions is unknown. Using a non-biased genome-
wide approach, we have identified reproducible AID-dependent DSBs in 
mouse splenic B cells induced to undergo CSR for two days in culture. 
Most interestingly, several of these DSB sites are syntenic with sites of 
translocations, deletions and amplifications in human B cell lymphomas.  
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MicroRNAs have been implicated as important regulators of many aspects 
of immune cell function. We and others have previously shown that 
deletion of the microRNA biogenesis enzymes Dicer and Drosha from T 
cells results in abnormal cytokine production and decreased proliferation of 
CD4 T cells ex vivo. We found that T cell specific deletion of the Drosha 
cofactor DGCR8 results in a similar phenotype. Reporter alleles and co-
culture assays showed that these defects are cell intrinsic. Furthermore, 
retroviral expression of DGCR8 in these cells was able to restore miRNA 
expression and rescue the defects in proliferation and cytokine production. 
These data suggest a complex role for the miRNA pathway in the regulation 
of cytokine production and cell differentiation in actively dividing and 
differentiating CD4 T cells, likely due to the contributions of many 
miRNAs. Utilizing newly developed techniques to deliver functional 
miRNAs and miRNA antagonists to both wildtype and DGCR8-deficient 
primary CD4 T cells, we aim to identify the specific functions of individual 
miRNAs during T helper cell activation and cytokine production. 
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Pyk2 is a non-receptor protein tyrosine kinase involved in cytoskeletal-
associated functions of immune cells. Pyk2 can act as a scaffold protein and 
has been shown to complex with many proteins including paxillin and 
several Src-family kinases. The activity and function of Pyk2 is regulated 
through a variety of mechanisms, including phosphorylation and alternative 
splicing. Our laboratory has generated polyclonal antibodies against the N-
terminus and the proline-rich regions in the C-terminus of Pyk2. Both of 
these antibodies are able to immunoprecipitate Pyk2, however in 
macrophages the N-terminal antibody pulls down a higher molecular weight 
form of the protein. We have found that this is not due to differential 
phosphorylation as treatment with alkaline phosphatase does not alter the 
relative mobility of the protein. In addition, Pyk2 precipitated with either 
antibody is tyrosine phosphorylated at similar levels. Through 
immunoprecipitation and immunoblotting, we show that Pyk2 pulled down 
with the C-terminal antibody constitutively associates with paxillin, 
whereas essentially no association is detected with Pyk2 recovered with the 
N-terminal antibody. Moreover, we demonstrate that the C-terminal 
antibody identifies a form of Pyk2 that is localized at the microtubule 
organizing center (MTOC) and along microtubules, where it colocalizes 
with paxillin. Conversely, the N-terminal antibody binds to Pyk2 that is 
predominantly membrane proximal and absent from the MTOC. Finally, 
Pyk2 associated with the Pyk2 recovered with the C-terminal antibody is 
complexed with a large number of proteins, consistent with its cytoskeletal 
location, whereas the Pyk2 associated with the N-terminal antibody does 
not seem to form large protein complexes. Biochemical and functional 
differences between the two populations of Pyk2 distinguished by these 
antibodies are currently being explored. All things considered, we propose 
that these antibodies identify two populations of Pyk2 that differ oin their 
association with other proteins, their localization and, possibly, their 
function. Further characterization of these two populations will provide 
significant insight in the diverse means by which Pyk2 is regulated, and 
how this regulation translates into differential protein binding, localization 
and function. 
 210 
EZH2 CONTROLS PHYSIOLOGICAL FUNCTION OF DENDRITIC 
CELLS 
 
Merry Gunawn1, Nandini Venkatesan1, Tiannan Guo2, Newman Sze 2, I-
hsin Su1  
 
1Nanyang Technological University, Division of Genomics and Genetics, 
Biological Sciences , 60 Nanyang Drive, Singapore, 637551, Singapore, 
2Nanyang Technological University, Division of Chemical Biology and 
Biotechnology, School of Biological Sciences , 60 Nanyang Drive, 
Singapore, 637551, Singapore 
 
Polycomb group protein Ezh2, one of the key regulators of embryonic 
development in different organisms, was not essential for the in vitro and in 
vivo differentiation of various dendritic cell (DC) subsets.  
 
The functional study however indicated the requirement of Ezh2 for the Fc-
receptor mediated endocytosis and cell migration in DCs. The compromised 
endocytosis and migratory ability in Ezh2-deficient DCs may be attributed 
by the reduced turnover rate of some adhesion structures.  
 
Furthermore, a genome wide proteomic analysis of the Ezh2-deficient DCs 
revealed that the protein biosynthesis, but not the transcripts of several 
adhesion and cytoskeleton related molecules were regulated by Ezh2. The 
molecular mechanisms by which, Ezh2 regulates these molecules, and 
hence the cellular functions will be addressed in this study.  
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Lymphocytes assemble the genes that encode antigen receptors, by 
rearranging component gene segments in a coordinated process termed 
V(D)J recombination. Recombination signal sequences (RSSs) flank these 
gene segments and are recognized and cut by the RAG (Recombination 
Activating Gene) proteins, which initiates V(D)J recombination. V(D)J 
recombination is highly ordered, and maintains lineage and stage specificity 
during the development of lymphocytes. Chromatin modifications are 
widely believed to be important for this tight regulation but the mechanistic 
details have not been determined. Reports indicate that the nucleosome 
structure prevents RSSs access to RAGs in vitro. Using staggered primers, 
we determined that a significant fraction of Jκ1 (used in most primary κ 
rearrangements) is present on a nucleosome in vivo, prompting us to further 
explore how this apparent inaccessibility is overcome in rearranging loci. 
Covalent modifications of histone tails in these nucleosomes have been 
shown to be associated with an increase or decrease in V(D)J 
recombination. To determine if any of the known enzymes that covalently 
modify histones are involved in the regulation of V(D)J recombination, we 
decreased their expression in pro B cells by shRNAs and assessed the effect 
on the frequency of κ rearrangement. We identified p300/CBP-associated 
factor (PCAF), a known histone acetyltransferase, as a promoter of κ 
rearrangement. Additionally, we have generated a pro-B cell line containing 
a chromatinized reporter that expresses a surface fluorescent marker when it 
undergoes RAG mediated recombination to perform an unbiased screen for 
factors that promote V(D)J recombination. When RAG expression was 
increased in these cells using a chemical inducer, these cell lines efficiently 
rearranged the reporter and expressed significant amounts of Green 
Fluorescent Protein (GFP). We are currently using these cells to screen a 
cDNA expression library for factors that promote V(D)J recombination. 
The reporter system is designed to recruit the expressed proteins to the 
rearranging locus, which increases the likelihood of identifying chromatin 
modifying factors. 
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A NOVEL IMMUNOGLOBULIN-LIKE RECEPTOR, ALLERGIN-1, 
INHIBITS IGE-MEDIATED ALLERGIC RESPONSES 
 
Satoko TAHARA-HANAOKA1, Kaori HITOMI1, Satoru SOMEYA1, Akira 
FUJIKI2, Hideaki TADA2, Tetsuya SUGIYAMA2, Shiro SHIBAYAMA2, 
Kazuko SHIBUYA1, Akira SHIBUYA1  
 
Immune responses are regulated by positive and negative signaling 
mediated by cell-surface receptors expressed on both lymphoid and myeloid 
cells. However, the molecular mechanism of these signaling, and patho-
physiological roles in immune responses have been incompletely 
understood. Here, we identified and characterized a novel ITIM-bearing 
Immunoglobulin-like receptor, ALGN-1. 
We identified human and mouse ALGN-1 by the signal sequence trap 
method. We generated monoclonal antibodies against ALGN-1, and found 
that it is highly expressed on peritoneal exudative and bone marrow-derived 
cultured mast cells. The cytoplasmic portion of ALGN-1 was tyrosine-
phosphorylated upon pervanadate stimulation, and associated with tyrosine-
phosphatases, including SHP-1, SHP-2 and SHIP. Moreover, co-ligation of 
ALGN-1 with FcεRI resulted in inhibition of FcεRI-mediated degranulation 
from bone marrow-derived mast cells. ALGN-1-deficient mice showed 
significantly enhanced IgE-mediated allergic responses, including passive 
systemic and cutaneous anaphylaxises.  
These results indicate that ALGN-1 is a novel ITIM-bearing receptor 
expressed on mast cells, which inhibits FcεRI-mediated activating signal. 
Thus, ALGN-1 may be a novel therapeutic target for allergic disorders. 
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YEAST BASED IMMUNOTHERAPY INDUCES IL-6 PRODUCTION 
THEREBY REDUCING ANTIGEN SPECIFIC CYTOTOXIC T 
LYMPHOCYTES 
 
Beth A Tamburini, Ross M Kedl, Donald Bellgrau  
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Saccharomyces cerevisiae are taken up by antigen presenting cells (APCs) 
while also binding to pattern recognition receptors (PRR) of the APC thus 
providing phagocytic and danger signals to the APC. The yeast are then 
processed and peptides are presented on the APC. Thus activation of APCs 
by yeast antigens provides both innate and adaptive immunity and under the 
appropriate conditions, yeast delivered with antigen can be cross-presented 
to induce a productive, antigen specific CD8 T cell response. Previous data 
with other TLR agonists and PRRs document the usefulness of adding an 
agonistic CD40 antibody to enhance the productive CD8 T cell response. 
We show the usefulness of this agonistic antibody with a yeast-based 
vaccine in providing an enhanced antigen specific CD8 T cell response. 
Additionally, the yeast-dependent antigen specific CD8 T cell responses 
produced are at a markedly higher frequency in IL6-/- mice than in the 
wild-type. Evidence indicates a link between immune responses to yeast 
and Th17 cell production. Th17 cells and the IL-17 they produce lead to the 
recruitment of neutrophils that eliminate fungal and certain bacterial 
infections. IL-6 and IL-23 are critical cytokines necessary for Th17 cell 
differentiation, maintenance and sustained IL-17 production. Thus, while 
Th17 cells may cause inflammation necessary to rid the host of fungal 
infection this appears to occur concomitant with Th1-mediated induction of 
CD8 T cells. Th17 cells share an avidity for TGF beta with regulatory T 
cells (Treg). IL-6 mediates the transition from naïve CD4 T cells into either 
Th17 or Treg cells by contributing to the differentiation of CD4s into Th17s 
and blocking the differentiation into Tregs. Indeed, Th17 are now 
considered to be dominant participants in autoimmunity in part through 
their negative effects on Treg development. We also provide evidence that 
boosting with yeast does not impair antigen specific CD8 T cell production 
in the IL-6-/- mouse. These data suggest that the experimental reduction of 
IL-6 may not necessarily promote excess Tregs that act to suppress the CD8 
response. We conclude that counteracting the Th17 pathway by reducing 
availability of IL-6 can strengthen and provide a durable yeast-induced 
antigen specific CD8 T cell response. Both Th17 cells and CD8 cytotoxic T 
cells likely have direct effects on tumor growth and Th17 mediated IL-21 
production may enhance memory CD8 responses that could also target 
infectious diseases. Therefore, modulation of yeast induced Th17, Th1, and 
CTL responses may provide opportunities in which whole yeast based 
immunotherapy can be tuned to preferentially target cancer or infectious 
disease. 
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TRANSCRIPTION FACTOR OCT1 STABILIZES AND AMPLIFIES 
BOTH REPRESSED AND INDUCIBLE STATES AT IL2 IN NAÏVE 
AND RESTING HELPER T CELLS 
 
Arvind Shakya, Jinsuk Kang, Matthew A Williams, Dean Tantin  
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Although Oct1 has been intensely studied, and although it targets a number 
of genes encoding key immunological regulators and effectors, surprisingly 
little is known about how it regulates gene transcription. Here, we identify 
two components of the NuRD chromatin remodeling complex associated 
with Oct1 bound to Il2 promoter DNA in vitro. Using ChIP we show that 
the NuRD subunit MTA-2 is bound to Il2 in highly purified naïve splenic 
CD4 cells, and that association is lost upon T cell activation. In contrast, 
NF-AT associates only in activated cells and Oct1 is constitutively bound. 
NuRD is not associated with Il2 in naïve T cells lacking Oct1, suggesting a 
regulated recruitment mechanism. Consistent with these findings, purified 
Oct1 deficient naïve T cells show inappropriate Il2 promoter demethylation 
as assessed by bisulfite sequencing, and aberrant Il2 activity as assessed by 
qRT-PCR. These findings indicate that Oct1 helps maintain a repressed 
state at Il2 in naïve cells. Surprisingly, we also identify an opposing 
phenomenon: in resting but previously stimulated CD4 T cells, Oct1 is 
required to maintain a demethylated state and promote the stronger Il2 
expression associated with secondary stimulation. These findings indicate 
that Oct1 also helps maintain a poised state at Il2 through an anti-repression 
mechanism. We propose that, rather than acting as a primary trigger of gene 
activation or repression, Oct1 acts as a bipotential “molecular transistor” 
that reinforces both repressed and inducible states at individual genes. We 
show that Oct1 is required for a strong CD4 (but not CD8) T cell response 
following challenge with LCMV and Listeria. 
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A BALB/C LOCUS ON CHROMOSOME 12 CONFERS RESISTANCE 
TO LUPUS IN FCΓR2-/- MICE. 
 
Tatiana Tarasenko, Silvia Bolland  
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FcγR2B-deficient (R2-/-) mice develop autoantibodies and 
glomerulonephritis with a pathology closely resembling human lupus when 
on the C57Bl/6 (B6) background. The same mutation on the BALB/c 
background does not lead to spontaneous disease, suggesting differences in 
lupus susceptibility between the BALB/c and B6 strains. An F2 genetic 
analysis from a B6/BALB cross identified regions from the B6 
chromosomes 12 and 17 with positive linkage for IgG autoantibodies. We 
have generated a congenic strain (B6.R2-/-sbb2) that contains the 
suppressor allele from the BALB/c centromeric region of chromosome 12 
in an otherwise B6.R2-/- background. We have observed that the presence 
of sbb2, even as heterozygote BALB/B6, renders B6.R2-/- mice resistant to 
lupus disease by suppressing all antibody autoreactivity and spontaneous 
immune cell activation. Mixed bone marrow reconstitution experiments 
indicated that the sbb2 resistant allele is most likely T cell intrinsic. The 
sbb2 congenic interval contains several candidate genes that are currently 
being investigated. We generated transgenic lines containing BAC DNA 
insertions spanning the sbb2 interval. The new BAC transgenic strains were 
tested for lupus suppression in the induced model of lupus by pristane 
administration. Newly generated BAC transgenic strains were also bred to 
B6.R2-/- to test for suppression of lupus in spontaneous disease. The goal of 
our current experiments is to identify a new lupus susceptibility gene within 
the sbb2 interval that is able to suppress lupus disease by altering T cell 
function. 
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GENOME-WIDE MAPPING OF RAG1 AND RAG2 PROTEIN BINDING 
 
Grace Teng1, Yanhong Ji1, Rafael Casellas2, David Schatz1  
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V(D)J recombination assembles the antigen-binding domains of 
immunoglobulin (Ig) and T cell receptor (TCR) genes from arrays of V, D, 
and J gene segments. The RAG1 and RAG2 proteins drive this process of 
somatic DNA rearrangement, inducing DNA breaks adjacent to 
recombination signal sequences (RSSs) in the antigen receptor loci. The full 
extent and patterns of RAG binding and activity, both within the antigen 
receptor loci, and at cryptic RSSs elsewhere in the genome, have not been 
comprehensively described. We have previously shown that the RAG 
proteins localize at discrete foci centered over the J segments in several 
antigen receptor loci. We are now in the process of extending our studies to 
a genome-wide survey of RAG1 and RAG2 binding using ChIP-seq. We 
have analyzed the RAG2 binding pattern in thymocytes of wild type mice 
and also in transgenic mice expressing a mutant version of RAG1 (D708A) 
that retains binding capacity but does not catalyze DNA breakage (thus 
preserving the germline configuration of sites bound by RAG proteins). We 
have found that RAG2 binds very broadly in the genome in conjunction 
with peaks of tri-methylated histone H3 lysine 4. We aim to correlate these 
maps of RAG binding to sites of oncogenic translocations that have long 
been associated with lymphoid malignancies arising from aberrant V(D)J 
recombination. 
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PLASMACYTOID DENDRITIC CELLS RESIDENT IN HUMAN 
THYMUS DRIVE NATURAL TREG CELL DEVELOPMENT 
 
María L Toribio, Enrique Martín-Gayo  
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Generation of natural regulatory T cells (nTregs) is crucial for the 
establishment of immunological self-tolerance and the prevention of 
autoimmunity. Still, the nature of nTreg precursors and the mechanisms 
governing their differentiation within the steady-state thymus are poorly 
understood, especially in humans. It has recently been shown that 
conventional dendritic cells (cDCs) resident in the human thymus are 
efficient inducers of nTreg generation in an allogeneic setting. However, the 
tolerogenic function of the major DC intrathymic subset, i.e., plasmacytoid 
DCs (pDCs) remains unknown, despite the fact that pDCs are key 
regulators of immunity and tolerance in the periphery. Here we report that, 
like cDCs, human thymic pDCs efficiently induced CD4+CD25+Foxp3+ 
nTreg cells from allogeneic CD4+CD25- single positive (SP) thymocytes, 
but in response to different signals (TSLP or CD40L plus IL-3, 
respectively). Thus activated pDCs and cDCs played non-redundant roles in 
the induction of functionally heterogeneous nTreg subsets, which displayed 
reciprocal IL-10/TGFβ expression profiles. Supporting their physiological 
relevance, activated pDCs and cDCs also induced nTreg cells from 
autologous thymocytes. Notably, pDC-primed nTreg cells selectively 
differentiated de novo from CD4+CD8+ double positive (DP) thymocytes 
undergoing positive selection (CD69hi TCRhi), which up-regulated CD40L 
upon TCR engagement, thereby promoting the activation of autologous 
pDCs. Visual proof of pDCs-nTreg contacts in the thymic medulla is 
provided in vivo, supporting the physiological relevance of pDCs in nTreg 
cell generation in the human thymus. 
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CD8+ T CELLS RESPONDING TO PULMONARY SELF-ANTIGEN 
DEMONSTRATE ALTERED PHENOTYPE AND IMPAIRED 
EFFECTOR FUNCTION 
 
Milena J Tosiek, Marcus Gereke, Dunja Bruder  
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Due to their cytotoxic potential CD8+ T lymphocytes are involved in the 
pathogenesis of many pulmonary disorders, e.g. chronic obstructive 
pulmonary disease (COPD), sarcoidosis and lymphoid interstitial 
pneumonia (LIP). However, immunological mechanisms underlying 
activation of lung-reactive CD8+ T lymphocytes and subsequently leading 
to induction or exacerbation of pulmonary disorders remain elusive to date. 
Using the transgenic SPC-HA mouse model which expresses self antigen 
(hemagglutinin, HA) exclusively in the lung epithelium, we aim to 
characterize phenotype and function of auto-reactive CD8+ T cells in the 
respiratory system. Surprisingly, naïve HA-(lung) specific CD8+ T cells 
ignored their antigen and did not expand clonally when adoptively 
transferred into SPC-HA mice. Histologically, no evidence of lung damage 
was observed. However, when pre-activated in vitro, self-reactive CD8+ T 
cells caused severe pulmonary inflammation. To investigate, which 
conditions may support in vivo activation of self-specific CD8+ T cells in 
the lung and promote their phenotypic switch towards cytotoxic effector 
cells, we combined adoptive transfers with proinflammatory stimuli. LPS 
stimulation, DC-licensing or provision of CD4+ T cell help all facilitated 
CD8+ T cell proliferation in the lung-draining lymph node but failed to 
trigger pulmonary inflammation. Phenotype and effector function of CD8+ 
T cells primed by self HA antigen (with help of CD4+ T cells) were 
compared to that of CD8+ T cells which recognize HA provided by 
influenza virus during respiratory infection. Though in both cases 
(autoimmune activation and infection) CD8+ T cells proliferated in the 
lung-draining lymph nodes, only those primed by the virus displayed 
classical effector phenotype by means of IFN-γ production and upregulation 
of activation markers (CD25, CD43). CD8+ T cells proliferating upon auto-
antigen encounter displayed only marginal expression of activation markers 
and much lower IFN-γ secretion. Thus, we demonstrate that lung-reactive 
CD8 T cells can reside quiescently in close proximity to self-antigen, 
display high priming requirements and their in vivo expansion is uncoupled 
from acquisition of effector phenotype. 
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CAMP-DEPENDENT NUCLEAR LOCALIZATION OF ICER IN 
EFFECTOR CD4+ T AND B CELLS  
 
Martin Vaeth1, Tea Gogishvili2, Tobias Bopp3, Friederike Berberich-
Siebelt1, Tim Sparwasser4, Edgar Schmitt3, Thomas Hünig2, Edgar 
Serfling1, Josef Bodor1  
 
1University of Wuerzburg, Institute of Molecular Pathology, Josef-
Schneider Str. 2, Wuerzburg, 97080, Germany, 2University of Wuerzburg, 
Institute of Immunology and Virology, Versbacher Str. 7, Würzburg, 
97080, Germany, 3University of Mainz, Institute of Immunology, Hochhaus 
am Augustusplatz, Mainz, 55131, Germany, 4 University of Hannover , 
Institute for Immunology of Infectious Disease, Carl-Neuberg Str. 1, 
Hannover, 30625, Germany 
 
High levels of cyclic adenosine monophosphate (cAMP) are typical for 
naturally occurring regulatory T (nTreg) cells and appear to contribute to 
their suppressive capacity. ICER (inducible cAMP early repressor) is a 
potent transcriptional repressor that is constitutively expressed in nuclei of 
nTreg cells. In effector CD4+ T or B cells, ICER is strongly induced by 
increasing cAMP levels followed by nuclear translocation. We show here 
that upon re-stimulation of effector CD4+ T cells by anti-CD3/CD28 
antibodies, ICER is sequestered to the cytoplasm whereas in nTreg cells its 
nuclear location remains unchanged. In two mice models we demonstrate 
that the cellular localization of ICER in effector CD4+ T cells is closely 
linked to Nuclear Factor of Activated T Cells (NFAT) – dependent IL-2 
synthesis: while depletion of nTreg cells in DEREG (“depletion of 
regulatory T cell”) mice resulted in cytosolic localization of ICER and a 
strong increase in IL-2 synthesis, direct contact between nTreg cells and 
effector CD4+ T and B cells led to cAMP infusion followed by nuclear 
accumulation of ICER. These findings suggest that nTreg cells suppress T 
cell responses by the cAMP-dependent nuclear accumulation of ICER and 
subsequent suppression of IL-2 expression. 
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ALTERED CD40 SIGNALING AND CELLULAR DISTRIBUTION IN 
EBV-INFECTED B CELLS 
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Lymphoblastic cell lines (LCLs) infected with Epstein Barr virus are 
constitutively activated through the CD40 signaling pathway through the 
expression of latent membrane-1 protein (LMP1). This protein has been 
shown to engage downstream effector pathways by binding to TRAF 
adaptor proteins 2,3 and 6 that are critical for CD40 signaling. It has 
previously been shown that signaling through CD40 in the presence of 
LMP1 can down regulate proliferation in EBV-generated LCLs. We wished 
to extend this work by asking how EBV infection in general and in 
particular LMP1 affects the signaling pathways and cellular location of 
CD40 in the infected B cell. Specifically, we found that signaling through 
CD40 results in a marked increase in NF-κB and MAPK-p38 but little to no 
increase in MAPK-JNK, ERK, PLCγ2, and Akt3. Relative to B cells 
conditionally expressing LMP1, we observe that LMP1 expression results 
in heightened phosphorylation of CD40. Additionally, past work revealed 
that both LMP1 and CD40 engages TRAFs in lipid rafts either 
constitutively (LMP1) or upon binding by CD40L. In analyzing the 
localization of CD40 in B cell lines infected with WT or recombinant EBV, 
we observed a distinct movement of CD40 to the lipid rafts in the absence 
of CD40L signals. We also observed differences in TRAF localization with 
and without CD40 signaling in the presence or absence of EBV or LMP1. 
Whether the expression of LMP1 is sufficient for this observed 
redistribution of CD40 into the lipid rafts is currently being investigated. 
These findings suggest that EBV infection alters both the phosphorylation 
status and the sub-cellular distribution of CD40 in the cell. Also, distinct 
CD40 pathways are differentiallly saturated by signals through LMP1 
suggesting differences in the overall response of B cells to LMP1 and 
CD40L. Supported by AI37081.  
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NOTCH LIGANDS REVEAL A SIGNAL STRENGTH HIERARCHY 
DURING HEMATOPOIESIS 
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Notch signaling is essential for inducing T-lineage commitment in 
hematopoietic progenitor cells. The mammalian genome encodes for 4 
Notch receptors (Notch1-4) which can be activated through interaction with 
2 serrate-like ligands (Jagged1 [Jag1] and Jagged2 [Jag2]) or 3 Delta-like 
ligands (DL-1, DL-3 and DL-4). It is clear that DL1 and DL4 can support 
early T lineage development but the role of the Jagged ligands remains 
unclear. Using the OP9 coculture system, we investigated the ability of the 
Notch ligands DL1, DL4, Jag1 and Jag2 to induce T cell commitment and 
maturation of human cord blood (CB) CD34+CD38-lin- progenitors. While 
all these ligands can bind Notch1, the most critical Notch receptor for 
inducing T-lineage commitment , our results show that the Notch ligand 
Jag2 is almost as efficient as DL1 and DL4 at initiating T cell development, 
in contrast to Jag1 which lacks this potential. However, Jag2/Notch 
signaling is less efficient in the generation of CD4+CD8+ double positive 
(DP) cells as well as in suppressing B cell differentiation. Furthermore, 
dose-dependent inhibition of Notch signaling with a gamma-secretase 
inhibitor demonstrates that B and myeloid differentiation is faster restored 
when Notch activation is induced by Jag2 compared to by Delta-like 
ligands. In contrast, Jag1/Notch signaling is not influenced by the Notch 
inhibitor. Strikingly, Fringe mediated glycosylation increases Jag2 induced 
Notch signaling in human HSC, similar as the DL ligands, but in contrast to 
expected for Serrate-like ligands. Thus, using hematopoiesis as a model 
system, our results reveal a signal strength hierarchy between the different 
Notch ligands and show important functional differences between Jag1 and 
Jag2.  
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THE NOVEL BLIMP-1 HOMOLOGUE HOBIT REGULATES THE 
MATURE POPULATION OF NKT CELLS IN THE THYMUS 
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The transcription factor Blimp-1 is expressed in T and B cells and regulates 
their terminal differentiation. Recently, we identified a novel homologue of 
Blimp-1 in T cells (Hobit) in a screen for transcription factors that are 
involved in human T cell differentiation. Hobit was strongly up-regulated in 
effector CD8 T cells as well as NK cells, indicating that it mediates 
transcriptional control of cytotoxic function.  
 
We found that the expression profile of Hobit is narrower in mice than in 
men, as expression of murine Hobit was confined to NKT cells. To further 
analyze the role of Hobit in mice, we have developed Hobit KO mice.  
 
In contrast to Blimp-1-deficient mice, formation of effector and memory T 
cells was normal in Hobit KO mice. However, within the thymus but not in 
the periphery reduced numbers of NKT cells were present in Hobit KO 
mice compared to WT mice. Hobit-dependent NKT cells were defined as 
the NK1.1highCD44high thymus-resident NKT population. Immature 
NK1.1low subsets of NKT cells were normally present within the thymus. 
This shows that Hobit transcriptionally regulates thymic retention of NKT 
cells or late stages of thymic NKT cell development.  
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IMMUNOGLOBULIN HEAVY CHAIN REGULATION THROUGH A 
KNOCKOUT MODEL  
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The immune system generates a large repertoire of antibodies to protect 
mammals from the numerous constellations of attacking pathogens. This 
diversity is achieved by genomic alterations of the IgH gene cluster, which 
include VDJ joining, class switch recombination (CSR) and somatic 
hypermutation (SHM). Such DNA modifications require tight regulation to 
ensure proper functioning of the immune system and to prevent potentially 
oncogenic processes if such modifications extend beyond the IgH locus. 
A key cis regulator of B cell specific expression of IgH genes is a large 
regulatory region that lies downstream of the IgH gene cluster (3’RR). The 
3’RR contains multiple DNaseI hypersensitive sites (hs3a, hs1,2, hs3b and 
hs4) and is required for expression and class switching of the IgH genes. A 
new extension of the 3’RR, hs5, 6 and 7, has been identified and its role in 
IgH regulation is unknown. Hs5-7 display marks of open/active chromatin 
as early as the pro-B stage of B cell development and is as cultured cell 
insulator assay, hs5 and 7 exhibit insulator activity. We hypothesize that 
hs5-7 are vital regulators of the IgH locus by impacting on the DNA 
modifications specific to the IgH locus and acting as a boundary element to 
insulate the IgH locus from neighboring, non-IgH genes.  
To test this hypothesis, I have generated a mouse knockout model. 
Preliminary data show that VDJ-joining, SHM and CSR occur in the hs5-7 
deleted mice. FISH data suggest that the hs5-7 deletion may affect aspects 
of IgH locus contraction and nuclear localization, giving rise to a 
‘molecular phenotype’. Deletion of Hs5-7 does not increase expression of 
downstream non-IgH genes, therefore, the deletion does not diminish 
insulation of the IgH locus. We are currently evaluating the hypothesis that 
hs5-7 promotes looping and regulates aspects of chromatin architecture in 
the IgH locus.  
Further elucidation of the role of hs5-7 will provide insight to mechanisms 
that regulate the IgH locus, and, in a more general sense, because hs5, 6 and 
7 are located 40-200kb away from DNA targets in the IgH gene cluster that 
they may regulate, understanding their role will elucidate aspects of long 
range gene regulation mechanisms. (Supported by NIH AI13509 and 
Immunology and Immuno Oncology Training Grant T32CA009173.) 
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Activation induced deaminase (AID) activities are differentially targeted to 
initiate, respectively, DNA double-strand breaks (DSBs) in IgH switch (S) 
regions during class switch recombination (CSR) and point mutations in the 
nearby V(D)J exons during somatic hypermutation (SHM) in germinal 
center (GC) B cells. AID can also target S regions to induce DSBs during 
CSR in the in vitro stimulated B cells but does not induce mutations in the 
adjacent V(D)J exons. It is unknown how AID activity is differentially 
regulated to induce different types of mutations or specifically target one 
region but not another within IgH locus. Here, we replace the V(D)J exon 
sequence in the endogenous IgH locus with a portion of core Sμ (cSμ) 
sequence and find that the replaced cSμ sequence, strikingly, can induce 
mutations in the in vitro activated B cells. Furthermore, the replaced cSμ 
sequence harbors much more frequent internal deletions indicative of DSBs 
generation in the position of V(D)J exon locus in GC B cells. Thus, our 
results reveal that DNA sequence plays a major role in determining the 
specificity of AID targeting.  
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LOSS OF SNAI3 ALTERS THE TRANSCRIPTIONAL PROFILE OF 
CD8+ T CELLS WHILE OVER-EXPRESSION IN HEMATOPOIETIC 
CELL LINEAGES SUPPRESSES LYMPHOCYTE DEVELOPMENT 
AND ENHANCES MYELOID LINEAGES 
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The role of the Snai3 protein in the derivation of mouse thymocytes and 
other cells of the hematopoietic system was investigated. Snai3 is highly 
expressed in skeletal and cardiac muscle, and in the thymus. Snai3 
expression in the thymus is restricted to early stages of thymocyte 
maturation and to the CD8+ T cell lineage cells in the thymus and 
periphery. Maturing thymocytes lacking Snai3 (either via a conditional 
knockout or germline deficiency) demonstrated normal thymocyte 
development and CD8+ T cell release from the thymus indicating Snai3 was 
not critical for T cell lineage development. However, gene expression array 
analysis of Snai3 knockout CD8+ T cells showed significant changes in the 
transcriptome indicating that there are specific gene targets for this 
transcription factor in T cells. Forced expression of Snai3 by retroviral 
transduction of hematopoietic stem cells demonstrated a block in lymphoid 
cell development and enhanced expansion of myeloid lineage cells. 
Analysis of Snai3 expressing hematopoietic precursor cells showed normal 
numbers of stem, myeloid, and lymphoid precursor cells, but a block in the 
development of cells committed to T and B cell lineages. 
 226 
BIFIDOBACTERIUM BIFIDUM ACTIVELY CHANGES THE GENE 
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Dendritic cells (DC) play a pivotal regulatory role in activation of the innate 
as well as the adaptive immune system by responding to environmental 
microorganisms and conducting an appropriate immune response. We have 
previously shown that individual lactic acid bacteria exert differential 
effects on DC, as some lactobacilli induce a strong production of the pro-
inflammatory cytokine IL-12, whereas bacteria of the bifidobacteria genus 
do not. In addition, bifidobacteria are able to inhibit the IL-12 production 
induced by lactobacilli. In the present study, we used genome wide 
microarrays to obtain a comprehensive view on how the two bacteria, 
Lactobacillus acidophilus NCFM and Bifidobacterium bifidum Z9, 
stimulate maturation and up-regulation of immune regulatory genes in 
murine bone marrow derived DC. L. acidophilus NCFM strongly induced a 
pro-inflammatory response including a high expression of the gene 
encoding IFN-β, multiple virus defence genes and genes related to both the 
adaptive and the innate immune response (cytokines IFN-β, IL-12, TNF-α, 
chemokines Cxcl9, Cxcl10, Cxcl11, Ccl12, etc.). Contrary, B. bifidum Z9 
induced an anti-inflammatory response and mostly up-regulated genes 
related to the innate immune response (cytokines IL-10, IL-33, chemokines 
Cxcl1, Cxcl2, Cxcl5, etc.). When DC were stimulated with both L. 
acidophilus NCFM and B. bifidum Z9 simultaneously, B. bifidum Z9 
strongly inhibited the expression of the genes initiating the adaptive 
immune response induced by L. acidophilus NCFM and significantly 
upregulated the expression of genes of the innate immune response. A 
number of genes were only induced by B. bifidum Z9 stimulation. In 
particular, the gene encoding Jun dimerization protein 2 (JDP2) was 
strongly upregulated. The use of MAPK kinase inhibitors (MAPK p38, 
JNK1/2, MEK1/2) revealed that blocking of the JNK1/2 pathway 
completely inhibited the expression of Ifn-β, and blocking of the p38 
pathway resulted in a downregulation of Ifn-β by 60%. We therefore 
suggest that B. bifidum Z9 employs an active mechanism to inhibit the 
induction of genes in DC triggering the adaptive immune system and that 
JPD2 is involved in this regulatory mechanism. 
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A subset of primary immune deficiency diseases such as Omenn syndrome, 
are associated with elevated IgE levels despite a severe reduction in 
lymphocyte numbers, but the mechanism for this is not clear. We show that 
mice with the Omenn syndrome-like hypomorphic Rag1 mutation have 
severely reduced peripheral B cells, which are skewed toward an early 
developmental phenotype. In vitro stimulation of these Rag1 hypomorphic 
B cells with anti-CD40/IL4 results in a strong class-switch preference to 
IgE. In contrast, wild-type littermate control B cells prefer switching to 
IgG1 with the same stimuli. To test whether B cell immaturity plays a role 
in IgE switch preference, early B lineage cells were prepared by developing 
wild-type fetal liver cells on IL7-producing fibroblasts. These fetal liver-
derived early B lineage cells proliferate, form blasts, and switch in response 
to anti-CD40/IL4 stimulation, similar to mature splenic B cells. However, 
the immature B cell population displays a strong preference for switching to 
IgE, similar to the hypomorphic Rag1 splenic B cells. Bone marrow B cells 
also demonstrate increased anti-CD40/IL4-induced IgE switching compared 
to more mature, splenic B cells. Additionally, mouse splenic B cells 
separated based on the immature B cell marker, AA4.1, show that B cells 
within the AA4.1-positive fraction prefer switching to IgE compared to 
cells in the more mature AA4.1-negative fraction. Moreover, splenic B cells 
from very young mice also prefer switching to IgE compared to splenic B 
cells from older mice. Quantitative real-time PCR reveals twice as much 
germline ε switch region transcript levels in anti-CD40/IL4-stimulated 
immature B cells compared to more mature B cells, despite an attenuated 
Stat6 phosphorylation in the former. We conclude that B lineage cell 
maturity influences isotype switch preference, with immature B cells 
favoring IgE. These data also suggest that peripheral B cell immaturity 
found in some types of primary immunodeficiency states due to lymphocyte 
developmental blockade may be a contributory mechanism leading to 
increased IgE levels in some of these disorders. Preliminary data suggest 
that developmentally distinct levels of Bcl6 may mediate this process. 
Ongoing studies are addressing the mechanism mediating this switch 
preference. 
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CD4+ “helper” T lymphocytes play a key role in the generation and 
maintenance of CD8+ T cell responses. CD4+ T cell help appears to operate 
through a “programming” mechanism during primary CD8+ T cell 
activation, resulting in specific patterns of gene expression. One key feature 
of this program occurs in “helpless” CD8+ T cells primed in the absence of 
CD4+ T cells, and involves the rapid induction of the pro-apoptotic 
molecule TRAIL upon restimulation that results in their subsequent death 
by activation-induced cell death (AICD). The “helped” CD8+ T cells, in 
contrast, do not induce TRAIL expression upon restimulation, and instead 
undergo a robust secondary response. We sought to understand the 
molecular events that define these disparate outcomes on the regulation of 
the TRAIL gene in CD8+ T cells by transcriptional profiling of helped 
versus helpless cells. The result of these studies reveals that TRAIL 
expression is inhibited during secondary antigenic stimulation in the helped 
CD8+ T cells through IL-2 dependent expression of the transcriptional co-
repressor/co-activator NGFI-A binding protein 2 (Nab2). These findings 
show that Nab2 acts a crucial molecular switch in the provision of CD4+ T 
cell help for secondary responses in CD8+ T cells. 
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Notch signaling promotes T and inhibits B cell differentiation. However, 
the underling mechanism remains unclear. We previously found that Notch 
induces the degradation of Janus Kinase 3 (Jak3) in B but not T cells in a 
MAP kinase-dependent manner. Given that Jak3 is essential for both B and 
T cell development, we hypothesize that Notch signaling inhibits B 
lymphopoiesis by inducing Jak3 degradation in B-linage cells. To test this 
hypothesis, we need Jak3 mutants that are insensitive to Notch-induced 
degradation but retain regulated kinase activity. Our laboratory also showed 
that Notch activates transcription of the gene encoding ankyrin-repeat 
SOCS box containing protein 2 (Asb2), capable of stimulating 
ubiquitination of several substrates including Jak3. Asb2 is known to 
associate with Cul5/ElonginB/C to form E3 ligase complexes. We have 
designed four Jak3 mutants by disrupting potential interaction with E3 
ligases (V979R and R980W) or eliminating predicted MAP kinase 
recognition sites (S985A and S1025A). These mutants were found to be 
able to phosphorylate its substrate, STAT5, upon IL-7 stimulation. Next, all 
mutants except S1025A were shown to be resistant to Asb2-induced 
ubiquitination and degradation. While the mechanism underlying Asb2-
mediated Jak3 degradation will be further investigated, suitable mutants 
will be expressed in hematopoietic cells in transgenic mice. We will 
examine B cell differentiation from transgenic progenitors in the presence 
of Notch signals. Lymphopoiesis in the bone marrow and peripheral 
lymphoid organs of these transgenic mice will be monitored to explore if 
Notch signaling plays a role in maintaining homeostasis of lymphoid 
differentiation and proliferation. 
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Asthma is considered as a chronic pulmonary inflammatory disease, 
characterized by the infiltration of eosinophils. Eotaxin-1 (CCL11) is 
secreted by lung epithelium cells and functions as the major chemokine for 
the recruitment of eosinophils. Hybrid adeno-associated virus (AAV) 
serotype 2/9, composed with AAV2 Rep and AAV9 Cap proteins, is one of 
the viral vectors that might achieve long-term gene delivery to lung 
epithelium cells. Thus, this study tested whether hybrid AAV2/9 virus 
carrying small hairpin RNA specific for CCL11, sh47 and sh137, could 
reduce eosinophilia in a mite allergen-induced asthmatic mouse model. 
Both sh47 and sh137 viruses significantly reduced CCL11 level in CCL11-
transformed NIH 3T3 cells, compared with AAV2/9, shRNA and no virus-
treated controls. We delivered 5X1011 genome copies (GC) of AAV2/9 
sh47 or sh137 viruses by intratrachea injection (IT) into Dp2 (group 2 
allergen of Dermatophagoides pteronyssinus) sensitized mice three days 
before the first challenge. The results showed that AAV2/9 sh47 and sh137 
viruses significantly reduced airway hyperresponsiveness (AHR), CCL11 
levels and eosinophilia in the lungs of Dp2-sensitized mice. Th2 cytokines, 
including IL-4, -5, and -10, were also significantly reduced in the 
bronchoalveolar lavage fluid (BALF) of AAV2/9 sh47 virus-treated mice. 
The levels of IL-4, -5, -10 and -13 were also reduced in Dp2-stimulated 
mediastinal lymphocytes of AAV2/9 sh47 and sh137 virus-treated mice. 
However, serum levels of Dp2-specific IgG1 and IgE as well as Th2 
cytokine levels in Dp2-stimulated splenocyte culture supernatants were at 
the comparable levels to the untreated group. The results suggest that 
AAV2/9 sh47 and sh137 viruses relieved local instead of systemic 
inflammatory responses. Therefore, the hybrid AAV2/9 viral vector, which 
is preferable to target lung epithelia cells, might be applied as a novel 
therapeutic approach for asthma. 
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CD4 and CD8 T cells differentiate from CD4+CD8+ double positive 
thymocytes (DP) that have received adequate intrathymic TCR signaling. 
DP thymocytes expressing MHC I-restricted TCRs mature into the CD8 
lineage, and function as cytotoxic effector cells upon antigen encounter; 
whereas thymocytes carrying MHC II-restricted TCR mature into CD4 T 
cells, which generally have helper functions. It is now clear that CD4 and 
CD8 surface protein expression, which is commonly used to track the 
emergence of CD4 or CD8 lineages, is in fact a poor indicator of early 
lineage differentiation. To escape this limitation, the current study has 
tracked expression of CD4- or CD8-lineage specific genes and defined 
histone modifications (H3K4me3 and H3K27me3) to investigate CD4-CD8 
lineage divergence in the thymus. Analysis of gene expression profiles and 
histone methylation changes revealed complex patterns with imperfect 
correlation between expression and histone methylation status. CD4- 
specific genes CD4, CD40L and Thpok were marked with H3K4me3 when 
actively transcribed, whereas they displayed heterogeneous enrichment in 
H3K27 trimethylation when they were repressed. Similar analysis were 
performed on CD8-lineage specific genes, including the use of a fluorescent 
Runx3 reporter transgene that assesses activity of both distal and proximal 
Runx3 promoters, and will be presented at the meeting. The significance of 
these observations for lineage choice mechanisms will be discussed. 
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GATA3 is crucial for the differentiation of naïve CD4 T cells into Th2 
cells. Deletion of Gata3 allowed the appearance of the IFNγ-producing cells 
in the absence of IL-12 and IFNγ. Such IFNγ production is T-bet-
independent both in vitro and in vivo. Eomes, but not T-bet expression is 
upregulated both in GATA3-deficient CD4 T cells differentiated under Th2 
conditions and in Th2 cells with enforced Runx3 expression, contributing to 
IFNγ production. GATA3 overexpression blocks Runx3-mediated Eomes 
induction and IFNγ production, and GATA3 protein physically interacts 
with Runx3 protein through its N-terminus and zinc fingers. Furthermore, 
Runx3 directly binds to multiple regulatory elements of Ifng gene and 
blockage of Runx3 function both in Th1 and GATA3-deficient “Th2” cells 
results in diminished IFNγ production by these cells. Thus, the Runx3-
mediated pathway, actively suppressed by GATA3, induces IFNγ 
production in a STAT4/T-bet-independent manner.  
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The D-type cyclins constitute an important component of the cell cycle 
engine that enables the cell proliferation program to respond to various 
physiological and pathological changes. Cell type- and developmental 
stage-specific use of the D-type cyclins has been described in certain 
situations but the cyclin D requirement during germinal center (GC) 
reaction has not been addressed. In this study, we first demonstrate that 
cyclin D3 is absent in resting follicular B cells but upregulated in GC 
centroblasts. In the spleen of Ccnd3-/- mice, a two-fold increase in marginal 
zone B cells is detected and is accompanied by a slight reduction in 
follicular B cells. Proliferation and Ig class switching of in vitro activated B 
cells are largely unperturbed by cyclin D3 deficiency. However, immunized 
Ccnd3-/- animals are profoundly impaired in GC development and in their 
T cell-dependent Ab response. In the few Ccnd3-/- GC B cells that can be 
identified, the cell cycle transition from G1 to S phase is notably delayed 
despite an apparent compensatory increase in cyclin D2 expression. Lastly, 
although cyclin D3 inactivation did not disrupt BCL6 expression in GC B 
cells, it completely blocked the GC promoting effect of BCL6 
overexpression suggesting that cyclin D3 acts downstream of BCL6 to 
regulate GC formation. This is the first demonstration that cyclin D3 plays 
an important and unique role at the GC stage of B cell development. 
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After undergoing Ig somatic hypermutation and antigen selection, germinal 
center (GC) B cells terminally differentiate into either memory or plasma 
cells (PCs). IRF4 and Blimp-1 are two transcription factors critically 
required for this process. It is also known that the NF-κB and STAT3 
signaling pathways play major roles in directing B cells to exit the germinal 
center program and to commit to plasma cell fate. It is unclear, however, 
how the B cell transcription program interprets and integrates these two 
types of T cell derived signals. The goal of this study is to define the key 
target genes of STAT3 and to understand how STAT3 and NF-κB 
collaborate to promote plasma cell differentiation. Using normal tonsilar B 
cells and a cell line-based PC differentiation system, we demonstrate that 
continued STAT3 activation is required for differentiating B cells to move 
beyond the pre-plasmablast stage, and that IRF4, a transcription factor 
involved in the early stage of PC differentiation is a direct target gene of 
STAT3. Our analysis also reveals that CD40/NF-κB synergizes with IL-
21/STAT3 by potentiating Jak/STAT3 signaling at the cytokine receptor 
level. Furthermore, STAT3 can directly transactivate Blimp-1 by binding to 
two separate regions in the human Blimp-1 locus and this effect is also 
enhanced by CD40 signaling due to its ability to relieve the suppressive 
effect of BCL6. Taken together, our study demonstrates that STAT3 
activation plays a central and unique role during the early stage of post-GC 
plasma cell differentiation. 
 235 
C101 HAS ANTI-INFLAMMATORY EFFECTS THROUGH THE 
DOWN-REGULATION OF NF-ΚB IN LPS-INDUCED RAW 264.7 
MACROPHAGE CELLS. 
 
Chang Hyeon Yun, Ji-Sun Shin, Kyung-Tae Lee  
 
Kyung-Hee University, Department of Pharmaceutical biochemistry, 
College of Pharmacy, Hoegi-Dong, Seoul, 130-701, South Korea 
 
We investigated the anti-inflammatory effects of C101, which is the 
oroxylin A derivative on lipopolysaccharide (LPS)-induced RAW 264.7 
cells. We synthesized 39 compounds containing similar structure of 
oroxylin A which is already well known having anti-inflammatory and anti-
fungal effect. We conducted MTT, nitric oxide (NO) and prostaglandin E2 
(PGE2) assay to select the most significant anti-inflammatory candidates. 
C101 is the only one compound which effects on the production of NO and 
PGE2 is significantly reduced in a dose-dependent manner. We measure 
some cytokines such as TNF-α, IL-6 and IL-1β induced by LPS was also 
markedly reduced in a dose-dependent manner. In addition, C101 
suppressed the expression of inducible nitric oxide synthase (iNOS) and 
cyclooxygenase-2 (COX-2) at the protein and iNOS, COX-2, TNF-α, IL-6 
and IL-1β at the mRNA levels. We studied NF-κB translocation because 
NF-κB plays important role as transcription factor. C101 substantially 
inhibited NF-κB p65 nuclear translocation and IκBα degradation in a dose-
dependent manner. Based on these data, we suggested that C101 inhibited 
pro-inflammatory gene expression via down-regulating NF-κB signaling 
pathway. 
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Activation induced deaminase (AID) is an enzyme required for somatic 
hypermutation (SHM) and class switch recombination (CSR), processes that 
ensure antibody maturation and expression of different immunoglobulin 
isotypes through mutation of Ig variable and switch regions. It has long 
been hypothesized that AID needs specific cofactors to initiate SHM and 
CSR. Here we show that AID physically interacts with PU.1, PAX5 and 
YY1, transcription factors that bind Ig heavy and light chain enhancers. 
Several studies demonstrated that AID is predominantly localized in the 
cytoplasm even though in order to deaminate DNA it has to be translocated 
to the nucleus. We found that overexpression of YY1, but not PU.1 or 
PAX5, led to accumulation of nuclear AID in transfected 293T cells. YY1 
conditional knock-out in activated splenic B cells interfered with CSR. 
Knock-out of YY1 did not affect B cell proliferation, transcription of the 
AID gene, or levels of various germline transcripts. Instead, we found that 
YY1 modulated levels of AID nuclear protein and thus compromised CSR. 
We show for the first time that YY1 plays a novel role in CSR by 
controlling AID nuclear protein levels. 
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Ig heavy chain (IgH) class-switch recombination (CSR) replaces the IgH Cμ 
constant region exons with one of several sets of downstream IgH constant 
region exons (e.g., Cγ, Cε, or Cα), which affects switching from IgM to 
another IgH class (e.g., IgG, IgE, or IgA). Activation induced cytidine 
deaminase (AID) initiates CSR by promoting DNA double-strand breaks 
(DSBs) within switch (S) regions flanking the donor Cμ (Sμ) and a 
downstream acceptor CH (e.g., Sγ, Sε, Sα) that are then joined to complete 
CSR. DSBs generated in Sμ frequently are joined within Sμ to form internal 
switch region deletions (ISD). AID-induced ISD and mutations have been 
considered rare in downstream S regions, suggesting that AID targeting to 
these S regions requires its prior recruitment to Sμ. We have now assayed 
for CSR and ISD in B cells lacking Sμ (Sμ−/− B cells). In Sμ−/− B cells 
activated for CSR to IgG1 and IgE, CSR to IgG1 was greatly reduced; but, 
surprisingly, CSR to IgE occurred at nearly normal levels. Moreover, 
normal B cells had substantial Sγ1 ISD and increased mutations in and near 
Sγ1, and levels of both were greatly increased in Sμ−/− B cells. Finally, Sμ−/− 
B cells underwent downstream CSR between Sγ1 and Sε on alleles that 
lacked Sμ CSR to these sequences. Our findings show that AID targets 
downstream S regions independently of CSR with Sμ and implicate an 
alternative pathway for IgE class switching that involves generation and 
joining of DSBs within two different downstream S regions before Sμ 
joining. 
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Somatic recombination of immunoglobulin or T cell antigen receptor genes 
occurs through recombination activating gene product (RAG)-mediated 
cleavage at recombination signal sequences (RSS) and subsequently, the 
broken DNA ends are repaired by non-homologous end joining (NHEJ) 
enzymes. Here, we show that RAG1, RAG2, and many NHEJ factors are 
associated with the nuclear matrix in mouse and human early B lineage 
cells and in mouse thymocytes. The core RAG1 and RAG2 proteins have 
their own nuclear matrix targeting regions. RAG-mediated double stranded 
DNA breaks at the Jκ4 RSS in murine B lineage cells or at the Dβ1 RSS in 
thymocytes can be readily detected in the nuclear matrix fraction, indicating 
that the recombination reaction is ongoing on the nuclear matrix. In the 
HEK 293 cell-based recombination system, artificial recombination 
substrates are recruited to the nuclear matrix for recombination. Moreover, 
nuclear matrix proteins purified from 293 cells expressing the core RAG 
proteins or human B lineage cells expressing endogenous RAG proteins 
support cleavage of RSS substrates in vitro. Based on these results, we 
propose that the V(D)J recombination machinery is associated with the 
nuclear matrix.  
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Epstein-Barr virus (EBV), a γ-Herpes virus infecting human B-lymphocytes 
and establishing a life-long latent infection in the host, has been associated 
with several diseases, including mononucleosis and B-cell lymphomas such 
as Hodgkin’s lymphoma and Burkitt lymphoma. EBV is also associated 
with Post-Transplant Lymphoproliferative Disorder (PTLD) and AIDS-
associated B-cell lymphoma in immunosuppressed patients. The biological 
function of the EBV latent membrane protein 1 (LMP1) is of special 
interest since LMP1 mimics constitutive CD40 signaling, transforms 
fibroblasts in vitro and increases the incidence of B cell lymphomas in 
mice. Using a system of conditional targeted gene activation, we induced 
LMP1 expression in B lineage cells in mice in vivo, and found that the 
LMP1-expressing B cells were eliminated by an immune surveillance 
mechanism, which was induced postnatally and involved T and NK cell 
activation. Interference with the immune surveillance of LMP1-expressing 
B cells resulted in a B-cell lymphoproliferative disorder resembling PTLD, 
with frequent development of B cell lymphomas. The LMP1-positive 
lymphoma cells expressed ligands for the NK cell receptor NKG2D on the 
surface and were thus targets for a novel NKG2D/Fc fusion protein, whose 
application to tumor-bearing animals resulted in dramatically reduced tumor 
growth in vivo. This work reveals a central role of LMP1 in the 
pathogenesis of PTLD and validates a promising therapeutic agent for this 
and similar diseases. 
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Recently, our lab has successfully generated a knockout mouse with 
targeted germline deletion of microRNA-146a (miR-146a). The miR-146a 
knockout mouse developed a progressive immunoproliferative phenotype 
involving multiple hematopoietic lineages, massive splenomegaly, enlarged 
lymph nodes, and eventually splenic tumors. To our knowledge, this is the 
first case that knocking out a single miRNA has led to the development of 
frank hematopoietic tumors. Histological analysis shows that some spleens 
from the older knockout mice have the characteristics of follicular 
hyperplasia, follicular lymphoma, and large-cell lymphoma morphology. 
Although the cellular lineage and molecular properties of these tumors 
haven’t been extensively characterized, some of them are likely to be of B-
cell lineage. Furthermore, B-cells isolated from knockout mouse spleen 
show increased production of inflammatory cytokines, such as IL6, and 
enhanced proliferation, over wild-type control, when stimulated with 
various toll-like receptor ligands. This shows that miR-146a is an important 
negative regulator of the inflammatory pathways, and suggests that 
increased IL6 production is at least partially responsible for the chronic 
inflammatory and hyperproliferative phenotype observed in the miR-146a 
knockout mouse. 
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Class-switch recombination (CSR) is an important event in antibody 
diversification. Prior to activation, the VDJ region in naïve B cells is 
proximal to the constant region μ (Cμ), with the other constant region genes 
located further downstream. These constant region genes are each preceded 
by a highly repetitive sequence known as the switch region. Upon 
activation, double strand breaks (DSBs) occur in these switch regions and 
repair between two different switch regions results in recombination and 
concomitant deletion of the intervening genomic sequences. This results in 
the association of the VDJ region to a new constant region gene (Cγ, Cε or 
Cα depending on the participating switch region), thereby coupling one 
antigen specificity to a broad spectrum of effector functions through these 
various isotypes.  
Defects in this process have been shown to give rise to hyper-IgM 
syndrome and dysregulated CSR has also been implicated in the 
pathogenesis of B cell lymphomas. However, this clinically important 
process has not been well characterized. In particular, the molecular 
mechanisms for the targeted generation and repair of DSBs in switch 
regions are still not fully understood. Identification of proteins localized to 
DSBs in switch regions during CSR would further our understanding of this 
process and offer insights into treatment of relevant diseases. 
For this, we have chosen to establish a reverse chromatin 
immunoprecipitation (ChIP) proteomic screen. This strategy involves 
labeling of DSBs in cells undergoing CSR with biotin, pull-down of 
biotinylated fragments of DNA, followed by identification of proteins 
associated with these labeled fragments by mass spectrometry. The strength 
of this screen lies in its unbiased approach and can thus potentially uncover 
novel proteins which play a role in CSR. At present, several proteins have 
been identified and their functions in CSR are currently being investigated. 
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The immune system must maintain a delicate balance. On the one hand, 
inflammation is required to fight harmful microorganisms, and on the other 
hand, too much inflammation can cause damage to healthy tissue. A 
complex mix of immune cells regulates this balance, including effector and 
regulatory T cells. Among effector cells, Th17 cells, characterized by the 
expression of the orphan nuclear receptor RORγt, secrete the signature 
cytokines IL-17, IL-17F, and IL-22. Th17 cells are required to clear certain 
bacterial or fungal infections at mucosal surfaces. Dysregulated Th17 
responses result in autoimmune diseases in mice and in humans. Regulatory 
T cells (Tregs), marked by the expression of Foxp3, control T cell 
responses, including Th17 cells. The balance between Th17 and Treg cells 
is influenced by the local cytokine microenvironment and is achieved 
through the concerted action of transcription factors such as RORγt and 
Foxp3. The aryl hydrocarbon receptor (AhR), a ligand-dependent 
transcription factor best known for mediating the effects of environmental 
toxins, is one of the most highly upregulated transcription factors in Th17 
cells. AhR can be activated by environmental toxins and by natural 
compounds generated by bacteria normally living in the intestines. 
Therefore, identification of a role for AhR in Th17 biology provides a 
fascinating link among environmental factors, gut microbiota, and human 
immunological diseases. The precise role for AhR in inflammation and 
chronic inflammatory disease remains to be determined. 
 
We have found that AhR can modulate the RORγt and Foxp3 balance 
thereby promoting Th17 over Treg differentiation. AhR is synergistically 
induced by the Th17 polarizing cytokines IL-6 and TGF-β, but cannot 
induce IL-22 or IL-17 expression in the absence of both RORγt and RORα 
(another member of the ROR family of transcription factors). Induction of 
Th17 cytokines, especially IL-22, requires cooperative action of AhR and 
RORγt, presumably through protein interaction. AhR inhibits Foxp3 
expression in vitro, consistent with the notion of a reciprocal relationship 
between Th17 cells and Tregs. Lack of AhR leads to impaired expression of 
the Th17 cytokine IL-22, and AhR-deficient mice are more susceptible to 
Citrobacter rodentium infection whose clearance is dependent on IL-22. We 
propose that AhR and RORγt have a differential impact on individual Th17 
cytokine expression and play an important role in gut immunity. Since AhR 
is a ligand-dependent transcription factor, modulation of AhR activity may 
offer a novel means to fine-tune the Th17-Treg balance to prevent or treat 
human diseases. 
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T-bet is the master regulator for Th1 cells. It is also expressed in CD8+ T 
cells, NK cells, NKT cells, dendritic cells and B cells. To identify and study 
T-bet-expressing cells in vivo, we generated BAC transgenic T-bet-GFP 
reporter mice in which GFP transcription is driven by DNA elements 
similar to those controlling endogenous T-bet. GFP expression, reporting 
the expression of T-bet, was detected in a subset of memory CD4+ T cells 
and all memory CD8+ T cells as well as NK and NKT cells in naïve mice. 
The CD4+GFP+ memory cells expressed T-bet mRNA while CD4+GFP- 
memory cells did not. T-bet-GFP was preferentially induced in Th1 but not 
Th2 or Th17 cultures in vitro. Toxoplasma gondii infection, eliciting Th1 
responses in vivo, dramatically induced GFP expression in both CD4+ and 
CD8+ T cells, which correlated with T-bet induction. The T-bet-reporter 
mice were then crossed onto a T-bet KO background. Both in vitro and in 
vivo experiments showed the existence of “Th1-wannabe” cells, which 
express GFP in the absence of endogenous T-bet. These “Th1-wannabe” 
cells produced little IFNγ but high levels of IL-4 correlated with GATA3 
up-regulation, implying that when T-bet is absent, a default Th2 program 
can be activated even under a strong Th1-biased environment.  
 
The work is supported by the Division of Intramural Research, National 
Institute of Allergy and Infectious Diseases, National Institutes of Health, 
USA. 
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Cell-cell interactions mediated by specific surface molecules are a general feature of 
multicellular organisms, but research in this area is hampered by the inaccessibility 
of these interactions to classical biochemical or molecular analyses. One of the best-
studied systems for cell-cell recognition involves specific T lymphocytes, whose 
antibody-like T cell receptor (TCR) molecule recognizes fragments of antigens (e.g., 
peptides) bound to major histocompatibility complex molecules on the surfaces of 
other cells. Here, we report that we are able to use bulk and single-molecule FRET 
to measure the affinity and kinetics of T cell receptor binding to peptide-MHC 
complexes within an “immunological synapse.” We find that the association rate of 
this interaction is much faster (~ 100x) than in solution, apparently because of the 
orientational congruence of the receptor and ligand on their respective membrane 
bilayers. We also find that the dissociation rate is significantly accelerated (5-10x) 
compared to solution measurements, and that this is due to an actin polymerization 
activity that accompanies synapse formation.  
 
We have also developed a photoactivatable form of the ligand to study the initiation 
of TCR binding and are working on extending this system to other T cell receptor 
systems and to include reporters for the “co-receptors” CD4 and CD8. In addition, 
we have used a high speed form of the PALM technique to demonstrate that TCRs 
congregate on specific “protein islands” prior to T cell activation and that these 
islands concatenate with islands containing the downstream adaptor molecule, LAT, 
to form signaling entities in the early stages of T cell recognition. These protein 
islands are a general feature of protein organization in the plasma membrane and are 
particularly well suited to “scanning” the surfaces of other cells for rare ligands, 
keeping unstable ligands engaged and in segregating all surface receptors from 
downstream signaling complexes until activation is initiated. 
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T cell activation requires the efficient recruitment of SLP-76 into persistent 
signaling microclusters (SLP-MC). Mutations eliminating the primary 
tyrosine phosphorylation sites within SLP-76 impair T cell activation and 
prevent the stabilization of SLP-MC. Biochemical studies have established 
that Vav1 binds directly to these sites via its SH2 domain. Here, we show 
that Vav1 enters SLP-MC, but is not appreciably enriched in distinct 
microclusters containing the T cell receptor (TCR). Using a Vav1-deficient 
T cell line (J.Vav1) and by performing knockdown/addback experiments, 
we demonstrate that Vav1 regulates the stability of SLP-MCs. The Vav1 
SH2 domain plays a crucial role in recruitment of Vav1 into SLP-MC, and 
is required for the stabilization of SLP-MC by Vav1. The C-terminal 
fragment of Vav1, which contains an SH3-SH2-SH3 cassette, is efficiently 
recruited into SLP-MC. However, this C-terminal fragment does not 
stabilize SLP-MC. Thus, N-terminal domains within Vav1 must contribute 
to the stability of SLP-MC. The N-terminus of Vav1 contains a GTP 
exchange factor (GEF) domain specific for Rho-family GTPases, and 
contributes to the initiation of calcium elevations via its N-terminal 
calponin homology (CH) domain. These effector functions are separable 
and are contingent on the recruitment of Vav1 into SLP-MC. The deletion 
of the GEF domain does not impact the recruitment of Vav1 to SLP-MC, or 
the stabilization of SLP-MC by Vav1. In contrast, a point mutation 
inactivating the GEF domain prevents the stabilization of SLP-MC by 
Vav1. We propose that the N-terminus of Vav1 contributes to microcluster 
stability via a module that is sequestered through an intramolecular 
interaction with the GEF domain, and is revealed by GEF-dependent 
conformational changes upon the recruitment of Vav1 into SLP-MCs via its 
C-terminal SH3-SH2-SH3 cassette. 
 
Work supported by grants from the American Heart Association 
(0635546T) and the NIH (R01 AI076575-01). 
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At presence most studies on the B cell antigen receptor are conducted with 
activated B cells whereas little is known about the structure and function of 
the BCR on resting B cells. By employing the bifluorescent 
complementation (BiFC) assay in S2 Schneider and in normal resting B 
cells, we have found evidence that the undisturbed BCR has an auto-
inhibited oligomeric structure. Furthermore, we have identified critical 
amino acids which are involved in auto-inhibition of the BCR and the stable 
expression of the receptor on resting B cells. This study is the first 
description of the structural requirements for the regulation of the BCR on 
resting cells. In a parallel study we have found that in resting B cells the tail 
of the Ig-α signalling subunit of the BCR is methylated on a highly 
conserved arginine by the protein arginine methyl transferase RPMT1. 
Interestingly, the arginine methylation is highest in resting B cells and 
declines after BCR activation. Therefore, this is the first protein 
modification at the BCR which is associated with the resting state of the 
receptor. By mutating this arginine to lysine we found that the BCR 
becomes more active in supporting the proliferation and preventing the 
differentiation of pre-B cells. Together, our data suggest that on resting B 
cells the B cell receptor is regulated by several layers that control its 
activation. Currently we are investigating how other proteins on the B cell 
surface are helping the BCR to maintain its resting state. 
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T cell antigen receptor (TCR) signaling initiates T cell responses by 
inducing downstream tyrosine phosphorylation dependent pathways. The 
Src family kinase Lck is the most upstream kinase in the TCR dependent 
pathway. Lck function is controlled, in part, by its phosphorylation at two 
tyrosines, Y394 in its activation loop and Y505 near its C-terminus. 
Phosphorylation of Y394, the result of trans-autophosphorylation, stabilizes 
the activated conformation of the catalytic domain. The Y505 site is 
regulated by the opposing actions by the cytosolic kinase Csk and the CD45 
receptor-like protein tyrosine phosphatase. Using an allelic series of mice 
with expression levels of 0-125% of wt CD45 levels and a genetically 
controlled inhibitor of Csk catalytic function, we have studied the relative 
requirements of CD45 and Csk during basal and induced TCR signaling. 
Our studies reveal dynamic signaling in the basal state which is subject to 
regulation by the level of the opposing activities of CD45 and Csk and 
suggest that basal signaling is subject to negative feedback control. Induced 
signaling must overcome a threshold set by Csk and is subject to be 
negatively regulated by high levels of CD45. 
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There are many different cells in the immune system. In order to mount an 
effective immune response they need to communicate with each other. One 
way in which this is done is by the formation of ‘immunological synapses’ 
between cells. The role of the immunological synapse has been 
controversial, with studies suggesting roles in both enhancing and down-
regulating signaling. Our own work has focused on the intracellular 
organization at the immune synapse. In cytotoxic T lymphocytes (CTL), we 
have found that the centrosome (which is the microtubule organizing center 
in T cells) polarizes to the cSMAC of the immune synapse, delivering the 
specialized lytic granules to the secretory domain where they release their 
contents and destroy their target. We have now begun to dissect the signals 
required for successful polarized secretion and find that centrosome and 
granule polarization are separately controlled. Our studies point to 
remarkable similarities between the structure formed at the immunological 
synapse and those formed at cilia and flagella. Our studies suggest that the 
immune synapse serves as a focal point for exocytosis and endocytosis. 
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The IL-17 receptor superfamily is unique in structure and sequence from 
other known cytokine subfamilies, and as such has a distinct profile of 
signaling mechanisms. The prototypical receptor of this family is IL-17RA, 
which is a common subunit for IL-17 and IL-17F. IL-17RA encodes a 
domain with homology to Toll-IL-1 receptors (TIR) domains, termed 
“SEFIR.” We have shown that the SEFIR domain is critical for activation of 
NF-κB, C/EBPδ and subsequent downstream signaling events. In addition, 
we have also identified an extension of this domain with homology to TIR 
BB-loops, which is also essential for signal transduction by IL-17. 
Moreover, we have defined a distal functional region within IL-17RA that 
mediates a distinct signaling pathways leading to control of the 
CCAAT/Enhancer Binding Protein (C/EBP) transcription factor, both at the 
level of alternative translation and inducible phosphorylation. The IL-17RC 
subunit is also needed for IL-17-mediated signaling and contains a 
predicted SEFIR domain, but less is known about its ability to mediate 
signaling. We have defined subregions within the IL-17RC cytoplasmic tail 
that are distinct from IL-17RA in terms of molecular function. 
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The B and T lymphocytes of the specific immune response use complex 
gene rearrangement machinery to generate a wide diversity of antigen 
receptors capable of recognizing any pathogen in the universe. Binding to 
receptors on both innate and specific immune system cells triggers intricate 
intracellular signaling pathways that lead to new gene transcription and 
effector cell activation. And yet, regulation is imposed on these responses 
so that paradise is not lost to the turning of the immune system onto self-
tissues, the spectre of autoimmunity. Lymphocyte activation requires 
multiple signals and intercellular interactions. Mechanisms exist to establish 
tolerance to self by the selection and elimination of cells recognizing self-
antigens. Immune system cell populations are reduced by programmed cell 
death once the pathogen threat is resolved. Once good health is 
reestablished, memory cells remain in the body to sharply reduce the impact 
of a second exposure to a pathogen. Over the last 15 years, our laboratory 
had been engaged in studying the molecular signaling pathways that confer 
cell survival or cell death in these lymphocytes. The special role of fas in 
germinal centre B cells survival, the function of the CARMA1/Bcl-
10/Malt1 complex in the differentiation and survival of the various subsets 
of lymphocytes, the importance of nfil3 the development of NK cells and 
the intriguing task of the vagal nerves in maintaining lymphocyte 
homeostasis will be presented.  
 
 251 
AID-INDUCED DECREASE IN TOPOISOMERASE 1 INDUCES DNA 
STRUCTURAL ALTERATION AND DNA CLEAVAGE FOR CLASS 
SWITCH RECOMBINATION 
 
Maki Kobayashi, Masatoshi Aida, Hitoshi Nagaoka, Nasim A Begum, 
Tasuku Honjo  
 
Kyoto University Graduate School of Medicine, Department of 
Immunology and Genomic Medicine, Yoshida, Sakyo-ku, Kyoto, 606-8501, 
Japan 
 
To initiate class switch recombination (CSR) activation-induced cytidine 
deaminase (AID) induces staggered nick cleavage in the S region which lies 
5’ to each immunoglobulin constant region gene and rich in palindromic 
sequences. Topoisomerase 1 (Top1) controls the supercoiling of DNA by 
nicking, rotating, and religating one strand of DNA. Curiously, Top1 
reduction or AID overexpression causes the genomic instability. Here we 
report that the inactivation of Top1 by its specific inhibitor camptothecin 
drastically blocked both the S region cleavage and CSR, indicating that 
Top1 is responsible for the S region cleavage in CSR. Surprisingly, AID 
expression suppressed Top1 mRNA translation and reduced its protein 
level. In addition, the decrease in the Top1 protein by RNA-mediated 
knockdown augmented the AID-dependent S region cleavage as well as 
CSR. Furthermore, Top1 reduction altered DNA structure of the Sμ region. 
Taken together, AID-induced Top1 reduction alters S region DNA structure 
probably to non-B form, on which Top1 can introduce nicks but cannot 
religate, resulting in S region cleavage. 
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Epstein-Barr-Virus (EBV) is endemic in the human population, where after 
clearance of an initial infection, it persists in a small population of B cells 
for life. Spreading of the virus is prevented by efficient immune 
surveillance through T and NK cells. In immunosuppressed individuals, 
such as post-transplantation or AIDS patients, immune surveillance may 
wane and severe EBV-caused pathologies develop, such as Post-Transplant 
Lymphoproliferative Syndrome (PTLD), often associated with EBV+ B cell 
lymphomas, or B cell lymphomas in AIDS patients. Burkitts lymphoma 
and, in about half of the cases, Hodgkin’s Disease are also associated with 
EBV. In attempts to model such diseases in mice, we have expressed latent 
membrane protein 1 (LMP1), an EBV-encoded protein critical for B cell 
transformation and mimicking constitutively active CD40 (a major B cell 
co-stimulatory receptor), conditionally in the B cell lineage. In the mutant 
mice, the developing LMP1+ B cells were efficiently eliminated by T and, 
likely, NK cells. Ablation of T and NK cells led to rapid death of the 
animals due to accumulation of LMP1+ B cell blasts. B cell-specific LMP1 
expression in T cell-deficient mice resulted in mild lymphoproliferation, 
rapidly followed by the development of aggressive, fatal LMP1+ B cell 
lymphomas. The lymphoma cells expressed activation-induced cytidine 
deaminase (AID) and stress antigens recognized by the activating NK cell 
receptor NKG2D. Accordingly, the in vivo growth of these tumors could be 
inhibited by a complement-binding NKG2D-Fc fusion protein. Taken 
together, we present evidence for a critical role of LMP1 in EBV immune 
surveillance and B cell transformation in vivo, and have generated a 
preclinical mouse model of LMP1-driven B lymphomagenesis under 
conditions of immunosuppression. 
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Alternative processing of the Immunoglobulin heavy chain (Igh) mRNA 
fundamentally regulates antibody production. When B cells differentiate 
into plasma cells the Igh mRNA is both alternatively processed to the 
secretory-specific form and increased in abundance; this leads to the 
production of large amounts of mature Ig protein. We recently showed that 
this shift to high levels of secretory-specific Igh mRNA production is 
accompanied by an increase in serine-5 phosphorylation of the carboxyl-
terminal domain (CTD) of RNA polymerase II near the Igh promoter. There 
is also an unexpected increase in ser-2 phosphorylation near the promoter, 
an event that increases polymerase processivity. These changes in serine 
phosphorylation of the CTD are accompanied by an increased association of 
the polyadenylation factors with the RNA pol II that is dependent on ELL2, 
a transcription elongation factor. This allows the polymerase to elongate 
more effectively, producing more mRNA per initiation cycle, and to 
increase the local concentration of polyadenylation factors, thereby 
facilitating the use of the secretory poly(A) site, to the exclusion of splicing 
to Ig membrane-specific exons (Martincic et al Nature Immunology, 2009). 
Thus transcription elongation influences RNA processing. 
We are now addressing two related questions: First, are other plasma cell 
genes affected by ELL2? We have evidence by Chromatin IP that ELL2 is 
associated with RNA pol II on essential plasma cell genes including IRF-4 
and blimp-1. There are concomitant changes in promoter-proximal CTD 
phosphorylation and histone modifications on these genes that indicate 
more efficient transcription. For IRF4 there is a shift to use of a proximal 
poly(A) site that could influence IRF4 mRNA abundance. The second issue 
is: what is the molecular mechanism leading to the increase in ser-2 
modification of the CTD? Hexim protein plus 7SK RNA sequester the 
factor that phosphorylates CTD at the ser-2 position (Cyclin T1 and cdk9, 
collectively known as pTEFb). Our results show higher levels of hexim in B 
cells which may be responsible for decreased pTEFb activation. In plasma 
cells with a paucity of hexim, splicing factors can be sequestered with the 
now available 7SK. This could lead to the decease in splicing we and others 
have seen for the Igh pre-mRNA in plasma cells. Thus changes in 
elongation can influence mRNA processing both directly at the polymerase 
by increasing polyadenylation and indirectly by squelching splicing. 
Together, these studies define a fundamental role for transcription 
elongation machinery in plasma cell differentiation. 
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Notch signaling pathways controls a variety of differentiation processes 
including several lineage decisions in lymphopoiesis, thus demanding 
versatile functions of Notch in these diverse situations. We have previously 
shown that signaling from Notch receptors accelerates ubiquitin-mediated 
degradation of several important regulators of lymphopoiesis, such as E2A 
and Janus kinases (Jak). Ubiquitination of E2A and Jak proteins has been 
known to be catalyzed by distinct E3 ubiquitin ligases, SCFSkp2 (Skp1-
Cul1-Skp2) and ECS (elongin B/C-Cul5-SOCS), respectively. How Notch 
enhances the activity of both types of E3 ligases remained to be understood. 
We have now found that Notch signaling dramatically activates the 
transcription of the ankyrin repeat and SOCS box-containing protein 2 gene 
(Asb2). Over-expression of Asb2 stimulates the ubiquitination of both E2A 
and Jak proteins whereas a dominant-negative mutant of Asb2 blocks 
Notch-induced degradation of these proteins. Furthermore, we demonstrate 
that Asb2 bridges the formation of a dimeric E3 ligase complex through 
interaction not only with elongin B/C and Cul5 via its SOCS box but also 
with Skp2, which in turns brings Skp1 and Cul1, as well as its substrates. In 
addition, Asb2 is able to associate with Jak2 with a high affinity. Together, 
these results explain how Notch signaling has significant impact on the 
turnover of different substrates. Our study helps establish a paradigm that 
biological processes can be controlled by influencing the stability of crucial 
regulators through a dimeric E3 ligase complex, which is thought to have 
higher activities based on structural studies. By shifting monomeric E3 
ligase complexes to dimeric ones through activation of Asb2 expression, 
Notch effectively exert its diverse effects on cell differentiation by 
controlling the turnover of a group of substrates previously known to be 
ubiquitination by Cul1 and Cul5-based E3 ligases. Among them, are E2A, 
SCL/Tal1, p27, IκBα and Jak2/3, which play important roles in various 
aspects of Immunobiology.  
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Mice with a homozygous point mutation in the rc3h1 gene that encodes the 
Roquin protein develop severe autoimmune disease (Vinuesa et al., 2005, 
Nature 435, 452-8). It has been shown that Roquin represses ICOS by 
promoting mRNA decay and increased ICOS expression in the mutant mice 
contributes significantly to pathology (Yu et al., 2007, Nature, 450, 299-
303).  
We investigated the molecular mechanism by which Roquin represses 
ICOS. Knockdown approaches revealed that ICOS expression is placed 
under the control of Roquin in Th1 and Th2 cells. In a deletion mutagenesis 
we identified a carboxy-terminal sequence in Roquin with a high content of 
asparagine and glutamine residues that is functionally important and 
specifies localization of Roquin to P bodies, but is not required for 
enrichment of Roquin in stress granules. Similarly, we determined that 
Roquin-mediated ICOS repression does not require the essential stress 
granule protein TIA-1, instead functionally depends on the P body 
component Rck. We genetically tested a requirement for cellular RNAi by 
using Dicer-deficient mouse embryonic fibroblasts clones, which are 
incapable of microRNA biogenesis, and by using mouse embryonic stem 
cells with gene deletion of argonaute 1-4, which are unable to form 
microRNA-induced silencing complexes (miRISC). Our data show no 
requirement for microRNAs and miRISC formation in Roquin-mediated 
ICOS repression. Instead, we demonstrate direct physical interaction of 
Roquin protein with ICOS mRNA in vitro and binding of Roquin to ICOS 
mRNA in primary T cells. Our experiments uncover a novel mode of RNA-
protein interaction, in which the amino-terminal ROQ domain cooperates 
with its adjacent zinc finger. Analyzing Roquin-interacting proteins we find 
specific and RNase-insensitive interactions of Roquin with Rck and Edc4 
proteins in mouse T cells, which are critical factors in P body-associated 
mRNA-decay. We therefore propose that Roquin prevents autoimmunity 
through interaction with ICOS mRNA and by coordinating assembly of 
functional messenger ribonucleoprotein complexes that downregulate ICOS 
expression posttranscriptionally. 
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T helper cells that produce IL-17 (Th17 cells) have recently emerged as a 
new T cell lineage. They can induce recruitment of neutrophils and trigger 
production of pro-inflammatory cytokines and chemokines by a broad range 
of cellular targets. Although these effector functions confer upon Th17 cells 
the ability to protect against certain extracellular bacteria and fungi, a dys-
regulated Th17 response can induce severe tissue destruction and 
autoimmunity. Therefore, mechanisms must be in place to shield the host 
from immune-mediated damage. The aim of this study was to investigate 
the stability and flexibility of the pro-inflammatory human Th17 subset and 
to identify factors that can modulate the cytokine profile of differentiated 
Th17 cells. We found that Th17 cells can produce IL-10, an immuno-
suppressive cytokine that confers regulatory functions. IL-10 can be 
induced in circulating CCR6+CCR4+ Th17 cell subset as well as in Th17 
clones under certain stimulatory conditions, which is accompanied by 
down-regulation of IL-17. We also found that the Th17 phenotype is subject 
to a complex modulation by other cytokines. IL-23, for example, which 
accounts for pathogenicity in the EAE mouse model by IL-10 suppression, 
promotes the regulatory Th17 phenotype in the human system by up-
regulation and maintenance of IL-10/IL-17 co-expression. This reciprocal 
regulation of pro- and anti-inflammatory cytokines might constitute a self-
regulatory mechanism that allows for self-limitation of the inflammatory 
Th17 cell response. The results of this study may have important 
implications for immune vaccination strategies and contribute to a better 
understanding of immuno-regulation in general. 
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Several gene deficiency models, including ITK, CBP, KLF2, and Id3, result 
in the development of CD8+ T cells that resemble memory cells and exhibit 
immediate effector cytokine production. Such “innate-like” CD8+ T cells 
express the transcription factor eomesodermin and have been shown to play 
an important role early in infections. We previously showed that in KLF2 
deficient mice, wild-type bystander CD8 T cells also adopt this phenotype, 
caused by high levels of IL-4 in vivo. Here we show that the source of 
increased IL-4 in KLF2 deficient mice is an expanded subset of T cells that 
express the transcription factor PLZF, including αβ NKT and γδ NKT cells. 
Indeed, in KLF2 deficient mice that also lacked PLZF, CD8+ T cells 
reverted to a normal phenotype. ITK, CBP, and Id3 deficient mice also 
display an expanded PLZF+ population that produces IL-4. Like KLF2 
deficiency, we show that the innate-like CD8+ T cell phenotype in ITK 
deficient mice is not cell-intrinsic, but dependent on overproduction of IL-4. 
Interestingly, humans and different inbred strains of mice have an expanded 
population of PLZF+ cells and a larger subset of innate-like CD8+ T cells. 
Indeed, in BALB/c mice, the innate-like CD8+ T cell population is 
dependent on IL-4. Thus we propose that PLZF+ αβ and γδ NKT cells 
regulate the population size of innate-like CD8+ T cells that rapidly produce 
cytokines early during infection. 
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Natural killer T cell (NKT cells) have an innate immunity-like rapidity of 
response and the capacity to modulate effector functions of other cells. We 
have shown that NKT cells specifically express the BTB-ZF transcriptional 
regulator PLZF. In the absence of PLZF, NKT cells developed, but lacked 
many innate T cell features. Factors that control the normal expression of 
PLZF in lymphocytes are unknown. We now have shown that PLZF 
expression is not restricted to NKT cells, but is also expressed by a subset 
of γδ T cells, functionally defining distinct subsets of this innate T cell 
population. Next, a second BTB-ZF gene, ThPOK, is shown to be important 
for the phenotype of the PLZF-expressing γδ Vγ1.1-Vδ6.3 T cells. Most 
importantly, it is shown that TCR signal strength and expression of Id3 
control the frequency of PLZF-expressing γδ T cells. Therefore, our studies 
define factors that control the propensity of the immune system to produce 
potentially disease causing T cell subsets.  
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Our laboratory’s work focuses on the signaling pathways that help govern T 
cell differentiation with an emphasis on molecules and pathways implicated 
in human genetic immune disorders and how they affect responses to 
infectious diseases. To this end, we are studying mice deficient in 
SH2D1A/SAP, mutations of which are associated with X-linked 
lymphoproliferative disease as well as mice deficient in the Tec kinases Itk, 
Rlk, Tec and Btk. SH2D1A/SAP encodes a small SH2 domain containing 
adaptor molecule that binds to the intracellular tails of receptors related to 
SLAM, including SLAM, Ly108, CD84, Ly9, and 2B4. We have found that 
mice deficient in SAP recapitulate and moreover, have revealed new 
phenotypes of XLP, including T cell hyperproliferation post-infection and 
impaired antibody responses with defective germinal center formation. Both 
SAP-deficient mice and XLP patients also fail to develop NKT cells, an 
innate-type T cell lineage. We have recently shown that SAP and SLAM 
family members are required for proper T:B lymphocyte adhesion required 
for germinal center formation. Our recent work is focused on how SAP and 
SLAM family receptors regulate distinct types of lymphocyte adhesion and 
their effects on lymphocyte development, function and homeostasis. We are 
also examining the role of the Tec kinases in T cell development and 
regulation of effector T helper cell function and cytokine production, with a 
focus on the role of TCR signaling on differential regulation of Th17 
cytokines. Together these studies provide insight into the differentiation of 
distinct T helper cell populations and how these cell populations contribute 
to the phenotypes of primary immune disorders.  
This work is supported by intramural funding of the NHGRI and NIAID, 
NIH. 
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In T lymphocytes the activation of Protein Kinase B /Akt via the p110delta 
catalytic isoform of phosphatidyl inositol 3 kinase and phosphoinositide 
dependent kinase 1 occurs in response to triggering of antigen 
receptors,cytokines and chemokines. There is a dogma that Akt controls T 
cell glucose metabolism and is thus essential for T cell survival and 
proliferation. However, experimental analysis of this concpet reveals that 
the Akt dependence of T cell metabolism and proliferation applies to some 
but not all T cell subpopulations and is dependent on the exogenous 
stimulus. For example, in cytotoxic T cells the loss of Akt function has no 
impact on cell survival or proliferation but rather co-ordinates a 
transcriptional program that causes CTL to decrease the expression of 
cytolytic effector molecules while increasing expression of adhesion 
molecules and cytokine and chemokine receptors diagnostic of memory T 
cells. Strikingly, inhibition of Akt re-programmes CTL trafficking to 
secondary lymphoid organs. PI3K and PKB/Akt are thus at the core of the 
molecular mechanisms that regulates the effector/memory fate of peripheral 
T cells but are not essential for cell survival and proliferation.  
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Upon activation, naïve CD4+ T-cells can differentiate into one out of few 
possible lineages, each invoking a specific immune response. This decision 
is influenced by the spectrum of cytokine signals the cells sense. However, 
the differentiating cells also actively alter these signals by producing 
relevant cytokines, thus influencing the differentiation process through 
extracellular feedbacks. IL-12 and IL-4 direct differentiation into the main 
fates of helper CD4+ T-cells, Th1 and Th2, respectively. This system is 
usually studied under polarized conditions, applying only one signal, 
typically together with antibodies against other cytokines thus interfering 
with intercellular communication. However, cells in vivo are expected to 
sense a more complex environment, in which they may be exposed to 
combinations of cytokines. How do cells respond under such mixed 
conditions is not well understood.  
Here, we explore differentiation under mixed input conditions by exposing 
cells to varied combinations of the two cytokines, experimentally mapping 
the "decision space" of the differentiation process. We measured, at the 
single cell level, eight key parameters relating to the state of the cells, from 
which we can deduce properties of the molecular network describing the 
system. Our data indicate that cells exposed to combinations of both IL-12 
and IL-4 give rise to a mixed response at the single cell level, with 
subpopulations of cells secreting either IFNγ, IL-4, or both upon 
restimulation. This is preceded by co-expression of the two lineage specific 
transcription factors T-bet and GATA3 at earlier time points. We build a 
mathematical model describing the system, which can reproduce our 
experimental data under specific assumptions regarding the underlying 
molecular network structure and kinetic constants. The model is extended to 
describe a multicellular system using a computational model in which each 
cell is simulated as a node on a dynamic network, whose links describe the 
propagation of intercellular cytokine signals. 
Our experiments provide information also on levels of heterogeneity in the 
population in response to mixed conditions. We find that heterogeneity in 
cytokine expression upon restimulation is much larger under mixed 
conditions than under a single cytokine input. Interestingly, the level of 
heterogeneity (or noise) of the transcription factors in the mixed state is 
much lower than that observed at the output stage. These findings support a 
model by which decision under mixed conditions follows a fuzzy logic, 
where cells project their internal state onto the output phenotype 
stochastically, with probabilities which depend on the system's input. 
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The forkhead-box O family of transcription factors (Foxos) are mammalian 
orthologs of Caenorhabditis elegans DAf16 and Drosophila melanogaster 
dFoxo with critical functions in control of ancient cellular processes such as 
nutrient sensing and stress responses. Three of the four Foxos (Foxo1, 
Foxo3, and Foxo4) are regulated via an evolutionarily conserved 
PI(3)K/Akt pathway, in which Akt activated by PI(3)K phosphorylates 
Foxos resulting in their nuclear exclusion and inactivation. Using a 
combination of genetic, genomic, and immunological approaches, we have 
started to dissect the functions of Foxos in T lymphocytes. T cell-specific 
deletion of Foxo1 gene results in compromised migration and survival of 
naïve T cells associated with defective expression of L-selection and IL-
7Rα. Functional studies validate IL-7Rα as a Foxo1 target gene essential for 
Foxo1 maintenance of naïve T cells. In addition, T cell-specific ablation of 
both Foxo1 and Foxo3 proteins triggers a fatal multifocal inflammatory 
disorder due in part to the defects of Foxp3+ regulatory T (Treg) cells. 
Foxos function in a Treg-intrinsic manner to control the expression of a 
subset of Treg-associated genes critical for Treg function. These findings 
reveal Foxos as pivotal regulators of T lymphocyte homeostasis and 
tolerance under the steady state, and suggest that the Foxo pathway may 
have been rewired to regulate highly specialized activities in the immune 
system. 
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Regulatory T (Treg) cells are required for peripheral tolerance. Recent 
evidence indicates that they can undergo specialized differentiation 
programs that in addition to Foxp3+ are controlled by other transcription 
factors, including T-bet and IRF-4.  
We and others have previously shown that the transcriptional repressor 
Blimp1 is required for the differentiation of plasma cells and short-lived 
CD8+ effector T cells. Here we demonstrate that expression of Blimp1 
defines a distinct population of Treg cells that localize predominantly to 
mucosal sites and constitute cells actively engaged in suppression. We show 
that Blimp1 is required for effector functions of Treg cells, for their correct 
tissue localization and for their homeostasis. Blimp1-deficient Treg cells 
fail to express the effector cytokine IL-10 and do not adequately regulate 
survival proteins and chemokine receptors, ultimately leading to 
accumulation and severe functional deficiencies of these cells. Our study 
illuminates some of the signals leading to Blimp1 expression in Treg cells 
and identifies molecular pathways required for effector Treg cell 
differentiation. It further demonstrates a remarkable conservation of the 
molecular requirements for the effector differentiation of different 
lymphocytic lineages. 
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Regulatory T cells (Treg) were originally discovered as immune 
suppressors critical for self-tolerance and immune homeostasis. Foxp3, an 
X-linked transcription factor highly and specifically expressed in Treg, is 
regarded as the master regulator and genetic marker for Treg cells. Treg 
cells were traditionally thought to be terminally differentiated and fully 
committed lineage specializing in immune suppression. However, 
accumulating evidence suggest that these cells have much more diverse 
functions than immune suppression. In fact, Treg cells are “plastic”, being 
able to convert into Th1, Th2, Th17 and Tfh cells to promote immune 
response. In particular, through yet-to-be-defined mechanisms, Treg cells 
become IL-4 producing Th2 cells in vivo upon the attenuation of Foxp3 
expression. Here we will discuss our recent findings on the underlying 
mechanisms of Treg-to-Th2 conversion. 
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Activation of innate immune receptors, such as the Toll-like receptors 
(TLRs), leads to induction of antimicrobial mechanisms that restrict 
pathogen growth. A lack of TLR function results in impaired host defense 
and increased susceptibility to pathogens. The host response applies strong 
selective pressure on microbial pathogens, and many virulence mechanisms 
work by subverting aspects of this innate immune response. Here we have 
examined the consequence of TLR deficiency on the replication and 
pathogenesis of the intracellular bacterial pathogen Salmonella enterica 
serovar typhimurium (S. typhimurium). Unexpectedly, we find that TLR 
function is required for S. typhimurium virulence. While mice lacking both 
TLR2 and TLR4 were highly susceptible to S. typhimurium infection, mice 
lacking additional TLRs were as resistant to infection as wildtype mice. 
Bacteria were unable to form a replicative compartment in macrophages 
lacking TLR function, and analysis of bacterial gene expression revealed a 
failure to upregulate virulence genes in these cells. Our results indicate that 
S. typhimurium requires cues from the innate immune system to regulate 
virulence gene expression and pathogenesis. This work provides a 
compelling example of host/pathogen coevolution, in which the pathogen 
has evolved virulence mechanisms whose induction depend on the very 
signals that selected their emergence. 
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Reactive oxygen species (ROS) are an essential component of the innate 
immune response against intracellular pathogens. Although ROS production 
by the phagosomal NADPH oxidase is well established, the contribution of 
mitochondrial-derived ROS (mROS) in the innate immune response and 
their interplay with phagosomal ROS remains unclear. We have found that 
engagement of Toll-like receptor 4 (TLR4) by bacterial lipopolysaccharide 
leads to increased production of mitochondrial and phagosomal ROS 
through a novel pathway. Disruption of this pathway in macrophages results 
in decreased levels of TLR4-induced ROS and reduced killing of 
intracellular bacteria. Furthermore, mitochondrially-targeted catalase 
expression results in significantly reduced ROS production and defective 
bacterial killing. Therefore TLR4 signaling activates a novel route to ROS 
production that is utilized by the innate immune system for robust 
bactericidal responses. 
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Sensors of pathogens, such as Toll-like receptors (TLRs), detect microbes 
to activate transcriptional programs that orchestrate adaptive responses to 
specific insults. Here we report that TLR4 and TLR2 specifically activate 
the ER-stress sensor kinase IRE1α and its downstream target, the 
transcription factor XBP1. Previously described XBP1 ER stress target 
genes are not induced by TLR signaling. Instead, TLR-activated XBP1 is 
required for optimal and sustained production of proinflammatory cytokines 
in macrophages. Consistent with this finding, IRE1α activation by ER-stress 
synergizes with TLR activation for cytokine production. Moreover, XBP1 
deficiency markedly increases bacterial burden in animals infected with the 
TLR2-activating human pathogen Francisella tularensis. Our findings 
uncover an unsuspected critical new function for the XBP1 transcription 
factor in mammalian host defenses. 
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NF-κB is a transcriptional activator regulating inflammation, immune 
responses, cell survival and cell cycle. Deregulation of the NF-κB is linked 
to inflammatory diseases and tumorgenesis and therefore NF-κB has 
become an important target for drug development. We are studying the 
mechanisms underlying transcription activation by NF-κB and have 
reported that NF-κB controls the re-initiation and elongation stages of 
transcription. Most recently we found that NF-κB differentially affects 
regulation by the elongation factors P-TEFb and DSIF in a manner 
dependent on core promoter type and pre-initiation complex. The 
significance and the molecular basis of this mode of regulation among NF-
κB target genes are as yet unknown. Here we report that DSIF selectively 
attenuates transcription elongation of the NF-κB negative feedback genes 
IκBα and A20. Surprisingly, inhibition of these genes by DSIF is actually 
essential for their productive protein synthesis. Investigating this apparent 
discrepancy between the effect of DSIF on mRNA and protein levels, we 
found that DSIF attenuation of elongating RNA Pol II is required for 
coordinating transcription elongation with mRNA processing. In the 
absence of DSIF large amounts of mature and immature mRNAs of IκBα 
and A20 are produced upon NF-kB induction but these mRNAs are not 
being exported into the cytoplasm. Consequenly much less IκBα and A20 
proteins are synthesized and NF-κB activity is not properly terminated. Our 
findings revealed a previously unknown interplay between NF-κB, 
transcription elongation factors and mRNA processing that operates 
selectively on NF-κB negative feedback regulatory genes. Thus, these 
results identify new targets for selective manipulation of specific subsets of 
genes in the NF-κB pathway which could be significant in NF-κB related 
diseases. 
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Th1 effector cells secrete potent proinflammatory cytokines involved in the 
induction of inflammation, apoptotic cell death and inhibition of 
tumorigenesis. Uncontrolled secretion of these leads to autoimmunity. Here 
we investigated the temporal and spatial regulation of cytokine gene 
expression in activated T-lymphocytes. Using three-dimensional DNA 
fluorescence in situ hybridization (3D-DNA FISH), we mapped the 
positions of the cytokine loci in interphase nuclei of T cells. We found that 
cytokine alleles were nonrandomly juxtaposed within the nuclear volume 
following T cell receptor (TCR) stimulation. We explored the functional 
significance of homologous associations by correlating this pairing event 
with the allelic transcription status. Our data suggests that alleles of a gene 
may cluster in the interchromosomal domain compartment, where both 
alleles are transcribed. We propose that locus repositioning and clustering 
may bring the homologous cytokines alleles into physical proximity to 
coordinate their activities and enhance the transcription output 
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Dendritic cells (DC) serve a key function in host defense, linking innate 
detection of microbes to the activation of pathogen-specific adaptive 
immune responses. Whether there is recognition of HIV-1 or other 
retroviruses by host innate pattern-recognition receptors and subsequent 
coupling to antiviral T cell responses is not yet known. DC are largely 
resistant to infection with HIV-1, due to a block in reverse transcription, but 
this host restriction can be overcome by co-infection with SIVmac 
pseudovirions. Under such conditions, HIV-1 induced maturation of 
monocyte-derived DC and peripheral blood DC, resulting in expression of 
costimulatory molecules and in a strong type- I interferon response. 
Productively infected MDDC induced potent activation of HIV-specific T 
cells. This innate response was dependent on the interaction of newly-
synthesized HIV-1 capsid (CA) with cellular cyclophilin A (CypA) and the 
subsequent activation of the transcription factor IRF3. Because the peptidyl-
prolyl isomerase CypA also interacts with CA to promote HIV-1 infectivity, 
our results suggest that CA conformation has evolved under opposing 
selective pressures to balance effective infectivity against potential 
activation of host antiviral immunity. Thus, an innate response to HIV-1 
exists, but is cryptic in the absence of dendritic cell infection. Manipulating 
this response may be essential to generate a HIV-1 vaccine. 
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The innate immune system acts as an initial line of defense against invading 
pathogens. Activation of innate immunity results in inflammation and pro-
inflammatory cytokine production, processes essential to combat pathogens. 
Uncontrolled inflammation and excess pro-inflammatory cytokine 
production are however deleterious and can lead to tissue damage and septic 
shock. As a result, negative feedback mechanisms and anti-inflammatory 
pathways are necessary to keep inflammatory signaling in check.  
Several pathways, including the ERK1/2 and p38 MAPK pathways are 
known to regulate pro-inflammatory cytokine production in innate immune 
cells. It is now apparent that these pathways also have roles in the negative 
feedback pathways controlling inflammation. MSK1 and MSK2 are nuclear 
kinases that act downstream of ERK1/2 and p38 in vivo, and their primary 
functions is to regulate the transcription of specific immediate early genes. 
We have found that these kinases regulate important negative control 
mechanisms in inflammation. MSK1/2 knockout mice are more sensitive to 
LPS induced endotoxic shock, and produce elevated levels of several pro-
inflammatory cytokines including TNF, IL-6, IL-12. MSKs do not directly 
regulate the transcription pro-inflammatory cytokine genes, but instead 
exert their effects via activating negative feedback mechanisms. For 
instance, MSKs directly regulate the transcription of the anti-inflammatory 
cytokines IL-10 and IL-1ra. The use of compound IL-10 / MSK knockouts 
has shown that the increase in IL-6 and IL-12 seen in MSK knockouts is 
mainly due to the role of MSK in regulating IL-10 production. Not all of 
MSKs effects are however IL-10 dependent, as MSKs regulate LPS induced 
TNF production in an IL-10 independent manner.  
MSKs can regulate transcription via both the phosphorylation of either 
histone H3 or transcription factors such as CREB and ATF1 and possibly 
NFκB. CREB is phosphorylated by MSKs on Ser133, which creates a 
binding site for the co-activator proteins p300 and CBP. Knockout of CREB 
in mice results in embryonic lethality, however unexpectedly we have found 
that mice with a knockin mutation of Ser133 to Ala are viable. Further 
study of these mice has shown that, similar to MSK knockouts, CREB 
Ser133Ala macrophages produce elevated levels of pro-inflammatory 
cytokines in response to TLR stimulation. Array screening has shown that 
most, but not all, of the MSK regulated genes in macrophages are also 
dependent on CREB phosphorylation. 
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Enhancers and other distant-acting cis-regulatory sequences determine 
tissue specific gene expression programs. Enhancers are marked by high 
levels of histone H3 lysine 4 mono-methylation (H3K4me1) and by binding 
of the acetyltransferase p300, which has allowed genome-wide enhancer 
identification.  However, the regulatory principles by which discrete subsets 
of enhancers become active in specific developmental and/or environmental 
contexts remain to be unraveled. Here we exploited inducible p300 binding 
to identify, and then mechanistically dissect, enhancers involved in a 
prototypical environmental response, endotoxin-stimulated inflammatory 
gene activation in macrophages.  The fundamental organizational principle 
of these enhancers is the combination of binding sites for the lineage-
restricted and constitutive Ets family member PU.1, with those for 
ubiquitous stress-inducible transcription factors such as NFkB, IRF and AP-
1. PU.1 was required for the maintenance of H3K4me1 at macrophage-
specific enhancers, independently from inflammatory stimuli. Reciprocally, 
ectopic expression of PU.1 caused re-activation of these enhancers in 
fibroblasts. Thus, the combinatorial assembly of tissue- and signal-specific 
transcription factors determines the activity of a distinct group of enhancers. 
We suggest that this may represent a general paradigm in tissue-restricted 
and stimulus-responsive gene regulation. 
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VISITOR INFORMATION 
 
EMERGENCY                CSHL                          BANBURY 
Fire (9) 742-3300 (9) 692-4747 
Ambulance (9) 742-3300 (9) 692-4747 
Poison (9) 542-2323 (9) 542-2323 
Police (9) 911 (9) 549-8800 
Safety-Security Extension 8870  
 
Emergency Room 
Huntington Hospital 
270 Park Avenue, Huntington 
631-351-2300 
(1037)  
Dentists 
Dr. William Berg 
Dr. Robert Zeman 
 
631-271-2310 
631-271-8090 
Doctor 
MediCenter 
234 W. Jericho Tpke., Huntington Station 
631-423-5400 
(1034) 
Drugs - 24 hours, 7 days 
Rite-Aid 
391 W. Main Street, Huntington 
631-549-9400 
(1039) 
Free Speed Dial 
Dial the four numbers (****) from any tan house phone to place a 
free call. 
GENERAL INFORMATION 
 
Books, Gifts, Snacks, Clothing, Newspapers 
 BOOKSTORE   367-8837 (hours posted on door) 
 Located in Grace Auditorium, lower level. 
 
Photocopiers, Journals, Periodicals, Books, Newspapers 
 Photocopying – Main Library 
 Hours:  8:00 a.m. – 9:00 p.m. Mon-Fri 
             10:00 a.m. – 6:00 p.m. Saturday 
Helpful tips - Obtain PIN from Meetings & Courses Office  
to enter Library after hours.  See Library staff for photocopier 
code. 
 
Computers, E-mail, Internet access 
 Grace Auditorium 
 Upper level: E-mail only 
 Lower level: Word processing and printing. 
 STMP server address: mail.optonline.net 
 To access your E-mail, you must know the name of your  
 home server.    
 
Dining, Bar 
 Blackford Hall 
  Breakfast  7:30–9:00, Lunch 11:30–1:30, Dinner  5:30–7:00 
  Bar  5:00 p.m. until late  
 Helpful tip - If there is a line at the upper dining area, try the  
 lower dining room 
 
 
 
Messages, Mail, Faxes 
 Message Board, Grace, lower level 
 
Swimming, Tennis, Jogging, Hiking 
June–Sept. Lifeguard on duty at the beach. 12:00 noon–6:00 p.m.  
Two tennis courts open daily. 
 
Russell Fitness Center 
 Dolan Hall, west wing, lower level 
 PIN#:  Press 64330 (then enter #) 
 
Concierge 
 On duty daily at Meetings & Courses Office. 
After hours – From tan house phones, dial x8870 for 
assistance 
  
Pay Phones, House Phones 
Grace, lower level; Cabin Complex; Blackford Hall; Dolan Hall, 
foyer  
 
CSHL’s Green Campus 
 
Cold Spring Harbor Laboratory is pledged to operate in an 
environmentally responsible fashion wherever possible.  In the past, 
we have removed underground oil tanks, remediated asbestos in 
historic buildings, and taken substantial measures to ensure the 
pristine quality of the waters of the harbor. Water used for irrigation 
comes from natural springs and wells on the property itself.  Lawns, 
trees, and planting beds are managed organically whenever possible.  
And trees are planted to replace those felled for construction 
projects.   
 
Two areas in which the Laboratory has focused recent efforts have 
been those of waste management and energy conservation.  The 
Laboratory currently recycles most waste.  Scrap metal, electronics, 
construction debris, batteries, fluorescent light bulbs, toner cartridges, 
and waste oil are all recycled.  For general waste, the Laboratory uses 
a “single stream waste management” system, removing recyclable 
materials and sending the remaining combustible trash to a 
cogeneration plant where it is burned to provide electricity, an 
approach considered among the most energy efficient, while providing 
a high yield of recyclable materials. 
 
Equal attention has been paid to energy conservation.  Most lighting 
fixtures have been replaced with high efficiency fluorescent fixtures, 
and thousands of incandescent bulbs throughout campus have been 
replaced with compact fluorescents.  The Laboratory has also 
embarked on a project that will replace all building management 
systems on campus, reducing heating and cooling costs by as much 
as twenty-five per cent. 
 
Cold Spring Harbor Laboratory continues to explore new ways in 
which we can reduce our environmental footprint, including 
encouraging our visitors and employees to use reusable containers, 
conserve energy, and suggest areas in which the Laboratory’s efforts 
can be improved. This book, for example, is printed on recycled 
paper. 
                       1-800 Access Numbers 
 
 AT&T  9-1-800-321-0288 
 MCI  9-1-800-674-7000 
 
Local Interest 
 Fish Hatchery   631-692-6768 
 Sagamore Hill   516-922-4447 
 Whaling Museum   631-367-3418 
 Heckscher Museum  631-351-3250 
 CSHL DNA Learning  x 5170 
   Center 
 
New York City 
 Helpful tip - 
 Take Syosset Taxi to Syosset Train Station 
 ($8.00 per person, 15 minute ride), then catch Long Island  
 Railroad to Penn Station (33rd Street & 7th Avenue).   
 Train ride about one hour. 
 
   TRANSPORTATION 
Limo, Taxi 
 Syosset Limousine  516-364-9681  (1031) 
 Super Shuttle  800-957-4533  (1033) 
  To head west of CSHL - Syosset train station 
  Syosset Taxi  516-921-2141  (1030) 
 To head east of CSHL - Huntington Village  
  Orange & White Taxi 631-271-3600  (1032) 
Executive Limo  631-696-8000  (1047) 
 
Trains 
 Long Island Rail Road   822-LIRR  
 Schedules available from the Meetings & Courses Office. 
 Amtrak   800-872-7245 
 MetroNorth   800-638-7646 
 New Jersey Transit  201-762-5100 
 
Ferries 
 Bridgeport / Port Jefferson 631-473-0286 (1036) 
 Orient Point/ New London 631-323-2525 (1038) 
 
Car Rentals 
 Avis   631-271-9300 
 Enterprise   631-424-8300 
 Hertz   631-427-6106 
  
Airlines 
 American   800-433-7300 
 America West  800-237-9292 
 British Airways  800-247-9297 
 Continental   800-525-0280 
 Delta   800-221-1212 
 Japan Airlines  800-525-3663 
 Jet Blue   800-538-2583 
 KLM   800-374-7747 
 Lufthansa   800-645-3880 
 Northwest   800-225-2525 
 United   800-241-6522 
 US Airways   800-428-4322 
